2025/07/01 更新

所属以外の情報はresearchmapへの登録情報を転載しています。

写真a

イナモリ マサヒコ
稲森 正彦
Masahiko Inamori
所属
医学研究科 医科学専攻 医学教育学 主任教授
医学部 医学科
職名
主任教授
プロフィール
「次世代の医師の教育はどうあるべきか」をテーマに,基礎から臨床にわたる行動情報科学分野に類する幅広い研究を行っています.
外部リンク

学位

  • 医学博士 ( 横浜市立大学 )

研究キーワード

  • 消化器内視鏡

  • 医学教育学

  • Gastroenterology

  • 消化器病学

研究分野

  • ライフサイエンス / 消化器内科学

  • ライフサイエンス / 内科学一般

学歴

  • 横浜市立大学   医学研究科   消化器内科

    - 2003年

      詳細を見る

    国名: 日本国

    researchmap

  • 横浜市立大学

    - 2003年

      詳細を見る

  • 横浜市立大学   医学部   医学部

    - 1996年

      詳細を見る

    国名: 日本国

    researchmap

  • 横浜市立大学

    - 1996年

      詳細を見る

所属学協会

▼全件表示

委員歴

  • 日本消化器内視鏡学会   関東地方会評議員  

      詳細を見る

    団体区分:学協会

    日本消化器内視鏡学会

    researchmap

  • 日本消化器内視鏡学会   学会評議員  

      詳細を見る

    団体区分:学協会

    researchmap

  • 日本平滑筋学会   評議員  

      詳細を見る

    団体区分:学協会

    researchmap

  • 日本消化管学会   評議員  

      詳細を見る

    団体区分:学協会

    日本消化管学会

    researchmap

  • 日本消化器病学会   学会評議員  

      詳細を見る

    団体区分:学協会

    researchmap

論文

  • 早期医療体験実習における行政、福祉現場との連携教育実践

    飯田 洋, 岩田 悠里, 西村 謙一, 藤田 浩司, 日下部 明彦, 太田 光泰, 稲森 正彦

    医学教育   55 ( Suppl. )   294 - 294   2024年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 急性疾患後の摂食嚥下障害患者に関する退院90日後経口摂取回復の予測因子

    西口 翔, 秋山 美代, 菅谷 渚, 稲森 正彦

    日本老年医学会雑誌   61 ( Suppl. )   117 - 117   2024年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本老年医学会  

    researchmap

  • Correction: Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.

    Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tatsuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike

    Journal of gastroenterology   58 ( 11 )   1165 - 1165   2023年11月

     詳細を見る

  • Identifying the unmet physical and psychological intimacy and sexual needs of partners of patients with terminal cancer. 国際誌

    Akihiko Kusakabe, Hironori Mawatari, Kazue Hirano, Mitsuyasu Ohta, Masahiko Inamori, Tatsuya Morita

    The journal of sexual medicine   20 ( 11 )   1312 - 1318   2023年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Palliative care aims to improve the quality of life of patients who are terminally ill, but support for the sexuality of these patients is often inadequate. AIM: To identify factors related to the unmet needs of bereaved partners whose significant others died of cancer during hospitalization. METHODS: Bereaved individuals in Japan aged >50 years who had lost their partners to cancer in a hospital in the last 5 years answered a questionnaire on the support desired for "time to nurture love with your partner." OUTCOMES: We used 3 sexual questions in the 34-item Supportive Care Needs Survey-Short Form (SCNS-SF34) and measured the unmet needs of partners of patients with terminal cancer. RESULTS: We obtained 290 responses (equal number of males and females). Respondents' age distribution was as follows: 50 to 59 years, 34.8%; 60 to 69 years, 44.5%; 70 to 79 years, 19.3%; ≥80 years, 1.4%. In total, 81% had children. Most partners died in the general ward (59.3%). Frequency of time to nurture love with one's partner before the illness was as follows: none at all, 44 (15.2%); very little, 84 (29.0%); once in a while, 76 (26.2%); occasionally, 45 (15.5%); and often, 41 (14.1%). Roughly 20% of participants reported experiencing unmet sexual needs across all 3 selected questions in the SCNS-SF34. Multivariate analysis showed that younger age (P = .00097) and a higher frequency of time to nurture love with one's partner before illness (P = .004) were positively associated with unmet needs for sexuality during hospitalization. CLINICAL IMPLICATIONS: The study may help health care workers identify patients who are seeking sexual support. STRENGTHS AND LIMITATIONS: This study identified the unmet needs and underlying factors regarding sexuality during hospitalization for partners of patients with terminal cancer. However, differences by cancer type could not be analyzed. Additionally, the modified version of the supportive care needs measure used in this study (SCNS-SF34) may have decreased validity owing to the alterations made for its use. CONCLUSION: Some hospitalized patients with terminal cancer could need support for time to nurture love with their partners. Health care providers can play a crucial role by anticipating the needs of patients, preparing them mentally, and offering counseling and information to help them maintain an intimate connection with their loved ones.

    DOI: 10.1093/jsxmed/qdad116

    PubMed

    researchmap

  • 急性疾患後の摂食嚥下障害患者の90日後転帰

    西口 翔, 菅谷 渚, 秋山 美代, 稲森 正彦

    日本老年医学会雑誌   60 ( Suppl. )   197 - 197   2023年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本老年医学会  

    researchmap

  • 終末期がん患者のパートナーの最期の入院における「パートナーとの愛を育む時間」についてのアンメットニーズの検討(第二報)

    日下部 明彦, 馬渡 弘典, 平野 和恵, 太田 光泰, 稲森 正彦, 森田 達也

    Palliative Care Research   17 ( Suppl. )   S.302 - S.302   2022年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本緩和医療学会  

    researchmap

  • Effects of Electrocardiographic Monitoring Education on Nurses’ Confidence and Psychological Stress: An Online Cross-Sectional Survey in Japan

    Sho Nishiguchi, Nagisa Sugaya, Yusuke Saigusa, Michinori Mayama, Takuhiro Moromizato, Masahiko Inamori, Yasuharu Tokuda, Takashi Watari

    International Journal of Environmental Research and Public Health   19 ( 8 )   2022年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    We aimed to investigate the association between nurses’ electrocardiographic (ECG) monitoring education and their confidence and psychological stress regarding ECG monitoring. In 2019, a web-based cross-sectional study was conducted among Japanese nurses. A multivariable logistic regression analysis was performed to evaluate the effects of education on nurses’ confidence and psychological stress regarding ECG monitoring. In total, 1652 nurses were included in the study. Factors significantly associated with nurses’ confidence were post-graduate education experience (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.6–3.6), ≥11 post-graduate years (OR, 2.2; 95% CI, 1.5–3.1), male gender (OR, 4.4; 95% CI, 2.9–6.6), ≥5 helpful experiences with ECG monitoring (OR, 10.7; 95% CI, 6.0–19.1), work experience in an intensive care unit (OR, 2.3; 95% CI, 1.5–3.7), and work experience in a cardiology department (OR, 1.7; 95% CI, 1.2–2.4). Factors significantly associated with nurses’ psychological stress were male gender (OR, 1.9; 95% CI, 1.2–2.9), ≥5 helpful experiences with ECG monitoring (OR, 1.9; 95% CI, 1.2–2.9), and work experience in an emergency room (OR, 2.4; 95% CI, 1.3–4.8). These results suggest that nurses’ post-graduate ECG monitoring education enhanced their confidence, but did not reduce psychological stress regarding ECG monitoring.

    DOI: 10.3390/ijerph19084742

    Scopus

    PubMed

    researchmap

  • 薬剤師を地域在宅緩和ケアに参画させることへの期待と問題点

    奈良 健, 日下部 明彦, 稲森 正彦, 飯田 洋, 宮崎 百合, 中里 裕之, 太田 光泰

    横浜医学   72 ( 4 )   503 - 511   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    がんなどの重い疾病を抱えた患者の住み慣れた自宅などの望む療養場所でつらい症状なく過ごすことが出来る支援を行うことが在宅緩和ケアの目標のひとつである.在宅緩和ケアに医療用麻薬などの症状緩和目的の薬剤は病院内と同様に必要であり,これらの薬剤を患者の元に届ける在宅訪問薬剤師は在宅緩和ケアの推進に不可欠な存在だと考えられる.しかし,実際には地域において医療用麻薬を扱う薬局は少なく,在宅医療に関わる訪問薬剤師の数は十分ではないと考えられている.そこで在宅医療の現場における,訪問薬剤師の印象と期待を聞き取り,今後の課題を考察した.医療,介護,教育,行政の各職種と地域住民などに対して,調査者と回答者が1対1で対面して聴取を行う個人面接を行って口頭データを収集し,インタヴュー形式による質的研究を行った.その結果,訪問薬剤師とその拠点となる保険薬局が在宅での終末期がん緩和ケアに対する医療資源になりうる事を認識している人が少ないなどの問題が明らかになった.在宅訪問薬剤師が在宅緩和医療に参画していくためには,患者にとっての生活の場である自宅と病院内との環境の違いを理解し,また在宅緩和ケアの一般的な在宅医療との相違点を理解し,それらに即した適切な業務を行っていくことが求められていると考えられた.(著者抄録)

    researchmap

    その他リンク: https://search-tp.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2021&ichushi_jid=J01499&link_issn=&doc_id=20211224360003&doc_link_id=http%3A%2F%2Fid.nii.ac.jp%2F1246%2F00002196%2F&url=http%3A%2F%2Fid.nii.ac.jp%2F1246%2F00002196%2F&type=%89%A1%95l%8Es%97%A7%91%E5%8Aw%81F%89%A1%95l%8Es%97%A7%91%E5%8Aw%8Aw%8Fp%8B%40%8A%D6%83%8A%83%7C%83W%83g%83%8A&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F80205_3.gif

  • Positioning of Bristol Stool Form Scale type 3 in constipation treatment satisfaction: A multicenter study in Japan

    Eiji Yamada, Seishi Tsunoda, Masumi Mimura, Masashi Akizuki, Yoichiro Miyazawa, Toshihiro Yamazaki, Yasuhiko Nagano, Reiko Murakami, Takashi Kitahara, Junichi Wakasugi, Yukihiro Ozawa, Tatsuji Komatsu, Masahiko Inamori, Kazuki Nagai, Atsushi Nakajima

    Journal of Gastroenterology and Hepatology (Australia)   36 ( 8 )   2125 - 2130   2021年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:John Wiley and Sons Inc  

    Background and Aim: Many patients are not satisfied with chronic constipation (CC) treatments. The aim of this study was to identify factors linked to CC treatment satisfaction or dissatisfaction. Methods: Our study population included patients who received CC treatment at a clinic or hospital. CC was diagnosed by a physician based on the patient's complaint. Treatment satisfaction was evaluated using the 28th question of the Patient Assessment of Constipation Quality of Life questionnaire. Results: We conducted this study at 28 facilities. We included 167 patients (mean age 66.7 ± 15.2 years, male:female ratio is 1:3.07). Sixty-eight (40.7%) of patients were satisfied with their constipation treatment. Treatment dissatisfaction of CC was significantly associated with frequency of bowel movement &lt
    3/week (odds ratio [OR] = 0.376, 95% confidence interval [CI]: 0.156–0.904, P = 0.029) or Bristol Stool Form Scale (BSFS) type 3 (OR = 0.401, 95% CI: 0.170–0.946, P = 0.037). Conclusions: Our study showed that CC patients with BSFS type3 were not satisfied with constipation treatment. In general, BSFS types 3–5 are defined as normal stools. Therefore, BSFS type 3 may be set as a treatment goal even though the patient is not satisfied. The pathophysiology of CC differs by region and patient background. Therefore, parameters used to define successful treatment will be different by patient or region. We should reconsider the positioning of BSFS type 3 to improve treatment satisfaction for CC.

    DOI: 10.1111/jgh.15428

    Scopus

    PubMed

    researchmap

  • 医師が知っておくとよい高齢者施設「特別養護老人ホーム」の"看取り介護"とは?

    西口 翔, 菅谷 渚, 稲森 正彦

    プライマリ・ケア   6 ( 3 )   74 - 75   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本プライマリ・ケア連合学会  

    researchmap

  • 終末期がん患者の「パートナーとの愛を育む時間」についての遺族調査

    日下部 明彦, 馬渡 弘典, 平野 和恵, 岡本 宗一郎, 結束 貴臣, 吉見 明香, 稲森 正彦, 太田 光泰, 森田 達也

    Palliative Care Research   16 ( Suppl. )   S289 - S289   2021年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本緩和医療学会  

    researchmap

  • Effect of interprofessional collaboration among nursing home professionals on end-of-life care in nursing homes.

    Sho Nishiguchi, Nagisa Sugaya, Yusuke Saigusa, Masahiko Inamori

    Drug discoveries & therapeutics   15 ( 2 )   93 - 100   2021年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    As end-of-life (EOL) care in nursing homes is gradually increasing, interprofessional collaboration in EOL care in nursing homes is becoming important. However, a method for measuring interprofessional collaboration has not been established. Therefore, this study aimed to clarify the effect of interprofessional collaboration on EOL care in nursing homes. Questionnaires were mailed to the facility directors of 378 nursing homes in Kanagawa Prefecture, Japan, and distributed to nurses, care managers, and professional caregivers. Three professionals from each nursing home completed the same questionnaire, which included 9 items on EOL care: shared facility policy, residents' wishes, each professional's roles, person in charge of the facility, residents' conditions, mental status of residents' families, emergency codes, residents' key people, and sufficient discussion among professionals. Based on the professionals' responses, interprofessional collaboration was assessed. We used multivariable analysis, with interprofessional collaboration as an independent factor. The outcome was the amount of EOL care in the nursing home. A total of 180 (47.6%) nursing homes participated. Multivariable analysis showed that interprofessional collaboration (beta [β] coefficient 2.5, 95% confidence interval [CI] 0.45-4.48; p = 0.017), availability of EOL care bonuses (β coefficient 4.4, 95% CI 1.41-7.38; p = 0.004), physician support for emergency care during off time (β coefficient 5.4, 95% CI 1.86-8.94; p = 0.003), and EOL care conferences (β coefficient 4.1, 95% CI 1.19-6.99; p = 0.006) were significant factors associated with the amount of EOL care in the nursing homes. We found evidence in the adjusted model that interprofessional collaboration among facility professionals is effective for EOL care in nursing homes.

    DOI: 10.5582/ddt.2021.01030

    PubMed

    researchmap

  • [Not Available].

    Megumi Kaai, Masahiko Inamori, Mizue Matsuura, Yuri Iwata, Hiroshi Iida, Koji Fujita, Akihiko Kusakabe, Atsushi Nakajima

    Journal of clinical biochemistry and nutrition   68 ( 3 )   264 - 267   2021年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The effects of acotiamide on gastrointestinal motility have not been sufficiently investigated. The aim of this study was to determine whether single preprandial acotiamide or mosapride intake might affect the gastric emptying rate using the 13C breath test. Here, 11 healthy volunteers participated in a randomized three-way crossover study. The subjects received acotiamide (100 mg) or mosapride (5 mg) or placebo before liquid test meal ingestion. Gastric emptying was estimated by determining following parameters: the time required for 50% emptying of the labeled meal (T1/2), lag time for 10% emptying of the labeled meal (Tlag), gastric emptying coefficient (GEC) and regression-estimated constants (β and κ). These parameters were calculated from a 13CO2 breath excretion curve using conventional formulas. The acotiamide, mosapride and placebo conditions were compared, revealing that for gastric emptying rates (values expressed as median), T1/2 (87.83571 min vs 79.95057 min vs 88.74378 min, p = 0.1496), Tlag (46.36449 min vs 42.2897 min vs 47.08094 min, p = 0.4966), GEC (4.382027 vs 4.211441 vs 4.248495, p = 0.8858), β (1.917728 vs 1.757062 vs 1.869141, p = 0.4066) and κ (0.834051 vs 0.819820 vs 0.789523, p = 0.1225) did not significantly differ. In this study, acotiamide (100 mg) or mosapride (5 mg) had no effect on gastric emptying.

    DOI: 10.3164/jcbn.20-162

    PubMed

    researchmap

  • Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.

    Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tastuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike

    Journal of gastroenterology   56 ( 3 )   193 - 217   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Managing irritable bowel syndrome (IBS) has attracted international attention because single-agent therapy rarely relieves bothersome symptoms for all patients. The Japanese Society of Gastroenterology (JSGE) published the first edition of evidence-based clinical practice guidelines for IBS in 2015. Much more evidence has accumulated since then, and new pharmacological agents and non-pharmacological methods have been developed. Here, we report the second edition of the JSGE-IBS guidelines comprising 41 questions including 12 background questions on epidemiology, pathophysiology, and diagnostic criteria, 26 clinical questions on diagnosis and treatment, and 3 questions on future research. For each question, statements with or without recommendations and/or evidence level are given and updated diagnostic and therapeutic algorithms are provided based on new evidence. Algorithms for diagnosis are requisite for patients with chronic abdominal pain or associated symptoms and/or abnormal bowel movement. Colonoscopy is indicated for patients with one or more alarm symptoms/signs, risk factors, and/or abnormal routine examination results. The diagnosis is based on the Rome IV criteria. Step 1 therapy consists of diet therapy, behavioral modification, and gut-targeted pharmacotherapy for 4 weeks. For non-responders, management proceeds to step 2 therapy, which includes a combination of different mechanistic gut-targeted agents and/or psychopharmacological agents and basic psychotherapy for 4 weeks. Step 3 therapy is for non-responders to step 2 and comprises a combination of gut-targeted pharmacotherapy, psychopharmacological treatments, and/or specific psychotherapy. These updated JSGE-IBS guidelines present best practice strategies for IBS patients in Japan and we believe these core strategies can be useful for IBS diagnosis and treatment globally.

    DOI: 10.1007/s00535-020-01746-z

    PubMed

    researchmap

  • 終末期がん患者のセクシュアリティ 「パートナーとの愛を育む時間」に対する緩和ケア病棟の看護師の認識、感情、支援への行動意図と実践経験についての実態調査

    日下部 明彦, 馬渡 弘典, 平野 和恵, 田辺 公一, 渡邉 眞理, 結束 貴臣, 吉見 明香, 太田 光泰, 稲森 正彦, 高橋 都, 森田 達也

    Palliative Care Research   16 ( 2 )   153 - 162   2021年

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本緩和医療学会  

    【目的】終末期がん患者のセクシュアリティへの支援に対する看護師の現状を明らかにする.【方法】2018年12月に神奈川県内緩和ケア病棟18施設の看護師313名を対象に終末期がん患者の「パートナーとの愛を育む時間」に対する認識,感情,支援への行動意図と実践について質問紙調査を行った.【結果】165名中(回収率52.7%)「パートナーとの愛を育む時間」への支援経験があるのは82名(49.7%)であった.行ったことのある具体的な支援内容は「スキンシップを勧める」,「傾聴」,「ハグを勧める」,「入室の際に,ノックや声掛け後に返事を待つなど十分な時間をとる」が多かった.一方,病棟カンファレンスで「パートナーとの愛を育む時間」について話したことがあるのは11名(6.7%)であった.【結論】現状,「パートナーとの愛を育む時間」への支援は個人に任され,組織的には行われていないことが示唆された.(著者抄録)

    researchmap

  • Early effects of acotiamide or mosapride intake on gastric emptying: A randomized 3-way crossover study using the 13C breath test

    Megumi Kaai, Masahiko Inamori, Mizue Matsuura, Yuri Iwata, Hiroshi Iida, Koji Fujita, Akihiko Kusakabe, Atsushi Nakajima

    Journal of Clinical Biochemistry and Nutrition   68 ( 3 )   264 - 267   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:The Society for Free Radical Research Japan  

    The effects of acotiamide on gastrointestinal motility have not been sufficiently investigated. The aim of this study was to determine whether single preprandial acotiamide or mosapride intake might affect the gastric emptying rate using the 13C breath test. Here, 11 healthy volunteers participated in a randomized three-way crossover study. The subjects received acotiamide (100 mg) or mosapride (5 mg) or placebo before liquid test meal ingestion. Gastric emptying was estimated by determining following parameters: the time required for 50% emptying of the labeled meal (T1/2), lag time for 10% emptying of the labeled meal (Tlag), gastric emptying coefficient (GEC) and regression-estimated constants (β and κ). These parameters were calculated from a 13CO2 breath excretion curve using conventional formulas. The acotiamide, mosapride and placebo conditions were compared, revealing that for gastric emptying rates (values expressed as median), T1/2 (87.83571 min vs 79.95057 min vs 88.74378 min, p = 0.1496), Tlag (46.36449 min vs 42.2897 min vs 47.08094 min, p = 0.4966), GEC (4.382027 vs 4.211441 vs 4.248495, p = 0.8858), β (1.917728 vs 1.757062 vs 1.869141, p = 0.4066) and κ (0.834051 vs 0.819820 vs 0.789523, p = 0.1225) did not significantly differ. In this study, acotiamide (100 mg) or mosapride (5 mg) had no effect on gastric emptying.

    DOI: 10.3164/JCBN.20-162

    Scopus

    researchmap

  • 卒後教育として内科医に行う、実技指導を交えた小外科講義の教育効果

    袴田 智伸, 國司 洋佑, 吉江 浩一郎, 福澤 邦康, 岩田 悠里, 稲森 正彦, 日下部 明彦, 太田 光泰

    地域医学   34 ( 12 )   1014 - 1019   2020年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)地域医療振興協会  

    目的:内科医に短時間の実技を交えた小外科講義を行うことで、プライマリ・ケア医に求められる小外科診療が可能となるか調査した。到達目標は「資料を確認すれば単独診療可能」とした。方法:病院勤務内科医14人を対象とした。平日夕方に1人の外科指導医が指切創、熱傷、四肢打撲の3つのテーマについて実技指導を交えた1時間程度の講義を行った。講義開始前、終了直後、終了3〜6ヵ月後の3回、診断、治療、後対応、総合評価の4項目について4段階の習熟度自己評価を行った。「資料を確認すれば単独診療可能」を3点に設定し、講義の短期・長期効果を評価した。結果:講義への参加者は指切創10人、熱傷11人、四肢打撲10人であった。全テーマ、全項目において、終了直後、終了3〜6ヵ月後の平均点は有意に上昇した。しかし、四肢打撲については全評価項目いずれも平均3点未満であった。結論:内科医に対する実技を交えた小外科講義には一定の効果が示唆されたが、四肢打撲の教育効果は限定的であった。(著者抄録)

    researchmap

  • "Guidebook on Doctors' Behaviors for Death Diagnosis Created by Community Healthcare Providers" Changed Residents' Mind for Death Diagnosis. 国際誌

    Akihiko Kusakabe, Jyunko Nozato, Kazue Hirano, Naohiro Saitou, Keiko Ikenaga, Hukiko Mikan, Takaomi Kessoku, Tetuya Matuura, Asuka Yoshimi, Hironori Mawatari, Akemi Naito, Masato Okita, Mitsuyasu Ohta, Tatsuya Morita, Masahiko Inamori

    Journal of palliative care   825859720951698 - 825859720951698   2020年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Education regarding death diagnosis is not often included in the medical education. OBJECTIVE: To investigate the change minds at the time of death diagnosis among residents after lectures based on our guidebook. DESIGN: Uncontrolled, open-label, multi-center trial. SUBJECTS: A total of 131 doctors undergoing their initial training were enrolled this study. MEASUREMENTS: Questionnaires were administered to volunteers before and after the lecture by the clinical training instructor presented information regarding doctors' behaviors at the death diagnosis based on our guidebook at each hospital. RESULTS: The subjects had an average age of 27.1 years and comprised 76 men (58.0%) and 54 women (41.2%). A total of 83 subjects (63.4%) had learned how to diagnose death as medical students, and 52 subjects (39.7%) had experienced death diagnosis scenes as medical students. Among those who had difficulties related to death diagnoses, the highest number (88.4%) indicated that "I do not know what to say to the family after a death diagnosis". Self-evaluation significantly increased after the lecture for many items concerning explanations to and considerations of the family: the effect size for "Give words of comfort and encouragement to family" increased significantly after the lecture to 0.9. CONCLUSIONS: Few of the residents felt that they had received education regarding death diagnoses; they reported difficulties with diagnosing death and responding to patients' families. After the lecture using our guidebook, residents' mind changed significantly for death diagnosis, suggesting that the guidebook at the time of death diagnosis may be useful.

    DOI: 10.1177/0825859720951698

    PubMed

    researchmap

  • 医学部1年生に対する早期医療体験実習の学習者評価に関する検討(第2報)

    飯田 洋, 岩田 悠里, 藤田 浩司, 日下部 明彦, 太田 光泰, 西巻 滋, 稲森 正彦

    医学教育   51 ( Suppl. )   240 - 240   2020年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 終末期がん患者の「パートナーとの愛を育む時間」に対するまなざしと支援 緩和ケア病棟看護師を対象とした実態調査

    日下部 明彦, 馬渡 弘典, 平野 和恵, 渡邉 眞理, 結束 貴臣, 吉見 明香, 田辺 公一, 稲森 正彦, 森田 達也, 太田 光泰

    日本在宅医療連合学会大会プログラム・講演抄録集   2回   295 - 295   2020年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本在宅医療連合学会  

    researchmap

  • “Guidebook on Doctors’ Behaviors for Death Diagnosis Created by Community Healthcare Providers” Changed Residents’ Mind for Death Diagnosis

    Akihiko Kusakabe, Jyunko Nozato, Kazue Hirano, Naohiro Saitou, Keiko Ikenaga, Hukiko Mikan, Takaomi Kessoku, Tetuya Matuura, Asuka Yoshimi, Hironori Mawatari, Akemi Naito, Masato Okita, Mitsuyasu Ohta, Tatsuya Morita, Masahiko Inamori

    Journal of Palliative Care   2020年

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    © The Author(s) 2020. Background: Education regarding death diagnosis is not often included in the medical education. Objective: To investigate the change minds at the time of death diagnosis among residents after lectures based on our guidebook. Design: Uncontrolled, open-label, multi-center trial. Subjects: A total of 131 doctors undergoing their initial training were enrolled this study. Measurements: Questionnaires were administered to volunteers before and after the lecture by the clinical training instructor presented information regarding doctors’ behaviors at the death diagnosis based on our guidebook at each hospital. Results: The subjects had an average age of 27.1 years and comprised 76 men (58.0%) and 54 women (41.2%). A total of 83 subjects (63.4%) had learned how to diagnose death as medical students, and 52 subjects (39.7%) had experienced death diagnosis scenes as medical students. Among those who had difficulties related to death diagnoses, the highest number (88.4%) indicated that “I do not know what to say to the family after a death diagnosis”. Self-evaluation significantly increased after the lecture for many items concerning explanations to and considerations of the family: the effect size for “Give words of comfort and encouragement to family” increased significantly after the lecture to 0.9. Conclusions: Few of the residents felt that they had received education regarding death diagnoses; they reported difficulties with diagnosing death and responding to patients’ families. After the lecture using our guidebook, residents’ mind changed significantly for death diagnosis, suggesting that the guidebook at the time of death diagnosis may be useful.

    DOI: 10.1177/0825859720951698

    Scopus

    researchmap

  • Comparison of computed tomography findings with clinical risks factors for endoscopic therapy in upper gastrointestinal bleeding cases.

    Fumitake Jono, Hiroshi Iida, Koji Fujita, Megumi Kaai, Kenji Kanoshima, Kanji Ohkuma, Takashi Nonaka, Tomonori Ida, Akihiko Kusakabe, Atsushi Nakamura, Shigeru Koyama, Atsushi Nakajima, Masahiko Inamori

    Journal of clinical biochemistry and nutrition   65 ( 2 )   138 - 145   2019年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Several risk scoring systems exist for acute upper gastrointestinal bleeding (UGIB). The clinical Rockall score (clinical RS) and the Glasgow-Blatchford score (GBS) are major risk scores that consider only clinical data. Computed tomography (CT) findings are equivocal in non-variceal UGIB. We compared CT findings with clinical data to predict mortality, rebleeding and need for endoscopic therapy in non-variceal UGIB patients. This retrospective, single-center study included 386 patients admitted to our emergency department with diagnosis of non-variceal UGIB by urgent endoscopy between January 2009 and March 2015. Multivariable logistic regression analysis was used to investigate CT findings and risk factors derived from clinical data. CT findings could not significantly predict mortality and rebleeding in non-variceal UGIB patients. However, upper gastrointestinal hemorrhage in CT findings better predicted the need for endoscopic therapy than clinical data. The adjusted odds ratios were 10.10 (95% CI 5.01-20.40) for clinical RS and 10.70 (95% CI 5.08-22.70) for the GBS. UGI hemorrhage in CT findings could predict the need for endoscopic therapy in non-variceal UGIB patients in our emergency department. CT findings as well as risk score systems may be useful for predicting the need for endoscopic therapy.

    DOI: 10.3164/jcbn.18-115

    PubMed

    researchmap

  • Low-dose ramosetron accelerates gastric emptying in the early phase: A crossover study in healthy volunteers using a continuous real-time 13C breath test (BreathID System)

    Sho Inoue, Yasunari Sakamoto, Yusuke Sekino, Takashi Nonaka, Hiroshi Iida, Hiroki Endo, Tomoko Koide, Hirokazu Takahashi, Shin Maeda, Atsushi Nakajima, Eiji Gotoh, Masahiko Inamori

    Turkish Journal of Gastroenterology   26 ( 2 )   123 - 127   2019年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AVES  

    Background/Aims: The aim of this study was to determine the correlation between low-dose ramosetron pretreatment and gastric emptying using a novel, non-invasive technique for measuring gastric emptying, namely, the continuous real-time 13C breath test (BreathID system: Exalenz Bioscience Ltd., Israel). Materials and Methods: Twelve healthy male volunteers participated in this randomized two-way crossover study. The subjects fasted overnight and were randomly assigned to receive the test meal (200 kcal per 200 mL) after an hour pre-treatment with 5 µg ramosetron or the test meal alone. Gastric emptying was monitored for 4 hours after administration of the test meal with the 13C-acetic acid breath test performed continuously using the BreathID system. Using Oridion Research Software (β version), T 1/2, T lag, GEC and the regression-estimated constants (β and κ) were calculated. The differences in the parameters measured at two time-points were analyzed using Wilcoxon’s signed-rank test. Results: There was a significant difference in the calculated parameter β. No significant differences in the calculated parameters T 1/2, T lag, GEC or κ were observed between the test meal with ramosetron group and the test meal alone group. Conclusion: This study showed that ramosetron pre-treatment enhances the early gastric emptying of liquid nutrients.

    DOI: 10.5152/TJG.2015.4768

    Scopus

    researchmap

  • 病院と在宅医療の連携 10年後への投資 医学生教育

    日下部 明彦, 飯田 洋, 稲森 正彦, 太田 光泰

    日本在宅医療連合学会大会プログラム・講演抄録集   1回   333 - 333   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本在宅医療連合学会  

    researchmap

  • 内科系救急初療設定でのメディカル・ラリーの試み

    太田 光泰, 倉上 優一, 安田 優, 岩渕 敬介, 高橋 幸大, 吉江 浩一郎, 袴田 智伸, 日下部 明彦, 岩田 悠里, 八百 壮大, 飯田 洋, 加藤 佳央, 稲森 正彦

    医学教育   50 ( Suppl. )   152 - 152   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 終末期がん患者の「パートナーとの愛を育む時間」に対する医療者の援助 多施設緩和ケア病棟看護師を対象とした質問紙による調査

    日下部 明彦, 馬渡 弘典, 平野 和恵, 渡邉 眞理, 久保田 顕子, 稲森 正彦, 太田 光泰, 森田 達也

    Palliative Care Research   14 ( Suppl. )   S341 - S341   2019年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本緩和医療学会  

    researchmap

  • [Are the Medical Staff Ready to Respond to the Suffering from Sexuality of Terminal Cancer Patients ?] 査読

    Kusakabe A, Hirano K, Mawatari H, Morita C, Nara T, Kessoku T, Matsuura T, Yoshimi A, Gotou A, Inamori M, Ohta M

    Gan to kagaku ryoho. Cancer & chemotherapy   46 ( Suppl 1 )   57 - 59   2019年5月

     詳細を見る

  • 終末期がん患者のセクシュアリティについての苦悩に医療者は備えているか?

    日下部 明彦, 平野 和恵, 馬渡 弘典, 森田 千雅子, 奈良 健, 結束 貴臣, 松浦 哲也, 吉見 明香, 後藤 歩, 稲森 正彦, 太田 光泰

    癌と化学療法   46 ( Suppl.I )   57 - 59   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)癌と化学療法社  

    緩和ケアの目標はがん患者・家族の理想の生活を支えることであるが、医療者は目の前のがん患者のニーズをすべて聞き取れているとは限らない。入院患者の様々な苦痛は相手や場面を選んで表出される。そして隠された苦悩の代表的なものはセクシュアリティの問題ではないだろうか。がん患者のセクシュアリティの苦悩はふさわしい相手がいなければ表出されることはないと予想される。医療者は患者・家族のセクシュアリティの問題に対して準備をしているだろうか?今回われわれ緩和ケアチームは、入院中に性についての発言があった終末期がん患者とのかかわりから現況調査が必要と考えた。(著者抄録)

    researchmap

  • 【慢性便秘症の診療の進歩】慢性便秘の診断の実際 病歴聴取、身体診察、検査

    稲森 正彦, 飯田 洋, 日下部 明彦

    日本内科学会雑誌   108 ( 1 )   16 - 21   2019年1月

  • End-of-life care conferences in Japanese nursing homes.

    Sho Nishiguchi, Nagisa Sugaya, Masahiko Inamori

    Drug discoveries & therapeutics   13 ( 1 )   47 - 51   2019年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    End-of-life (EOL) care conferences have an important role in promoting EOL care in nursing homes. However, the details of the conferences remain poorly understood. A Japanese prefecture-wide survey was conducted to investigate the factors involved in such conferences that contribute to an increase in the amount of EOL care. One hundred fifty-three nursing homes performed the conferences. The outcome was the amount of EOL care provided in nursing homes after adjusting for the facility beds in 2014. We investigated the factors of staff experience with EOL care, frequency of the conferences, years the conferences were conducted, review conferences after EOL care, and professional participants in the conferences. The multivariate analysis revealed significant associations between EOL care in nursing homes and nurses' experience with EOL care (adjusted β coefficient 2.9, 95% confidence interval (CI) 0.52 ~ 5.22, p = 0.017), more than 5 years of continuous conferences (adjusted β coefficient 3.8, 95% CI 0.46 ~ 7.05, p = 0.026), and family participation (adjusted βcoefficient ‒4.0, 95% CI ‒7.5 ~ ‒0.48, p = 0.026). In conclusion, the continuation of conferences and enrollment of the nurse with experience in EOL care may promote EOL care in nursing homes, while family enrollment in conferences may decrease EOL care in nursing homes. EOL care conferences in nursing homes should be continuously performed by staff, with an experienced nurse undertaking the task of information sharing before discussing EOL care with the patients' families.

    DOI: 10.5582/ddt.2019.01002

    PubMed

    researchmap

  • Functional test of digestive tract

    Masahiko Inamori, Hiroshi Iida, Koji FUJITAi

    Journal of Japanese Society of Gastroenterology   116 ( 10 )   801 - 808   2019年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Japanese Society of Gastroenterology  

    DOI: 10.11405/nisshoshi.116.801

    Scopus

    PubMed

    researchmap

  • Comparison of the early effects of vonoprazan, lansoprazole and famotidine on intragastric pH: a three-way crossover study. 査読

    Ohkuma K, Iida H, Inoh Y, Kanoshima K, Ohkubo H, Nonaka T, Fujita K, Kusakabe A, Inamori M, Nakajima A

    J Clin Biochem Nutr   63 ( 1 )   80 - 83   2018年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    researchmap

  • Googleフォームを用いた試験運用の経験

    稲森 正彦, 岩田 悠里, 飯田 洋正, 日下部 明彦, 太田 光泰, 原 良紀, 藤田 浩司, 西巻 滋

    医学教育   49 ( Suppl. )   221 - 221   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • A phase II study of s-1 in elderly patients with unresectable pancreatic cancer

    Hitoshi Kuriyama, Masahiko Inamori, Hiroshi Iida, Koji Fujita, Akihiko Kusakabe, Hidenori Ohkubo, Eiji Sakai, Yoriko Murata, Shin Maeda, Atsushi Nakajima, Yasuo Hata

    Surgery, Gastroenterology and Oncology   23 ( 3 )   191 - 197   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Celsius Publishing House  

    Background/Aims: The aim of this study was to investigate the efficacy and safetyof the oral fluoropyrimidine derivativeS-1 in elderly patients with unresectable pancreatic cancer. Methods: Patients were eligible if they were at least 70 years old and had unresectable pancreatic carcinoma. S-1 was administered orally twice daily after meals at doses of 80, 100, and 120 mg/day forbody surface areasfor 28 consecutive days, followed by a 14-day rest period. Administration was repeated until the appearance of disease progression or unacceptable toxicity. Results: Twenty-one patients were enrolledin this study. Five patients (23.8%) achieved a partial response (95% CI, 8.2-47.2%),stable disease was observed in 9 patients (42.9%), and progressive disease was observed in 5 patients (23.8%).The disease control rate was 66.7%. The median time to progression and overall survivaltime were 3.7 months (95% CI, 2.3-6.5 months) and 7.3 months (95% confidence interval, 4.9-12.1 months), respectively. Toxicity was generally mild, and the most common grade 3/4 toxicities were neutro-penia (14.3%), anemia (14.3%), leucopenia (9.5%), thrombocytopenia (9.5%), anorexia (9.5%), and diarrhea (9.5%). There were no treatment-related deaths. Conclusions: Monotherapy with S-1 is an effective and well-tolerated regimen for elderly patients with unresectable pancreatic cancer.

    DOI: 10.21614/sgo-23-3-191

    Scopus

    researchmap

  • Comparison of clinical findings with symptom assessment systems (gerdq and fssg) for functional gastrointestinal diseases

    Mizue Matsuura, Masahiko Inamori, Takashi Nonaka, Yumi Inoh, Kenji Kanoshima, Takuma Higurashi, Hidenori Ohkubo, Yusuke Sekino, Hiroshi Iida, Koji Fujita, Akihiko Kusakabe, Atsushi Nakajima

    Surgery, Gastroenterology and Oncology   23 ( 3 )   198 - 203   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Celsius Publishing House  

    Background/Aims: We conducted a trial to evaluate the FSSG questionnaire and GerdQ questionnaire for diagnostic accuracy given correlation with clinical findings. Methods: One hundred three consecutive patients who were seen in the Yokohama City University hospital with a gastrointestinal symptom in May 2011 were enrolled as potential subjects. Of these, 94 patients underwent upper gastrointestinal endoscopy, and clinical symptoms were evaluated using both the FSSG and GerdQ questionnaires. Results: There were 94 subjects with GERD and 9 subjects with functional dyspepsia as defined by the Rome III criteria. We investigated the sensitivity and specificity of FSSG and GerdQ for GERD. For FSSG, the sensitivity was 0.564, the specificity was 0.778, and the odds ratio was 4.462. For GerdQ, the sensitivity was 0.298, the specificity was 0.889, and the odds ratio was 3.363. When combining the FSSG and GerdQ, the sensitivity was 0.255, the specificity was 0.888, and the odds ratio was 2.722. When using either the FSSG or GerdQ, the sensitivity was 0.723, the specificity was 0.888, and the odds ratio was 5.307. Conclusions: We conclude that having patients complete both the FSSG and GerdQ may be more useful in routine medical examinations than completing only one questionnaire.

    DOI: 10.21614/sgo-23-3-198

    Scopus

    researchmap

  • 特別養護老人ホームにおける看取り介護に関するケアカンファレンス

    西口 翔, 菅谷 渚, 稲森 正彦

    日本老年医学会雑誌   55 ( Suppl. )   133 - 133   2018年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本老年医学会  

    researchmap

  • 【慢性便秘-新たな分類と病態・診断・治療】診断

    稲森 正彦, 飯田 洋, 藤田 浩司, 日下部 明彦

    臨床消化器内科   33 ( 4 )   387 - 392   2018年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本メディカルセンター  

    <文献概要>便秘は医師として基本的な診療対象の一つであるが,わが国の実地診療のなかでは混沌とした概念である.今回,慢性便秘症ガイドラインが刊行され,そのなかで診断につき概説された.問診,身体診察,検体検査,画像検査,専門的な医療機関で行う検査という流れのなかで,解説が行われている.問診では警告症状,危険因子の概念のほか,ブリストル便形状スケールの紹介が盛り込まれている.検体検査では二次性便秘を念頭においた検体検査についても言及されている.画像検査に関しては除外診断としての腹部単純X線検査と注腸X線検査,内視鏡検査が紹介され,一部,保険適用外であるが専門的施設で行われる検査についても触れられている.本稿ではその一部を紹介する.

    researchmap

  • 【便秘症-古くて新しいcommon disease】便秘症、便秘型過敏性腸症候群の診断の実際

    稲森 正彦, 飯田 洋, 藤田 浩司, 日下部 明彦

    臨床栄養   132 ( 2 )   156 - 161   2018年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:医歯薬出版(株)  

    researchmap

  • Can sedation using a combination of propofol and dexmedetomidine enhance the satisfaction of the endoscopist in endoscopic submucosal dissection? 査読 国際誌

    Nonaka T, Inamori M, Miyashita T, Inoh Y, Kanoshima K, Higurashi T, Ohkubo H, Iida H, Fujita K, Kusakabe A, Gotoh T, Nakajima A

    Endosc Int Open   6 ( 1 )   E3 - E10   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1055/s-0043-122228

    PubMed

    researchmap

  • The author’s reply: Comment on: Clinical characteristics of severe erosive esophagitis among patients with erosive esophagitis: A case-control study 査読

    Masahiko Inamori, Tomonori Ida

    Internal Medicine   57 ( 12 )   1811 - 1811   2018年

     詳細を見る

    記述言語:英語   出版者・発行元:Japanese Society of Internal Medicine  

    DOI: 10.2169/internalmedicine.0341-17

    Scopus

    PubMed

    researchmap

  • Assessment of colonic contents in patients with chronic constipation using MRI 査読

    Yumi Inoh, Kenji Kanoshima, Kanji Ohkuma, Akiko Fuyuki, Shiori Uchiyama, Hidenori Ohkubo, Takuma Higurashi, Hiroshi Iida, Takashi Nonaka, Koji Fujita, Akihiko Kusakabe, Masahiko Inamori, Kazumasa Hiroishi, Hajime Nagase, Atushi Nakajima, Taro Takahara

    Journal of Clinical Biochemistry and Nutrition   62 ( 3 )   277 - 280   2018年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:The Society for Free Radical Research Japan  

    Although chronic constipation is common, colonic functional evaluating tests are uncommon. This study examines whether chronic constipation and gastrointestinal symptoms are correlated with the lateral diameter of the colon measured from MRI images. We included chronic constipation patients in a prospective, cross- sectional study using MRI at three centers. We divided 3D MRI colorectal images into 6 segments using with specified sequences and selected the maximum luminal diameter from each segment. We used the GSRS questionnaire to evaluate gastrointestinal symptoms. We evaluated the correlation between luminal dia- meters and GSRS scores. We found the following positive correla- tions: descending colon and unsatisfactory defecation symptoms
    sigmoid colon and diarrhea
    and rectum and constipation. The sum and ratio of the ascending and sigmoid colon diameters correlated with nausea and diarrhea. The sum of the transvers to the sigmoid colon diameter also correlated with nausea and diarrhea. The sum of all segment diameters correlated with nausea and constipation. In conclusion, we showed cross-sectional study of colonic MRI correlate with gastrointestinal symptoms. MRI might be useful for colonic motility evaluations to determine appropriate constipation treatments (Clinical trial registry number UMIN 000021274).

    DOI: 10.3164/jcbn.17-104

    Scopus

    researchmap

  • Association between endoscopic findings related to colonic diverticula and bowel habits: A multicenter study in Japan 査読

    Eiji Yamada, Hitoshi Kuriyama, Eri Uchida, Yoriko Murata, Yasuo Hata, Masataka Tagri, Yutaka Isozaki, Hirokazu Oyamada, Yukihiro Ozawa, Takafumi Ito, Akira Mizuki, Masahiko Inamori, Noriaki Manabe, Ken Haruma, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   32 ( 12 )   1938 - 1942   2017年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Background and AimFew studies have shown the associations between colonic diverticula and endoscopic findings such as location, inflammation, number of diverticula, sigmoid colon rigidity, and bowel habits.
    MethodsJapanese subjects who underwent total colonoscopies at six centers in Japan from November 2015 to October 2016 were analyzed. Bowel habits were evaluated using the Gastrointestinal Symptom Rating Scale. Location and number of diverticula, inflammation, and sigmoid colon rigidity were evaluated from endoscopy results.
    ResultsA total of 762 subjects (486 men and 276 women [ratio, 1.76:1]) whose mean age was 65.511.4years were evaluated. In multivariate analysis, presence of constipation was associated with a significantly lower likelihood of left-sided colonic diverticula (odds ratio=0.40, 95% confidence interval 0.20-0.82, P=0.012), whereas right-sided and bilateral-sided colonic diverticula, multiple colonic diverticula, inflammation findings, and sigmoid colon rigidity were not related to bowel habits.
    ConclusionsAmong endoscopic findings related to colonic diverticula and bowel habits, only left-sided colonic diverticula were inversely associated with constipation, whereas inflammation findings, multiple diverticula, and sigmoid colon rigidity were not related to bowel habits. However, the association of inflammation findings with colonic diverticula and bowel habits should be further studied. Investigation of changes in left-sided colonic diverticula may lead to new treatments for constipation.

    DOI: 10.1111/jgh.13805

    Web of Science

    researchmap

  • Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO) 査読

    H. Ohkubo, A. Fuyuki, J. Arimoto, T. Higurashi, T. Nonaka, Y. Inoh, H. Iida, M. Inamori, T. Kaneda, A. Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   29 ( 12 )   2017年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    BackgroundsChronic intestinal pseudo-obstruction (CIPO) is an intractable rare digestive disease manifesting persistent small bowel distension without any mechanical cause. Intestinal decompression is a key treatment, but conventional method including a trans-nasal small intestinal tube is invasive and painful. Therefore, a less invasive and tolerable new decompression method is urgently desired. We conducted a pilot study and assessed the efficacy and safety of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy in CIPO patients.
    MethodsSeven definitive CIPO patients (2 males and 5 females) were enrolled. All patients received PEG-J decompression therapy. The number of days with any abdominal symptoms in a month (NODASIM), body mass index (BMI), serum albumin level (Alb), and small intestinal volume before and after PEG-J were compared in all patients.
    ResultsPercutaneous endoscopic gastro-jejunostomy was well tolerated and oral intake improved in all patients. NODASIM has significantly decreased (24.3 vs 9.3days/months) and BMI/Alb have significantly increased (14.9 vs 17.2kg/m(2) and 2.6 vs 3.8g/dL, respectively), whereas total volume of the small intestine has not significantly reduced (4.05 vs 2.59L, P=.18). Reflux esophagitis and chemical dermatitis were observed in one case but was successfully treated conservatively.
    Conclusions & InferencesPercutaneous endoscopic gastro-jejunostomy decompression therapy can contribute greatly to improvement of abdominal symptoms and nutritional status in CIPO patients. Although sufficient attention should be paid to acid reflux symptoms, PEG-J has the potential to be a non-invasive novel decompression therapy for CIPO available at home. However, accumulation of more CIPO patients and long-term observation are needed (UMIN000017574).

    DOI: 10.1111/nmo.13127

    Web of Science

    researchmap

  • Lubiprostone improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled 2-way crossover study. 査読 国際誌

    Matsuura M, Inamori M, Inou Y, Kanoshima K, Higurashi T, Ohkubo H, Iida H, Endo H, Nonaka T, Kusakabe A, Maeda S, Nakajima A

    Endosc Int Open   5 ( 6 )   E424 - E429   2017年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1055/s-0043-105487

    PubMed

    researchmap

  • Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma 査読

    Jun Hamanaka, Tohru Goto, Shuhei Nishigori, Shihoko Seki, Tomonori Ida, Taiki Morohashi, Hiroshi Ohara, Masahiko Inamori, Shin Maeda

    TURKISH JOURNAL OF GASTROENTEROLOGY   28 ( 3 )   197 - 201   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AVES  

    Background/Aims: This study's purpose was to compare the efficacy of CO2-enhanced ultrasonography (US) with that of Sonazoid-enhanced US and conventional US in detecting local tumor residue after percutaneous radiofrequency (RF) ablation therapy for hepatocellular carcinoma.
    Materials and Methods: Between February 2009 and March 2010, 141 lesions of 121 hepatocellular carcinoma patients were treated by percutaneous RF ablation, and 22 tumor residues were detected in 22 patients by contrast-enhanced computed tomography. These 22 patients were examined by conventional US, Sonazoid-enhanced US (0.5 mL/body of Sonazoid, intravenous administration), and CO2-enhanced US (10 mL of CO2, hepatic arterial administration).
    Results: Tumor residue was confirmed by CO2-enhanced US in all the 22 patients (sensitivity: 100%) in 19 of the 22 patients by Sonazoid-enhanced US (sensitivity: 86%; 3 lesions that were not detected by this modality were located deeper than the sonographic depth (p=0.0109)), and in 17 of the 22 patients by conventional US (sensitivity: 77%; 5 lesions that were not detected by this modality were smaller in terms of the sonographic tumor size (p= 0.0278)).
    Conclusion: Although CO2-enhanced US requires angiography, it was superior to both Sonazoid-enhanced US and conventional US for detecting tumor residues, particularly deep-seated ones, after percutaneous RF ablation.

    DOI: 10.5152/tjg.2017.16641

    Web of Science

    researchmap

  • Clinical importance of cine-MRI assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction: a retrospective study of 33 patients 査読

    Akiko Fuyuki, Hidenori Ohkubo, Takuma Higurashi, Hiroshi Iida, Yumi Inoh, Masahiko Inamori, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   52 ( 5 )   577 - 584   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER JAPAN KK  

    Although chronic intestinal pseudo-obstruction (CIPO) is a rare and extremely severe functional digestive disorder, its clinical course and severity show various patterns. We assessed small bowel peristalsis in CIPO patients using cine-MRI (video-motion MRI) and their clinical characteristics to evaluate the clinical importance of performing cine-MRI in patients with this intractable disease.
    The medical records of 131 patients referred to our institution with a suspected diagnosis of CIPO between 2010 and 2015 were retrospectively evaluated. Thirty-three patients (22 female/11 male; age range 16-79 years) who met the criteria for CIPO and underwent cine-MRI were enrolled. Mean luminal diameter (MLD), contraction ratio (CR), and contraction cycle (CC) were determined and compared with these parameters in healthy volunteers. Clinical outcomes in patients with CIPO were also evaluated.
    The median follow-up time was 25.2 months (range, 1-65 months). Of the 33 patients with CIPO, 23 (70 %) showed apparently disturbed small intestinal peristalsis, whereas 10 (30 %) did not. The percentage of patients requiring intravenous alimentation was significantly higher (p = 0.03), and the mean serum albumin level was significantly lower (p = 0.04), in patients with than without impaired small intestinal peristalsis. Although both cine-MRI and CT findings in the latter ten cases were within the normal range, MLD and CR differed significantly from healthy volunteers.
    Cine-MRI is useful in predicting severe clinical features in patients with CIPO, and in detecting slightly impaired small contractility that cannot be detected on CT.

    DOI: 10.1007/s00535-016-1251-8

    Web of Science

    researchmap

  • The α-glucosidase inhibitor voglibose stimulates delayed gastric emptying in healthy subjects: a crossover study with a 13C breath test. 査読

    Kanoshima K, Matsuura M, Kaai M, Inoh Y, Ohkuma K, Iida H, Nonaka T, Fujita K, Ida T, Kusakabe A, Nakajima A, Inamori M

    J Clin Biochem Nutr   60 ( 3 )   216 - 218   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3164/jcbn.16-100

    Web of Science

    researchmap

  • Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy? 査読

    Hiroki Endo, Takayuki Kato, Eiji Sakai, Leo Taniguchi, Jun Arimoto, Harunobu Kawamura, Takuma Higurashi, Hidenori Ohkubo, Takashi Nonaka, Masataka Taguri, Masahiko Inamori, Takeharu Yamanaka, Takashi Sakaguchi, Yasuo Hata, Hajime Nagase, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   52 ( 2 )   194 - 202   2017年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER JAPAN KK  

    Background Aspirin use is reportedly not to be associated with fecal immunochemical occult blood test (FIT) false-positive results for the detection of colorectal cancer. The need for additional small bowel exploration in FIT-positive, low-dose aspirin users with a negative colonoscopy is controversial. The aim of this study was to assess the ability of FIT to judge whether capsule endoscopy (CE) should be performed in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy findings by comparing FIT results with CE findings.
    Methods A total of 264 consecutive low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy who were scheduled to undergo CE at five hospitals in Japan were enrolled. Patients had been offered FIT prior to the CE. The association between the FIT results and the CE findings was then assessed.
    Results One hundred and fifty-seven patients were included in the final analysis. Eighty-four patients (53.5 %) had positive FIT results. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of positive FIT results for small bowel ulcers were 0.56, 0.47, 0.30, and 0.73, respectively. Furthermore, the NPV of positive FIT results for severe small bowel injury (Lewis score C790) was markedly high (0.90). When the analysis was performed only in low-dose aspirin users with anemia, the sensitivity of the positive FIT results was notably improved (0.72).
    Conclusions Small bowel evaluation using CE is not recommended for FIT-negative, low-dose aspirin users. However, small bowel evaluation using CE should be considered in both FIT-positive and anemic low-dose aspirin users.

    DOI: 10.1007/s00535-016-1212-2

    Web of Science

    researchmap

  • 食道ESDに対するプロポフォール・デクスメデトミジン塩酸塩併用鎮静の実現性

    野中 敬, 稲森 正彦, 宮下 徹也, 原田 紳介, 稲生 優海, 鹿野島 健二, 松浦 瑞恵, 日暮 琢磨, 大久保 秀則, 飯田 洋, 遠藤 宏樹, 日下部 明彦, 前田 慎, 後藤 隆久, 中島 淳

    Gastroenterological Endoscopy   59 ( 2 )   226 - 233   2017年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    【目的】従来のベンゾジアゼピン系薬剤を用いた鎮静と比較して、食道ESDにおけるプロポフォール(PF)とデクスメデトミジン(DEX)を併用した鎮静の有効性と安全性について検討する。【方法】当施設で食道ESDが施行された連続40症例の臨床情報を遡及的に解析した。20例はベンゾジアゼピン系薬剤による鎮静(従来群)、20例はPF・DEX併用による鎮静(併用群)が行われた。鎮静の有効性と安全性に関する各パラメータを両群で比較した。【結果】併用群は処置時間が有意に短く(61分vs 89分、P=0.03)、抑制を要する体動が見られた患者の割合も有意に少なかった(25% vs 65%、P=0.025)。一方、併用群は低血圧(60% vs 15%、P=0.008)と徐脈(60% vs 15%、P=0.008)の発生率が有意に高かった。治療中断を要する重篤な有害事象は両群ともになかった。【結論】PFとDEXを併用した鎮静は食道ESDにおいて患者体動を抑えた安定した鎮静となり得る可能性が示唆された。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J00192&link_issn=&doc_id=20170321290011&doc_link_id=10.11280%2Fgee.59.226&url=https%3A%2F%2Fdoi.org%2F10.11280%2Fgee.59.226&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_2.gif

  • 「地域の多職種でつくった死亡診断時の医師の立ち居振る舞いについてのガイドブック」の医学教育に用いた報告

    日下部 明彦, 野里 洵子, 平野 和恵, 齋藤 直裕, 池永 恵子, 櫁柑 富貴子, 結束 貴臣, 松浦 哲也, 吉見 明香, 内藤 明美, 沖田 将人, 稲森 正彦, 山本 裕司, 森田 達也

    Palliative Care Research   12 ( 1 )   906 - 910   2017年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本緩和医療学会  

    死亡診断時の医師の立ち居振る舞いは,その後の遺族の悲嘆に大きく影響を及ぼすと考えられているが,現在の医学教育プログラムのなかには,死亡診断時についての教育内容はほとんど含まれていない.われわれは遺族アンケートを基に「地域の多職種でつくった死亡診断時の医師の立ち振る舞いについてのガイドブック」(以下ガイドブック)を作成した.本ガイドブックを用い,横浜市立大学医学部4年次生に対し授業を行い,授業前後で死亡診断時の困難感,自己実践の可能性を評価するアンケート調査を行い解析した.有効回答を得た39名において死亡確認についての困難感についての項目は,「死亡確認の具体的な方法」が最も高く,89.5%であった.しかし,授業前後では,死亡診断時における自己実践を評価する項目で有意な改善がみられた.死亡診断時の医師の立ち居振る舞いについての卒前教育にわれわれが作成したガイドブックは有効な可能性が示唆された.(著者抄録)

    researchmap

    その他リンク: https://search-tp.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J05370&link_issn=&doc_id=20170908220014&doc_link_id=10.2512%2Fjspm.12.906&url=https%3A%2F%2Fdoi.org%2F10.2512%2Fjspm.12.906&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • 「地域の多職種でつくった死亡診断時の医師の立ち居振る舞いについてのガイドブック」の医学教育に用いた報告

    日下部 明彦, 野里 洵子, 平野 和恵, 齋藤 直裕, 池永 恵子, 櫁柑 富貴子, 結束 貴臣, 松浦 哲也, 吉見 明香, 内藤 明美, 沖田 将人, 稲森 正彦, 山本 裕司, 森田 達也

    Palliative Care Research   12 ( 1 )   906 - 910   2017年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本緩和医療学会  

    死亡診断時の医師の立ち居振る舞いは,その後の遺族の悲嘆に大きく影響を及ぼすと考えられているが,現在の医学教育プログラムのなかには,死亡診断時についての教育内容はほとんど含まれていない.われわれは遺族アンケートを基に「地域の多職種でつくった死亡診断時の医師の立ち振る舞いについてのガイドブック」(以下ガイドブック)を作成した.本ガイドブックを用い,横浜市立大学医学部4年次生に対し授業を行い,授業前後で死亡診断時の困難感,自己実践の可能性を評価するアンケート調査を行い解析した.有効回答を得た39名において死亡確認についての困難感についての項目は,「死亡確認の具体的な方法」が最も高く,89.5%であった.しかし,授業前後では,死亡診断時における自己実践を評価する項目で有意な改善がみられた.死亡診断時の医師の立ち居振る舞いについての卒前教育にわれわれが作成したガイドブックは有効な可能性が示唆された.(著者抄録)

    DOI: 10.2512/jspm.12.906

    researchmap

  • Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone 査読

    Hiroshi Iida, Megumi Kaai, Yumi Inoh, Kenji Kanoshima, Kanji Ohkuma, Takashi Nonaka, Koji Fujita, Tomonori Ida, Akihiko Kusakabe, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    Annals of Gastroenterology   30 ( 4 )   424 - 428   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Hellenic Society of Gastroenterology  

    Background An ideal medication for acid-related diseases would offer prompt stopping of blood flow as well as efficient symptom resolution. The aim of this study was to investigate the gastric acid suppression potency of a single oral dose of rabeprazole alone, compared with administration of rabeprazole plus mosapride. Methods Twelve male volunteers, Helicobacter pylori (H. pylori)-negative, participated in this randomized, three-way crossover study. After a single oral administration of rabeprazole, rabeprazole with mosapride, or rabeprazole administered 1 h after mosapride, we monitored their intragastric pH constantly for 6 h. A 7-day washout period was allowed between each administration. Results The median 6-h intragastric pH after the administration of rabeprazole 1 h after mosapride was 4.41±1.22 (mean±s.d.), significantly higher than after rabeprazole alone 3.45±1.33, P=0.0376). There was no significant difference between the median 6-h pH after the administration of rabeprazole plus mosapride and that after rabeprazole alone (3.81±0.98 vs. 3.45±1.33, respectively
    P=0.0927). Conclusion An oral dose of rabeprazole administered 1 h after mosapride increased the intragastric pH more rapidly than rabeprazole alone, in healthy, male, H. pylori-negative volunteers.

    DOI: 10.20524/aog.2017.0161

    Scopus

    researchmap

  • Clinical Characteristics of Severe Erosive Esophagitis among Patients with Erosive Esophagitis: A Case-control Study 査読

    Tomonori Ida, Masahiko Inamori, Yumi Inoh, Koji Fujita, Jun Hamanaka, Hideyuki Chiba, Akihiko Kusakabe, Taiki Morohashi, Toru Goto, Shin Maeda

    INTERNAL MEDICINE   56 ( 11 )   1293 - 1300   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Objective The risk factors associated with severe erosive esophagitis are not well defined in Japan. We aimed to evaluate the risk factors associated with the endoscopic severity of esophageal mucosal injury.
    Methods Eighty consecutive Japanese patients with severe erosive esophagitis [Los Angeles (LA) classification grade C or D] who had undergone upper endoscopies in the Gastroenterology Division of Omori Red Cross Hospital between June 2010 and March 2013 were retrospectively analyzed. For each case, a control with mild erosive esophagitis (LA classification grade A or B) who was matched by sex and age was randomly selected during the same period. Among the endoscopic findings, the condition of the gastroesophageal flap valve (GEFV) was graded according to Hill's classification. We identified the risk factors for severe erosive esophagitis using a multivariable logistic regression model.
    Results A poor performance status (PS) (odds ratio [OR]=17.1201, 95% confidence interval [CI]=3.0268-140.3121, p=0.0008) and an abnormal GEFV (OR=3.0176, 95% CI=1.0589-9.4939, p=0.0385) were risk factors for severe erosive esophagitis, while the presence of open-type gastric mucosal atrophy (GMA) was inversely associated with severe erosive esophagitis (OR=0.2772, 95% CI=0.1087-0.6675, p=0.0040).
    Conclusion Among patients with erosive esophagitis, a poor PS and an abnormal GEFV were associated while GMA was inversely associated with severe erosive esophagitis. Drug therapy alone or in combination with physical therapy may improve the therapeutic effect on severe erosive esophagitis in patients with a poor PS.

    DOI: 10.2169/internalmedicine.56.8058

    Web of Science

    researchmap

  • Feasibility of deep sedation with a combination of propofol and dexmedetomidine hydrochloride for esophageal endoscopic submucosal dissection

    Takashi Nonaka, Masahiko Inamori, Tetsuya Miyashita, Shinsuke Harada, Yumi Inoh, Kenji Kanoshima, Mizue Matsuura, Takuma Higurashi, Hidenori Ohkubo, Hiroshi Iida, Hiroki Endo, Akihiko Kusakabe, Shin Maeda, Takahisa Gotoh, Atsushi Nakajima

    Gastroenterological Endoscopy   59 ( 2 )   226 - 233   2017年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Japan Gastroenterological Endoscopy Society  

    Background and Aim: The aim of the present study was to evaluate the efficacy and safety of sedation with a combination of propofol (PF) and dexmedetomidine (DEX) compared with sedation with benzodiazepines in esophageal endoscopic submucosal dissection (ESD). Methods: We retrospectively reviewed clinical data for 40 consecutive patients who had undergone esophageal ESD at the Yokohama City University Hospital between July 2012 and August 2014. Of these patients, 20 were sedated with benzodiazepines (conventional group) and another 20 patients were sedated with a combination of PF and DEX (combination group). Parameters for efficacy and safety of sedation were evaluated by comparisons between the two groups. Results: Median procedural times in the combination group were shorter than those in the conventional group (61min vs 89 min, P = 0.03), and the percentage of patients who showed restlessness in the combination group was significantly lower than that in the conventional group (25% vs 65%, P = 0.025). Incidences of hypotension and bradycardia in the combination group were higher than those in the conventional group (60% vs 15%, P=0.008, and 60% vs 15%, P = 0.008, respectively). Conclusion: This retrospective study suggests that a combination of PF and DEX may provide stable deep sedation with less body movement than benzodiazepines during esophageal ESD.

    Scopus

    researchmap

  • Can magnifying endoscopy with narrow-band imaging discriminate between carcinomas and low grade adenomas in gastric superficial elevated lesions? 査読 国際誌

    Takashi Nonaka, Masahiko Inamori, Yasushi Honda, Kenji Kanoshima, Yumi Inoh, Mizue Matsuura, Shiori Uchiyama, Eiji Sakai, Takuma Higurashi, Hidenori Ohkubo, Hiroshi Iida, Hiroki Endo, Koji Fujita, Akihiko Kusakabe, Kazuhiro Atsukawa, Hisao Takahashi, Yoko Tateishi, Shin Maeda, Kenichi Ohashi, Atsushi Nakajima

    Endoscopy international open   4 ( 11 )   E1203-E1210 - E1210   2016年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background and study aims: The aim of this study was to investigate the capability of magnifying endoscopy with narrow-band imaging (ME-NBI) to discriminate between early carcinomas (EC) and low grade adenomas (LGA) in gastric superficial elevated epithelial neoplasias. Patients and methods: We investigated 100 consecutive cases of gastric superficial elevated epithelial neoplasias that were removed using endoscopic submucosal dissection. The pathological diagnostic criteria were based on the revised Vienna classification; category 4 (mucosal high grade neoplasia) and category 5 (submucosal invasion by carcinoma) lesions were diagnosed as EC, whereas category 3 (mucosal low grade neoplasia) lesions were diagnosed as LGA. The associations between the postoperative pathological diagnoses and the ME-NBI findings were analyzed, and included the shape, specification, and area of irregularity in the microvascular architecture (MV) and the microsurface structure (MS). Results: Seventy-nine EC and 21 LGA cases diagnosed postoperatively were evaluated retrospectively. The lesion size (median; range (mm)) was significantly larger in the EC group (14; 2 - 95) compared to the LGA group (5; 2 - 16) (P < 0.001). Wavy forms in the MV shapes (P = 0.031), extension in the MV specifications (P = 0.035), and area with MV irregularity (P = 0.001) were found to be statistically significant predictive findings for EC. Villous forms in the MS shapes (P = 0.026), enlargement in the MS specifications (P = 0.044), and area with MS irregularity (P = 0.021) were also found to be statistically significant predictive findings for EC. The rates of preoperative sensitivity, specificity, and diagnostic accuracy of ME-NBI for discriminating EC were 86.1 %, 38.9 %, and 75 %, respectively. Conclusions: The present study suggests that ME-NBI is useful for the differential diagnosis of EC and LGA in gastric superficial elevated epithelial neoplasias. STUDY REGISTRATION: UMIN000012925.

    PubMed

    researchmap

  • Liquid-containing Refluxes and Acid Refluxes May Be Less Frequent in the Japanese Population Than in Other Populations: Normal Values of 24-hour Esophageal Impedance and pH Monitoring 査読

    Osamu Kawamura, Yukie Kohata, Noriyuki Kawami, Hiroshi Iida, Akiyo Kawada, Hiroko Hosaka, Yasuyuki Shimoyama, Shiko Kuribayashi, Yasuhiro Fujiwara, Katsuhiko Iwakiri, Masahiko Inamori, Motoyasu Kusano, Micho Hongo

    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY   22 ( 4 )   620 - 629   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY  

    Background/Aims
    Twenty-four-hour esophageal impedance and pH monitoring allows detection of all types of reflux episodes and is considered the best technique for identifying gastroesophageal refluxes. However, normative data for the Japanese population are lacking. This multicenter study aimed to establish the normal range, of 24-hour esophageal impedance and pH data both in the distal and the proximal esophagus in Japanese subjects.
    Methods
    Forty-two healthy volunteers (25 men and 17 women) with a mean +/- standard deviation age of 33.3 +/- 12.4 years (range: 22-72 years) underwent a combined 24-hour esophageal impedance and pH monitoring. According to the physical and pH properties, distal or proximal esophageal reflux events were categorized.
    Results
    Median 45 reflux events occurred in 24 hours, and the 95th percentile was 85 events. Unlike previous reports, liquid-containing reflux events are median 25/24 hours with the 95th percentile of 62/24 hours. Acidic reflux events were median 11/24 hours with the 95th percentile of 39/24 hours. Non-acidic gas reflux events were median 15/24 hours with the 95th percentile of 39/24 hours. Proximal reflux events accounted for 80% of the total reflux events and were mainly non-acidic gas refluxes. About 19% of liquid and mixed refluxes reached the proximal esophagus.
    Conclusions
    Unlike previous studies, liquid-containing and acidic reflux events may be less frequent in the Japanese population. Non-acidic gas reflux events may be frequent and a cause of frequent proximal reflux events. This study provides important normative data for 24 hour impedance and pH monitoring in both the distal and the proximal esophagus in the Japanese population.

    DOI: 10.5056/jnm15195

    Web of Science

    researchmap

  • Death Pronouncements: Recommendations Based on a Survey of Bereaved Family Members 査読

    Akihiko Kusakabe, Akemi Shirado Naito, Kazue Hirano, Keiko Ikenaga, Naohiro Saitou, Hukiko Mikan, Masato Okita, Masahiko Inamori, Tatsuya Morita

    JOURNAL OF PALLIATIVE MEDICINE   19 ( 6 )   646 - 651   2016年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MARY ANN LIEBERT, INC  

    Purpose: To clarify the family-perceived necessity of improvement in death pronouncement and explore the potential association between behaviors of physicians and the family-perceived necessity of improvement.
    Subjects and Methods: A questionnaire survey was conducted involving 226 bereaved family members of patients who had died at home while receiving hospice service. A total of 91 responses were analyzed (response rate, 47%).
    Results: All pronouncements were performed by physicians. A total of 89% (n=81, 95% confidence interval, 81%-94%) of family members reported that they felt no necessity of improvement at all or that almost no improvement was needed. Behaviors of physicians significantly positively correlated with the family-perceived necessity of improvement were that physicians acted calmly, and were not rushed. Those negatively associated were that physicians did not verify the time of death clearly, left the patient's clothes disheveled, and touched the family members' backs or shoulders as an expression of empathy. More than 90% of family members recommended that physicians act calmly, have a suitable appearance for the situation, introduce themselves to family members, explain the cause of death explicitly, and conduct a check using a light and stethoscope for death pronouncement.
    Conclusion: Most of the family members who had experienced a patient's death at home were satisfied with the death pronouncement. Several factors were associated with family satisfaction, and further large studies are needed to confirm the results.

    DOI: 10.1089/jpm.2015.0333

    Web of Science

    researchmap

  • Evaluation of endoscopic findings for discriminating between early carcinomas and low-grade adenomas in superficial elevated gastric lesions 査読

    Takashi Nonaka, Masahiko Inamori, Kenji Kanoshima, Kanji Ohkuma, Yumi Inoh, Mizue Matsuura, Akiko Fuyuki, Shiori Uchiyama, Takuma Higurashi, Hidenori Ohkubo, Hiroshi Iida, Hiroki Endo, Yoko Tateishi, Akihiko Kusakabe, Kenichi Ohashi, Shin Maeda, Atsushi Nakajima

    TURKISH JOURNAL OF GASTROENTEROLOGY   27 ( 2 )   108 - 114   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AVES  

    Background/Aims: This study aimed to determine the useful endoscopic findings in a differential diagnosis between early carcinomas (EC) and low-grade adenomas (LGA) in superficial elevated gastric epithelial neoplasia during conventional endoscopy with white- light imaging (C-WLI).
    Materials and Methods: We investigated 270 consecutive cases of superficial elevated gastric epithelial neo-plasias, which were removed by endoscopic submucosal dissection. The pathological diagnostic criteria were based on the revised Vienna classification: category 4 (mucosal high-grade neoplasia) or 5 (submucosal invasion by carcinoma) lesions were diagnosed as EC, while category 3 (mucosal low-grade neoplasia) lesions were diagnosed as LGA. The association between the postoperative pathological diagnoses (EC or LGA) and the following endoscopic findings: localized site, lesion size, color (reddish or whitish), shape (smooth, petal, or irregular), and presences of depression, erosion, ulceration, or nodularity on the surface, were evaluated.
    Results: Of 270 epithelial neoplasias, 222 (58 LGA and 164 EC) were retrospectively evaluated. Multiple logistic regression analysis revealed that the lesion size [odds ratio (OR), 1.216; p&lt;0.001) and reddish color (OR, 5.274; p&lt;0.001) were independent findings for EC.
    Conclusion: The lesion size and reddish color were useful optical findings for discriminating between EC and LGA.

    DOI: 10.5152/tjg.2015.150359

    Web of Science

    researchmap

  • Feasibility of deep sedation with a combination of propofol and dexmedetomidine hydrochloride for esophageal endoscopic submucosal dissection 査読

    Takashi Nonaka, Masahiko Inamori, Tetsuya Miyashita, Shinsuke Harada, Yumi Inoh, Kenji Kanoshima, Mizue Matsuura, Takuma Higurashi, Hidenori Ohkubo, Hiroshi Iida, Hiroki Endo, Akihiko Kusakabe, Shin Maeda, Takahisa Gotoh, Atsushi Nakajima

    DIGESTIVE ENDOSCOPY   28 ( 2 )   145 - 151   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Background and AimThe aim of the present study was to evaluate the efficacy and safety of sedation with a combination of propofol (PF) and dexmedetomidine (DEX) compared with sedation with benzodiazepines in esophageal endoscopic submucosal dissection (ESD).
    MethodsWe retrospectively reviewed clinical data for 40 consecutive patients who had undergone esophageal ESD at the Yokohama City University Hospital between July 2012 and August 2014. Of these patients, 20 were sedated with benzodiazepines (conventional group) and another 20 patients were sedated with a combination of PF and DEX (combination group). Parameters for efficacy and safety of sedation were evaluated by comparisons between the two groups.
    ResultsMedian procedural times in the combination group were shorter than those in the conventional group (61min vs 89min, P=0.03), and the percentage of patients who showed restlessness in the combination group was significantly lower than that in the conventional group (25% vs 65%, P=0.025). Incidences of hypotension and bradycardia in the combination group were higher than those in the conventional group (60% vs 15%, P=0.008, and 60% vs 15%, P=0.008, respectively).
    ConclusionThis retrospective study suggests that a combination of PF and DEX may provide stable deep sedation with less body movement than benzodiazepines during esophageal ESD.

    DOI: 10.1111/den.12559

    Web of Science

    researchmap

  • Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome 査読

    Shin Fukudo, Hiroshi Kaneko, Hirotada Akiho, Masahiko Inamori, Yuka Endo, Toshikatsu Okumura, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Toshimi Chiba, Kenji Furuta, Shigeru Yamato, Tetsuo Arakawa, Yoshihide Fujiyama, Takeshi Azuma, Kazuma Fujimoto, Tetsuya Mine, Soichiro Miura, Yoshikazu Kinoshita, Mamoru Watanabe, Kentaro Sugano, Tooru Shimosegawa

    JOURNAL OF GASTROENTEROLOGY   50 ( 7 )   817 - 818   2015年7月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER JAPAN KK  

    DOI: 10.1007/s00535-015-1074-z

    Web of Science

    researchmap

  • Effectiveness of therapeutic barium enema for diverticular hemorrhage 査読

    Mizue Matsuura, Masahiko Inamori, Atsushi Nakajima, Yasuhiko Komiya, Yumi Inoh, Keigo Kawasima, Mai Naitoh, Yuji Fujita, Akiko Eduka, Noriyoshi Kanazawa, Shiori Uchiyama, Rie Tani, Kennichi Kawana, Setsuya Ohtani, Hajime Nagase

    WORLD JOURNAL OF GASTROENTEROLOGY   21 ( 18 )   5555 - 5559   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BAISHIDENG PUBLISHING GROUP INC  

    AIM: To evaluate the effectiveness of barium impaction therapy for patients with colonic diverticular bleeding.
    METHODS: We reviewed the clinical charts of patients in whom therapeutic barium enema was performed for the control of diverticular bleeding between August 2010 and March 2012 at Yokohama Rosai Hospital. Twenty patients were included in the review, consisting of 14 men and 6 women. The median age of the patients was 73.5 years. The duration of the follow-up period ranged from 1 to 19 mo (median: 9.8 mo). Among the 20 patients were 11 patients who required the procedure for re-bleeding during hospitalization, 6 patients who required it for re-bleeding that developed after the patient left the hospital, and 3 patients who required the procedure for the prevention of rebleeding. Barium (concentration: 150 w%/v%) was administered per the rectum, and the leading edge of the contrast medium was followed up to the cecum by fluoroscopy. After confirmation that the ascending colon and cecum were filled with barium, the enema tube was withdrawn, and the patient's position was changed every 20 min for 3 h.
    RESULTS: Twelve patients remained free of rebleeding during the follow-up period (range: 1-19 mo) after the therapeutic barium enema, including 9 men and 3 women with a median age of 72.0 years. Re-bleeding occurred in 8 patients including 5 men and 3 women with a median age of 68.5 years: 4 developed early re-bleeding, defined as re-bleeding that occurs within one week after the procedure, and the remaining 4 developed late re-bleeding. The DFI (disease-free interval) decreased 0.4 for 12 mo. Only one patient developed a complication from therapeutic barium enema (colonic perforation).
    CONCLUSION: Therapeutic barium enema is effective for the control of diverticular hemorrhage in cases where the active bleeding site cannot be identified by colonoscopy.

    DOI: 10.3748/wjg.v21.i18.5555

    Web of Science

    researchmap

  • Early Effects of Oral Administration of Esomeprazole and Omeprazole on the Intragastric Ph 査読

    Hiroshi Iida, Masahiko Inamori, Kotone Okuno, Yusuke Sekino, Eiji Sakai, Hidenori Okubo, Takuma Higurashi, Hiroki Endo, Kunihiro Hosono, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Ayumu Goto, Kensuke Kubota, Satoru Saito, Shin Maeda, Atsushi Nakajima, Eiji Gotoh

    HEPATO-GASTROENTEROLOGY   62 ( 138 )   493 - 496   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of our study was to investigate the inhibitory effects on gastric acid secretion of a single oral dose of a proton pump inhibitor, esomeprazole 20 mg and omeprazole 20 mg. Methodology: A total of 14 Helicobacter pylori-negative male subjects participated in this study. Intragastric pH was monitored continuously for 6 hours after a single oral dose of omeprazole 20 mg and a single oral dose of esomeprazole 20 mg. Each administration was separated by a 7-day washout period. Results: During the 6-hour study period, the average pH after administration of esomeprazole was higher than that after the administration of omeprazole. Also during the 6-hour study period, each of pH &gt; 2, 3, 3.5, 4, and 5 was maintained for a longer duration after administration of esomeprazole 20 mg than after administration of omeprazole 20 mg (median: 75.4% vs. 53.8%, p = 0.0138; 52.1% vs. 33.4%, p = 0.0188; 45.8% vs. 28.2%, p = 0.0262; 42.5% vs. 20.7%, p = 0.0414; 35.8% vs. 11.6%, p = 0.0262; respectively). Conclusions: In Helicobacter pylori-negative healthy male subjects, single oral administration of esomeprazole 20 mg increased the intragastric pH more rapidly than single oral administration of omeprazole 20 mg.

    DOI: 10.5754/hge13850

    Web of Science

    researchmap

  • Low-dose ramosetron accelerates gastric emptying in the early phase: A crossover study in healthy volunteers using a continuous real-time 13C breath test (BreathID System) 査読

    Sho Inoue, Yasunari Sakamoto, Yusuke Sekino, Takashi Nonaka, Hiroshi Iida, Hiroki Endo, Tomoko Koide, Hirokazu Takahashi, Shin Maeda, Atsushi Nakajima, Eiji Gotoh, Masahiko Inamori

    TURKISH JOURNAL OF GASTROENTEROLOGY   26 ( 2 )   123 - 127   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AVES  

    Background/Aims: The aim of this study was to determine the correlation between low-dose ramosetron pretreatment and gastric emptying using a novel, non-invasive technique for measuring gastric emptying, namely, the continuous real-time 13C breath test (BreathID system: Exalenz Bioscience Ltd., Israel).
    Materials and Methods: Twelve healthy male volunteers participated in this randomized two-way crossover study. The subjects fasted overnight and were randomly assigned to receive the test meal (200 kcal per 200 mL) after an hour pre-treatment with 5 mu g ramosetron or the test meal alone. Gastric emptying was monitored for 4 hours after administration of the test meal with the 13C-acetic acid breath test performed continuously using the BreathID system. Using Oridion Research Software (beta version), T 1/2, T lag, GEC and the regression-estimated constants (beta and kappa) were calculated. The differences in the parameters measured at two time-points were analyzed using Wilcoxon's signed-rank test.
    Results: There was a significant difference in the calculated parameter beta. No significant differences in the calculated parameters T 1/2, T lag, GEC or. were observed between the test meal with ramosetron group and the test meal alone group.
    Conclusion: This study showed that ramosetron pre-treatment enhances the early gastric emptying of liquid nutrients.

    DOI: 10.5152/tjg.2014.4768

    Web of Science

    researchmap

  • Constipation is not associated with colonic diverticula: a multicenter study in Japan 査読

    E. Yamada, M. Inamori, S. Watanabe, T. Sato, M. Tagri, E. Uchida, E. Tanida, M. Izumi, K. Takeshita, N. Fujisawa, K. Komatsu, J. Hamanaka, A. Kanesaki, N. Matsuhashi, A. Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   27 ( 3 )   333 - 338   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    BackgroundThe association of diverticula with bowel habits is unclear. We therefore analyzed the association between diverticula and bowel habits in over 1000 Japanese individuals.
    MethodsJapanese subjects who underwent total colonoscopies at seven centers in Japan from June to September 2013 were analyzed. Bowel habits were evaluated using the Gastrointestinal Symptom Rating Scale, and stool form was assessed using a part of the Bristol Scale and Rome criteria. Diverticula were diagnosed by colonoscopy with a transparent soft-short hood.
    Key ResultsThe study evaluated 1066 subjects, 648 males and 418 females (ratio, 1.55:1), of mean age 63.913.0years. After adjusting for age and sex, the presence of constipation was associated with a significantly reduced likelihood of diverticula (odds ratio [OR]=0.70, 95% confidence interval [CI] 0.52-0.93). When assessed according to the location of diverticula, the presence of constipation was associated with a significantly decreased likelihood of left-sided (OR=0.39, 95% CI 0.16-0.93), but not right-sided (OR=1.10, 95% CI 0.48-2.53), diverticula. Furthermore, stool form was unrelated with the presence or absence of diverticula.
    Conclusions & InferencesThe wide-spread hypothesis that constipation was associated with colonic diverticula was not supported. Rather, we found that the absence of diverticula was associated with constipation, suggesting the need to reassess the etiology of colonic diverticula.

    DOI: 10.1111/nmo.12478

    Web of Science

    researchmap

  • Evidence-based clinical practice guidelines for irritable bowel syndrome 査読

    Shin Fukudo, Hiroshi Kaneko, Hirotada Akiho, Masahiko Inamori, Yuka Endo, Toshikatsu Okumura, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Toshimi Chiba, Kenji Furuta, Shigeru Yamato, Tetsuo Arakawa, Yoshihide Fujiyama, Takeshi Azuma, Kazuma Fujimoto, Tetsuya Mine, Soichiro Miura, Yoshikazu Kinoshita, Kentaro Sugano, Tooru Shimosegawa

    JOURNAL OF GASTROENTEROLOGY   50 ( 1 )   11 - 30   2015年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER JAPAN KK  

    New strategies for the care of irritable bowel syndrome (IBS) are developing and several novel treatments have been globally produced. New methods of care should be customized geographically because each country has a specific medical system, life style, eating habit, gut microbiota, genes and so on. Several clinical guidelines for IBS have been proposed and the Japanese Society of Gastroenterology (JSGE) subsequently developed evidence-based clinical practice guidelines for IBS. Sixty-two clinical questions (CQs) comprising 1 definition, 6 epidemiology, 6 pathophysiology, 10 diagnosis, 30 treatment, 4 prognosis, and 5 complications were proposed and statements were made to answer to CQs. A diagnosis algorithm and a three-step treatment was provided for patients with chronic abdominal pain or abdominal discomfort and/or abnormal bowel movement. If more than one alarm symptom/sign, risk factor and/or routine examination is positive, colonoscopy is indicated. If all of them, or the subsequent colonoscopy, are/is negative, Rome III or compatible criteria is applied. After IBS diagnosis, step 1 therapy consisting of diet therapy, behavioral modification and gut-targeted pharmacotherapy is indicated for four weeks. Non-responders to step 1 therapy proceed to the second step that includes psychopharmacological agents and simple psychotherapy for four weeks. In the third step, for patients non-responsive to step 2 therapy, a combination of gut-targeted pharmacotherapy, psychopharmacological treatments and/or specific psychotherapy is/are indicated. Clinical guidelines and consensus for IBS treatment in Japan are well suited for Japanese IBS patients; as such, they may provide useful insight for IBS treatment in other countries around the world.

    DOI: 10.1007/s00535-014-1017-0

    Web of Science

    researchmap

  • Risk factors for low response to proton-pump inhibitor treatment in reflux esophagitis and non-erosive reflux disease evaluated by the frequency scale for the symptoms of gastroesophageal reflux disease 査読

    12   2015年

     詳細を見る

    記述言語:英語  

    researchmap

  • 消化管機能性疾患患者に対する画像検査の施行状況について : 消化器内科の立場から(機能性消化管障害の最適治療を求めて,2014年,第55回日本心身医学会総会ならびに学術講演会(千葉))

    稲森 正彦, 松浦 瑞恵

    心身医学   55 ( 3 )   214 - 217   2015年

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本心身医学会  

    消化管機能性疾患患者に対するわが国での画像検査の施行状況に関する報告はほとんどみられない.また診断時だけではなく,その後どのくらいの間隔で検査が行われているかについての報告はさらに少ない.今回われわれは診療データを調査するとともに,大学病院,市中病院,クリニックの消化器内科医を対象にアンケート調査を行ったところ,消化管機能性疾患患者においても多くの症例で定期的な消化管内視鏡検査が行われている現状を把握することができた.貴重な資料と考え,文献的考察を加え報告する.

    DOI: 10.15064/jjpm.55.3_214

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2015170661

  • Recent Trends in Colonic Diverticulosis in Yokohama City: A Possibility of Changing to a More Western Profile 査読

    Kazuo Tarao, Yusuke Sekino, Takashi Nonaka, Hiroshi Iida, Masahiko Inamori, Atsushi Nakajima, Shin Maeda, Yutaka Natsumeda, Tadashi Ikegami, Kenji Ohshige

    INTERNAL MEDICINE   54 ( 20 )   2545 - 2550   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Objective Right-sided type colonic diverticulosis has been predominant in Japan, in contrast to European counties where the left-sided type is predominant. Considering the recent change in the dietary habits of Japanese people to a more Western diet in urban areas of Japan, the features of colonic diverticulosis may also change to reflect a more Western type. Therefore, we attempted to clarify the current situation.
    Methods A total of 435 consecutive outpatients who agreed to a barium enema and complete examination were enrolled in this study.
    Results 113 patients (26.0%) revealed colon diverticulosis; 50.4% of the patients had more than ten diverticula. The percentage of man with ten or more diverticula (67.4%) was significantly higher than that of women patients (40.0%, p &lt; 0.01). Among the 88 patients who had four or more diverticula, 39 patients (44.3%) were right-side dominant, 27 (30.7%) left-side dominant and 22 (25.0%) were both-sides. Thirteen (68.4%) of the 19 patients who had more than 30 diverticula were left-side dominant.
    Conclusion The clinical features of colon diverticulosis in the patients living in Yokohama may be changing to reflect a more Western type, in particular decreased right-side dominance, increases in the left-side and both-sides dominant patients, and the emergence of patients with crowded diverticula in the left-side colon was observed.

    DOI: 10.2169/internalmedicine.54.4813

    Web of Science

    researchmap

  • Association Between the Location of Diverticular Disease and the Irritable Bowel Syndrome: A Multicenter Study in Japan 査読

    Eiji Yamada, Masahiko Inamori, Eri Uchida, Emiko Tanida, Motoyoshi Izumi, Kimiya Takeshita, Tetsuro Fujii, Kazuto Komatsu, Jun Hamanaka, Shin Maeda, Akira Kanesaki, Nobuyuki Matsuhashi, Atsushi Nakajima

    AMERICAN JOURNAL OF GASTROENTEROLOGY   109 ( 12 )   1900 - 1905   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    OBJECTIVES: No previous reports have shown an association between location of diverticular disease (DD) and the irritable bowel syndrome (IBS).
    METHODS: We included 1,009 consecutive patients undergoing total colonoscopy in seven centers in Japan from June 2013 to September 2013. IBS was diagnosed using Rome III criteria, and diverticulosis was diagnosed by colonoscopy with transparent soft-short-hood. Left-sided colon was defi ned as sigmoid colon, descending colon, and rectum. Right-sided colon was defi ned as cecum, ascending colon, and transverse colon. We divided the patients into IBS and non-IBS groups and compared characteristics.
    RESULTS: Patient characteristics included mean age, 64.2 +/- 12.9 years and male: female ratio, 1.62: 1. Rightsided DD was identifi ed in 21.6% of subjects. Left-sided and bilateral DD was identifi ed in 6.6 and 12.0% of subjects, respectively. IBS was observed in 7.5% of subjects. Multiple logistic regression analysis showed left-sided DD (odds ratio, 3.1; 95% confi dence interval (CI): 1.4-7.1; P = 0.0060) and bilateral DD (odds ratio, 2.6; 95% CI, 1.3-5.2; P = 0.0070) were independent risk factors for IBS. Right-sided DD was not a risk factor for IBS.
    CONCLUSIONS: Our data showed that the presence of left-sided and bilateral DD, but not right-sided disease, was associated with a higher risk of IBS, indicating that differences in pathological factors caused by the location of the DD are important in the development of IBS. Clarifying the specifi c changes associated with left-sided DD could provide a better understanding of the pathogenic mechanisms of IBS

    DOI: 10.1038/ajg.2014.323

    Web of Science

    researchmap

  • ["Manual on physician behavior at the time of death certification" created through collaboration with different local healthcare workers]. 査読

    Kusakabe A, Hirano K, Ikenaga K, Saitou N, Mikan F, Okita M, Inamori M, Shirado A, Morita T

    Gan To Kagaku Ryoho   41 ( Suppl 1 )   42 - 44   2014年12月

     詳細を見る

    記述言語:日本語  

    researchmap

  • A metastatic melanoma of the small intestine diagnosed by single-balloon enteroscopy 査読

    Kaori Suzuki, Keiko Akimoto, Nobutaka Fujisawa, Shigeru Koyame, Akisa Tsunemi, Michio Tanaka, Yusuke Sekino, Hiroshi Iida, Takashi Nonaka, Atsushi Nakajima, Shin Maeda, Eiji Gotoh, Masahiko Inamori

    TURKISH JOURNAL OF GASTROENTEROLOGY   25 ( Suppl 1 )   262 - 263   2014年12月

     詳細を見る

    記述言語:英語   出版者・発行元:AVES  

    DOI: 10.5152/tjg.2014.4113

    Web of Science

    researchmap

  • Percutaneus endoscopic gastrostomy in a patient with hemophilia A 査読

    Tomoko Koide, Mizue Iinuma, Eiji Sakai, Eiji Yamada, Takuma Higurashi, Hidenori Ohkubo, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Takashi Nonaka, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Tomonori Ida, Akihiko Kusakabe, Atsushi Nakajima, Shin Maeda, Eiji Gotoh, Masahiko Inamori

    TURKISH JOURNAL OF GASTROENTEROLOGY   25 ( Suppl 1 )   241 - 241   2014年12月

     詳細を見る

    記述言語:英語   出版者・発行元:AVES  

    DOI: 10.5152/tjg.2014.5262

    Web of Science

    researchmap

  • 地域の多職種で作る「死亡診断時の医師の立ち居振る舞いについてのマニュアル」

    日下部 明彦, 平野 和恵, 池永 恵子, 齊藤 直裕, 櫁柑 富貴子, 沖田 将人, 稲森 正彦, 白土 明美, 森田 達也

    癌と化学療法   41 ( Suppl.I )   42 - 44   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)癌と化学療法社  

    死亡診断の場面での医師の立ち居振る舞いは、その後の遺族の悲嘆に大きく影響を及ぼすと考えられる。死亡診断時の医師の立ち居振る舞いについてのマニュアルを作成し、研修医や医学部生の教育に利用している。現在、これをアップグレードする目的で地域の多職種(訪問看護師、薬剤師)で共同研究を行っている。当地域の現場で在宅医療を行っている医師・看護師へマニュアル作成について、また実際の看取りの場面についてのインタビューを行った。試みに対してはおおむね高評価であり、インタビューに協力的であった。地域の多職種連携は様々な形で行うことができる。地域の多職種で共同研究を行うことで地域連携はより円滑になると思われ、この過程を経てできあがったマニュアルは同地域で受け入れられやすいと思われる。(著者抄録)

    researchmap

  • Ischemic gastritis 査読

    Akito Oshima, Kunihiro Hosono, Shinya Ito, Yusuke Sekino, Hiroshi Iida, Takashi Nonaka, Shoji Yamanaka, Atsushi Nakajima, Shin Maeda, Eiji Gotoh, Masahiko Inamori

    TURKISH JOURNAL OF GASTROENTEROLOGY   25 ( Suppl 1 )   289 - 290   2014年12月

     詳細を見る

    記述言語:英語   出版者・発行元:AVES  

    DOI: 10.5152/tjg.2014.4114

    Web of Science

    researchmap

  • Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry 査読

    Hiroki Endo, Eiji Sakai, Leo Taniguchi, Takaomi Kessoku, Yasuhiko Komiya, Akiko Ezuka, Harunobu Kawamura, Masataka Taguri, Takuma Higurashi, Hidenori Ohkubo, Eiji Yamada, Hirokazu Takahashi, Masahiko Inamori, Shin Maeda, Takashi Sakaguchi, Yasuo Hata, Hajime Nagase, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   80 ( 5 )   826 - 834   2014年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MOSBY-ELSEVIER  

    Background: To develop appropriate management strategies for patients who take low-dose aspirin, it is important to identify the risk factors for GI injury. However, few studies have described the risk factors for small-bowel injury in these patients.
    Objective: To investigate factors influencing the risk of small-bowel mucosal breaks in individuals taking continuous low-dose aspirin.
    Design: Capsule endoscopy data were collected prospectively from 5 institutions.
    Setting: Yokohama City University Hospital and 4 other hospitals.
    Patients: A total of 205 patients receiving treatment with low-dose aspirin for over 3 months.
    Interventions: Colonoscopic and upper GI endoscopy had been performed in all of the patients before the capsule endoscope evaluation.
    Main Outcome Measurements: Risk factors for small-bowel mucosal breaks.
    Results: Of the 198 patients (141 male; mean age 71.9 years) included in the final analysis, 114 (57.6%) had at least 1 mucosal break. Multivariate analysis identified protein pump inhibitor (PPI) use (OR 2.04; 95% confidence interval [CI], 1.05-3.97) and use of enteric-coated aspirin (OR 4.05; 95% CI, 1.49-11.0) as independent risk factors for the presence of mucosal breaks.
    Limitations: Cross-sectional study.
    Conclusion: PPI use appears to increase the risk of small-bowel injury in patients who take continuous low-dose aspirin. Clinicians should be aware of this effect of PPIs; new strategies are needed to treat aspirin-induced gastroenteropathy.

    DOI: 10.1016/j.gie.2014.03.024

    Web of Science

    researchmap

  • Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison 査読

    Kenji Furuta, Yukie Kohata, Yasuhiro Fujiwara, Mitsushige Sugimoto, Takahiro Uotani, Mihoko Yamade, Shu Sahara, Hitomi Ichikawa, Takahisa Furuta, Kenta Nio, Ryuichi Iwakiri, Masahiko Inamori, Osamu Kawamura, Motoyasu Kusano, Mototsugu Kato, Noriyuki Kawami, Katsuhiko Iwakiri, Toshihisa Takeuchi, Kazuhide Higuchi, Masahito Aimi, Kohji Naora, Kazuma Fujimoto, Tetsuo Arakawa, Yoshikazu Kinoshita

    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION   55 ( 3 )   178 - 183   2014年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION  

    Comparisons between the acid inhibitory effects of rabeprazole and esomeprazole after single oral administration with standard doses have not been previously presented. We examined intragastric pH after oral administrations of these two proton pump inhibitors using 24-h pH monitoring. Fifty-four normal volunteers not infected by Helicobacter pylori were investigated. Using a cross-over design, we administered 10 mg of rabeprazole or 20 mg of esomeprazole in 27 at 30 min after supper and in the remaining 27 subjects at 15 min before supper, and performed 24-h pH monitoring. Intra-gastric pH data were nearly identical when the proton pump inhibitors were taken after meals. Even if the data were compared in different CYP2C19 genotypes, rabeprazole and esomeprazole did not show the difference. In poor metabolizer, both of the drugs showed stronger acid inhibition. When taken before meals, intra-gastric pH after esomeprazole administration was slightly but not significantly higher than that observed after rabeprazole administration not only in daytime but also in nighttime period. In conclusion, rabeprazole and esomeprazole were similarly effective when administered after a meal.

    DOI: 10.3164/jcbn.14-41

    Web of Science

    researchmap

  • Correlation between Gastric Transtit Time Measured by Vtideo Capsule Endoscopy and Gastric Emptying Determined by the Continuous real-Time 13C Breath Test (BreathID System) 査読

    Takashi Nonaka, Masahiko Inamori, Hiroki Endo, Mizue Matsuura, Shiori Uchiyama, Eiji Yamada, Yusuke Sekino, Eiji Sakai, Takuma Higurashi, Hidenori Ohkubo, Keiko Akimoto, Hiroshi Iida, Hirokazu Takahashi, Tomoko Koide, Wataru Shibata, Tomonori Ida, Akihiko Kusakabe, Eiji Gotoh, Atsushi Nakajima, Shin Maeda

    HEPATO-GASTROENTEROLOGY   61 ( 135 )   2159 - 2162   2014年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to deter,. mine the possible existence of a correlation between the gastric transit time (GTT) measured by video capsule endoscopy (VCE) and the parameters of gastric empty! ing determined using 13C breath test (BreathID system). Methods: Eight healthy male volunteers participated in this randomized; two-way crossover study. The subjects were randomly assigned to undergo VCE using the pillCam SB capsule endoscopy system or the 13C breath test for 4 hours after a test meal (400 kcal per 400 mL) containing 100 mg of 13C acetic acid administered after overnight fasting. The VCE images were analyzed and the GTT was determined using the proprietary RAPID software. The parameters, namely T lag, T1/2 and GEC were calculated using the Oridion Research Software (beta version). The GTT measured by VCE and the parameters of gastric emptying were compared statistically. Results: No significant correlation was observed between the GTT and T lag (p = 0.5263), T 1/2 (p = 0.4100) or GEC (p = 0.2410), as determined by calculation of the Spearman's rank correlation coefficient. Conclusions: GTT measured by VCE cannot serve as a substitute for the gastric emptying time measured by the 13C breath test.

    DOI: 10.5754/hge13358

    Web of Science

    researchmap

  • Comparative Study of the QUEST Questionnaire and GerdQ. Questionnaire for Japanese students 査読

    Naomi Kikkawa, Masahiko Inamori, Sho Inoue, Yumi Mori, Hiroshi Iida, Takashi Nonaka, Akihiko Kusakabe, Atsushi Nakajima, Shin Maeda, Eiji Gotoh

    HEPATO-GASTROENTEROLOGY   61 ( 134 )   1605 - 1610   2014年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to comparatively examine the convenience of use of the QUEST and GerdQ questionnaires as self- administered diagnostic instruments. Methodology: This was a two-way crossover study conducted from December 2011 to April 2012. The subjects were 70 third-year nursing students of Yokohama Soei University in Yokohama, Japan. They were randomly assigned to fill in either of the study questionnaires first, and then the other on a later. Results: A significant difference was observed in the questionnaire completion time between the QUEST and GerdQ questionnaires (125.5 vs. 44 seconds, P &lt; 0.0001) and also in the number of subjects asking questions while completing the questionnaires (26 vs. 1 subject, respectively: P &lt; 0.0001). To detect GERD based on a QUEST score &gt;= 4 of ROC analysis revealed an area under the curve for the GerdQ score of 0.616. The sensitivity and specificity calculated using this cutoff value were 0.842 and 0.312, respectively. Conclusion: This study revealed that Japanese subjects may find it easier to complete the GerdQ than the QUEST questionnaire.

    DOI: 10.5754/hge14396

    Web of Science

    researchmap

  • [Current status of endoscopic diagnosis and treatment for superficial esophageal squamous cell carcinoma]. 査読

    稲森 正彦

    Nonaka T, Inamori M, Nakajima A.   41 ( 9 )   1082 - 1086   2014年9月

     詳細を見る

    記述言語:日本語  

    researchmap

  • Protective Effect of Lactoferrin on Acute Acid Reflux-Induced Esophageal Mucosal Damage 査読

    Masahiko Inamori, Jun-ichi Togawa, Shuhei Matsumoto, Koji Hara, Mizue Matsuura, Hiroshi Iida, Keiko Akimoto, Hiroki Endo, Takashi Nonaka, Hirokazu Takahashi, Tomoko Koide, Wataru Shibata, Tomonori Ida, Akihiko Kusakabe, Hajime Nagase, Shizuo Tominaga, Katsuaki Tanaka, Eiji Gotoh, Atsushi Nakajima, Shin Maeda

    HEPATO-GASTROENTEROLOGY   61 ( 134 )   1595 - 1600   2014年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background /Aims: The natural immunomodulator actoferrin is known to possess anti-inflammatory effects. However, there have been no studies examininig the mode of action of lactoferrin in protecting the esophageal mucosa against damage. We investigated the effect of lactoferrin on gastric acid secretion and in protecting against acute acid reflux-induced esophagitis in rats. Methodology: Male Wistar rats aged 8 weeks, weighing 210-240 g, were used for all the experiments. A gastric perfusion system was installed using the method of Ghosh et al. Lactoferrin was administered once via he caudate vein, starting 24 hours before an acute acid reflux (treatment mode), or saline (control). Statistical comparison of the parameters between the two test conditions was performed. Results: No significant differences in basal or stimulated gastric acid secretion, or in the serum gastrin level were observed between the two test conditions. Esophageal damage was attenuated by the improvement in the esophageal tissue weight and macroscopic scores. Significant reductions in the histological scores, myeloperoxidase activity and the levels of proinflammatory cytokines, tumor necrosis factor-a and interleukin-1 beta were also observed following lactoferrin administration. Conclusions: We concluded that lactoferrin exerts a protective effect against acute acid reflux-induced esophageal damage in rats.

    DOI: 10.5754/hge13380

    Web of Science

    researchmap

  • Effects of Ramosetron Oral Disintegrating Tablets on Gastric Emptying: Crossover Study Using the 13(C)-Acetic Acid Breath Test 査読

    Akihiko Kusakabe, Takashi Nonaka, Yusuke Sekino, Hiroshi Iida, Hiroki Endo, Tomoko Koide, Hirokazu Takahashi, Koji Fujita, Masato Yoneda, Ayumu Goto, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Chihiro Nosaka, Masahiko Inamori

    HEPATO-GASTROENTEROLOGY   61 ( 133 )   1279 - 1282   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Ramosetron is a new selective 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist that reportedly has more potent antiemetic effects than other 5-HT3 receptor antagonists. The aim of this study was to determine the effect of ramosetron pretreatment on gastric emptying using the 13c-acetic acid breath test. Methodology: Ten healthy male and female volunteers participated in this randomized, twoway crossover study. After they had fasted overnight, the subjects were randomly assigned to receive 0.1 mg ramosetron 1 hour before ingestion of a test meal (200 kcal per 200 mL, containing 100 mg 13(c) acetate) or to receive the test meal alone. Under both conditions, breath samples were collected for 150 min following ingestion of the meal. Statistical com arison of the parameters tetween e two test conditions was formed. Results: No significant differences in the lated parameters, including T 1/2, T lag, GEC or beta and kappa, were observed between the two test conditions. Conclusions: The present study revealed that 0.1 mg mosetron had no significant effect on the rate of gastric emptying. Thus, our results suggest that ramosetron can be administered safely, without gastrointestinal adverse effects, even to terminal cancer patients with delayed or accelerated gastric emptying abnormality.

    DOI: 10.5754/hge13057

    Web of Science

    researchmap

  • Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients 査読

    Masahiro Takihata, Akinobu Nakamura, Kazutaka Aoki, Mari Kimura, Yusuke Sekino, Masahiko Inamori, Shin Maeda, Eiji Gotoh, Atsushi Nakajima, Yasuo Terauchi

    OBESITY RESEARCH & CLINICAL PRACTICE   8 ( 4 )   E331 - E338   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    This study compared the impacts of intragastric balloon (IGB) therapy and intensive lifestyle modification therapy on abdominal fat distribution. Sixteen extremely obese Japanese patients were assigned to an intensive lifestyle modification therapy group with educational hospitalisation (8 patients) or an IGB therapy group (8 patients) and were followed up for 6 months. The main outcome measures were the differences at 6 months, relative to the baseline values, in the visceral fat area (VFA), subcutaneous fat area (SFA), and liver volume as measured using computed tomography. At 0 month, the body weights (BWs) were 121.3 +/- 19.0 kg and 127.1 +/- 24.4 kg and the VFAs were 299 +/- 55 cm(2) and 257 +/- 56 cm(2) in the intensive lifestyle modification therapy group and the IGB therapy group, respectively. No statistically significant differences in the baseline characteristics were observed between these two groups. At 6 months, no difference in the changes in BW from the baseline value (-11.5 [-16.4, -6.6] kg vs. -11.2 [-18.9, -3.4] kg) was seen between the two groups. However, a statistically significant difference in the change in the VFA (-66 [-87, -44] cm(2) vs. -22 [-70, 26] cm(2) [P = 0.027]) was observed; no significant changes in the SFA or liver volume were seen. In conclusion, IGB therapy was as effective as intensive lifestyle modification therapy for weight reduction but was less effective with respect to the improvement in abdominal visceral fat accumulation and liver steatosis in super-obese Japanese patients. (C) 2013 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.orcp.2013.07.002

    Web of Science

    researchmap

  • Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients

    Mio Komatsu-Tanaka, Ryuichi Iwakiri, Kazuma Fujimoto, Yasuhiro Fujiwara, Masahiko Inamori, Junji Tanaka, Tomohiko Shimatani, Junichi Akiyama, Takashi Ando, Noriaki Manabe, Fukunori Kinjo, Ryuzo Deguchi, Motoyasu Kusano

    Gastroenterological Endoscopy   56 ( 4 )   1589 - 1596   2014年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Japan Gastroenterological Endoscopy Society  

    Aim: The main aim of this study was to determine whether questionnaire evaluations of clinical symptoms in gastroesophageal reflux discase were useful to assess proton pump inhibitor therapy. Methods: A total of 185 Japanese patients (men, 88
    women, 97
    age : 55.7 ± 16.1 years) with gastroesophageal reflux disease were enrolled. The patients were divided based on the frequency scale for symptoms of gastroesophageal reflux disease : severe symptoms with scores ≥8 and mild symptoms with scores ≤7. Quality of life was evaluated with the Medical Outcomes Study 8-Item Short-Form Health Survey. All patients were treated with a proton pump inhibitor, rabe-prazole (10mg/day), for 8 weeks. Results: Patients were classified into four groups : reflux esophagitis with severe symptoms (n=92, 49.7%)
    reflux esophagitis with mild symptoms (n=17, 9.2%)
    non-erosive reflux disease with severe symptoms (n=66, 35.7%)
    and non-erosive reflux disease with mild symptoms (n=10, 5.4%). The dysmotility score was high in non-erosive reflux disease with severe symptoms compared with reflux esophagitis with severe symptoms (9.1 ± 0.5 vs 6.8 ± 0.5, P&lt
    0.05). The symptom score and quality of life in the severe symptoms groups for both reflux esophagitis and non-erosive reflux disease were significantly improved by rabeprazole treatment. Only the reflux score was improved by rabeprazole in the reflux esophagitis with mild symptoms group
    no therapeutic effect was observed for the non-erosive reflux disease with mild symptoms group. Conclusions: Low scores on the frequency scale for the symptoms of gastroesophageal reflux disease indicate poor responsiveness to proton pump inhibitor treatment, and high scores indicate good responsiveness.

    Scopus

    researchmap

  • Early colon cancer presenting as intussusception and successfully treated using endoscopic submucosal dissection 査読

    Hideyuki Chiba, Akihiro Takahashi, Masahiko Inamori, Toru Goto, Ken Ohata, Nobuyuki Matsuhashi, Atsushi Nakajima

    ENDOSCOPY   46 ( Suppl 1 )   E326 - E327   2014年

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0034-1377224

    Web of Science

    researchmap

  • Lubiprostone Decreases the Small Bowel Transit Time by Capsule Endoscopy: An Exploratory, Randomised, Double-Blind, Placebo-Controlled 3-Way Crossover Study 査読

    Mizue Matsuura, Masahiko Inamori, Hiroki Endo, Tetsuya Matsuura, Kenji Kanoshima, Yumi Inoh, Yuji Fujita, Shotaro Umezawa, Akiko Fuyuki, Shiori Uchiyama, Takuma Higurashi, Hidenori Ohkubo, Eiji Sakai, Hiroshi Iida, Takashi Nonaka, Seiji Futagami, Akihiko Kusakabe, Shin Maeda, Atsushi Nakajima

    GASTROENTEROLOGY RESEARCH AND PRACTICE   2014   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:HINDAWI PUBLISHING CORPORATION  

    The aim of this study was to investigate the usefulness of lubiprostone for bowel preparation and as a propulsive agent in small bowel endoscopy. Six healthy male volunteers participated in this randomized, 3-way crossover study. The subjects received a 24 mu g tablet of lubiprostone 60 minutes prior to the capsule ingestion for capsule endoscopy (CE) and a placebo tablet 30 minutes before the capsule ingestion (L-P regimen), a placebo tablet 60 minutes prior to CE and a 24 mu g tablet of lubiprostone 30 minutes prior to CE (P-L regimen), or a placebo tablet 60 minutes prior to r CE and a placebo tablet again 30 minutes prior to CE (P-P regimen). The quality of the capsule endoscopic images and the amount of water in the small bowel were assessed on 5-point scale. The median SBTT was 178.5 (117-407) minutes in the P-P regimen, 122.5 (27-282) minutes in the L-P regimen, and 110.5 (11-331) minutes in the P-L regimen (P = 0.042). This study showed that the use of lubiprostone significantly decreased the SBTT. We also confirmed that lubiprostone was effective for inducing water secretion into the small bowel during CE.

    DOI: 10.1155/2014/879595

    Web of Science

    researchmap

  • Endoscopic removal of a migrated stent in the gallbladder 査読

    Tomonori Ida, Masahiko Inamori, Jun Hamanaka, Hideyuki Chiba, Akihiko Kusakabe, Taiki Morohashi, Atsushi Nakajima, Shin Maeda, Toru Goto

    ENDOSCOPY   46 ( Suppl 1 )   E539 - E540   2014年

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0034-1377634

    Web of Science

    researchmap

  • 死亡診断時の医師の立ち振る舞いについてのマニュアル作成の意義

    日下部 明彦, 大谷 洋一, 角藤 厚美, 岩見 加奈子, 佐藤 晶子, 平田 知子, 横井 信人, 津崎 洋子, 八木 宏章, 田村 陽一, 沖田 将人, 稲森 正彦

    癌と化学療法   40 ( Suppl.II )   199 - 201   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)癌と化学療法社  

    死亡診断の場面での医師の立ち振る舞いは、その後の遺族の悲嘆に大きく影響を及ぼすと考えられる。医師教育のなかには死後の内容はほとんど含まれず、グリーフケアを意識して死亡確認を行う医師は少ないことが予想される。緩和ケア病棟の看護師へのアンケート調査を行った結果、主治医と主治医以外の医師では死亡診断の際の立ち振る舞いに違いがあることが示された。主治医以外の医師であってもグリーフケアを意識した死亡確認ができるように、立ち会う看護師の声に基づき、死亡診断時の医師の立ち振る舞いについてのマニュアルを作成した。(著者抄録)

    researchmap

  • [Case report; a case of congenital haptoglobin deficiency diagnosed after transfusion for esophageal varix rupture]. 査読

    Azuma A, Iida H, Yoneda M, Takahashi H, Inamori M, Kirikoshi H, Nakajima A, Maeda S, Saito S, Kamijyo A

    Nihon Naika Gakkai Zasshi   102 ( 11 )   2980 - 2982   2013年11月

     詳細を見る

    記述言語:日本語  

    researchmap

  • Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan 査読

    R. Iwakiri, K. Tominaga, K. Furuta, M. Inamori, T. Furuta, H. Masuyama, K. Kanke, A. Nagahara, K. Haruma, Y. Kinoshita, K. Higuchi, S. Takahashi, M. Kusano, K. Iwakiri, M. Kato, M. Hongo, H. Hiraishi, S. Watanabe, H. Miwa, Y. Naito, K. Fujimoto, T. Arakawa

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS   38 ( 7 )   729 - 740   2013年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Background
    The efficacy of proton pump inhibitors (PPIs) for treating functional dyspepsia (FD) is not well established.
    Aim
    This study, named the SAMURAI study, aimed to assess the efficacy and dose-response relationship of rabeprazole in Japanese patients with FD in a multicentre, double-blinded, randomised, placebo-controlled trial.
    Methods
    Investigated FD was diagnosed using the Rome III criteria. Subjects who did not respond to 1 week of single-blind placebo treatment in a run-in period were randomly assigned to 8 weeks of double-blind treatment with rabeprazole 10 mg, 20 mg, 40 mg or placebo, once daily. Dyspeptic symptoms were assessed by a dyspepsia symptom questionnaire (7-point Likert scale) and symptom diary.
    Results
    Of 392 subjects entered into the run-in period, 338 were randomly assigned. Although there was no significant difference between placebo and rabeprazole groups in complete symptom relief for four major dyspeptic symptoms, the satisfactory symptom relief of rabeprazole 20 mg was significantly higher than placebo according to the dyspepsia symptom questionnaire (45.3% vs. 28.2%, P = 0.027) and the symptom diary assessment (48.7% vs. 30.0%, P = 0.016). The efficacy was not influenced by syndrome type or Helicobacter pylori status. No statistically significant differences in the incidence of adverse events were seen among treatment groups.
    Conclusions
    Rabeprazole 20 mg once daily but not 10 or 40 mg significantly provides satisfactory symptom relief for functional dyspepsia.

    DOI: 10.1111/apt.12444

    Web of Science

    PubMed

    researchmap

  • Factors predicting the presence of small bowel lesions in patients with obscure gastrointestinal bleeding 査読

    Eiji Sakai, Hiroki Endo, Leo Taniguchi, Yasuo Hata, Akiko Ezuka, Hajime Nagase, Eiji Yamada, Hidenori Ohkubo, Takuma Higurashi, Yusuke Sekino, Tomoko Koide, Hiroshi Iida, Kunihiro Hosono, Takashi Nonaka, Hirokazu Takahashi, Masahiko Inamori, Shin Maeda, Atsushi Nakajima

    Digestive Endoscopy   25 ( 4 )   412 - 420   2013年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Aim To identify the predictive factors for the presence of small bowel lesions in patients with obscure gastrointestinal bleeding (OGIB). Methods A total of 242 patients with OGIB (overt 149: occult 93) were retrospectively included in the present study. Capsule endoscopy (CE) was carried out to investigate the small bowel, and detected lesions were classified according to the P0-P2 system. Only P2 lesions were defined as significant lesions. Univariate and multivariate logistic regression analyses were carried out to define the predictive factors for the presence of small bowel lesions. Results In patients with overt OGIB, chronic kidney disease (CKD) ≥stage 4 (odds ratio [OR] 4.03
    95% confidence interval [CI] 1.45-11.1, P = 0.007) was identified as an independent predictor of the presence of vascular lesions, and a history of non-steroidalanti-inflammatory drug (NSAID) use as that of erosive/ulcerated lesions (OR 4.73
    95% CI 1.47-15.2, P = 0.009). However, in patients with occult OGIB, no significant predictors of the presence of vascular lesions were identified, whereas a history of low-dose aspirin (LDA) (OR 3.57
    95% CI 1.21-10.5, P = 0.02) and proton pump inhibitor (PPI) use (OR 3.18
    95% CI 1.02-9.92, P = 0.05) were identified as independent predictors of the presence of erosive/ulcerated lesions. Conclusions Our results indicated that bleeding pattern and clinical characteristics could contribute to predicting the origin of OGIB. © 2012 The Authors.

    DOI: 10.1111/den.12002

    Scopus

    PubMed

    researchmap

  • Assessment of Small Bowel Motility in Patients With Chronic Intestinal Pseudo-Obstruction Using Cine-MRI 査読

    Hidenori Ohkubo, Takaomi Kessoku, Akiko Fuyuki, Hiroshi Iida, Masahiko Inamori, Tetsuro Fujii, Harunobu Kawamura, Yasuo Hata, Noriaki Manabe, Toshimi Chiba, Thomas C. Kwee, Ken Haruma, Nobuyuki Matsuhashi, Atsushi Nakajima, Taro Takahara

    AMERICAN JOURNAL OF GASTROENTEROLOGY   108 ( 7 )   1130 - 1139   2013年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    OBJECTIVES : Chronic intestinal pseudo-obstruction (CIPO) is a rare, serious motility disorder, with life-threatening complications over time. However, lack of an established, non-invasive diagnostic method has caused delays in the diagnosis of this intractable disease. Cine-magnetic resonance imaging (MRI) is an emerging technique, with a potential to evaluate the motility of the entire bowel. We compared small bowel motility in healthy volunteers, patients with irritable bowel syndrome (IBS), and those with CIPO, using cine-MRI, and evaluated the usefulness of cine-MRI as a novel diagnostic method for CIPO.
    METHODS: Twelve healthy volunteers, IBS patients, and CIPO patients prospectively underwent cine-MRI at 1.5 T. Luminal diameter, contraction ratio, and contraction cycle were measured and compared between the groups.
    RESULTS: Cine-MRI provided sufficient dynamic images to assess the motility of the entire small bowel. Luminal diameter (mean +/- s.d.) in CIPO patients was significantly higher than that in healthy volunteers and IBS patients (43.4 +/- 14.1, 11.1 +/- 1.5, and 10.9 +/- 1.9 mm, respectively), and contraction ratio was significantly lower in CIPO patients than that in healthy volunteers and IBS patients (17.1 +/- 11.0%, 73.0 +/- 9.3%, and 74.6 +/- 9.4%, respectively). No significant differences were observed in the contraction cycle.
    CONCLUSIONS: This study is the first to assess the clinical utility of cine-MRI in CIPO patients. Cine-MRI clearly detected contractility impairments in CIPO patients. Cine-MRI is noninvasive, radiation-free, and can directly evaluate the entire small bowel peristalsis, and can detect the affected loops at a glance; therefore, it might be extremely useful for the diagnosis and follow-up of CIPO patients in clinical practice.

    DOI: 10.1038/ajg.2013.57

    Web of Science

    PubMed

    researchmap

  • Factors predicting the presence of small bowel lesions in patients with obscure gastrointestinal bleeding 査読

    Eiji Sakai, Hiroki Endo, Leo Taniguchi, Yasuo Hata, Akiko Ezuka, Hajime Nagase, Eiji Yamada, Hidenori Ohkubo, Takuma Higurashi, Yusuke Sekino, Tomoko Koide, Hiroshi Iida, Kunihiro Hosono, Takashi Nonaka, Hirokazu Takahashi, Masahiko Inamori, Shin Maeda, Atsushi Nakajima

    Digestive Endoscopy   25 ( 4 )   412 - 420   2013年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:4  

    Aim To identify the predictive factors for the presence of small bowel lesions in patients with obscure gastrointestinal bleeding (OGIB). Methods A total of 242 patients with OGIB (overt 149: occult 93) were retrospectively included in the present study. Capsule endoscopy (CE) was carried out to investigate the small bowel, and detected lesions were classified according to the P0-P2 system. Only P2 lesions were defined as significant lesions. Univariate and multivariate logistic regression analyses were carried out to define the predictive factors for the presence of small bowel lesions. Results In patients with overt OGIB, chronic kidney disease (CKD) ≥stage 4 (odds ratio [OR] 4.03
    95% confidence interval [CI] 1.45-11.1, P = 0.007) was identified as an independent predictor of the presence of vascular lesions, and a history of non-steroidalanti-inflammatory drug (NSAID) use as that of erosive/ulcerated lesions (OR 4.73
    95% CI 1.47-15.2, P = 0.009). However, in patients with occult OGIB, no significant predictors of the presence of vascular lesions were identified, whereas a history of low-dose aspirin (LDA) (OR 3.57
    95% CI 1.21-10.5, P = 0.02) and proton pump inhibitor (PPI) use (OR 3.18
    95% CI 1.02-9.92, P = 0.05) were identified as independent predictors of the presence of erosive/ulcerated lesions. Conclusions Our results indicated that bleeding pattern and clinical characteristics could contribute to predicting the origin of OGIB. © 2012 The Authors.

    DOI: 10.1111/den.12002

    Scopus

    PubMed

    researchmap

  • Epidemiology and Clinical Experience of Chronic Intestinal Pseudo-Obstruction in Japan: A Nationwide Epidemiologic Survey 査読

    Hiroshi Iida, Hidenori Ohkubo, Masahiko Inamori, Atsushi Nakajima, Hajime Sato

    JOURNAL OF EPIDEMIOLOGY   23 ( 4 )   288 - 294   2013年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN EPIDEMIOLOGICAL ASSOC  

    Background: We estimated the prevalence and incidence of chronic intestinal pseudo-obstruction (CIPO) in Japan, investigated the patterns of hospital visits among those with CIPO, and examined present knowledge of CIPO among medical professionals.
    Methods: A self-administered questionnaire survey was distributed to targeted hospitals throughout Japan, which were selected using stratified random sampling. The questionnaire asked about the number of patients receiving treatment for CIPO, the frequency of their hospital visits, and overall clinical knowledge of CIPO among medical professionals.
    Results: CIPO prevalence was estimated to be 1.00 and 0.80 cases per 100 000 males and females, respectively. Incidence was 0.21 and 0.24 cases per 100 000 males and females, respectively. Prevalence and incidence did not significantly differ males and females. Mean age of patients was 63.1 years for males and 59.2 for females. Accurate diagnosis of CIPO sometimes required more than 3 months after initial presentation. Most medical professionals were unaware of or poorly understood CIPO.
    Conclusions: We estimated the prevalence and incidence of CIPO in Japan, using data from a nationwide survey. The findings suggest that knowledge of CIPO should be further disseminated so that the disease is not overlooked and is diagnosed without delay.

    DOI: 10.2188/jea.JE20120173

    Web of Science

    PubMed

    researchmap

  • Is the Completion Time of a Questionnaire a Pivotal Factor When Proving Feasibility?: Author's Reply 査読

    Takashi Nonaka, Masahiko Inamori

    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY   19 ( 2 )   268 - 269   2013年4月

     詳細を見る

    記述言語:英語   出版者・発行元:KOREAN SOC NEUROGASTERONTEROL & MOTILITY  

    DOI: 10.5056/jnm.2013.19.2.268

    Web of Science

    PubMed

    researchmap

  • Early effect of single-dose sitagliptin administration on gastric emptying: Crossover study using the 13C breath test 査読

    Takashi Nonaka, Yusuke Sekino, Hiroshi Iida, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Takuma Higurashi, Kunihiro Hosono, Hiroki Endo, Tomoko Koide, Hirokazu Takahashi, Koji Fujita, Masato Yoneda, Ayumu Goto, Akihiko Kusakabe, Noritoshi Kobayashi, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Chihiro Nosaka, Masahiko Inamori

    Journal of Neurogastroenterology and Motility   19 ( 2 )   227 - 232   2013年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:2  

    Background/Aims: The gastrointestinal motility effects of endogenous incretin hormones enhanced by dipeptidyl peptidase-IV (DPP-IV) inhibitors have not yet been sufficiently investigated. The aim of this study was to determine whether single pre-prandial sitagliptin, the DPP-IV inhibitor, administration might have an effect on the rate of liquid gastric emptying using the 13C-acetic acid breath test. Methods Ten healthy male volunteers participated in this randomized, two-way crossover study. The subjects fasted for overnight and were randomly assigned to receive 50 mg sitagliptin 2 hours before ingestion of the liquid test meal (200 kcal per 200 mL, containing 100 mg 13C-acetate) or the test meal alone. Under both conditions, breath samples were collected for 150 minutes following the meal. Liquid gastric emptying was estimated by the values of the following parameters: the time required for 50% emptying of the labeled meal (T1/2), the analog to the scintigraphy lag time for 10% emptying of the labeled meal (Tlag), the gastric emptying coefficient and the regression-estimated constants (β and κ), calculated by using the 13CO2 breath excretion curve using the conventional formulae. The parameters between the 2 test conditions were compared statistically. Results No significant differences in the calculated parameters, including T1/2, Tlag, gastric emptying coefficient or ß and κ, were observed between the 2 test conditions. Conclusions The present study revealed that single-dose sitagliptin intake had no significant influence on the rate of liquid gastric emptying in asymptomatic volunteers. © 2013 The Korean Society of Neurogastroenterology and Motility.

    DOI: 10.5056/jnm.2013.19.2.227

    Scopus

    PubMed

    researchmap

  • Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma 査読

    Kenichiro Yabuki, Akira Kubota, Choichi Horiuchi, Takahide Taguchi, Goshi Nishimura, Masahiko Inamori

    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY   270 ( 2 )   727 - 733   2013年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    The aim of this study was to verify the effectiveness of PET (positron emission tomography) or PET/CT (fusion images of PET with computed tomography) in detecting synchronous cancer in patients with head and neck carcinoma. We reviewed 682 patients with carcinoma of the head and neck between January 2001 and December 2010. In 98 patients, 111 synchronous cancers were diagnosed. Of these 98 patients, the index cancer was predominantly located in the hypopharynx (47 cases), followed by the larynx (23 cases), oropharynx (12 cases) and the oral cavity (6 cases). Esophageal cancer was diagnosed as the most synchronous cancer (57 lesions), followed by gastric cancer (20 lesions), lung cancer (9 lesions) and head and neck cancer (8 lesions). Among these 98 patients, PET or PET/CT was performed in 82 patients. Of these 82 patients, PET or PET/CT detected 34 out of 94 (36.2 %) synchronous cancers. No significant difference was observed between PET and PET/CT in terms of lesion detectability (p = 0.21). Regarding synchronous T1 and Tis upper gastrointestinal (UGI) cancer, PET or PET/CT detected 4 out of 43 (9.3 %) of the cancers. No statistical difference in detectability was observed in patients who underwent PET or PET/CT scanning before or after histological examination of synchronous UGI cancer. In conclusion, synchronous cancer was most frequently observed in the UGI, especially in the esophagus in patients with head and neck carcinoma. PET and PET/CT have limitations in the detection of these lesions.

    DOI: 10.1007/s00405-012-2081-9

    Web of Science

    PubMed

    researchmap

  • Involvement of the apelin receptor APJ in Fas-induced liver injury 査読

    Hiroaki Yasuzaki, Shin-ichirou Yoshida, Tatsuo Hashimoto, Wataru Shibata, Masahiko Inamori, Yoshiyuki Toya, Kouichi Tamura, Shin Maeda, Satoshi Umemura

    LIVER INTERNATIONAL   33 ( 1 )   118 - 126   2013年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Background Apelin-APJ signalling is known to play important roles in heart physiology and pathology; however, its functions in liver physiology and pathology remain unclear. On the other hand, Fas is an important molecule in hepatitis and other liver disease that belongs to the death receptor family. The aim of this study was to assess the relationship between apelin-APJ signaling and Fas-mediated liver injury in mice. Methods APJ-/- mice and wild type (WT) mice were administered an intraperitoneal injection of an agonistic anti-Fas antibody (clone; Jo2), and sacrificed after 3 or 6 h to assess the liver histology. The expression levels of apelin and APJ, plasma levels of transaminases, activities of hepatic caspases and activations of stress-activated protein kinases were also analysed. Results Before the Jo2 injection, APJ was weakly expressed in the hepatocytes in spots; on the other hand, after the Jo2 injection, it had spread into whole hepatocytes. Moreover, the mRNA expression level of apelin and APJ in the liver increased after Jo2 injection. In the APJ-/- mice, the liver injuries and apoptotic changes were significantly inhibited as compared with those in the WT mice. Dramatic increase in JNK activation was observed in the WT mice after Jo2 injection, whereas such activation was completely absent in the APJ-/- mice. JNK inhibitor partially, but significantly suppressed Jo2-mediated liver injury in WT mice. Conclusion Apelin-APJ signalling may promote Fas-induced liver injury at least partially via JNK activation, and may thus serve as a potential therapeutic target in cases of acute liver injury.

    DOI: 10.1111/liv.12006

    Web of Science

    PubMed

    researchmap

  • Comparative Study of 2 Different Questionnaires in Japanese Patients: The Quality of Life and Utility Evaluation Survey Technology Questionnaire (QUEST) Versus the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease Questionnaire (FSSG) 査読

    Takashi Nonaka, Takaomi Kessoku, Yuji Ogawa, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Yusuke Sekino, Hiroshi Iida, Hiroki Endo, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Shin Maeda, Atsushi Nakajima, Eiji Gotoh, Masahiko Inamori

    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY   19 ( 1 )   54 - 60   2013年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KOREAN SOC NEUROGASTERONTEROL & MOTILITY  

    Background/Aims
    The aim of this study was to examine the convenience of the quality of life and utility evaluation survey technology (QUEST) questionnaire and the frequency scale for the symptoms of gastroesophageal reflux disease (FSSG) questionnaire as self-assessment diagnostic instrument.
    Methods
    This was a two-way crossover study conducted over 6 weeks from September 2010 to November 2010. The subjects were 60 consecutive patients admitted to the Hiratsuka city hospital with a gastrointestinal condition, regardless of the coexistence of heartburn. They were assigned to fill in both the QUEST and FSSG questionnaires in random order. We analyzed the time taken to complete the questionnaires, whether subjects asked any questions as they filled in the questionnaire, and the questionnaire scores.
    Results
    Comparison of the QUEST and the FSSG revealed significant differences in the completion time (196.5 vs. 97.5 seconds, respectively; P &lt; 0.0001) and in whether subjects asked any questions (37 vs. 15 subjects, respectively; P &lt; 0.0001). Completion time in QUEST scores of &gt;= 4 was lower than &lt; 4 (170.5 vs. 214.0 seconds, respectively; P = 0.022), and the QUEST score was significantly higher without questions than with question (3 vs. 1 points, respectively; P = 0.025).
    Conclusions
    This study revealed that the FSSG questionnaire may be easier for Japanese subjects to complete than the QUEST questionnaire.

    DOI: 10.5056/jnm.2013.19.1.54

    Web of Science

    PubMed

    researchmap

  • Characteristics of the small bowel lesions detected by capsule endoscopy in patients with chronic kidney disease 査読

    Harunobu Kawamura, Eiji Sakai, Hiroki Endo, Leo Taniguchi, Yasuo Hata, Akiko Ezuka, Hajime Nagase, Takaomi Kessoku, Eiji Yamada, Hidenori Ohkubo, Takuma Higrashi, Yusuke Sekino, Tomoko Koide, Hiroshi Iida, Takashi Nonaka, Hirokazu Takahashi, Masahiko Inamori, Shin Maeda, Atsushi Nakajima

    Gastroenterology Research and Practice   2013   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Obscure gastrointestinal bleeding (OGIB) is one of the common complications in patients with chronic kidney disease (CKD), especially those who are on maintenance hemodialysis (HD). However, little is known about the characteristics of the small-bowel lesions in these patients, or of the factors that could predict the presence of such lesions. Therefore we enrolled a total of 42 CKD patients (including 19 HD patients and 23 non-HD patients), and compared the incidence of the small-bowel lesions among two groups. Furthermore, to identify predictive factors for the presence of small-bowel lesions, we performed multivariate logistic-regression-analyses. The incidence of small-bowel vascular lesions was significantly higher in CKD patients than in age-and-sex matched non-CKD patients (P &lt
    0.001). On the other hand, there was any significant difference of the incidence of small-bowel lesions between HD and non-HD patients. In CKD patients, past history of blood transfusion (OR 5.66
    95% CI 1.10-29.1, P = 0.04) was identified as an independent predictor of the presence of vascular lesions, and history of low-dose aspirin use (OR 6.00
    95% CI 1.13-31.9, P = 0.04) was identified as that of erosive/ulcerated lesions. This indicated that proactive CE examination would be clinically meaningful for these patients. © 2013 Harunobu Kawamura et al.

    DOI: 10.1155/2013/814214

    Scopus

    researchmap

  • Assessment of Small Bowel Motility in Patients With 査読

    Hidenori Ohkubo, MD, Takaomi Kessoku, MD, Akiko Fuyuki, MD, Hiroshi Iida, MD, PhD, Masahiko Inamori, MD, PhD

    The American Journal of GASTROENTEROLOGY   10 ( 1038 )   2013年

     詳細を見る

  • Postpyloric decompression tube placement through a gastrostomy for malignant bowel obstruction 査読

    Yusuke Kurita, Tomoko Koide, Seitaro Watanabe, Tatsuya Ogawa, Yusuke Sekino, Hiroshi Iida, Takashi Nonaka, Akihiko Kusakabe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    BMC Research Notes   6 ( 1 )   217   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: Malignant bowel obstruction affect a patient's quality of life, but, management of MBO is controversial. Case presentation. A 51-year-old woman who had been diagnosed as uterine cervix cancer 2 years ago and had undergone surgery, chemotherapy and radiotherapy, was admitted to our hospital. She was diagnosed as having a recurrence of peritoneal metastasis and bowel obstruction. For her nasal pain, we considered insertion of a postpyloric decompression tube through the gastrostomy instead of via the nasal cavity. After insertion of a percutaneous gastrostomy tube was performed endoscopically, we introduced a postpyloric decompression tube through her gastrostomy. She could be discharged home, and 91 days later, she died in her home under hospice care, as she had wished. Conclusions: Insertion of a postpyloric decompression tube through a gastrostomy might be useful in the management of advanced cancer patients with bowel obstruction. © 2013 Kurita et al.
    licensee BioMed Central Ltd.

    DOI: 10.1186/1756-0500-6-217

    Scopus

    PubMed

    researchmap

  • Gastric Neuroendocrine Carcinoma with Non-islet Cell Tumor Hypoglycemia Associated with Enhanced Production of Insulin-like Growth Factor II 査読

    Tomonori Ida, Taiki Morohashi, Hiroshi Ohara, Toru Goto, Masahiko Inamori, Atsushi Nakajima, Shin Maeda, Yoko Tsukumo, Atsuhiko Sakamoto, Yukio Ishikawa

    INTERNAL MEDICINE   52 ( 7 )   757 - 760   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    A 75-year-old man was admitted to the hospital with a loss of consciousness. His blood glucose level was 24 mg/dL. Abdominal computed tomography revealed multiple metastatic lesions in the liver, while upper endoscopy disclosed advanced gastric cancer. The hypoglycemia was refractory despite the administration of glucose and steroid therapy. The patient died within one month of admission. An autopsy revealed neuroendocrine-type gastric cancer, which, on examination with immunohistochemistry, was found to be negative for insulin and insulin-like growth factor I and positive for insulin-like growth factor II (IGF-II). The patient was diagnosed as having gastric cancer with non-islet cell tumor hypoglycemia (NICTH) caused by IGF-II.

    DOI: 10.2169/internalmedicine.52.9372

    Web of Science

    PubMed

    researchmap

  • Hepatic portal venous gas development following percutaneous endoscopic gastrostomy 査読

    Yuichiro Kadomatsu, Takuto Kojima, Mana Kohara, Masahiko Inamori

    Internal Medicine   52 ( 1 )   153   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:1  

    DOI: 10.2169/internalmedicine.52.8782

    Scopus

    PubMed

    researchmap

  • [Operational management in our hospice ward-from the viewpoint of supporting a patient's recuperation at home]. 査読

    Kusakabe A, Sugiura R, Yamamoto K, Yokoi N, Tsuzaki Y, Noda Y, Satou A, Okita M, Mawatari H, Inamori M

    Gan to kagaku ryoho. Cancer & chemotherapy   39 Suppl 1   39 - 41   2012年12月

     詳細を見る

  • Influence of sumatriptan on gastric accommodation and on antral contraction in healthy subjects assessed by ultrasonography 査読

    Y. Sekino, E. Yamada, E. Sakai, H. Ohkubo, T. Higurashi, H. Iida, H. Endo, H. Takahashi, T. Koide, Y. Sakamoto, T. Nonaka, E. Gotoh, S. Maeda, A. Nakajima, M. Inamori

    NEUROGASTROENTEROLOGY AND MOTILITY   24 ( 12 )   1083 - +   2012年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Background Oral sumatriptan administration has been reported to delay gastric emptying after liquid meals. The aim of this study was to determine whether delayed gastric emptying is caused by enhanced gastric accommodation, impaired antral contractions, or both using ultrasonography. Methods Ten healthy volunteers were enrolled in this randomized two-way crossover study. After overnight fasting, the subjects received the liquid meal 60 min after ingesting a 50 mg sumatriptan tablet with 50 mL of water or 50 mL of water alone (control). The cross-sectional area of the proximal stomach was measured in a supine position after every 100 mL. The frequency and amplitude of the antral contractions were measured in a slightly backward sitting position. The intragastric distribution of the liquid meal was assessed by calculating the proximal stomach/distal stomach ratio (prox/distal ratio). Key Results The cross-sectional area after drinking 100, 200, and 300 mL of the liquid meal (oral sumatriptan vs control) was 34.49 vs 15.11 cm2 (P = 0.0051), 48.00 vs 30.61 cm2 (P = 0.0166), and 58.67 vs 47.19 cm2 (P = 0.0125), respectively. There was no significant difference in the amplitude of contractions, contraction cycle, motility index, and prox/distal ratio (97.15 vs 97.93%, P = 0.0745; 19.42 vs 19.5 s, P = 0.8590; and 887.58 vs 889.22, P = 0.5751; 9.75 vs 8.41, P = 0.8785; respectively). Conclusions & Inferences Oral sumatriptan administration enhanced gastric accommodation after the ingestion of liquid nutrients, but had no significant effect on antral contractions or intragastric distribution in healthy subjects.

    DOI: 10.1111/j.1365-2982.2012.01984.x

    Web of Science

    PubMed

    researchmap

  • [Usefulness of a manual on physician behavior at the time of death confirmation]. 査読

    Kusakabe A, Otani Y, Kakuto A, Iwami K, Sato A, Hirata T, Yokoi N, Tsuzaki Y, Yagi H, Tamura Y, Okita M, Inamori M

    Gan To Kagaku Ryoho   40 ( Suppl 2 )   199 - 201   2012年12月

     詳細を見る

    記述言語:日本語  

    researchmap

  • 当院ホスピス病棟の運用システム 在宅療養を支えるには

    日下部 明彦, 杉浦 龍太, 山本 かおり, 横井 信人, 津崎 洋子, 野田 優子, 佐藤 晶子, 沖田 将人, 馬渡 弘典, 稲森 正彦

    癌と化学療法   39 ( Suppl.I )   39 - 41   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)癌と化学療法社  

    多くの終末期がん患者がホスピス・緩和ケア病棟での療養を希望するが、実際に利用できる患者は非常に少ない。当院は、「なるべく多くの方に緩和ケアを提供する」ことを目標とし、「一般病棟も含め緩和ケアの場とする」、「ホスピスへの入院はホスピスを希望する方のなかで最も予後予測の悪い方を優先する」を実践してきた。2007年4月~2011年3月の集計で87%の患者が希望するタイミングで当院に入院できた。地域の医療資源を考慮してホスピス病棟の運用を工夫することで、終末期がん患者はより多くの時間を自宅で過ごせる可能性があると考える。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/default/link?pub_year=2012&ichushi_jid=J00296&link_issn=&doc_id=20121228360014&doc_link_id=issn%3D0385-0684%26volume%3D39%26issue%3D12%26spage%3D39&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0385-0684%26volume%3D39%26issue%3D12%26spage%3D39&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients 査読

    Mio Komatsu-Tanaka, Ryuichi Iwakiri, Kazuma Fujimoto, Yasuhiro Fujiwara, Masahiko Inamori, Junji Tanaka, Tomohiko Shimatani, Junichi Akiyama, Takashi Ando, Noriaki Manabe, Fukunori Kinjo, Ryuzo Deguchi, Motoyasu Kusano

    DIGESTIVE ENDOSCOPY   24 ( 6 )   407 - 411   2012年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim: The main aim of this study was to determine whether questionnaire evaluations of clinical symptoms in gastroesophageal reflux disease were useful to assess proton pump inhibitor therapy. Methods: A total of 185 Japanese patients (men, 88; women, 97; age: 55.7 +/- 16.1 years) with gastroesophageal reflux disease were enrolled. The patients were divided based on the frequency scale for symptoms of gastroesophageal reflux disease: severe symptoms with scores =8 and mild symptoms with scores =7. Quality of life was evaluated with the Medical Outcomes Study 8-Item Short-Form Health Survey. All patients were treated with a proton pump inhibitor, rabeprazole (10 mg/day), for 8 weeks. Results: Patients were classified into four groups: reflux esophagitis with severe symptoms (n = 92, 49.7%); reflux esophagitis with mild symptoms (n = 17, 9.2%); non-erosive reflux disease with severe symptoms (n = 66, 35.7%); and non-erosive reflux disease with mild symptoms (n = 10, 5.4%). The dysmotility score was high in non-erosive reflux disease with severe symptoms compared with reflux esophagitis with severe symptoms (9.1 +/- 0.5 vs 6.8 +/- 0.5, P &lt; 0.05). The symptom score and quality of life in the severe symptoms groups for both reflux esophagitis and non-erosive reflux disease were significantly improved by rabeprazole treatment. Only the reflux score was improved by rabeprazole in the reflux esophagitis with mild symptoms group; no therapeutic effect was observed for the non-erosive reflux disease with mild symptoms group. Conclusions: Low scores on the frequency scale for the symptoms of gastroesophageal reflux disease indicate poor responsiveness to proton pump inhibitor treatment, and high scores indicate good responsiveness.

    DOI: 10.1111/j.1443-1661.2012.01301.x

    Web of Science

    PubMed

    researchmap

  • Assessment of gastric emptying function after gastrectomy using a real-time ¹³C breath test. 査読

    Homma Y, Akiyama H, Matsuyama R, Makino H, Sakamoto Y, Inamori M, Nakajima A, Maeda S, Tanaka K, Kunisaki C, Endo I

    Hepato-gastroenterology   59 ( 119 )   2335 - 2338   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:119  

    DOI: 10.5754/hge11849

    Web of Science

    PubMed

    researchmap

  • [Current topics related to the management of functional dyspepsia: discussion]. 査読

    Nagahara A, Inamori M, Iwakiri R, Tomita T, Furuta K

    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology   109   1730 - 1744   2012年10月

     詳細を見る

    出版者・発行元:10  

    PubMed

    researchmap

  • Clinical associations and risk factors for bleeding from colonic angiectasia: a case-controlled study 査読

    Y. Sekino, H. Endo, E. Yamada, E. Sakai, H. Ohkubo, T. Higurashi, H. Iida, K. Hosono, H. Takahashi, T. Koide, T. Nonaka, Y. Abe, E. Gotoh, S. Maeda, A. Nakajima, M. Inamori

    COLORECTAL DISEASE   14 ( 10 )   E740 - E746   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim A case-controlled study was performed to investigate the association of colonic angiectasia with other conditions and to identify risk factors for bleeding. Method Information was collected from all patients who underwent colonoscopy at our hospital between January 2008 and December 2010. Data on 90 individuals with angiectasia [58 men; median age 69 (2692) years] were compared with those of 180 individuals without angiectasia, matched for gender and age. Results Multivariate analysis showed that occult gastrointestinal bleeding [odds ratio (OR) 2.523; 95% confidence interval (CI) 1.2385.142], liver cirrhosis (OR 13.195; 95% CI 3.50249.711), chronic renal failure (OR 6.796; 95% CI 1.59828.904) and valvular heart disease (OR 6.425; 95% CI 1.02840.165) were identified as significant predictors of the presence of colonic angiectasia. Eight patients were diagnosed with bleeding from angiectasia. Cardiovascular disease (OR 22.047; 95% CI 1.063457.345) and multiple angiectasias (P-value 0.0019) were identified as significant risk factors for active bleeding. Medication and a large size were not associated with an increased risk of bleeding. Conclusion The presence of colonic angiectasia was associated with valvular heart disease, liver cirrhosis and chronic renal failure. Valvular heart disease and multiple lesions increased the risk of bleeding.

    DOI: 10.1111/j.1463-1318.2012.03132.x

    Web of Science

    PubMed

    researchmap

  • Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas 査読

    Kunihiro Hosono, Eiji Yamada, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Yoshitaka Hippo, Hitoshi Nakagama, Atsushi Nakajima

    WORLD JOURNAL OF GASTROENTEROLOGY   18 ( 38 )   5360 - 5368   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BAISHIDENG PUBL GRP CO LTD  

    AIM: To determine the expression statuses of tumor necrosis factor (TNF)-alpha, its receptors (TNF-R) and downstream effector molecules in human colorectal adenomas.
    METHODS: We measured the serum concentrations of TNF-alpha and its receptors in 62 colorectal adenoma patients and 34 healthy controls. The protein expression of TNF-alpha, TNF-R1, TNF-R2 and downstream signals of the TNF receptors, such as c-Jun N-terminal kinase (JNK), nuclear factor-kappa B and caspase-3, were also investigated in human colorectal adenomas and in normal colorectal mucosal tissues by immunohistochemistry. Immunofluorescence confocal microscopy was used to investigate the consistency of expression of TNF-R1 and phospho-JNK (p-JNK).
    RESULTS: The serum levels of soluble TNF-R1 (sTNF-R1) in adenoma patients were significantly higher than in the control group (3.67 +/- 0.86 ng/mL vs 1.57 +/- 0.72 ng/mL, P &lt; 0.001). Receiver operating characteristic analysis revealed the high diagnostic sensitivity of TNF-R1 measurements (AUC was 0.928) for the diagnosis of adenoma, and the best cut-off level of TNF-R1 was 2.08 ng/mL, with a sensitivity of 93.4% and a specificity of 82.4%. There were no significant differences in the serum levels of TNF-alpha or sTNF-R2 between the two groups. Immunohistochemistry showed high levels of TNF-R1 and p-JNK expression in the epithelial cells of adenomas. Furthermore, a high incidence of co-localization of TNF-R1 and p-JNK was identified in adenoma tissue.
    CONCLUSION: TNF-R1 may be a promising biomarker of colorectal adenoma, and it may also play an important role in the very early stages of colorectal carcinogenesis. (C) 2012 Baishideng. All rights reserved.

    DOI: 10.3748/wjg.v18.i38.5360

    Web of Science

    PubMed

    researchmap

  • Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy 査読

    Hiroki Endo, Eiji Sakai, Takuma Higurashi, Eiji Yamada, Hidenori Ohkubo, Hiroshi Iida, Tomoko Koide, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Kunihiro Hosono, Hirokazu Takahashi, Kensuke Kubota, Atsushi Nakajima

    DIGESTIVE AND LIVER DISEASE   44 ( 10 )   833 - 838   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE INC  

    Background: The differences in the small intestinal toxicity of low-dose aspirin based on the type of aspirin used remains unclear. The purpose of this study was to evaluate the differences in the small bowel mucosal injury between buffered and enteric-coated aspirin users by capsule endoscopy.
    Methods: We retrospectively reviewed the findings in chronic low-dose aspirin users (&gt;3 months) who underwent capsule endoscopy for the investigation of obscure gastrointestinal bleeding. The patients were classified into two groups based on the type of low-dose aspirin that they had been prescribed (enteric-coated aspirin group or buffered aspirin group), and evaluated the numbers of small bowel lesions and the Lewis score.
    Results: Capsule-endoscopic findings of a total of 70 patients taking low-dose aspirin were reviewed. Significant differences in the number of erosions and ulcers were observed between the buffered and enteric-coated aspirin groups (P = 0.017 and P = 0.037, respectively). The median Lewis score for the small bowel mucosal inflammatory change was significantly higher in the enteric-coated aspirin group than in the buffered aspirin group (P = 0.035).
    Conclusions: The results of this study suggested that enteric-coated aspirin might be more injurious to the small bowel mucosa than buffered aspirin. (C) 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.dld.2012.05.016

    Web of Science

    PubMed

    researchmap

  • Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseases 査読

    Yusuke Sekino, Masahiko Inamori, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Takuma Higurashi, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Takashi Nonaka, Hirokazu Takahashi, Tomoko Koide, Yasunobu Abe, Eiji Gotoh, Shigeru Koyano, Yoshiyuki Kuroiwa, Shin Maeda, Atsushi Nakajima

    WORLD JOURNAL OF GASTROENTEROLOGY   18 ( 33 )   4557 - 4562   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BAISHIDENG PUBL GRP CO LTD  

    AIM: To reveal the frequency, characteristics and prognosis of chronic intestinal pseudo-obstruction (CIP) in mitochondrial disease patients.
    METHODS: Between January 2000 and December 2010, 31 patients (13 males and 18 females) were diagnosed with mitochondrial diseases at our hospital. We conducted a retrospective review of the patients' sex, subclass of mitochondrial disease, age at onset of mitochondrial disease, frequency of CIP and the age at its onset, and the duration of survival. The age at onset or at the first diagnosis of the disorder that led to the clinical suspicion of mitochondrial disease was also examined.
    RESULTS: Twenty patients were sub-classified with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS), 8 with chronic progressive external ophthalmoplegia (CPEO), and 3 with myoclonus epilepsy associated with ragged-red fibers (MERRF). Nine patients were diagnosed with CIP, 8 of the 20 (40.0%) patients with MELAS, 0 of the 8 (0.0%) patients with CPEO, and 1 of the 3 (33.3%) patients with MERRF. The median age (range) at the diagnosis and the median age at onset of mitochondrial disease were 40 (17-69) and 25 (12-63) years in patients with CIP, and 49 (17-81) and 40 (11-71) years in patients without CIP. During the survey period, 5 patients (4 patients with MELAS and 1 with CPEO) died. The cause of death was cardiomyopathy in 2 patients with MELAS, cerebral infarction in 1 patient with MELAS, epilepsy and aspiration pneumonia in 1 patient with MELAS, and multiple metastases from gastric cancer and aspiration pneumonia in 1 patient with CPEO.
    CONCLUSION: Patients with CIP tend to have disorders that are suspected to be related to mitochondrial diseases at younger ages than are patients without CIP. (C) 2012 Baishideng. All rights reserved.

    DOI: 10.3748/wjg.v18.i33.4557

    Web of Science

    PubMed

    researchmap

  • Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence 査読

    Takashi Uchiyama, Hirokazu Takahashi, Hiroki Endo, Shingo Kato, Eiji Sakai, Kunihiro Hosono, Masato Yoneda, Masahiko Inamori, Yoshitaka Hippo, Hitoshi Nakagama, Atsushi Nakajima

    DIGESTIVE ENDOSCOPY   24 ( 5 )   353 - 357   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim: Endoscopic screening and removal of colorectal adenomas can reduce the incidence of colorectal cancer. However, given the possibility of adenoma recurrence, surveillance colonoscopy is currently recommended after the initial screening and removal of colorectal adenomas. Aberrant crypt foci (ACF) have been shown to serve as a reliable surrogate marker of colorectal carcinogenesis. In this study, the relationship between the number of ACF at the initial endoscopic polypectomy and the likelihood of colorectal adenoma recurrence after polypectomy were investigated. Methods: High-magnification chromoscopic colonoscopy was performed in 82 subjects who underwent endoscopic polypectomy to identify ACF in the lower rectum. Surveillance colonoscopy was then performed 3 years after the baseline polypectomy at Yokohama City University Hospital. Results: The number of ACF was greater in patients who showed adenoma recurrence (7.88 +/- 6.35) than in those who did not (2.19 +/- 2.95) (P &lt; 0.001). Receiveroperating curve analysis showed that the number of ACF was a highly specific predictor of the risk of adenoma recurrence. Conclusions: This is the first study conducted to investigate the relationship between the number of ACF after endoscopic polypectomy and the likelihood of recurrence of colorectal adenomas. These results suggest that the number of ACF is a useful predictor of the likelihood of colorectal adenoma recurrence.

    DOI: 10.1111/j.1443-1661.2012.01289.x

    Web of Science

    PubMed

    researchmap

  • Non-Alcoholic Fatty Liver Disease Adversely Affects the Glycemic Control Afforded by Sitagliptin 査読

    Tomoyuki Iwasaki, Wataru Tomeno, Masato Yoneda, Masahiko Inamori, Jun Shirakawa, Kento Imajo, Keigo Kawashima, Yasuo Terauchi, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   59 ( 117 )   1522 - 1525   2012年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Recently, high serum DPP-4 activity was found in patients with NAFLD. Therefore, the possibility of NAFLD adversely influencing the therapeutic effect afforded by DPP-4 inhibitors in type 2 diabetic patients was suggested. Methodology: A total of 20 type 2 DM patients with NAFLD and 85 type 2 DM patients without NAFLD were enrolled in the present study. The patients were administered sitagliptin at the dose of 50 mg/day for 12 weeks. Results: The change in HbA1c from the baseline following treatment with sitagliptin was -0.47% (4 weeks), -0.73% (8 weeks) and -0.88% (12 weeks) in the type 2 DM patients with NAFLD and -0.26% (4 weeks), -0.41% (8 weeks) and -0.49% (12 weeks) in type 2 DM without NAFLD. The changes in the HbA1c from the baseline after sitagliptin treatment for 8 and 12 weeks were significantly greater in type 2 DM patients with NAFLD than in type 2 DM patients without NAFLD. Conclusions: The results of this study suggest that NAFLD might adversely affect the therapeutic effect afforded by sitagliptin treatment in patients with type 2 DM. NAFLD may be an independent predictor of the effect of sitagliptin in patients with type 2 DM.

    DOI: 10.5754/hge11689

    Web of Science

    PubMed

    researchmap

  • Endoscopic diagnosis of Barrett's esophagus 査読

    Tomoyuki Akiyama, Yusuke Sekino, Hiroshi Iida, Shigeru Koyama, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    WORLD JOURNAL OF GASTROENTEROLOGY   18 ( 26 )   3477 - 3478   2012年6月

     詳細を見る

    記述言語:英語   出版者・発行元:BAISHIDENG PUBL GRP CO LTD  

    The Prague C and M Criteria have been developed for the objective endoscopic diagnosis of Barrett's esophagus (BE). BE arises between the squamocolumnar junction and the gastroesophageal junction at the proximal margin of the gastric folds. In this study, we reported that 43.0% of the subjects examined were diagnosed with BE based on the Prague C and M Criteria. Previous criticism by John Dent proposed that our data should be considered invalid because the prevalence of BE reported in our study was extraordinarily high and discordant with previous studies. Dent predicted that the position of the gastroesophageal junction in our study was judged to be lower than the actual position due to the effacement of the proximal ends of the gastric folds because of the routine use of a high degree of air distension during typical Japanese endoscopic examinations. The endoscopic evaluation of the superior gastric folds is certainly influenced by the degree of air distension of the esophagus. However, in our study, the proximal limit of the gastric nnucosal folds was prospectively imaged while the oesophagus was minimally insufflated. Then, under a high level of air distension, the distal ends of the palisade-shaped longitudinal vessels were imaged because they are more easily observed when distended. In the majority of patients, the distal ends of the palisade-shaped longitudinal vessels correspond to the proximal limit of the gastric mucosal folds. Our endoscopic evaluation was appropriately performed according to the Prague C and M Criteria. We suspect that the high prevalence of BE in our study may be due to the inclusion of ultrashort-segment BE, which defines BE with an affected mucosal length under 5 mm, in our positive results. (C) 2012 Baishideng. All rights reserved.

    DOI: 10.3748/wjg.v18.i26.3477

    Web of Science

    PubMed

    researchmap

  • Effect of sumatriptan on gastric emptying: A crossover study using the BreathID system 査読

    Yasunari Sakamoto, Yusuke Sekino, Eiji Yamada, Takuma Higurashi, Hidenori Ohkubo, Eiji Sakai, Hiroki Endo, Hiroshi Iida, Takashi Nonaka, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    WORLD JOURNAL OF GASTROENTEROLOGY   18 ( 26 )   3415 - 3419   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BAISHIDENG PUBLISHING GROUP INC  

    AIM: TO determine the effect of oral sumatriptan on gastric emptying using a continuous C-13 breath test (BreathID system).
    METHODS: Ten healthy male volunteers participated in this randomized, 2-way crossover study. The subjects fasted overnight and were randomly assigned to receive a test meal (200 kcal/200 mL) 30 min after pre-medication with sumatriptan 50 mg (sumatriptan condition), or the test meal alone (control condition). Gastric emptying was monitored for 4 h after administration of the test meal by the C-13-acetic acid breath test performed continually using the BreathID system. Then, using Oridion Research Software (beta version), the time taken for emptying of 50% of the labeled meal (T-1/2) similar to the scintigraphy lag time for 10% emptying of the labeled meal (T-lag), the gastric emptying coefficient (GEC), and the regression-estimated constants (beta and kappa) were calculated. The statistical significance of any differences in the parameters were analyzed using Wilcoxon's signed-rank test.
    RESULTS: In the sumatriptan condition, significant differences compared with the control condition were found in T-1/2 [median 131.84 min (range, 103.13-168.70) vs 120.27 min (89.61-138.25); P = 0.0016], T-lag [median 80.085 min (59.23-125.89) vs 61.11 min (39.86-87.05); P = 0.0125], and beta [median 2.3374 (1.6407-3.8209) vs 2.0847 (1.4755-2.9269); P = 0.0284]. There were no significant differences in the GEC or kappa between the 2 conditions.
    CONCLUSION: This study showed that oral sumatriptan significantly delayed gastric emptying of a liquid meal. (C) 2012 Baishideng. All rights reserved.

    DOI: 10.3748/wjg.v18.i26.3415

    Web of Science

    PubMed

    researchmap

  • Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas 査読

    K. Okada, T. Tsuchida, A. Ishiyama, T. Taniguchi, S. Suzuki, Y. Horiuchi, Y. Matsuo, N. Yoshizawa, T. Suganuma, M. Omae, M. Kubota, T. Hirasawa, Y. Yamamoto, M. Inamori, N. Yamamoto, A. Nakajima, J. Fujisaki, E. Hoshino, K. Kawabata, M. Igarashi

    ENDOSCOPY   44 ( 6 )   556 - 564   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:GEORG THIEME VERLAG KG  

    Background and study aim: Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are being used increasingly to treat superficial oropharyngeal and hypopharyngeal carcinomas. The aim of this study was to clarify whether ESD provided better results than EMR for en bloc and complete resection of superficial pharyngeal carcinomas.
    Patients and methods: A total of 76 superficial pharyngeal carcinomas in 59 consecutively treated patients were included. Patients underwent either conventional EMR (using a transparent cap or strip biopsy) (n=45 lesions) or ESD (n=31 lesions) between October 2006 and January 2011. The rates of en bloc resection, complete resection (defined as en bloc resection with tumor-free margins), major complications, and local recurrence were evaluated retrospectively as the therapeutic outcomes.
    Results: ESD yielded significantly higher rates of both en bloc and complete resection compared with EMR (en bloc 77.4% [24/31] vs. 37.8% [17/45], P=0.0002; complete 54.8% [17/31] vs. 28.9% [13/45], P=0.0379). ESD was more frequently complicated by severe laryngeal edema (4/21 [19.0 %] vs. 1/31 [3.2%], P=0.1446) and was also more time-consuming (124.9+/-65.1 minutes vs. 57.2+/-69.6 minutes; P=0.0014). Local recurrence was observed more often after EMR than after ESD (3/45 [6.7 %] vs. 0/31 [0 %]), although this difference did not reach statistical significance (P=0.2658).
    Conclusions: ESD appears to be a superior method of endoscopic resection of superficial pharyngeal carcinomas for achieving both en bloc and complete resection, although these benefits were also associated with a higher incidence of complications and a significantly longer procedure time. Large prospective studies are needed to compare ESD with conventional EMR for superficial pharyngeal carcinomas.

    DOI: 10.1055/s-0032-1309720

    Web of Science

    PubMed

    researchmap

  • [Risk of carcinogenesis caused by infection and inflammation]. 査読

    Shibata W, Inamori M, Maeda S

    Nihon rinsho. Japanese journal of clinical medicine   70 Suppl 2   50 - 55   2012年4月

     詳細を見る

  • Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH 査読

    Hiroshi Iida, Masahiko Inamori, Tetsuro Fujii, Yusuke Sekino, Hiroki Endo, Kunihiro Hosono, Takashi Nonaka, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Eiji Gotoh, Shin Maeda, Atsushi Nakajima

    BMC GASTROENTEROLOGY   12   25   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: The ideal medication for acid-related diseases should have a rapid onset of action to promote hemostasis and cause efficient resolution of symptoms. The aim of our study was to comparatively investigate the inhibitory effect on gastric acid secretion of a single oral administration of omeprazole plus mosapride with that of omeprazole alone.
    Methods: Ten Helicobacter pylori-negative male subjects participated in this randomized, two-way crossover study. Intragastric pH was monitored continuously for 6 hours after a single oral administration of omeprazole 20 mg or that of omeprazole 20 mg plus mosapride 5 mg (the omeprazole being administered one hour after the mosapride). Each administration was separated by a 7-days washout period.
    Results: The average pH during the 6-hour period after administration of omeprazole 20 mg plus mosapride 5 mg was higher than that after administration of omeprazole 20 mg alone (median: 3.22 versus 4.21, respectively; p = 0.0247).
    Conclusions: In H. pylori -negative healthy male subjects, an oral dose of omeprazole 20 mg plus mosapride 5 mg increased the intragastric pH more rapidly than omeprazole 20 mg alone.

    DOI: 10.1186/1471-230X-12-25

    Web of Science

    PubMed

    researchmap

  • Successful endoscopic removal of a press-through package in the terminal ileum causing obstructive ileus 査読

    Tomoyuki Akiyama, Kazuro Chiba, Fumitake Jono, Keiko Akimoto, Ayako Takahata, Nobutaka Fujisawa, Masahiko Inamori, Shin Maeda, Atsushi Nakajima, Atsushi Nakamura, Shigeru Koyama

    GASTROINTESTINAL ENDOSCOPY   75 ( 3 )   671 - 672   2012年3月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2011.11.008

    Web of Science

    PubMed

    researchmap

  • A New Non-Invasive Modality for Recording Sequential Images and the pH of the Small Bowel 査読

    Hiroshi Iida, Hiroki Endo, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Kunihiro Hosono, Takashi Nonaka, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    HEPATO-GASTROENTEROLOGY   59 ( 114 )   413 - 414   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Before the introduction of capsule endoscopy and double-balloon endoscopy, there were no effective modalities for reliable evaluation of the small bowel. Recently, the SmartPill, a wireless pH/pressure recording capsule, has been utilized to measure:the whole gut transit time. However, there are few studies on the small bowel pH. The aim of this study was to investigate the relationship between small bowel disease and the small bowel pH, we designed a new modality, the "pH capsule", to non-invasively record sequential images and the pH. Methodology: Ten healthy male volunteers swallowed the "pH capsule" with 50mL of water. The "pH capsule" transmitted the acquired images and the pH to the recorder unit located outside the body for about ten hours while the subject was fasting. Results: All subjects completed this study. The intra-gastric pH was low and the pH in the whole small intestine was 7.61, 7.55: 7.2-8.1 (mean, median: range). The pH value increased from the duodenum to the terminal ileum (p&lt;0.0001). Conclusions: We could non-invasively monitor sequential images and the pH of the small intestine with this new modality. The "pH capsule", is expected to become a valuable tool for clinical assessment of the small bowel.

    DOI: 10.5754/hge11394

    Web of Science

    PubMed

    researchmap

  • Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer 査読

    K. Okada, J. Fujisaki, T. Yoshida, H. Ishikawa, T. Suganuma, A. Kasuga, M. Omae, M. Kubota, A. Ishiyama, T. Hirasawa, A. Chino, M. Inamori, Y. Yamamoto, N. Yamamoto, T. Tsuchida, Y. Tamegai, A. Nakajima, E. Hoshino, M. Igarashi

    ENDOSCOPY   44 ( 2 )   122 - 127   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:GEORG THIEME VERLAG KG  

    Background and study aim: Endoscopic submucosal dissection (ESD) of undifferentiated-type early gastric cancer (UD-EGC) is technically feasible; however, the long-term clinical outcomes of the procedure have not yet been fully investigated. The aim of our study was to elucidate long-term outcomes of ESD for UD-EGC.
    Patients and methods: Between September 2003 and October 2009, a total of 153 patients were diagnosed endoscopically as having UD-EGC fulfilling the expanded criteria for ESD. After informed consent was obtained, 101 patients were selected to undergo ESD and 52 to undergo surgical operation. We assessed the clinical outcomes of ESD in 101 consecutive patients with 103 UD-EGC lesions who were undergoing ESD for the first time. The overall mortality and disease-free survival rates after ESD were evaluated as the long-term outcomes.
    Results: The rates of en bloc and curative resection were 99.0% (102/103) and 82.5% (85/103), respectively. We encountered one patient with nodal metastasis detected by computed tomography before diagnostic ESD, although curative resection of the primary lesion was achieved based on routine histological examination. Among the 78 patients without a past history of malignancy within the previous 5 years in whom curative resection of the primary lesion was achieved, no cases of local recurrence or distant metastasis were observed during follow-up; however, 1 synchronous and 2 metachronous lesions were detected in 2 patients (2.6%) after primary ESD. Thus, estimated over a median follow-up period of 40.0 months (range 19-92 months) and 36.0 months (range 9-92 months), the 3- and 5-year overall mortality rates were 1.9% and 3.9%, respectively, and the 3- and 5-year overall disease-free survival rates were both 96.7%.
    Conclusions: Although our single-center retrospective study may be considered to be only preliminary, our data indicate that ESD for UD-EGC may yield good long-term outcomes.

    DOI: 10.1055/s-0031-1291486

    Web of Science

    PubMed

    researchmap

  • Early effects of oral administration of omeprazole and roxatidine on intragastric pH 査読

    Hiroshi Iida, Shingo Kato, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B   13 ( 1 )   29 - 34   2012年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ZHEJIANG UNIV  

    Objective: The ideal medication for the treatment of acid-related diseases, e.g., peptic ulcers, stress-related gastric bleeding, functional dyspepsia, and gastroesophageal reflux disease, should have a rapid onset of action to promote hemostasis and relieve the symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion of a single oral administration of a proton pump inhibitor, omeprazole 20 mg, and an H-2-receptor antagonist, roxatidine 75 mg. Methods: Ten Helicobacterpylori-negative male subjects participated in this randomized, two-way crossover study. Intragastric pH was monitored continuously for 6 h after single oral administration of omeprazole 20 mg and roxatidine 75 mg. Each administration was separated by a 7-d washout period. Results: During the 6-h study period, the average pH after administration of roxatidine was higher than that after administration of omeprazole (median: 4.45 vs. 2.65; P=0.0367). Also during the 6-h study period, a longer duration of maintenance at pH above 2, 5, and 6 was observed after administration of roxatidine 75 mg than after administration of omeprazole 20 mg (median: 90.6% vs. 55.2%, P=0.0284; 43.7% vs. 10.6%, P=0.0125; 40.3% vs. 3.3%, P=0.0125; respectively). Conclusions: In Helicobacter pylori-negative healthy male subjects, oral administration of roxatidine 75 mg increased the intragastric pH more rapidly than that of omeprazole 20 mg.

    DOI: 10.1631/jzus.B1100078

    Web of Science

    PubMed

    researchmap

  • Imaging Findings of Pancreatic Cystic Lesions in von Hippel-Lindau Disease 査読

    Noritoshi Kobayashi, Takamitsu Sato, Shingo Kato, Seitaro Watanabe, Kunihiro Hosono, Takeshi Shimamura, Hiroshi Iida, Hiroki Endo, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Wataru Shibata, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Shin Maeda, Atsushi Nakajima, Kensuke Kubota

    INTERNAL MEDICINE   51 ( 11 )   1301 - 1307   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Objectives The aim of this study was to characterize the pancreatic cystic lesions in von Hippel-Lindau (VHL) disease and to document the changes that occur in the pancreas.
    Methods We retrospectively analyzed the medical records and the computed tomography (CT) and magnetic resonance imaging (MRI) findings of 20 VHL patients who were diagnosed between 1996 and 2010 at our hospital. The clinical findings, family history and type of tumors and/or cysts were reviewed for each patient. We also analyzed the imaging findings for the pancreas in detail.
    Results Pancreatic involvement was noted in 16 of the 20 patients (80%). Eleven patients had multiple cysts diffusely distributed in the pancreas, and one patient had a single cyst in the pancreas head. Two patients had serous cystic neoplasms (SCNs) with multiple cysts, and another two patients had neuroendocrine tumors (NETs) which were conventional radiological findings. The largest cysts of four patients (26.7%) increased in size and that of three patients (20%) decreased in size during the follow-up period. We performed surgical resections for the pancreatic tumors (one NET and one SCN) and also performed endoscopic treatment for a pancreatic cyst in one VHL patient with obstructive jaundice. None of the patients died as a result of pancreatic disease.
    Conclusion The most common type of pancreatic lesions was multiple cysts. SCNs were present in only 10% of the VHL patients. Pancreatic cysts showed positive and/or negative growth according to the CT and MRI findings. The pancreatic cystic lesions did not influence the outcome of the VHL patients.

    DOI: 10.2169/internalmedicine.51.7194

    Web of Science

    PubMed

    researchmap

  • Can the Japanese discriminate between manpuku (satiety) and bouman (epigastric bloating)?

    Yasunari Sakamoto, Masahiko Inamori, Sho Inoue, Mizue Iinuma, Yusuke Sekino, Hiroshi Iida, Hiroki Endo, Takashi Nonaka, Tomoko Koide, Hirokazu Takahashi, Masato Yonedau, Akihiko Kusakabe, Eiji Gotoh, Atsushi Nakajima, Shin Maeda, Michio Hongo

    Yokohama Medical Journal   63 ( 4 )   589 - 595   2012年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Introduction: Recently, attention is being paid to gastrointestinal symptoms for Rome III criteria. The aim of this study was to determine whether Japanese volunteers could discriminate between manpuku (satiety) and bouman (epigastric bloating) in Japanese volunteers. Methods: Seventeen healthy subjects were recruited for a modified Boeckxstaens' water drink test. Data from the drink test and a questionnaire were analyzed. Results: The median value of maximum ingested volume was 1350mL. Maximum ingested volume and body mass index were correlated (P=0.0445). All subjects felt manpuku (satiety), bouman (epigastric bloating) and nausea. The time courses of manpuku (satiety) and bouman (epigastric bloating) in the questionnaires were classified into 5 groups: manpuku (satiety) dominant type (29.4%), bouman (epigastric bloating) dominant type (23.5%), manpuku (satiety) preceding type (11.7%), bouman (epigastric bloating) preceding type (29.4 %) and equal type (5.8%). Conclusion: Some Japanese discriminate between manpuku and bouman, but others feel them as identical symptoms.

    Scopus

    researchmap

  • Risk Factors for Colonic Diverticular Hemorrhage: Japanese Multicenter Study 査読

    Kaori Suzuki, Shiori Uchiyama, Kento Imajyo, Wataru Tomeno, Eiji Sakai, Eiji Yamada, Emiko Tanida, Tomoyuki Akiyama, Seitaro Watanabe, Hiroki Endo, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Minoru Kawaguchi, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    DIGESTION   85 ( 4 )   261 - 265   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Background and Aim: Diverticular hemorrhage is the common cause of lower gastrointestinal bleeding, and its incidence has been increasing in Japan. However, the exact cause of diverticular hemorrhage is not well understood. We investigated the risk factors for diverticular hemorrhage. Methods: We selected 103 patients with diverticular hemorrhage as cases and patients with colonic diverticulosis without a history of bleeding were selected as control subjects, exactly matched for age and gender. We collected the data from the medical records of each of the patients, such as those related to the comorbidities, medications and findings of colonoscopy, and conducted a matched case-control study to analyze the risk factors for diverticular hemorrhage. Results: Both groups were composed of 75 men and 28 women. The median age of the patients in both groups was 72.0 years (47.0-87.0). The body weight (p = 0.0065), body mass index (p = 0.006), prevalence of hypertension (p = 0.0242), prevalence of ischemic heart disease (p = 0.0015), and frequency of use of low-dose aspirin (p = 0.042) were significantly different between the two groups. The percentage of patients with bilateral diverticula, that is, diverticula on both the right and left hemicolon, was significantly higher in the diverticular hemorrhage group (p = 0.0011). Multiple regression analysis identified only the diverticular location as being significantly associated with the risk of diverticular hemorrhage (p = 0.0021). Conclusions: Only the diverticular location (bilateral) was found to be an independent risk factor for diverticular hemorrhage. Copyright (C) 2012 S. Karger AG, Basel

    DOI: 10.1159/000336351

    Web of Science

    PubMed

    researchmap

  • An Epidemiologic Survey of Chronic Intestinal Pseudo-Obstruction and Evaluation of the Newly Proposed Diagnostic Criteria 査読

    Hidenori Ohkubo, Hiroshi Iida, Hirokazu Takahashi, Eiji Yamada, Eiji Sakai, Takuma Higurashi, Yusuke Sekino, Hiroki Endo, Yasunari Sakamoto, Masahiko Inamori, Hajime Sato, Kazuma Fujimoto, Atsushi Nakajima

    DIGESTION   86 ( 1 )   12 - 19   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Background and Aims: Chronic intestinal pseudo-obstruction (CIPO) is an intractable disease in which clinical symptoms of intestinal obstruction appear without mechanical cause. No clear diagnostic criteria have been established; therefore, we proposed diagnostic criteria to facilitate the diagnosis of this rare disease and aim to evaluate their usefulness and validity. Materials and Methods: A questionnaire was sent to 378 institutions belonging to the Japanese Society of Gastroenterology between December 2009 and February 2010. We summarized the returned data and performed a statistical analysis. Results: A total of 160 cases were included, and 141 cases (88.1%) fulfilled the criterion of disease duration of &gt;6 months, 157 cases (98.1%) the criterion of the clinical symptoms of abdominal pain and/or bloating and 154 cases (96.2%) fulfilled the criterion of imaging findings. Eventually, 138 cases (86.3%) fulfilled all criteria. Conclusions: The proposed diagnostic criteria were useful, with a high sensitivity of 86.3% for Japanese patients. Improved recognition of CIPO and practical use of the criteria are desired. The criteria should be appropriately modified by additional researchers to make them more practical and internationally applicable. Copyright (C) 2012 S. Karger AG, Basel

    DOI: 10.1159/000337528

    Web of Science

    PubMed

    researchmap

  • Is It Worthwhile to Perform Capsule Endoscopy for Asymptomatic Patients with Positive Immunochemical Faecal Occult Blood Test? 査読

    Hideyuki Chiba, Masau Sekiguchi, Takafumi Ito, Yosuke Tsuji, Ken Ohata, Akiko Ohno, Shotaro Umezawa, Suguru Takeuchi, Kantaro Hisatomi, Takuma Teratani, Nobuyuki Matsuhashi, Hiroki Endo, Masahiko Inamori, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   56 ( 12 )   3459 - 3462   2011年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Background The immunochemical faecal occult blood test (IFOBT) is widely performed for colorectal cancer screening, but the usefulness of IFOBT in the detection of disorders of the small intestine is unknown. The objective of this study was to investigate what proportion of IFOBT-positive subjects with negative colonoscopy and oesophagogastroduodenoscopy has pathologies of the small intestine detected by capsule endoscopy (CE).
    Methods Between October 2008 and June 2010, asymptomatic IFOBT-positive patients with negative total colonoscopy and oesophagogastroduodenoscopy underwent CE. CE findings were classified into three categories: P0 (no abnormalities, or findings without potential for bleeding), P1 (findings with uncertain potential for bleeding), P2 and (findings with high potential for bleeding).
    Results Fifty-three patients (37 males, 16 females; 52.1 +/- A 13.0 years) were included. There were no cases with P2, 19 cases with P1, and 34 cases with P0 (there were no abnormalities in 25 of 34 cases). As a result, lesions in the small intestine were detected in 28 cases. Additional examination was considered necessary for five patients after CE, but no abnormality was detected, and therapeutic intervention was not undertaken in any case. Caecal completion rate was 92.5%.
    Conclusions No significant pathologies of the small intestine were detected in asymptomatic IFOBT-positive cases with negative colonoscopy and oesophagogastroduodenoscopy. CE is of limited use in asymptomatic patients with positive IFOBT.

    DOI: 10.1007/s10620-011-1798-4

    Web of Science

    PubMed

    researchmap

  • 緩和医療における胃瘻適応の標準化に向けて

    日下部 明彦, 佐藤 晶子, 杉浦 龍太, 古出 智子, 稲森 正彦

    癌と化学療法   38 ( Suppl.I )   85 - 86   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)癌と化学療法社  

    緩和医療における胃瘻の適応は十分に論議されていないのが現状である。内視鏡やデバイスの進化により従来は不可能だった症例も安全に胃瘻造設が行えるようになった。胃瘻はがん患者の在宅療養に非常に有用なツールの一つである。緩和医療における胃瘻の適応は引き続き論議されるべきテーマと考えられる。当院においての適応は、(1)必要な栄養・水分を自発的に摂取できない(通過障害に加え口腔内疼痛も含む)、(2)消化管吸収機能正常、(3)生命予後予測4週以上(+悪液質ではない)、(4)本人の意思としている。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/default/link?pub_year=2011&ichushi_jid=J00296&link_issn=&doc_id=20111222400029&doc_link_id=issn%3D0385-0684%26volume%3D38%26issue%3D12%26spage%3D85&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0385-0684%26volume%3D38%26issue%3D12%26spage%3D85&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • [The role of percutaneous endoscopic gastrostomy(PEG)in palliative care]. 査読

    Kusakabe A, Sato A, Sugiura R, Koide T, Inamori M

    Gan to kagaku ryoho. Cancer & chemotherapy   38 Suppl 1   85 - 86   2011年12月

     詳細を見る

  • Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus 査読

    Tomoyuki Iwasaki, Masato Yoneda, Masahiko Inamori, Jun Shirakawa, Takuma Higurashi, Shin Maeda, Yasuo Terauchi, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   58 ( 112 )   2103 - 2105   2011年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury, and is considered as the hepatic manifestation of metabolic syndrome. However, no effective drug therapy for NAFLD has been established yet. In the present study, we evaluated the efficacy of 4 months of treatment with sitagliptin in NAFLD patients with type 2 diabetes mellitus (DM). Methodology: We evaluated 30 NAFLD patients with type 2 DM. NAFLD was diagnosed by ultrasonography. The patients were administered sitagliptin (50mg/body/day) for 4 months. Results: Significant decreases of the plasma glucose and serum HbA1c, AST, ALT and gamma-GTP levels were observed after 4 months of treatment with sitagliptin. Conclusions: In this study, not only the parameters of diabetes, but also those of liver tests were improved by the treatment with sitagliptin. Our study demonstrated the efficacy of sitagliptin in NAFLD patients with type 2 DM, suggesting that a large-scale clinical trial is warranted in the future.

    DOI: 10.5754/hge11263

    Web of Science

    PubMed

    researchmap

  • Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer 査読

    Shingo Kato, Kensuke Kubota, Takeshi Shimamura, Yoshiyasu Shinohara, Noritoshi Kobayashi, Seitaro Watanabe, Masato Yoneda, Masahiko Inamori, Fumio Nakamura, Hitoshi Ishiguro, Noboru Nakaigawa, Yoji Nagashima, Masataka Taguri, Yoshinobu Kubota, Yoshio Goshima, Satoshi Morita, Itaru Endo, Shin Maeda, Atsushi Nakajima, Hitoshi Nakagama

    CANCER SCIENCE   102 ( 11 )   2029 - 2037   2011年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor, for which the development of new biomarkers and therapeutic targets has become critical. The main cause of poor prognosis in PDAC patients is the high invasive and metastatic potential of the cancer. In the present study, we report a new signaling pathway that was found to mediate the enhanced tumor cell motility in pancreatic cancer. Semaphorin 4D (Sema4D) is a ligand known to be expressed on different cell types, and has been reported to be involved in the regulation of immune functions, epithelial morphogenesis, and tumor growth and metastasis. In this study, we revealed for the first time that the cancer tissue cells expressing Sema4D in PDAC are tumor-infiltrating lymphocytes. The overexpression of Sema4D and of its receptor, plexinB1, was found to be significantly correlated with clinical factors, such as lymph node metastasis, distant metastasis, and poor prognosis in patients with PDAC. Through in vitro analysis, we demonstrated that Sema4D can potentiate the invasiveness of pancreatic cancer cells and we identified the downstream molecules. The binding of Sema4D to plexinB1 induced small GTPase Ras homolog gene family, member A activation and resulted in the phosphorylation of MAPK and Akt. In addition, in terms of potential therapeutic application, we clearly demonstrated that the enhanced-cell invasiveness induced by Sema4D could be inhibited by knockdown of plexinB1, suggesting that blockade of plexinB1 might diminish the invasive potential of pancreatic cancer cells. Our findings provide new insight into possible prognostic biomarkers and therapeutic targets in PDAC patients. (Cancer Sci 2011; 102: 2029-2037)

    DOI: 10.1111/j.1349-7006.2011.02053.x

    Web of Science

    PubMed

    researchmap

  • Effective Treatment for Duodenal Variceal Bleeding Using Endoscopic Ligation 査読

    Yutaka Kawakami, Hirokazu Takahashi, Shingo Kato, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   58 ( 112 )   2024 - 2025   2011年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Duodenal variceal rupture is rare, and there is little agreement on the best therapeutic option. A 72-year-old man treated for liver cirrhosis with HCV visited the emergency room complaining of dizziness and tarry stool. Fiberscope images showed varices (F2CbRC+) with white plaques at the horizontal region of the duodenum. The patient was treated using endoscopic variceal ligation (EVL), and no more bleeding has been detected.

    DOI: 10.5754/hge09470

    Web of Science

    PubMed

    researchmap

  • Localized primary AL amyloidosis of the colon without other GI involvement 査読

    Chikako Tokoro, Masahiko Inamori, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Hiroaki Yasuzaki, Ayumu Goto, Yasunobu Abe, Ichiro Kawana, Atsushi Nakajima, Shin Maeda, Hisashi Oshiro, Yoshiaki Inayama

    GASTROINTESTINAL ENDOSCOPY   74 ( 4 )   925 - 927   2011年10月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2011.06.022

    Web of Science

    PubMed

    researchmap

  • Mosapride Accelerates the Delayed Gastric Emptying of High-Viscosity Liquids: A Crossover Study Using Continuous Real-Time C-13 Breath Test (BreathID System) 査読

    Yasunari Sakamoto, Yusuke Sekino, Eiji Yamada, Hidenori Ohkubo, Takuma Higurashi, Eiji Sakai, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Takashi Nonaka, Tamon Ikeda, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY   17 ( 4 )   395 - 401   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KOREAN SOC NEUROGASTERONTEROL & MOTILITY  

    Background/Aims
    The administration of liquid nutrients to patients is often accompanied by complications such as gastroesophageal reflux. To prevent gastroesophageal reflux, high-viscosity liquid meals are used widely, however, it still remains controversial whether high-viscosity liquid meals have any effect on the rate of gastric emptying. The present study was conducted with the aim of determining whether high-viscosity liquid meals had any effect on the rate of gastric emptying and mosapride might accelerate the rate of gastric emptying of high-viscosity liquid meals.
    Methods
    Six healthy male volunteers underwent 3 tests at intervals of &gt; 1 week. After fasting for &gt; 8 hours, each subject received one of three test meals (liquid meal only, high-viscosity liquid meal [liquid meal plus pectin] only, or high-viscosity liquid meal 30 minutes after intake of mosapride). A C-13-acetic acid breath test was performed, which monitored the rate of gastric emptying for 4 hours. Using the Oridion Research Software (beta version), breath test parameters were calculated. The study parameters were examined for all the 3 test conditions and compared using the Freidman test.
    Results
    Gastric emptying was significantly delayed following intake of a high-viscosity liquid meal alone as compared with a liquid meal alone; however, intake of mosapride prior to a high-viscosity liquid meal was associated with a significantly accelerated rate of gastric emptying as compared with a high-viscosity liquid meal alone.
    Conclusions
    This study showed that high-viscosity liquid meals delayed gastric emptying: however, mosapride recovered the delayed rate of gastric emptying by high-viscosity liquid meals.

    DOI: 10.5056/jnm.2011.17.4.395

    Web of Science

    PubMed

    researchmap

  • Diagnosis of undifferentiated type early gastric cancers by magnification endoscopy with narrow-band imaging 査読

    Kazuhisa Okada, Junko Fujisaki, Akiyoshi Kasuga, Masami Omae, Toshiaki Hirasawa, Akiyoshi Ishiyama, Masahiko Inamori, Akiko Chino, Yorimasa Yamamoto, Tomohiro Tsuchida, Atsushi Nakajima, Etsuo Hoshino, Masahiro Igarashi

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   26 ( 8 )   1262 - 1269   2011年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Background and Aims: The diagnostic use of magnification endoscopy with narrow-band imaging (ME-NBI) to assess histopathologically undifferentiated-type early gastric cancers (UD-type EGCs) is not well elucidated. The purpose of this study was to examine the comparative relationship between ME-NBI images and histopathological findings in UD-type EGCs.
    Methods: We analyzed 78 consecutive cases of UD-type EGCs &lt;= 20 mm in diameter that underwent ME-NBI &lt;= 2 weeks prior to resection. The ME-NBI images were compared with histopathological findings following either endoscopic submucosal dissection (ESD) or surgery. Applying the comparative results, we prospectively evaluated the success of identifying the lateral extent of UD-type EGCs resected by ESD in additional consecutive cases.
    Results: Lesions with preserved but irregular surface microstructures (S-type based on ME-NBI) showed mucosal atrophy and corresponded histologically to the non-whole-layer type of intramucosal cancer (24/24, 100%). Lesions with an irregular microvasculature type (V-type, for example, corkscrew pattern) or mixed type upon ME-NBI corresponded histopathologically to the non-whole-layer type of intramucosal cancer (15/54, 27.8%), the whole-layer type of intramucosal cancer (27/54, 50.0%) or submucosal (sm) invasion cancer (12/54, 22.2%). Applying these comparative results, we used ME-NBI to successfully predict the lateral extent of cancer, which corresponded to the histopathological lateral extent in all 18 additional consecutive UD-type EGCs resected by ESD.
    Conclusions: ME-NBI images of UD-type EGCs were very closely related to the histopathological findings. Thus, ME-NBI can be useful in the pretreatment assessment of the histopathological patterns of cancer development and the lateral extent of such lesions.

    DOI: 10.1111/j.1440-1746.2011.06730.x

    Web of Science

    PubMed

    researchmap

  • Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time C-13 Breath Test (BreathID System) 査読

    Takashi Nonaka, Takaomi Kessoku, Yuji Ogawa, Kento Imajyo, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Yasunobu Abe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY   17 ( 3 )   287 - 293   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KOREAN SOC NEUROGASTERONTEROL & MOTILITY  

    Background/Aims
    The effects of Histamine-2 receptor antagonists and proton pump inhibitors on the gastrointestinal motility have not yet been sufficiently investigated. The aim of this study was to determine the effects of intravenous bolus administration of famotidine and omeprazole on the rate of gastric emptying using the continuous C-13 breath test (BreathID system, Exalenz Bioscience Ltd, Israel).
    Methods
    Twelve healthy male volunteers participated in this randomized, 3-way crossover study. After fasting overnight, the subjects were randomly assigned to receive 20 mg of famotidine, 20 mg of omeprazole or 20 mL of saline alone by intravenous bolus injection before a test meal (200 kcal per 200 mL, containing 100 mg of C-13-acetate). Gastric emptying was monitored for 4 hours after the ingestion of test meal by the C-13-acetic acid breath test performed using the BreathID system.
    Results
    No significant differences in the calculated parameters, namely, the T-1/2, T-lag, GEC, beta and kappa, were observed among the 3 test conditions.
    Conclusions
    The study revealed that intravenous administration of gastric acid suppressant drugs had no significant influence on the rate of gastric emptying in comparison with that of saline alone as a placebo. Our results indicating the absence of any effect of either famotidine or omeprazole on accelerating the rate of gastric emptying suggest that both medications can be administered safely to patients suffering from hemorrhagic peptic ulcers who need to be kept nil by mouth from the viewpoint of possible acceleration of gastrointestinal motility in the clinical setting.

    DOI: 10.5056/jnm.2011.17.3.287

    Web of Science

    PubMed

    researchmap

  • Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study 査読

    Hiroki Endo, Takuma Higurashi, Kunihiro Hosono, Eiji Sakai, Yusuke Sekino, Hiroshi Iida, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   46 ( 7 )   894 - 905   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Few studies have investigated measures to prevent small bowel injuries induced by aspirin. Our aim was to evaluate the effect of probiotic treatment on the small bowel injuries induced by chronic low-dose aspirin use.
    Thirty-five patients who took low-dose enteric-coated aspirin 100 mg daily (for more than 3 months) plus omeprazole 20 mg daily and were diagnosed as having unexplained iron deficiency anemia participated in this prospective randomized controlled trial. We assigned the patients to receive probiotic treatment with Lactobacillus casei for 3 months (L. casei group) or not receive the probiotic (control group). Patients underwent capsule endoscopy (CE) before and after treatment.
    Twenty-five patients, including 13 in the L. casei group and 12 in the control group, underwent the full analysis. Significant decreases in the number of mucosal breaks and the CE score were observed at the 3-month evaluation in the L. casei group as compared with the results in the control group (P = 0.039). The change from the baseline in the median number of mucosal breaks in the L. casei group was -2, as compared with 0.5 in the control group. The change from the baseline in the median CE score in the L. casei group was -228 compared with -4 in the control group (P = 0.026).
    Co-administration of L. casei is effective for the treatment of aspirin-associated small bowel injury.

    DOI: 10.1007/s00535-011-0410-1

    Web of Science

    PubMed

    researchmap

  • Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study 査読

    Hiroki Endo, Takuma Higurashi, Kunihiro Hosono, Eiji Sakai, Yusuke Sekino, Hiroshi Iida, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   46 ( 7 )   894 - 905   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Few studies have investigated measures to prevent small bowel injuries induced by aspirin. Our aim was to evaluate the effect of probiotic treatment on the small bowel injuries induced by chronic low-dose aspirin use.
    Thirty-five patients who took low-dose enteric-coated aspirin 100 mg daily (for more than 3 months) plus omeprazole 20 mg daily and were diagnosed as having unexplained iron deficiency anemia participated in this prospective randomized controlled trial. We assigned the patients to receive probiotic treatment with Lactobacillus casei for 3 months (L. casei group) or not receive the probiotic (control group). Patients underwent capsule endoscopy (CE) before and after treatment.
    Twenty-five patients, including 13 in the L. casei group and 12 in the control group, underwent the full analysis. Significant decreases in the number of mucosal breaks and the CE score were observed at the 3-month evaluation in the L. casei group as compared with the results in the control group (P = 0.039). The change from the baseline in the median number of mucosal breaks in the L. casei group was -2, as compared with 0.5 in the control group. The change from the baseline in the median CE score in the L. casei group was -228 compared with -4 in the control group (P = 0.026).
    Co-administration of L. casei is effective for the treatment of aspirin-associated small bowel injury.

    DOI: 10.1007/s00535-011-0410-1

    Web of Science

    researchmap

  • A review of the reported cases of chronic intestinal pseudo-obstruction in Japan and an investigation of proposed new diagnostic criteria 査読

    Hiroshi Iida, Masahiko Inamori, Yusuke Sekino, Yasunari Sakamoto, Shigeru Yamato, Atsushi Nakajima

    Clinical Journal of Gastroenterology   4 ( 3 )   141 - 146   2011年6月

     詳細を見る

    記述言語:英語  

    Intestinal pseudo-obstruction is a clinical syndrome in which the clinical symptoms of intestinal obstruction appear without mechanical obstruction of the intestine. We searched for articles from Japana Centra Revuo Medicina for the period 1983-2009 using the keywords 'chronic' and 'intestinal pseudo-obstruction'. 124 articles were identified, and of these 121 cases were investigated using our diagnostic criteria. The patients were between 0 (just after birth) and 84 years of age, indicating that chronic intestinal pseudo-obstruction (CIP) can occur at any age. The mean age was 43.6 years and the median age was 47 years. Forty-nine patients were male and 72 were female, showing a slight tendency towards female predominance. Five cases (4.2%) had a definitive family history. Of the identified causes of secondary CIP, systemic sclerosis was the most common. Abdominal bloating was the most common initial symptom, seen in 90 (81%) patients. Patients having poor intestinal peristalsis with stagnation of the contents of the small intestines causing fatty stools and bacterial overgrowth complained of diarrhea. The interval between the initial symptoms and diagnosis ranged from 0 to 60 years, with a mean and median interval of 7.3 and 2 years, respectively. In case reports of CIP in Japan, the sensitivity of our diagnostic criteria was found to be 85.9%, indicating that the criteria are useful. For improvement in the rate of recognition of CIP and practical application of the diagnostic criteria in Japan, it is important to conduct further studies. © 2011 Springer.

    DOI: 10.1007/s12328-011-0219-8

    Scopus

    researchmap

  • Usefulness of endoscopic biopsy using FOXP3(+) Treg up-regulation in the duodenal papilla in the differential diagnosis between autoimmune pancreatitis and pancreatic cancer 査読

    Kensuke Kubota, Shingo Kato, Seitaro Watanabe, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Masahiko Inamori, Takeshi Shimamura, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Kantaro Hisatomi, Nobuyuki Matsuhashi, Atsushi Nakajima

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   18 ( 3 )   414 - 421   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Expression of the forkhead/winged helix family of transcription factor P3+ regulatory T cells (FOXP3(+) Treg), a master gene of regulatory T cells (Treg) is observed in patients with autoimmune pancreatitis (AIP). We investigated the usefulness of detection of FOXP3(+) Treg in the main duodenal papilla for differential diagnosis between AIP and pancreatic cancer (Pca).
    Firstly, we determined the cut-off value of FOXP3 expression in duodenal papilla taken from the patients with AIP (n = 22) and chronic pancreatitis (n = 21). Data from 32 patients with AIP and 30 patients with Pca who had undergone endoscopic biopsy were then studied. The numbers of FOXP3(+) Treg-positive lymphocytes and IgG4-positive plasma cells per high-power field (HPF) were counted in all the histopathological specimens.
    The areas under the receiver-operating characteristic (AUROC) curves for FOXP3(+) and IgG4 expression were 0.934 and 0.953, respectively. Cut-off values calculated based on AUROC data were 14/HPF in FOXP3 and 10/HPF in IgG4. Seropositivity for IgG4 was observed in 22 out of the 31 patients with AIP (sensitivity 71.0%, specificity 84.6%, accuracy 75.0%). Significant infiltration of the major duodenal papilla by FOXP3(+) lymphocytes (a parts per thousand yen14/HPF) was recognized in 18 of the 32 patients with AIP (sensitivity 56.3%, specificity 100%, accuracy 77.4%). Significant infiltration of the major duodenal papilla by IgG4-positive plasma cells (a parts per thousand yen10/HPF) was recognized in 27 of the 32 patients with AIP (sensitivity 84.4%, specificity 80.0%, accuracy 82.3%).
    Observation of FOXP3(+) cells in the main duodenal papilla may be useful in the differential diagnosis between AIP and Pca.

    DOI: 10.1007/s00534-010-0359-0

    Web of Science

    PubMed

    researchmap

  • Change of Gastric Emptying With Chewing Gum: Evaluation Using a Continuous Real-Time C-13 Breath Test (BreathID System) 査読

    Yasunari Sakamoto, Shingo Kato, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Koji Fujita, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY   17 ( 2 )   174 - 179   2011年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KOREAN SOC NEUROGASTERONTEROL & MOTILITY  

    Background/Aims
    There are few reports on the correlation between chewing gum and the gastrointestinal functions. But previous report showed use of chewing gum to be an effective method for controlling gastrointestinal symptoms. The aim of this study was to determine the correlation between chewing gum and gastric emptying using the continuous real time C-13 breath test (BreathID system).
    Methods
    Ten healthy male volunteers participated in this randomized, 2-way crossover study. The subjects fasted overnight and were randomly assigned to chewing gum (Xylish, 2-3/1 tablet) for an hour following intake of a test meal (200 kcal/200 mL) or intake of the test meal alone. Gastric emptying was monitored for 4 hours after administration of the test meal by the C-13-acetic acid breath test performed continually using the BreathID system.
    Results
    No significant differences in the calculated parameters, namely, T-1/2 (median, 111.82 vs 109.26 minutes; P = 0.575), T-lag (median, 53.28 vs 56.53 minutes; P = 0.333), gastric emptying coefficient (median, 3.58 vs 3.65; P = 0.285), regression-estimated constant beta (median, 1.85 vs 1.80; P = 0.575) and regression-estimated constant kappa (median, 0.61 vs 0.62; P = 0.959) were observed between the test meal alone group and the test meal and chewing gum group.
    Conclusions
    This study showed that chewing gum had no effect on the rate of gastric emptying. Therefore, since chewing gum did not enhance the speed of gastric emptying, it may ameliorate gastrointestinal symptoms through other mechanisms, such as saliva and autonomic nervous system.

    DOI: 10.5056/jnm.2011.17.2.174

    Web of Science

    PubMed

    researchmap

  • Clostridium difficile infection in patients with ulcerative colitis: Investigations of risk factors and efficacy of antibiotics for steroid refractory patients 査読

    Takashi Kaneko, Reikei Matsuda, Masataka Taguri, Masahiko Inamori, Asami Ogura, Eiji Miyajima, Katsuaki Tanaka, Shin Maeda, Hideaki Kimura, Reiko Kunisaki

    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY   35 ( 4 )   315 - 320   2011年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER MASSON  

    Background and objective: The incidence of Clostridium difficile infection (CDI) has increased throughout the world and patients with ulcerative colitis (UC) are at a high risk for CDI. Potentially, CDI can exacerbate UC. Therefore, knowledge on the prevalence of CDI should contribute to better management of UC patients.
    Methods: The presence of toxin A antigen was defined as CDI, and the outcome of the test in patients with active UC during 2006-2009 was reviewed for identifying patients with CDI. Demographic data (disease profile, clinical response to medications and the need for colectomy) in UC patients with CDI were compared with the data from CDI free UC patients.
    Results: Fifty-five of 137 patients (40.1%) were CDI positive. Univariate and multivariate analyses revealed that CDI was not associated with any demographic factor. Intensive antibiotic therapy spared five of 17 (29.4%) steroid refractory patients with CDI from steroids. CDI was not a predictor of colectomy although this could be an outcome of efficient eradication strategy.
    Conclusion: CDI was not associated with any demographic factor or colectomy rate. However, CDI eradication therapy allowed some refractory patients to withdraw from steroids. Patients with active UC benefit from regular CDI test and eradication treatment for CDI. (C) 2011 Elsevier Masson SAS. All rights reserved.

    DOI: 10.1016/j.clinre.2011.02.004

    Web of Science

    PubMed

    researchmap

  • Serum nitric oxide metabolite as a biomarker of visceral fat accumulation: Clinical significance of measurement for nitrate/nitrite 査読

    Koji Fujita, Koichiro Wada, Yuichi Nozaki, Masato Yoneda, Hiroki Endo, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    MEDICAL SCIENCE MONITOR   17 ( 3 )   CR123 - CR131   2011年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:INT SCIENTIFIC LITERATURE, INC  

    Background: A visceral fat area of more than 100 cm(2) as measured by computed tomography (CT) at the umbilical level has been included as a criterion for obesity in all the proposed criteria for metabolic syndrome. However, CT cannot be used frequently because of radiation exposure. We evaluated the usefulness of measurement of the serum levels of nitric oxide (NO), instead of CT and the waist circumference, as a marker of abdominal visceral fat accumulation.
    Material/Methods: The study was carried out in 80 subjects. The serum levels of NO metabolites (nitrate/nitrite) were measured using the Griess reagent.
    Results: Simple and multiple regression analysis revealed that the serum levels of NO metabolites showed the greatest degree of correlation with the visceral fat area (r = 0.743, p &lt; 0.0001), and corresponded to a visceral fat area of 100 cm(2), as determined using the ROC curve, was 21.0 mu mol/ml (sensitivity 88%, specificity 82%); this method was more sensitive than the waist circumference for evaluation of the visceral fat accumulation.
    Conclusions: Measurement of the serum levels of NO metabolites may be a simple, safe, convenient and reliable method for the evaluation of visceral fat accumulation in clinical diagnostic screening.

    Web of Science

    researchmap

  • Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer. 査読

    Kuriyama H, Kawana K, Taniguchi R, Jono F, Sakai E, Ohubo H, Suzuki H, Kobayashi S, Murata Y, Inamori M, Hata Y, Nahajima A

    Hepato-gastroenterology   58 ( 106 )   270 - 274   2011年3月

     詳細を見る

  • Liver Microsomal Triglyceride Transfer Protein Activator May Be a Possible Therapeutic Agent in Non-alcoholic Steatohepatitis 査読

    Koji Fujita, Kento Imajo, Yoshiyasu Shinohara, Yuichi Nozaki, Koichiro Wada, Masato Yoneda, Hiroki Endo, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Takeshi Shimamura, Noritoshi Kobayashi, Hiroyuki Kirikoshil, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    JOURNAL OF PHARMACOLOGICAL SCIENCES   115 ( 3 )   270 - 273   2011年3月

     詳細を見る

    記述言語:英語   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    The factors involved in the progression of non-alcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) are not fully understood and thus it is urgently needed to elucidate these factors. Steatosis is not causal in the development of NASH, but rather it sensitizes the liver to the damaging effects of second hits such that stressors innocuous to a healthy liver lead to the development of NASH in the steatotic liver. In the previous study, most of the hepatic lipid metabolite profiles were similar in the NAFL and NASH groups. However, very-low-density lipoprotein (VLDL) synthesis, especially hepatic microsomal triglyceride transfer protein (MTP) mRNA expression, was impaired in the NASH group. Moreover, NASH showed significantly higher incidence of minor alley appearance compared with NAFL, indicating the possibility of association between NASH pathogenesis and decreased congenital MTP activity. MTP is one of the enzymes that transfer triglycerides to nascent apolipoprotein B, producing VLDL and removing lipid from the hepatocyte. A growing body of literature suggests that the measurement of hepatic MTP expression may be helpful for diagnosis; and moreover, hepatic MTP activator may be a possible therapeutic agent for the treatment of NASH.

    DOI: 10.1254/jphs.10R14FM

    Web of Science

    researchmap

  • Effects of Domperidone on Gastric Emptying: A Crossover Study Using a Continuous Real-Time C-13 Breath Test (BreathID System) 査読

    Yasunari Sahamoto, Shingo Kato, Yusuke Sehino, Eiji Sakai, Takashi Uchiyama, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Koji Fujita, Tomoho Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuhe Kubota, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    HEPATO-GASTROENTEROLOGY   58 ( 106 )   637 - 641   2011年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: To determine the correlation between domperidone and gastric emptying using the continuous real time C-13 breath-test (BreathID system), a novel non-invasive technique for measuring gastric emptying.
    Methodology: Six healthy male volunteers participated in this randomized, two-way crossover study. Subjects fasted overnight and were randomly assigned to receive a test meal (400kcal per 400mL) 30 minutes after intake of domperidone (10mg) with 50mL of water or intake of 50mL of water alone. Gastric emptying was monitored for 4h after administration of the test meal by C-13-acetic acid breath test continually performed using the BreathID system. The time taken for emptying of 50% of the labeled meals (T1/2), the analog to the scintigraphy lag time for 10% emptying of the labeled meal (T lag), the gastric emptying coefficient (GEC), and the regression-estimated constants (6 and K) were calculated. Differences in the parameters measured at two time-points were analyzed using the Wilcoxon&apos;s signed-rank test.
    Results: No significant differences in calculated parameters (T lag, T1/2, GEC, beta or kappa) were observed between the treated and non-treated groups.
    Conclusions: This study showed that domperidone had no effect on gastric emptying. The drug ameliorates nausea and vomiting via its antagonic activity against dopamine receptor. Therefore, domperidone probably ameliorates nausea through other mechanisms.

    Web of Science

    PubMed

    researchmap

  • Risk factors for mortality in patients with mallory-weiss syndrome 査読

    Nobutaka Fujisawa, Masahiko Inamori, Yusuke Sekino, Keiko Akimoto, Hiroshi Iida, Ayako Takahata, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Tomoyuki Akiyama, Tomoko Koide, Chikako Tokoro, Hirokazu Takahashi, Kumiko Saito, Yasunobu Abe, Atsushi Nakamura, Kensuke Kubota, Satoru Saito, Shigeru Koyama, Atsushi Nakajima

    Hepato-Gastroenterology   58 ( 106 )   417 - 420   2011年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:106  

    Background/Aims: Although the majority of patients with Mallory-Weiss syndrome (MWS) have a benign course, in some patients MWS results in a fatal outcome. Therefore, this study was carried out to analyze the risk factors for mortality in patients with MWS. Methodology: The medical records of patients with MWS seen between March 1994 and July 2007 were reviewed retrospectively. The demographic characteristics, clinical and laboratory parameters, and endoscopic findings of the patients were analyzed and the risk factors for mortality were evaluated. Results: A total of ninety-three patients (13 female and 80 male patients
    median age, 53 years) were treated. The mortality rate was 9.7% (9/93). The patients with a fatal outcome were of advanced age and had a higher frequency of shock on arrival, lower hemoglobin level, more prolonged prothrombin time, higher AST and ALT levels, higher frequency of detection of exposed vessels on endoscopy, higher frequency of rebleeding, longer hospital stay, and required a larger volume of blood transfusion than those who did not have a fatal outcome. According to the results of a multivariate analysis, the significant risk factors for mortality in the MWS patients were advanced age (OR 1.222, 95% CI 1.015-1.028), very low hemoglobin level (OR 2.137, 95% CI 1.063-4.295), elevated AST level (OR 1.007, 95% CI 1.001-1.013), and presence of the clinical symptom of tarry stool (OR 45.45, 95% CI 1.080-1000). Conclusions: Intensive care with close monitoring is required for patients of advanced age with a low hemoglobin level, an elevated AST level, and the clinical symptom of tarry stool, since these are of prognostic importance in terms of the mortality in MWS patients. © H.G.E. Update Medical Publishing S.A.

    Scopus

    PubMed

    researchmap

  • Leptin receptor is involved in STAT3 activation in human colorectal adenoma 査読

    Takashi Uchiyama, Hirokazu Takahashi, Michiko Sugiyama, Eiji Sakai, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Masato Yoneda, Masahiko Inamori, Yoji Nagashima, Yoshiaki Inayama, Koichiro Wada, Atsushi Nakajima

    CANCER SCIENCE   102 ( 2 )   367 - 372   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    The possible role of leptin in colorectal tumors has been investigated in previous studies; however, to date, the conclusions remain under debate. Therefore, we investigated the serum leptin levels in colorectal adenoma patients. In addition, expression of the leptin receptor, and the leptin receptor-mediated signaling pathways were investigated in biopsy specimens collected from human patients with colorectal adenoma. No significant difference in the mean serum leptin level was observed between the colorectal adenoma patients and the control subjects; however, increased expression and activation of the leptin receptor, as indicated by findings such as the phosphorylation of Tyr 1141, was observed in the colorectal adenoma tissues. In addition, activation of the JAK/STAT signaling pathway mediated by the leptin receptor and increased transcriptional regulation of downstream target molecules were observed in colorectal adenomas compared with the non-adenoma tissues. These results indicate STAT3-mediated leptin receptor signaling pathways may be activated in human colorectal adenomas. (Cancer Sci 2011; 102: 367-372)

    DOI: 10.1111/j.1349-7006.2010.01803.x

    Web of Science

    PubMed

    researchmap

  • Sporadic Nonampullary Duodenal Adenoma in the Natural History of Duodenal Cancer: A Study of Follow-up Surveillance 査読

    Kazuhisa Okada, Junko Fujisaki, Akiyoshi Kasuga, Masami Omae, Manabu Kubota, Toshiaki Hirasawa, Akiyoshi Ishiyama, Masahiko Inamori, Akiko Chino, Yorimasa Yamamoto, Tomohiro Tsuchida, Atsushi Nakajima, Etsuo Hoshino, Masahiro Igarashi

    AMERICAN JOURNAL OF GASTROENTEROLOGY   106 ( 2 )   357 - 364   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    OBJECTIVES: Although sporadic nonampullary duodenal adenoma (SNDA) is regarded as a precancerous lesion, its natural course is uncertain. The aim of this study was to evaluate the risk of development of adenocarcinoma in SNDA lesions initially diagnosed as showing low-grade dysplasia (LGD; category 3) or high-grade dysplasia (HGD; category 4.1).
    METHODS: We analyzed 68 SNDAs, diagnosed based on initial and subsequent biopsies, in 66 consecutive patients. Of these, 46 (43 LGD lesions, 3 HGD lesions) were followed up for &gt;= 6 months without treatment (mean 27.7 +/- 16.9 months; range 6-72 months), including 8 lesions that were eventually resected during follow-up. Sixteen lesions (eight LGD lesions, eight HGD lesions) were resected immediately, either endoscopically or surgically, and six lesions were excluded because of a short follow-up (&lt; 6 months). The histopathological diagnoses and macroscopic changes were evaluated.
    RESULTS: Among the 43 LGD lesions followed up for &gt;= 6 months, 34 (79.1%) showed no histopathological changes during follow-up, whereas the remaining 9 (20.9%) showed progression to HGD, including 2 (4.7%) that progressed eventually to noninvasive carcinoma (category 4.2). Macroscopically, 76.7% (33 of 43) of the LGD lesions showed no notable changes in size, 16.3% (7 of 43) became undetectable, 4.7% (2 of 43) reduced in size, and 2.3% (1 of 43) became larger in size. In contrast, all the three HGD lesions that were followed up for &gt;= 6 months remained unchanged histologically, based on biopsy, and showed no notable macroscopic changes, although one of these HGD lesions resected endoscopically revealed evidence of noninvasive carcinoma. Although we diagnosed all lesions as HGD from biopsy samples, a high percentage of cancers (54.5%, 6 of 11) were diagnosed from resected specimens. A multivariate analysis identified HGD diagnosed at first biopsy and a lesion diameter of &gt;= 20 mm as being significantly predictive of progression to adenocarcinoma.
    CONCLUSIONS: LGD lesions show a low risk of progression to adenocarcinoma, but some risk of progression to HGD, which warrants careful follow-up biopsy. However, HGD lesions and large SNDAs &gt;= 20 mm in diameter show a high risk of progression to adenocarcinoma. Therefore, they should be treated immediately.

    DOI: 10.1038/ajg.2010.422

    Web of Science

    PubMed

    researchmap

  • Liver abscess caused by periodontal bacterial infection with Fusobacterium necrophorum 査読

    Masato Yoneda, Shingo Kato, Hironori Mawatari, Hiroyuki Kirikoshi, Kento Imajo, Koji Fujita, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Iwai Tohnai, Kei Watanuki, Koichiro Wada, Shin Maeda, Atsushi Nakajima

    HEPATOLOGY RESEARCH   41 ( 2 )   194 - 196   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Liver abscess is recognized as a life-threatening disease. However, even in recent years, approximately 50% of liver abscess cases are considered to be cryptogenic. Here, we report a case of liver abscess associated with periodontal bacterial infection by Fusobacterium necrophorum, which is commonly found in the oropharyngeal flora. A 36-year-old man presented with fever and contrast-enhanced abdominal computed tomography revealed multiple liver abscesses. F.necrophorum was isolated from oral smears, liver aspirates and blood samples. Liver abscesses caused by periodontal bacterial infection are rare, however, the incidence is expected to increase in the future, as periodontitis is extremely common and is on the rise as one of the most common chronic infections in the world. A systemic survey including periodontitis may be required for the exact diagnosis of the source of infection.

    DOI: 10.1111/j.1872-034X.2010.00748.x

    Web of Science

    PubMed

    researchmap

  • Incidence of and Risk Factors for Upper Gastrointestinal Complications in Patients Taking Low-dose Aspirin in Japan 査読

    Nobutaka Fujisawa, Masahiko Inamori, Hiroki Endo, Takashi Uchiyama, Kunihiro Hosono, Tomoyuki Akiyama, Ayako Tomimoto, Sigeru Koyama, Aya Sawabe, Emiko Tanida, Shogo Yanagisawa, Yasuo Hata, Kazuhisa Okada, Kazuhiro Atsukawa, Seitaro Watanabe, Harunobu Kawamura, Takuma Higurashi, Hajime Nagase, Keiko Akimoto, Nobuyuki Matsuhashi, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   58 ( 105 )   229 - 234   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Low-dose aspirin is widely used for the prevention of cardiovascular and cerebrovascular diseases. However, administration of low-dose aspirin is associated with an increased risk of upper gastrointestinal complications, such as upper gastrointestinal erosions, ulcers and bleeding. The aim of this study was to clarify the prevalence and various clinical factors of upper gastrointestinal complications associated with low-dose aspirin treatment.
    Methodology: A total of 1213 patients taking low-dose aspirin were evaluated with upper endoscopi.c examinations. We studied retrospectively the incidence of and risk factors for upper gastrointestinal complications associated with low-dose aspirin use.
    Results: Of the 1213 patients taking low-dose aspirin, 598 patients and 72 patients were found to have gastroduodenal erosions (57.3%) and peptic ulcers (5.9%), respectively. Of these 72 peptic ulcers, 27 were diagnosed as hemorrhagic ulcers. Previous ulcer history was identified as a risk factor for peptic ulcer and upper gastrointestinal bleeding during low-dose aspirin therapy. Upper gastrointestinal symptoms and no use of gastroprotective agents were also identified as risk factors for peptic ulcers. In this study, the use of a histamine-2 receptor antagonist was indicated as a protective factor for peptic ulcers.
    Conclusions: Low-dose aspirin therapy is associated with an increased risk of developing upper gastrointestinal complications. Administration of a histamine-2 receptor antagonist was effective for the prevention of low-dose aspirin induced peptic ulcers.

    Web of Science

    PubMed

    researchmap

  • DISCRIMINATION BETWEEN SCLEROSING CHOLANGITIS-ASSOCIATED AUTOIMMUNE PANCREATITIS AND PRIMARY SCLEROSING CHOLANGITIS, CANCER USING INTRADUCTAL ULTRASONOGRAPHY 査読

    Kensuke Kubota, Shingo Kato, Takashi Uchiyama, Seitaro Watanabe, Yuich Nozaki, Koji Fujita, Masato Yoneda, Masahiko Inamori, Takeshi Shimamura, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima

    DIGESTIVE ENDOSCOPY   23 ( 1 )   10 - 16   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Background and Aim:
    Differentiation of sclerosing cholangitis-associated autoimmune pancreatitis (SC-AIP), primary sclerosing cholangitis (PSC) and cancer of the hilar part of the bile duct (CHB) has been challenging. The aim of the present study was to evaluate characteristic intraductal ultrasonography (IDUS) features that could be used to discriminate SC-AIP from PSC and CHB.
    Methods:
    Six patients with SC-AIP, 10 patients with PSC and 12 patients with CHB were identified. We reviewed the following bile duct features observed using IDUS to determine their usefulness for differentiating SC-AIP from PSC and CHB: presence of symmetrical wall thickness, wall thickness, presence of homogeneous internal foci and presence of lateral mucosal lesions continuous to the hilar.
    Results:
    IDUS results (SC-AIP, PSC, CHB) were as follows: wall thickness (mm), 3.7 +/- 0.9, 2.6 +/- 0.9, 2.8 +/- 0.0.6; presence of symmetrical wall thickness, 100% (6/6), 20% (2/10), 8.3% (1/12); presence of homogeneous internal foci, 100% (6/6), 10% (1/10), 8.3% (1/12); and presence of lateral mucosal lesions continuous to the hilar, 83.3% (5/6), 40%(4/10), 25% (3/12). Symmetrical wall thickness of the bile duct, homogeneous internal foci and lateral mucosal lesions continuous to the hilar were detected significantly more often among the patients with SC-PSC than among the patients with PSC or CHB (P &lt; 0.05).
    Conclusions:
    IDUS findings, such as symmetrical wall thickness, presence of homogeneous internal foci and presence of lateral mucosal lesions continuous to the hilar can facilitate the differential diagnosis of SC-AIP from PSC and CHB.

    DOI: 10.1111/j.1443-1661.2010.01039.x

    Web of Science

    PubMed

    researchmap

  • HEMOLYTIC EPISODE FOLLOWING AN UPPER GASTROINTESTINAL ENDOSCOPY IN A PATIENT WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 査読

    Shinya Ito, Akito Oshima, Takashi Uchiyama, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    DIGESTIVE ENDOSCOPY   23 ( 1 )   99 - 99   2011年1月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    DOI: 10.1111/j.1443-1661.2010.01056.x

    Web of Science

    PubMed

    researchmap

  • QUANTITATIVE ANALYSIS OF LOW-DOSE ASPIRIN-ASSOCIATED SMALL BOWEL INJURY USING A CAPSULE ENDOSCOPY SCORING INDEX 査読

    Hiroki Endo, Kunihiro Hosono, Takuma Higurashi, Eiji Sakai, Hiroshi Iida, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Tomoko Koide, Masato Yoneda, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Nobuyuki Matsuhashi, Atsushi Nakajima

    DIGESTIVE ENDOSCOPY   23 ( 1 )   56 - 61   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Aim:
    The major limitation of capsule endoscopy (CE) has been the lack of a standardized and validated severity scale for mucosal injury. The aim of the present study was to verify the usefulness of quantifying small bowel mucosal changes associated with giving low-dose aspirin (LDA) using a CE scoring index.
    Methods:
    The CE score for small bowel mucosal injury was investigated to evaluate the severity of mucosal injury. Healthy volunteers and patients suspected of having small bowel disease were recruited for this study. The short-term LDA group (V + S-LDA group) consisted of volunteers who took low-dose aspirin for 14 days; this group was then compared with healthy volunteers who did not receive LDA treatment (V-Control group). The long-term LDA group (L-LDA group) consisted of patients with at least a 3-month history of daily LDA use; this group was compared with non-users of LDA (P-Control group).
    Results:
    The CE score was significantly higher in the V + S-LDA group than in the V-Control group. In the V-Control group, almost all the subjects were categorized as exhibiting a &apos;normal&apos; change. &apos;Mild&apos; changes were observed significantly more frequently in the V + S-LDA group than in the V-Control group. The CE score was significantly higher in the L-LDA group than in the P-Control group. &apos;Mild&apos; or &apos;moderate or severe&apos; changes were observed significantly more frequently in the L-LDA group than in the P-Control group.
    Conclusion:
    The CE scoring system was useful for evaluating LDA-associated small bowel mucosal disease activity and for objectively scoring the small bowel inflammatory disease state.

    DOI: 10.1111/j.1443-1661.2010.01044.x

    Web of Science

    PubMed

    researchmap

  • Single-Agent Gemcitabine in Elderly Patients with Unresectable Biliary Tract Cancer 査読

    Hitoshi Kuriyama, Kenichi Kawana, Reo Taniguchi, Fumitake Jono, Eiji Sakai, Hidenori Okubo, Hirobumi Suzuki, Satoshi Kobayashi, Yoriko Murata, Masahiko Inamori, Yasuo Hata, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   58 ( 105 )   26 - 30   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: This study examines the effect of systemic chemotherapy with gemcitabine (GEM) on survival in elderly patients (aged &gt;= 70 years) with unresectable biliary tract cancer and compares it with best supportive care (BSC).
    Methodology: We conducted a retrospective study of consecutive patients aged &gt;= 70 years, with unresectable biliary tract cancer who were administered GEM (800-1,000 mg/m2) on days 1, 8, and 15 every 4 weeks as a first-line treatment.
    Results: Twenty-eight patients were enrolled: 13 (46.4%) received chemotherapy with GEM and 15 (53.6%) received BSC. No cases of complete or partial response were observed. Stable disease was observed in 9 patients (69.2%) and progressive disease in 2 patients (15.4%). Disease control rate was 69.2%. The median overall survival time of patients treated with GEM and BSC was 9.1 and 2.9 months, and the 1-year survival rates were 15.4% and 6.7% respectively. Grade 3/4 neutropenia occurred in three patients (23.1%), leukopenia in two patients (15.4%) and anemia in one patient (7.7%). Grade 3 non-hematologic toxicities were constipation (7.7%) and fatigue (7.7%).
    Conclusions: Chemotherapy with single-agent GEM is a safe and well tolerated regimen for elderly patients with unresectable biliary tract cancer.

    Web of Science

    PubMed

    researchmap

  • Early Effects of Oral Administration of Lafutidine with Peppermint Oil, Compared with Lafutidine Alone, on Intragastric pH Values 査読

    Hiroshi Iida, Masahiko Inamori, Takashi Uchiyama, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   58 ( 105 )   235 - 238   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: ideally, medications for the treatment of acid-related diseases should have a rapid onset of action to promote hemostasis and the resolution of symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion of a single oral administration of lafutidine alone or combined with peppermint oil.
    Methodology: Ten Helicobacter pylori-negative male subjects participated in this randomized, two-way crossover study. Intragastric pH was monitored continuously for 4 hours after a single oral administration of lafutidine (10mg) or the administration of lafutidine (10mg) with peppermint oil (0.64mL). Each administration was separated by a 7-day washout period.
    Results: No significant difference in the average pH was observed during the 4-hour period after the combined administration of lafutidine and peppermint oil and after the administration of lafutidine alone (median gastric pH: 5.09 versus 5.29; p=0.3122).
    Conclusions: In H. pylori-negative healthy male subjects, an oral dose of lafutidine combined with peppermint oil did not increase the intragastric pH faster than lafutidine alone.

    Web of Science

    PubMed

    researchmap

  • Does Postprandial Itopride Intake Affect the Rate of Gastric Emptying?: A Crossover Study Using the Continuous Real Time C-13 Breath Test (BreathID System) 査読

    Takashi Nonaka, Takaomi Kessoku, Yuji Ogawa, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Yusuke Sekino, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Yasunobu Abe, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    HEPATO-GASTROENTEROLOGY   58 ( 105 )   224 - 228   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to determine whether oral Itopride hydrochloride (itopride) intake might have any effect on the rate of gastric emptying, using a novel non-invasive technique for measuring the rate of gastric emptying, namely, the continuous real time C-13 breath test (BreathID system: Exalenz Bioscience Ltd., Israel).
    Methodology: Eight healthy male volunteers participated in this randomized, two-way crossover study. The subjects fasted overnight and were randomly assigned to receive 50mg itopride following a test meal (200 kcal per 200mL, containing 100mg C-13 acetate), or the test meal alone. Under both conditions, gastric emptying was monitored for 4 hours after administration of the test meal by the C-13-acetic acid breath test performed continually using the BreathID system. Using Oridion Research Software (6 version), the time required for emptying of 50% of the labeled meal (T 1/2), the analog to the scintigraphy lag time for 10% emptying of the labeled meal (T lag), the gastric emptying coefficient (GEC), and the regression-estimated constants (6 and x) were calculated. The parameters measured under the two conditions were compared using the Wilcoxon&apos;s signed-rank test.
    Results: No significant differences in the calculated parameters, namely, the T 1/2, T lag, GEC, B or K, were observed between the two test conditions, namely, administration of a test meal+itopride and administration of the test meal alone.
    Conclusions: The present study revealed that postprandial itopride intake had no significant influence on the rate of gastric emptying. Recently, several studies have shown that itopride may be effective in the treatment of patients with functional dyspepsia. Our results suggest that the efficacy of itopride in patients with functional dyspepsia may be based on its effect of improving functions other than the rate of gastric emptying, such as the activities at neuronal sites, brain-gut correlation, visceral hypersensitivity, gastric accommodation and distension-induced adaptation.

    Web of Science

    PubMed

    researchmap

  • Novel Endoscopic Technique for the Diagnosis of Early Gastric Cancer: Endoscopy with Crystal Violet Staining 査読

    Ken Ohata, Ryoichi Misaka, Takafumi Ito, Hideyuki Chiba, Yosuke Tsuji, Makoto Yamawaki, Tomohiko Ohya, Masahiko Inamori, Atsushi Nakajima, Nobuyuki Matsuhashi

    DIGESTION   84 ( 1 )   60 - 61   2011年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000313694

    Web of Science

    PubMed

    researchmap

  • Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication 査読

    Chikako Tokoro, Masahiko Inamori, Tomoko Koide, Yusuke Sekino, Hiroshi Iida, Yasunari Sakamoto, Hiroki Endo, Kunihiro Hosono, Hirokazu Takahashi, Masato Yoneda, Hiroaki Yasuzaki, Masami Ogawa, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Ichiro Kawana, Atsushi Nakajima, Shin Maeda, Reikei Matsuda, Daisuke Takahashi

    Medical Science Monitor   17 ( 5 )   CR235 - CR240   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:International Scientific Literature Inc.  

    Background: Pretreatment with a proton pump inhibitor (PPI) reportedly decreases the efficacy of Helicobacter pylori (H. pylori) eradication, however, the effect of pretreatment with an H2 receptor antagonist (H2RA) on H. pylori eradication has not yet been studied. We compared the efficacy of eradication regimen (lansoprazole/amoxicillin/clarithromycin) in patients with H. pylori infection with or without H2RA pretreatment. Material/Methods: In this retrospective study conducted at three centers, 310 patients with H. pylori infection were treated. The diagnosis of H. pylori infection was made using the rapid urease test, bacterial cultures and histological examination of endoscopic biopsy specimens. The patients were assigned to receive an eradication regimen first or following pretreatment with H2RA. Eradication was assessed using the 13C-urea breath test more than 4 weeks after the completion of therapy. Results: Overall, H. pylori was eradicated in 79.7% of the cases: the eradication rate was 81.6% in the pretreatment group, and 77.6% in the eradication first group (p=0.3799, chi-square test). No significant difference in the eradication rate was observed between the two groups. Conclusions: Pretreatment with H2RA had no significant influence on the efficacy of H. pylori eradication therapy. © Med Sci Monit, 2011.

    DOI: 10.12659/MSM.881762

    Scopus

    PubMed

    researchmap

  • Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication 査読

    Chikako Tokoro, Masahiko Inamori, Tomoko Koide, Yusuke Sekino, Hiroshi Iida, Yasunari Sakamoto, Hiroki Endo, Kunihiro Hosono, Hirokazu Takahashi, Masato Yoneda, Hiroaki Yasuzaki, Masami Ogawa, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Ichiro Kawana, Atsushi Nakajima, Shin Maeda, Reikei Matsuda, Daisuke Takahashi

    Medical Science Monitor   17 ( 5 )   CR235 - CR240   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:International Scientific Literature Inc.  

    Background: Pretreatment with a proton pump inhibitor (PPI) reportedly decreases the efficacy of Helicobacter pylori (H. pylori) eradication, however, the effect of pretreatment with an H2 receptor antagonist (H2RA) on H. pylori eradication has not yet been studied. We compared the efficacy of eradication regimen (lansoprazole/amoxicillin/clarithromycin) in patients with H. pylori infection with or without H2RA pretreatment. Material/Methods: In this retrospective study conducted at three centers, 310 patients with H. pylori infection were treated. The diagnosis of H. pylori infection was made using the rapid urease test, bacterial cultures and histological examination of endoscopic biopsy specimens. The patients were assigned to receive an eradication regimen first or following pretreatment with H2RA. Eradication was assessed using the 13C-urea breath test more than 4 weeks after the completion of therapy. Results: Overall, H. pylori was eradicated in 79.7% of the cases: the eradication rate was 81.6% in the pretreatment group, and 77.6% in the eradication first group (p=0.3799, chi-square test). No significant difference in the eradication rate was observed between the two groups. Conclusions: Pretreatment with H2RA had no significant influence on the efficacy of H. pylori eradication therapy. © Med Sci Monit, 2011.

    DOI: 10.12659/MSM.881762

    Scopus

    researchmap

  • Capsule Endoscopic Evaluation of Eosinophilic Enteritis before and after Treatment 査読

    Hiroki Endo, Kunihiro Hosono, Masahiko Inamori, Shingo Kato, Takashi Uchiyama, Hiroshi Iida, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Tomoko Koide, Masato Yoneda, Chikako Tokoro, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Kiyotaka Nagahama, Yoshiaki Inayama, Atsushi Nakajima

    DIGESTION   83 ( 1-2 )   134 - 135   2011年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000308654

    Web of Science

    PubMed

    researchmap

  • Two cases of laparoscopic wedge resection for gastric submucosal tumor using laparoscopy-endoscopy cooperative surgery (LECS)

    Yasushi Rino, Nono Yukawau, Roppei Yamada, Tsutomu Sato, Masahiko Inamori, Yasunobu Abe, Tomoko Koide, Atsushi Nakajima, Shin Maeda, Takashi Oshima, Naoki Hiki, Toshio Imada, Munetaka Masuda

    Yokohama Medical Journal   62 ( 4 )   519 - 524   2011年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Laparoscopic wedge resections are increasingly performed for gastric submucosal tumors such as gastrointestinal stromal tumor (GIST). Despite this, no defined strategy exists to guide the surgeon in choosing the appropriate laparoscopic technique for an individual case on the basis of tumor characteristics such as location or size. Laparoscopy-endoscopy cooperative surgery (LECS) can be used for submucosal tumor resection independent of tumor location and size. Both mucosal and submucosal layers around the tumor were circumferentially dissected using endoscopic submucosal dissection via intraluminal endoscopy. Subsequently, the seromusclar layer was laparoscopically dissected on the exact three-fourths cut line around the tumor. The submucosal tumor then was exteriorized to the abdominal cavity and dissected with a standard endoscopic stapling device. We employed LECS for the resection of gastric submucosal tumors. In two cases with GIST, the LECS procedure was successful in dissecting out the gastric submucosal tumor. In the first case, the tumor was more than 5cm in diameter and was located in the lower gastric portion near the pyloric ring. In the second case, the tumor was located in the upper gastric portion near the esophagogastric junction. The postoperative course was uneventful in both cases. The LECS procedure for dissection of gastric submucosal tumors such as GIST may be performed safely with reasonable operation times, less bleeding, and adequate cut lines. In addition, the success of the procedure does not depend on tumor location such as in the vicinity of the esophagogastric junction or pyloric ring.

    Scopus

    researchmap

  • A case report of laparoscopic toupet fundoplication for gastroesophageal reflux disease

    Yasushi Rino, Soji Ozawa, Hiroshi Iida, Norio Yukawa, Roppei Yamada, Tsutomu Sato, Nobuhiro Sugano, Daisuke Inagaki, Hirohito Fujikawa, Koichiro Yamaoku, Kenji Inafuku, Masahiko Inamori, Atsushi Nakajima, Shin Maeda, Sockon Koh, Munetaka Masuda, Toshio Imada

    Yokohama Medical Journal   62 ( 4 )   533 - 537   2011年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    According to the guidelines of the Japanese Society of Gastroenterology, when the diagnosis of gastroesophageal reflux disease (GERD) is objectively confirmed, surgical therapy should be considered in individuals for whom medical management has failed. A large body of literature on the laparoscopic surgical treatment of GERD exists. The majority of published studies have demonstrated lower dysphagia rates after Toupet fundoplication and no difference in heartburn control between the Toupet and Nissen procedures at follow up. On the basis of these reports, we selected Toupet fundoplication. This case was a 65-year-old male who complained of heartburn and was diagnosed as having GERD 4years previously, but medical management failed. The postoperative course was uneventful. After Toupet fundoplication, he had no complications of GERD without proton pump inhibitor.

    Scopus

    researchmap

  • Time-course of Changes of Visceral Fat Area, Liver Volume and Liver Fat Area during Intragastric Balloon Therapy in Japanese Super-obese Patients 査読

    Yusuke Sekino, Kento Imajo, Eiji Sakai, Takashi Uchiyama, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Satoru Saito, Shin Maeda, Eiji Gotoh, Masahiro Takihata, Yasuo Terauchi, Atsushi Nakajima, Masahiko Inamori

    INTERNAL MEDICINE   50 ( 21 )   2449 - 2455   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Objective The aim of this study was to assess the changes in the clinical parameters during intragastric balloon therapy for Japanese obese patients.
    Methods Between March 2009 and September 2010, 8 patients underwent intragastric balloon therapy at our hospital. The visceral fat area, liver volume and the liver-spleen ratio were measured by computed tomography. Blood examination and computerized tomography were performed before the balloon placement, and at 1, 3 and 6 months after the balloon placement in all of the patients.
    Results Eight patients (5 males and 3 females, median age, 39 years; median BMI, 44.0 kg/m(2)) underwent intragastric balloon therapy without severe complications. The median weight loss was 8.6 kg, mean BMI loss was 2.8 kg/m(2), and the percent excess weight loss was 14.8% at 6 months after the balloon placement. The body weight and liver volume decreased significantly during the first month, and the results were maintained at the same levels until after the second month. The liver-spleen ratio also improved significantly during the first month, but worsened again during the last 3 months. The visceral fat area showed no significant differences during the treatment as well as no differences in liver enzymes, glucose and lipid metabolism.
    Conclusion Intragastric balloon therapy achieved a moderate effect in weight and liver volume reduction during the early months of the treatment. Intragastric balloon therapy may have a role as a minimally invasive method for pretreatment before laparoscopic surgery.

    DOI: 10.2169/internalmedicine.50.5672

    Web of Science

    researchmap

  • Solitary peutz-jeghers type hamartomatous polyps in the duodenum are not always associated with a low risk of cancer: Two case reports 査読

    Yusuke Sekino, Masahiko Inamori, Mitsuru Hirai, Kaori Suzuki, Kaoru Tsuzawa, Keiko Akimoto, Ayako Takahata, Nobutaka Fujisawa, Kumiko Saito, Akisa Tsunemi, Michio Tanaka, Hiroshi Iida, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Atsushi Nakajima, Shin Maeda, Shigeru Koyama

    Journal of Medical Case Reports   5   240   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Introduction. A hamartomatous polyp without associated mucocutaneous pigmentation or a family history of Peutz-Jeghers Syndrome is diagnosed as a solitary Peutz-Jeghers type hamartomatous polyp. As compared with Peutz-Jeghers Syndrome, Peutz-Jeghers type hamartomatous polyps are diagnosed with a lower risk of cancer and are regarded as a different disorder. Case presentation. In case one, we describe an 84-year-old Japanese man with a 14 mm duodenal polyp. Endoscopic mucosal resection was performed and histological examination showed findings suggestive of a hamartomatous polyp with a focus of well-differentiated adenocarcinoma. In case two, we describe a 76-year-old Japanese man who had been treated for prostate, rectal and lung cancer. Upper gastrointestinal endoscopy revealed a duodenal polyp measuring 15 mm in diameter. Endoscopic mucosal resection was performed, and histological examination showed findings suggestive of a hamartomatous polyp. Liver and thyroid cancers were found after the endoscopic treatment. Conclusion: Although duodenal solitary hamartomatous polyps are associated with a lower risk of cancer, four patients, including our cases, have been diagnosed with cancerous polyps. Patients with duodenal solitary hamartomatous polyps should be treated by endoscopic or surgical resection and need whole-body screening. © 2011 Sekino et al
    licensee BioMed Central Ltd.

    DOI: 10.1186/1752-1947-5-240

    Scopus

    PubMed

    researchmap

  • Capsule-Endoscopic Findings of Ulcerative Colitis Patients 査読

    Takuma Higurashi, Hiroki Endo, Masato Yoneda, Kunihiro Hosono, Eiji Sakai, Hirokazu Takahashi, Masahiko Inamori, Shiori Uchiyama, Takuto Kojima, Kenichi Kawana, Yutaka Natsumeda, Hajime Nagase, Atsushi Nakajima

    DIGESTION   84 ( 4 )   306 - 314   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Background/Aims: Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by diffuse mucosal inflammation, traditionally regarded as being limited to the colorectum. Although several gastroduodenal lesions have also been reported recently in cases of UC, in general, small-bowel lesions in UC are believed to be extremely rare. The aim of this study was to examine the small bowel by capsule endoscopy in patients with UC. Methods: The study was conducted in 23 well-documented UC patients and 23 control volunteers. The frequency of small-bowel lesions, the number of small-bowel lesions per patient and the capsule endoscopy score were comparatively evaluated between the two groups. Results: Of the 23 UC patients, 13 (57%) showed small-bowel lesions, and 8 (35%) had erosions. There were significant differences in the frequency of the small-bowel lesions (p &lt; 0.001) and erosions (p = 0.009) between the two groups. The capsule endoscopy score was correlated with the UC disease activity index (r = 0.718, p &lt; 0.001). Conclusions: This is the first capsule-endoscopic study conducted to examine the small-bowel involvement in UC patients as compared with the healthy volunteers. It was concluded that UC, a chronic inflammatory bowel disease, can also involve the small bowel. Copyright (C) 2011 S. Karger AG, Basel

    DOI: 10.1159/000333086

    Web of Science

    PubMed

    researchmap

  • A Case of Rectal Cancer Arising from Long-Standing Prolapsed Mucosa of the Rectum 査読

    Takashi Nonaka, Masahiko Inamori, Tadaomi Kessoku, Yuji Ogawa, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sakaguchi, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Kazuhiro Atsukawa, Hisao Takahasi, Yoshikiyo Akasaka

    INTERNAL MEDICINE   50 ( 21 )   2569 - 2573   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Mucosal prolapse syndrome (MPS) has been recognized as a chronic benign inflammatory disorder, characterized mainly by rectal mucosal prolapse. Disorders representing this condition include solitary rectal ulcer syndrome (SRUS), rectal prolapse, proctitis cystica profunda, and inflammatory cap polyps. The gross appearance of rectal MPS can be occasionally misinterpreted as rectal cancer. In contrast, there have been a few reports of colorectal cancer originating from prolapsed mucosa. Herein, we report a case of MPS associated with two independent rectal cancers extending into the submucosal layer. We speculate that long-standing MPS may increase the risk of malignant transformation.

    DOI: 10.2169/internalmedicine.50.5924

    Web of Science

    researchmap

  • Effectiveness of Repeated Intragastric Balloon Therapy in a Morbidly Obese Japanese Patient 査読

    Yusuke Sekino, Hiroshi Iida, Hiroki Endo, Yasunari Sakamoto, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Yasunobu Abe, Atsushi Nakajima, Shin Maeda, Masahiro Takihata, Yasuo Terauchi, Masahiko Inamori

    INTERNAL MEDICINE   50 ( 2 )   109 - 112   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    A 19-year-old Japanese male with a BMI of 55.4 kg/m(2) who also had liver dysfunction, dyslipidemia and hyperuricemia underwent repeated intragastric balloon therapy. The percent excess weight loss was 22.5% at the first balloon removal and 28.6% at the second balloon removal. The hepatic dysfunction resolved after the second balloon therapy, however, the dyslipidemia and hyperuricemia did not improve. The Japanese population is regarded as a high-risk race for obesity-related diseases at lower BMI values, and morbidly obese Japanese patients may need more serious weight reduction protocols to improve the comorbidities than similarly obese Americans or Europeans.

    DOI: 10.2169/internalmedicine.50.4528

    Web of Science

    researchmap

  • Behçet's disease and colon cancer. 査読

    Inamori Masahiko, Takeno Mitsuhiro

    Internal medicine (Tokyo, Japan)   50 ( 6 )   537 - 8   2011年

     詳細を見る

  • Behçet's disease and colon cancer. 査読

    Inamori M, Takeno M

    Internal medicine (Tokyo, Japan)   50 ( 6 )   537 - 538   2011年

     詳細を見る

    記述言語:英語   出版者・発行元:6  

    DOI: 10.2169/internalmedicine.50.5009

    Web of Science

    PubMed

    researchmap

  • Optimal Approach for Small Bowel Capsule Endoscopy Using Polyethylene Glycol and Metoclopramide with the Assistance of a Real-Time Viewer 査読

    Kunihiro Hosono, Hiroki Endo, Eiji Sakai, Yusuke Sekino, Takashi Uchiyama, Seitaro Watanabe, Hiroshi Iida, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima

    DIGESTION   84 ( 2 )   119 - 125   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Aim: Capsule endoscopy is limited by the poor image quality of the distal bowel and incomplete small bowel transit. The aim of this study was to establish an optimal medication protocol for capsule endoscopy performed using a real-time viewer. Methods: A total of 80 patients were prospectively recruited. The patients were randomized into two groups: the &apos;conventional group&apos; (without any preparation) and the &apos;real-time group&apos; (in which a real-time viewer was attached). At 60 min after swallowing the capsule, if the capsule had reached the small bowel, 500 ml of polyethylene glycol was administered; if the capsule was still located in the stomach, 10 mg of metoclopramide was given intramuscularly, followed by 500 ml of polyethylene glycol solution. Results: The completion rate was significantly higher in the real-time group as compared with that in the conventional group (72.5 vs. 90.0%). Our protocol yielded a significantly improved image quality of the distal small bowel [image quality score = 1.6 vs. 3.0 (max 4.0)]. The detection rate of lesions in the distal small bowel was higher in the real-time group than in the conventional group. Conclusions: The present study clearly showed that our protocol yielded an improved completion rate and also improved image quality. Copyright (C) 2011 S. Karger AG, Basel

    DOI: 10.1159/000323225

    Web of Science

    PubMed

    researchmap

  • Covered Stent Placement for Duodenal Obstruction in Pancreatic Cancer 査読

    Hiromi Kasugai, Yumi Asano, Kenta Iguchi, Takashi Uchiyama, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shin Maeda, Atsushi Nakajima, Masahiko Inamori

    DIGESTION   83 ( 4 )   296 - 296   2011年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000313695

    Web of Science

    PubMed

    researchmap

  • Visceral Obesity and the Risk of Barrett's Esophagus 査読

    Tomoyuki Akiyama, Masato Yoneda, Shin Maeda, Atsushi Nakajima, Shigeru Koyama, Masahiko Inamori

    DIGESTION   83 ( 3 )   142 - 145   2011年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    It still remains controversial whether simple obesity, as measured by the body mass index (BMI), is an independent risk factor for Barrett's esophagus (BE). Recent studies have shown abdominal obesity, as defined by the waist circumference (WC) and the waist-to-hip ratio (WHR), to be a risk factor for BE, independent of the BMI, with the association between BMI and BE being no longer observed after adjustment for the WC and WHR. Moreover, visceral obesity, as directly measured by the surface area of the visceral adipose tissue (VAT) on abdominal CT images, has also been reported to have an association with the risk of BE. In addition to the mechanical effects of abdominal obesity, that is, increase of the intra-abdominal pressure by the large amount of adipose tissue, circulating factors secreted from the VAT, such as tumor necrosis factor-alpha, interleukin-6, leptin, and adiponectin, have also been proposed to be pathogenetically linked to BE and esophageal adenocarcinoma. Obesity is associated with the risk of BE, and this risk appeared to be mediated for the most part by abdominal obesity, especially visceral obesity. This raises several questions regarding the pathogenesis of obesity-related BE. Larger studies with prospective enrollment of patients are required for further examination of this issue. Copyright (C) 2011 S. Karger AG, Basel

    DOI: 10.1159/000321810

    Web of Science

    PubMed

    researchmap

  • Serum nitric oxide metabolite as a biomarker of visceral fat accumulation: Clinical significance of measurement for nitrate/nitrite 査読

    Koji Fujita, Koichiro Wada, Yuichi Nozaki, Masato Yoneda, Hiroki Endo, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    Medical Science Monitor   17 ( 3 )   5 - 31   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:International Scientific Literature Inc.  

    Background: A visceral fat area of more than 100 cm2 as measured by computed tomography (CT) at the umbilical level has been included as a criterion for obesity in all the proposed criteria for metabolic syndrome. However, CT cannot be used frequently because of radiation exposure. We evaluated the usefulness of measurement of the serum levels of nitric oxide (NO), instead of CT and the waist circumference, as a marker of abdominal visceral fat accumulation. Material/Methods: The study was carried out in 80 subjects. The serum levels of NO metabolites (nitrate/nitrite) were measured using the Griess reagent. Results: Simple and multiple regression analysis revealed that the serum levels of NO metabolites showed the greatest degree of correlation with the visceral fat area (r=0.743, p&lt
    0.0001), and corresponded to a visceral fat area of 100 cm2, as determined using the ROC curve, was 21.0 μmol/ml (sensitivity 88%, specificity 82%)
    this method was more sensitive than the waist circumference for evaluation of the visceral fat accumulation. Conclusions: Measurement of the serum levels of NO metabolites may be a simple, safe, convenient and reliable method for the evaluation of visceral fat accumulation in clinical diagnostic screening. © Med Sci Monit.

    Scopus

    PubMed

    researchmap

  • Endoscopic hemostasis through gastrostomy 査読

    T. Uchiyama, A. Goto, E. Sakai, Y. Sekino, H. Iida, H. Endo, K. Hosono, Y. Sakamoto, T. Koide, H. Takahashi, M. Yoneda, C. Tokoro, Y. Abe, T. Shimamura, N. Kobayashi, K. Kubota, S. Maeda, A. Nakajima, Y. Ichikawa, M. Inamori

    ENDOSCOPY   42   E270 - E270   2010年12月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0030-1255772

    Web of Science

    PubMed

    researchmap

  • Acute obstructive cholangitis caused by an enterolith in a duodenal diverticulum 査読

    T. Nonaka, M. Inamori, T. Kessoku, Y. Ogawa, K. Imajyo, S. Yanagisawa, T. Shiba, T. Sakaguchi, A. Nakajima, S. Maeda, K. Atsukawa, H. Takahashi

    ENDOSCOPY   42   E204 - E205   2010年12月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0030-1255704

    Web of Science

    PubMed

    researchmap

  • Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b 査読

    H. Mawatari, M. Yoneda, K. Fujita, Y. Nozaki, Y. Shinohara, H. Sasaki, H. Iida, H. Takahashi, M. Inamori, Y. Abe, N. Kobayashi, K. Kubota, H. Kirikoshi, A. Nakajima, S. Saito

    JOURNAL OF VIRAL HEPATITIS   17 ( 12 )   859 - 865   2010年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Pegylated interferon and ribavirin combination therapy is the standard treatment for patients with chronic hepatitis C (CHC), but treatment failure can be difficult to predict. We and others have reported a relation between lipid values and sustained viral responses in patients with CHC. However, the relationship between lipid values and treatment failure has not been previously reported. The present study investigated the association between the profiles of phospholipids and free cholesterol (FC), the main constitutive ingredients of the surface of lipoprotein, classified according to particle size and hepatitis C treatment, and determined the usefulness of these parameters for predicting the outcome of treatment. Fifty-five patients with CHC (33 men and 22 women) were included in the study. The serum total cholesterol, triglyceride, phospholipids, and FC levels in the lipoprotein subclasses were determined using high-performance liquid chromatography with gel permeation columns, enabling the lipoproteins to be classified into 13 subclasses according to particle size. According to a univariate analysis, the treatment failure group had a significantly higher serum phospholipid level overall in the high-density lipoprotein (HDL) and medium HDL fractions as well as a higher serum FC level in the HDL fraction and all HDL subclass fractions compared with the corresponding values in the non-nonvirological response group. Higher serum phospholipid and FC concentrations in the HDL subclasses were predictive of a failure to respond in patients with genotype 1b.

    DOI: 10.1111/j.1365-2893.2009.01253.x

    Web of Science

    PubMed

    researchmap

  • A case of recurrent infective endocarditis following colonoscopy 査読

    Y. Sekino, N. Fujisawa, K. Suzuki, K. Akimoto, A. Takahata, K. Miharada, S. Koyama, H. Iida, H. Endo, K. Hosono, Y. Sakamoto, H. Takahashi, T. Koide, C. Tokoro, Y. Abe, S. Maeda, A. Nakajima, A. Tatsumoto, H. Sakurada, M. Inamori

    ENDOSCOPY   42   E217 - E217   2010年12月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0030-1255719

    Web of Science

    PubMed

    researchmap

  • Does Pretreatment with Proton Pump Inhibitors Influence the Eradication Rate of Helicobacter Pylori? 査読

    Chikako Tokoro, Masahiko Inamori, Tomoko Koide, Hiroshi Iida, Yasunari Sakamoto, Hiroki Endo, Kunihiro Hosono, Hirokazu Takahashi, Masato Yoneda, Hiroaki Yasuzaki, Masami Ogawa, Yasunobu Abe, Kensuhe Kubota, Satoru Saitou, Ichiro Kawana, Reikei Matsuda, Daisuke Takahashi, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   57 ( 104 )   1645 - 1649   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Pretreatment with a proton pump inhibitor (PPI) has been reported to decrease the efficacy of Helicobacter pylori (H. pylori) eradication. We compared the efficacy of an eradication regimen (lansoprazole/amoxicillin/clarithromycin) first or following pretreatment with a PPI.
    Methodology: In this retrospective study conducted at three centers, 353 patients infected with H. pylori were treated. The H. pylori status was determined using the rapid urease test, bacterial cultures, and the histological examination of endoscopic biopsy specimens. The patients were assigned to receive an eradication regimen first or following pretreatment with a PPI. Eradication was assessed using the C-13-urea breath test more than 4 weeks after the completion of therapy.
    Results: Overall, H. pylori was eradicated in 78.8% of the cases: 79.6% in the pretreatment group, and 77.6% in the eradication first group (p=0.6541 by chi square test). No significant difference in the eradication rates was observed between the two groups.
    Conclusions: This retrospective study indicated that pretreatment with a PPI does not significantly reduce the efficacy of eradication therapy in patients infected with H. pylori.

    Web of Science

    PubMed

    researchmap

  • The Histamine H2 Receptor Antagonist Lafutidine in Japanese Patients with Non-erosive Reflux Disease 査読

    Masahiko Inamori, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noboru Hiratsuka, Atsushi Nakajima, Masami Fujita

    HEPATO-GASTROENTEROLOGY   57 ( 104 )   1430 - 1434   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: This study aims to investigate whether histamine H2-receptor antagonists are sufficient to treat nonerosive reflux disease in Japanese patients. The efficacy of lafutidine in Japanese nonerosive reflux disease patients was studied.
    Methodology: The subjects were 24 heartburn patients with two or more cases of heartburn in a week before the period of observation, QUEST score of 6 or above and diagnosed as no erosion in esophagus by upper gastrointestinal endoscopy. Following obtained informed consent, gastroesophageal 24-hour pH was monitored after the placebo period (2 weeks) and the completion of the lafitidine period (at the dose of 10 mg twice daily for 4 weeks).
    Results: Twenty three patients completed the study. The percentage of time that the intraesophageal pH was less than 4 decreased significantly, from 3.07% to 1.17%, after the lafutidine administration. The overall percentage of time that the intragastric pH was above 3 increased significantly from 26.6% to 56.5% after the lafutidine administration, and increased from 22.7% to 51.0% (daytime period) and 34.6% to 67.2% (nighttime period), respectively. Lafutidine markedly improved heartburn and other symptoms, as recorded in patient diaries.
    Conclusions: Lafutidine markedly improved the intraesophageal pH and the symptoms of heartburn in Japanese patients with nonerosive reflux disease. Lafutidine also inhibited gastric acid secretion not only during the nighttime but also during the daytime.

    Web of Science

    PubMed

    researchmap

  • Early Complications Following Percutaneous Endoscopic Gastrostomy: Results of Use of a New Direct Technique 査読

    Tomoko Koide, Masahiko Inamori, Akihiho Kusakabe, Takashi Uchiyama, Seitaro Watanabe, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Chikaho Tokoro, Hiroaki Yasuzaki, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   57 ( 104 )   1639 - 1644   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Percutaneous endoscopic gastrostomy is the standard method for enteral feeding in patients predicted to require long-term enteral nutrition because of dysphagia. A direct techinique with gastropexy is available, in which oropharyngeal passage of the internal bumper can be avoided. The aim of this study was to assess the early complications of percutaneous endoscopic gastrostomy performed using the new direct technique.
    Methodology: Between August 2005 and July 2009, 231 patients underwent percutaneous endoscopic gastrostomy at our hospital. We analyzed the clinical characteristics of the patients related to the development of early complications such as bleeding or local infection. Early complications were defined as complications occurring within 7 days of the percutaneous endoscopic gastrostomy.
    Results: The study population comprised 231 patients: 157 men and 74 women (median age, 73 years; range, 28-92 years). The percutaneous endoscopic gastrostomy was performed using the pull-through technique in 134 of these patients (58%), whereas the direct technique with gastropexy was employed in the remaining 97 patients (42%). In the multiple logistic regression analyses, only the use/non-use of the direct technique was identified as a variable significantly associated with the incidence of bleeding (odds ratio 5.236, 95% confidence interval 1.040 - 26.316; p=0.0447) and the incidence of local infection (odds ratio 0.283, 95% confidence interval 0.100 - 0.802; p=0.0175).
    Conclusions: Use of the direct technique for performing percutaneous endoscopic gastrostomy was associated with the increased incidence of the early complication of bleeding, but the decreased incidence of local infection.

    Web of Science

    PubMed

    researchmap

  • Relationship between Upper Gastrointestinal Symptoms and Diet Therapy: Examination Using Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease 査読

    Yasunari Sakamoto, Masahiko Inamori, Tomoyuki Iwasaki, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tamon Ikeda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   57 ( 104 )   1635 - 1638   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to evaluate the correlation between gastrointestinal symptoms and diet therapy.
    Methodology: The subjects comprised of 8 patients who attended the diabetes division at Fujisawa City Hospital between April and June 2007. The subjects were diagnosed as having diabetes mellitus based on the results of a blood analysis. The body weight of the subjects was measured, and the subjects were asked to score their gastrointestinal symptoms according to the Frequency Scale for the Symptoms of GERD (FSSG) before and after diet therapy for 9 to 14 days.
    Results: Diet therapy for diabetic subjects was effective for weight reduction. The total FSSG score was decreased, and the reduction in dysmotility-like symptoms was greater than the reduction in acid-reflux-related symptoms.
    Conclusions: Diet therapy for mild diabetic patients also improves gastrointestinal symptoms.

    Web of Science

    PubMed

    researchmap

  • 腹腔鏡補助下に切除した虫垂粘液嚢胞腺腫の1例

    湯川 寛夫, 利野 靖, 菅野 伸洋, 村上 仁志, 佐藤 勉, 荒井 宏雅, 足立 広幸, 稲森 正彦, 大城 久, 今田 敏夫, 益田 宗孝

    日本内視鏡外科学会雑誌   15 ( 7 )   434 - 434   2010年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内視鏡外科学会  

    researchmap

  • Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial 査読

    Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Michiko Sugiyama, Eiji Sakai, Takashi Uchiyama, Kaori Suzuki, Hiroshi Iida, Yasunari Sakamoto, Kyoko Yoneda, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Masahiko Inamori, Hitoshi Nakagama, Atsushi Nakajima

    CANCER PREVENTION RESEARCH   3 ( 9 )   1077 - 1083   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER ASSOC CANCER RESEARCH  

    The biguanide metformin is widely used for treating diabetes mellitus. We previously showed the chemopreventive effect of metformin in two rodent models of colorectal carcinogenesis. However, besides epidemiologic studies, little is known about the effects of metformin on human colorectal carcinogenesis. The objective of this pilot study was to evaluate the chemopreventive effect of metformin on rectal aberrant crypt foci (ACF), which are an endoscopic surrogate marker of colorectal cancer. We prospectively randomized 26 nondiabetic patients with ACF to treatment with metformin (250 mg/d, n = 12) or no treatment (control, n = 14); 23 patients were evaluable for end point analyses (9 metformin and 14 control); the two groups were similar in ACF number and other baseline clinical characteristics. Magnifying colonoscopy determined the number of rectal ACF in each patient at baseline and after 1 month in a blinded fashion (as were all laboratory end point analyses). We also examined proliferative activity in colonic epithelium (via proliferating cell nuclear antigen labeling index) and apoptotic activity (via terminal deoxynucleotidyl transferase dUTP nick-end labeling). At 1 month, the metformin group had a significant decrease in the mean number of ACF per patient (8.78 +/- 6.45 before treatment versus 5.11 +/- 4.99 at 1 month, P = 0.007), whereas the mean ACF number did not change significantly in the control group (7.23 +/- 6.65 versus 7.56 +/- 6.75, P = 0.609). The proliferating cell nuclear antigen index was significantly decreased and the apoptotic cell index remained unaltered in normal rectal epithelium in metformin patients. This first reported trial of metformin for inhibiting colorectal carcinogenesis in humans provides preliminary evidence that metformin suppresses colonic epithelial proliferation and rectal ACF formation in humans, suggesting its promise for the chemoprevention of colorectal cancer. Cancer Prev Res; 3(9); 1077-83. (C) 2010 AACR.

    DOI: 10.1158/1940-6207.CAPR-10-0186

    Web of Science

    PubMed

    researchmap

  • Mesenteric phlebosclerosis 査読

    A. Oshima, S. Ito, Y. Abe, T. Uchiyama, H. Iida, H. Endo, K. Hosono, Y. Sakamoto, K. Fujita, M. Yoneda, H. Takahashi, T. Koide, C. Tokoro, A. Goto, M. Inamori, N. Kobayashi, K. Kubota, S. Saito, A. Nakajima

    ENDOSCOPY   42   E156 - E157   2010年7月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0029-1244147

    Web of Science

    PubMed

    researchmap

  • A mucosa-associated lymphoid tissue (MALT) lymphoma of the small intestine that was difficult to diagnose endoscopically 査読

    K. Yoneda, H. Takahashi, Y. Abe, M. Inamori, S. Kato, T. Uchiyama, H. Iida, H. Mawatari, K. Hosono, H. Endo, Y. Nozaki, T. Akiyama, K. Fujita, M. Yoneda, N. Kobayashi, H. Kirikoshi, K. Kubota, S. Saito, A. Nakajima

    ENDOSCOPY   42   E175 - E175   2010年7月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0029-1214857

    Web of Science

    PubMed

    researchmap

  • Metformin Suppresses Azoxymethane-Induced Colorectal Aberrant Crypt Foci by Activating AMP-Activated Protein Kinase 査読

    Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Michiko Sugiyama, Takashi Uchiyama, Kaori Suzuki, Yuichi Nozaki, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Masahiko Inamori, Akiko Tomatsu, Takeshi Chihara, Kan Shimpo, Hitoshi Nakagama, Atsushi Nakajima

    MOLECULAR CARCINOGENESIS   49 ( 7 )   662 - 671   2010年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-LISS  

    Metformin is widely used for the treatment of diabetes mellitus. Adenosine monophosphate-activated protein kinase (AMPK) is known to be activated by metformin and to inhibit the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway plays an important role in the protein translational machinery and cell proliferation. We examined the effect of metformin on the suppression of colorectal carcinogenesis in chemical carcinogen-induced models. Seven-wk-old BALB/c mice were intraperitoneally (i.p.) injected with azoxymethane (AOM, 10 mg/kg) and then treated with or without metformin (250 mg/kg/d) for 6 wk (for the investigation of aberrant crypt foci [ACF] formation) or 32 wk (for polyp formation). We next investigated colonic epithelial proliferation using bromodeoxyuridine (BrdU) and the proliferating cell nuclear antigen (PCNA) labeling indices. Furthermore, to examine the indirect effect of metformin, the insulin resistance status and the serum lipid levels were assessed. Treatment with metformin significantly reduced ACF formation. The effect of metformin on colon polyp inhibition was relatively modest. No significant difference in body weight or glucose concentration was observed. The BrdU and PCNA indices decreased in mice treated with metformin. A Western blot analysis revealed that the phosphorylated mTOR, S6 kinase, and S6 protein levels in the colonic mucosa decreased significantly in mice treated with metformin. In conclusion, metformin suppresses colonic epithelial proliferation via the inhibition of the mTOR pathway through the activation of AMPK. As metformin is already used daily as an antidiabetic drug, it might be a safe and promising candidate for the chemoprevention of colorectal cancer. (c) 2010 Wiley-Liss, Inc.

    DOI: 10.1002/mc.20637

    Web of Science

    PubMed

    researchmap

  • Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis 査読

    Kaori Suzuki, Hiroyuki Kirikoshi, Masato Yoneda, Hironori Mawatari, Koji Fujita, Yuichi Nozaki, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Takeshi Shimamura, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATOLOGY RESEARCH   40 ( 7 )   693 - 700   2010年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim: Although non-alcoholic fatty liver disease (NAFLD) is now a common cause of chronic liver disease, discriminating between simple steatosis and non-alcoholic steatohepatitis (NASH), especially early-stage NASH, remains difficult. We investigated the clinical usefulness of measuring the spleen volume as a marker of early-stage NASH.
    Methods: We evaluated computed tomography (CT) images obtained in 84 patients with histologically diagnosed NAFLD (22 with simple steatosis, 62 with NASH with mild fibrosis [stages 1-2]). We defined the data obtained by the following formula as a spleen-body index (SBI): SBI = maximal CT axial section area of the spleen (cm(2))/body surface area (BSA) (cm(2)) x 10(4). We compared the SBI between patients with simple steatosis and those with NASH with mild fibrosis.
    Results: The mean SBI of the simple steatosis group was 15.8 +/- 3.9, while that of the NASH with mild fibrosis group was 18.7 +/- 5.7. This difference between the two groups was significant (P = 0.0314). A multiple logistic regression analysis showed that the SBI was significantly correlated with the discrimination of simple steatosis and NASH with mild fibrosis. The area under the receiver-operator curve was 0.661 for distinguishing between simple steatosis and NASH with mild fibrosis (P = 0.026, 95% confidence interval = 0.532-0.789).
    Conclusion: Spleen enlargement may be a distinct feature of NASH, especially early-stage NASH. SBI might be a non-invasive and simple method of differentiating NASH and simple steatosis.

    DOI: 10.1111/j.1872-034X.2010.00643.x

    Web of Science

    PubMed

    researchmap

  • Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study 査読

    Masato Yoneda, Koji Fujita, Yuichi Nozaki, Hiroki Endo, Hirokazu Takahashi, Kunihiro Hosono, Kaori Suzuki, Hironori Mawatari, Hiroyuki Kirikoshi, Masahiko Inamori, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Kensuke Kubota, Shiro Maeyama, Atsushi Nakajima

    HEPATOLOGY RESEARCH   40 ( 6 )   566 - 573   2010年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim:
    Non-alcoholic steatohepatitis (NASH) is considered a hepatic manifestation of metabolic syndrome. However, effective drug therapy for NASH has not been established yet. In the present study, we evaluated the efficacy of 6 months of ezetimibe treatment for NASH patients with dyslipidemia for the comparison of improvement of the clinical parameters and histological alterations.
    Methods:
    We prospectively evaluated 10 consecutive NASH patients with dyslipidemia who agreed to participate in this study. The patients were given ezetimibe (10 mg/day) for 6 months, and clinical parameters and histological alterations were comparatively evaluated before and after treatment. All the patients were given standard calorie diet (30 kcal/kg per day, carbohydrate 50-60%, fat 20-30%, protein 15-20%) and exercise counseling from 3 months before the ezetimibe treatment.
    Results:
    The serum aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transpeptidase, low-density lipoprotein cholesterol, high-sensitivity C-reactive protein and type IV collagen 7 s levels were significantly improved by the treatment with ezetimibe for 6 months. In histological observations, follow-up liver biopsies revealed that the NAS score and steatosis grade were also significantly improved. The fibrosis stage did not change significantly, but six of the 10 patients exhibited an improvement in their fibrosis stage.
    Conclusion:
    Major clinical parameters and histological observations were significantly improved by the treatment with ezetimibe. Our pilot study demonstrated the efficacy of ezetimibe for drug therapy of NASH and may lead to a large-scale clinical trial in the future.

    DOI: 10.1111/j.1872-034X.2010.00644.x

    Web of Science

    PubMed

    researchmap

  • A duodenal mucosal lesion coming from pancreatic arteriovenous malformation 査読

    Shingo Kato, Noritoshi Kobayashi, Kensuke Kubota, Hiroyuki Kirikoshi, Seitaro Watanabe, Masami Ogawa, Masahiko Inamori, Takeshi Shimamura, Wataru Tomeno, Atsushi Nakajima, Kazuhisa Takeda, Itaru Endo, Yoji Nagashima, Ichiro Aoki

    GASTROINTESTINAL ENDOSCOPY   71 ( 7 )   1299 - 1300   2010年6月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2010.01.033

    Web of Science

    PubMed

    researchmap

  • Endoscopic therapy using an endoscopic variceal ligation for minute cancer of the esophagogastric junction complicated with esophageal varices: a case report. 査読 国際誌

    Tomoyuki Akiyama, Yasunobu Abe, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Hirokazu Takahashi, Masahiko Inamori, Akihide Ryo, Shoji Yamanaka, Yoshiaki Inayama, Atsushi Nakajima

    Journal of medical case reports   4   149 - 149   2010年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: Standard endoscopic mucosal resection or endoscopic submucosal dissection is a procedure for patients with minute cancers, complicated with esophageal varices that puts them at high risk of bleeding. CASE PRESENTATION: We present the case of a 77-year-old Japanese man with alcoholic cirrhosis who underwent a routine endoscopy examination as a screening procedure for esophageal varices and was incidentally diagnosed as having minute cancer of the esophagogastric junction with esophageal varices. Endoscopic ultrasonography findings suggested that the minute cancer was a non-invasive carcinoma (carcinoma in situ) and a 2 mm in diameter blood vessel, feeding the esophageal varices, pierced the lesion. Following the examination, we carried out endoscopic treatment of the minute cancer and esophageal varices. Endoscopic variceal ligation was performed using a pneumo-activated device (Sumitomo Bakelite, Tokyo, Japan). Two years after the treatment, during the follow-up endoscopic examination on the patient, recurrence of carcinoma was not detected endoscopically or histologically. CONCLUSION: Endoscopic therapy using an endoscopic variceal ligation device for minute cancer of the esophagogastric junction, complicated with esophageal varices, may be an acceptable and easily applicable method.

    DOI: 10.1186/1752-1947-4-149

    PubMed

    researchmap

  • Gastric surgery is not a risk factor for erosive esophagitis or Barrett&apos;s esophagus 査読

    Tomoyuki Akiyama, Masahiko Inamori, Keiko Akimoto, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tamon Ikeda, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Akihiko Moriya, Yasushi Rino, Toshio Imada, Atsushi Nakajima

    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY   45 ( 4 )   403 - 408   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS AS  

    Objective. The role of gastric acid reflux is difficult to separate from that of pancreatic-biliary reflux in the pathogenesis of erosive esophagitis (EE) and Barrett&apos;s esophagus (BE). Gastric surgery patients provide a good mode. for both significant pancreatic-biliary reflux and marked gastric acid inhibition. We assessed the risk of EE and BE after distal gastrectomy in a case-controlled study. Material and methods. One hundred and sixty patients (121 men, 39 women; median age 68 years; range 32-86 years) with distal gastrectomies (Billroth-I) and 160 sex- and age-matched controls with intact stomachs were enrolled. The presence of EE and BE were diagnosed based on the Los Angeles Classification and the Prague C & M Criteria, respectively. A conditional logistic regression model with adjustments for potential confounding factors was used to assess the associations. Results. According to the multivariate analyses, patients with distal gastrectomies tended to have inverse associations with the risks of EE and BE, and the inverse association with the risk of BE reached a significant level. Conclusions. Distal gastrectomy is not a risk factor for the development of BE and BE. This lack of a. positive association between distal gastrectomy and BE and BE may suggest that pancreatic-biliary reflux with a limited amount of acid is not sufficient to damage the esophageal mucosa.

    DOI: 10.3109/00365520903536507

    Web of Science

    PubMed

    researchmap

  • RISKY ENDOSCOPIC ULTRASONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION FOR ASYMPTOMATIC RETROPERITONEAL TUMORS 査読

    Kensuke Kubota, Shingo Kato, Hironori Mawatari, Hiroshi Iida, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima

    DIGESTIVE ENDOSCOPY   22 ( 2 )   144 - 146   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Paraganglioma, a sporadically occurring rare tumor should be included in the differential diagnosis of retroperitoneal tumors, such as malignant lymphomas, gastrointestinal stromal tumors, sarcoma and carcinoma of unknown primary site. A 58-year-old Japanese woman presented with a large retroperitoneal tumor detected by ultrasonography (US). She had no medical history of hypertension. Computed tomography showed a mass, 7 cm in diameter, located between the pancreas and the inferior vena cava. It was unclear whether the mass originated from the duodenum or the mesentery. Endoscopic ultrasonography (EUS) demonstrated a large solid paraduodenal mass. Doppler US revealed sparse vascularity in the tumor. With the differential diagnosis of retroperitoneal tumor, we carried out EUS-FNA. At the time of the third needle puncture, transient severe hypertension was noted, with a blood pressure measurement of 269/130 mmHg. Data obtained from urine and blood examinations after EUS-fine-needle aspiration indicated a diagnosis of paraganglioma.

    DOI: 10.1111/j.1443-1661.2010.00939.x

    Web of Science

    researchmap

  • Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b 査読

    H. Mawatari, M. Yoneda, K. Fujita, Y. Nozaki, Y. Shinohara, H. Sasaki, H. Iida, H. Takahashi, M. Inamori, Y. Abe, N. Kobayashi, K. Kubota, H. Kirikoshi, A. Nakajima, S. Saito

    JOURNAL OF VIRAL HEPATITIS   17 ( 4 )   274 - 279   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Pegylated interferon and ribavirin combination therapy is the standard treatment for patients with chronic hepatitis C (CHC). Some groups have reported a relation between lipid values and response while others have reported that microsomal triglyceride transfer protein, a key enzyme in the assembly and secretion of lipoproteins, was related to hepatitis C virus (HCV). The aim of this study was to investigate the association between the lipoprotein profiles, classified according to size, and hepatitis C treatment and the usefulness for predicting the outcome of treatment. Forty-four patients with CHC (27 men and 17 women) were included in the study. The serum cholesterol and triglyceride (TG) levels in the lipoprotein subclasses were determined using high-performance liquid chromatography with gel permeation columns, which classified lipoproteins into 20 subfractions based on particle size. According to a univariate analysis, those who achieved an sustained viral response (SVR) had a significantly higher serum total cholesterol level, higher cholesterol levels in the low-density lipoprotein subfraction (25.5 nm in diameter) and the very low-density lipoprotein (VLDL) subfraction (44.5 and 36.8 nm), and a higher serum TG level in the VLDL subfraction (44.5 nm), compared with the corresponding values in the non-SVR group. Higher serum cholesterol and TG concentrations in the lipoprotein subfractions were predictive of an SVR to therapy for HCV infection with genotype 1b prior to the start of interferon treatment.

    DOI: 10.1111/j.1365-2893.2009.01179.x

    Web of Science

    PubMed

    researchmap

  • Gender differences of low-dose aspirin-associated gastroduodenal ulcer in Japanese patients 査読

    Kazuhisa Okada, Masahiko Inamori, Kento Imajyo, Hideyuki Chiba, Takashi Nonaka, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiko Atsukawa, Hisao Takahashi, Etsuo Hoshino, Atsushi Nakajima

    WORLD JOURNAL OF GASTROENTEROLOGY   16 ( 15 )   1896 - 1900   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:W J G PRESS  

    AIM: To clarify the gender differences about the clinical features and risk factors of low-dose aspirin (LDA) (81-100 mg daily)-associated peptic ulcer in Japanese patients.
    METHODS: There were 453 patients under treatment with LDA (298 males, 155 females) who underwent esophagogastroduodenoscopy at the Department of Gastroenterology and Hepatology of Hiratsuka City Hospital between January 2003 and December 2007. They had kept taking the LDA or started treatment during the study period and kept taking LDA during the whole period of observation. Of these, 119 patients (87 males, 32 females) were diagnosed as having LDA-associated peptic ulcer. We examined the clinical factors associated with LDA-associated peptic ulcer in both sexes.
    RESULTS: A history of peptic ulcer was found to be the risk factor for LDA-associated peptic ulcer common to both sexes. In female patients, age greater than 70 years (prevalence ORs 8.441, 95% CI: 1.797-33.649, P = 0.0069) was found to be another significant risk factor, and the time to diagnosis as having LDA-associated peptic ulcer by endoscopy was significantly shorter than that in the male patients (P = 0.0050).
    CONCLUSION: We demonstrated gender differences about the clinical features and risk factors of LDA-associated peptic ulcer. Special attention should be paid to aged female patients taking LDA. (C) 2010 Baishideng. All rights reserved.

    DOI: 10.3748/wjg.v16.i15.1896

    Web of Science

    PubMed

    researchmap

  • A case of a peculiarly shaped gastrointestinal stromal tumor 査読

    K. Suzuki, H. Takahashi, Y. Abe, M. Inamori, S. Watanabe, T. Koide, C. Tokoro, H. Iida, K. Hosono, H. Endo, T. Shimamura, N. Kobayashi, H. Kirikoshi, K. Kubota, S. Saito, H. Ono, H. Akiyama, T. Yazawa, A. Nakajima

    ENDOSCOPY   42   E65 - E66   2010年3月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0029-1215119

    Web of Science

    PubMed

    researchmap

  • Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation 査読

    Masato Yoneda, Yuichi Nozaki, Hiroki Endo, Hironori Mawatari, Hiroshi Iida, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Kikuko Hotta, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   55 ( 3 )   808 - 814   2010年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. The spectrum of NAFLD is broad, extending from simple steatosis through nonalcoholic steatohepatitis (NASH). Iron is regarded as a putative element that interacts with oxygen radicals, and high rates of hyperferritinemia and increased hepatic iron stores have been demonstrated in NASH. We investigated serum ferritin concentrations, HFE gene mutations, and insulin resistance in Japanese NASH patients and the diagnostic utility of serum ferritin concentrations as a means of distinguishing NASH. Serum ferritin concentrations were measured in 86 patients with histopathologically verified NAFLD (24 with steatosis and 62 with NASH) and 20 control subjects, they were tested for HFE gene mutations and their insulin resistance was measured. The serum ferritin concentration was significantly higher in the NASH patients than in the patients with simple steatosis (P = 0.006). There was no significant difference between the groups in HFE gene mutation (C282Y, H63D, and S65C), and the serum ferritin level was related with insulin resistance. The area under the ROC curve was 0.732 for distinguishing NASH from simple steatosis (P = 0.005; 95% CI, 0.596-0.856). In conclusion high serum ferritin concentrations are a distinguishing feature of Japanese NASH patients independent of HFE gene mutations.

    DOI: 10.1007/s10620-009-0771-y

    Web of Science

    PubMed

    researchmap

  • Gastric Variceal Rupture Successfully Treated with Repeated EIS and EVL 査読

    Y. Kawakami, H. Takahashi, H. Mawatari, L. Taniguchi, K. Hosono, H. Endo, K. Yoneda, M. Inamori, Y. Abe, A. Nakajima

    HEPATO-GASTROENTEROLOGY   57 ( 98 )   377 - 378   2010年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    A 68-year-old female with liver cirrhosis presented at the Emergency Room of our hospital with copious tarry stools. Upper gastrointestinal endoscopy showed an isolated gastric variceal rupture, and we performed endoscopic injection sclerotherapy using cyanoacrylate, on four occasions, resulting in successful hemostasis. Injection of CA is a useful emergency treatment option for gastric variceal bleeding without gastro-renal shunt.

    Web of Science

    PubMed

    researchmap

  • Perforation with retroperitoneal emphysema after endoscopic submucosal dissection for a rectal carcinoid tumor 査読

    H. Chiba, K. Ohata, A. Ohno, Y. Sekino, T. Ito, Y. Tsuji, T. Ohya, M. Inamori, A. Nakajima, N. Matsuhashi

    ENDOSCOPY   42   E85 - E86   2010年3月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0029-1243873

    Web of Science

    PubMed

    researchmap

  • 超高齢者に対する内視鏡的胃ろう造設術の経験

    池田 多聞, 稲森 正彦, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 米田 正人, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 日下部 明彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 神里 信夫, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A250 - A250   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • GERD spectrumと肥満、内臓脂肪、液性因子の関与

    秋田 智之, 稲森 正彦, 米田 正人, 内山 崇, 飯田 洋, 遠藤 宏樹, 細野 邦広, 藤田 浩司, 坂本 康成, 藤沢 信隆, 高橋 宏和, 古出 智子, 所 知加子, 後藤 歩, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 斉藤 聡, 小山 茂, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A211 - A211   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Nitric Oxide Plays a Crucial Role in the Development/Progression of Nonalcoholic Steatohepatitis in the Choline-Deficient, l-Amino Acid-Defined Diet-Fed Rat Model 査読

    Koji Fujita, Yuichi Nozaki, Masato Yoneda, Koichiro Wada, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shiro Maeyama, Atsushi Nakajima

    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH   34 ( 2 )   S18 - S24   2010年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Background. The pathogenesis of nonalcoholic steatohepatitis (NASH) is still unclear. Recently, the 2-hit hypothesis was proposed, in which nitric oxide production, representing oxidative stress, was proposed as a very important candidate for the second hit.
    Methods. The total study period was 10 weeks. A total of 20 rats were randomly divided into 2 groups. Group 1 was administered the Choline-Deficient, l-Amino Acid-Defined diet to produce a NASH model, and Group 2 as control received the Choline-Sufficient, l-Amino Acid-defined diet. The blood and tissue concentrations of nitrate + nitrite were measured using the Griess reagent and the expression levels of inducible nitric oxide synthase (iNOS) proteins and mRNA was determined by Western blotting.
    Results. In regard to nitric oxide (NO) and NO metabolites, there were significant differences in the blood (especially portal venous blood) as well as tissue (liver and visceral fat) concentrations between the 2 animal groups; the amounts of NO metabolites in the tissues were much higher in the NASH models. The level of nitrotyrosine was much markedly higher in the NASH models than in the controls. In regard to the tissue expression of iNOS a significant difference between the 2 groups was found in the visceral fat, especially in the mesenterium.
    Conclusions. Based on these results, we hypothesize that the iNOS expression and NO levels in the visceral fat increase, with increased diffusion of NO and its metabolites into the liver, resulting in increased nitrotyrosine formation in the liver; this, in turn, induces inflammation, apoptosis, and fibrosis in the liver, which are one of the characteristic features of NASH.

    DOI: 10.1111/j.1530-0277.2008.00756.x

    Web of Science

    PubMed

    researchmap

  • Esophagomediastinal and esophagobronchial fistulas associated with invasive aspergillosis 査読

    S. Kato, S. Inoue, M. Inamori, N. Miyazawa, T. Sato, N. Kobayashi, K. Mishina, M. Sasaki, Y. Ishigatsubo, A. Nakajima

    ENDOSCOPY   42   E48 - E49   2010年2月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0029-1215414

    Web of Science

    PubMed

    researchmap

  • Highly Active State of Autoimmune Pancreatitis With Mikulicz Disease 査読

    Kensuke Kubota, Tomoko Wada, Shingo Kato, Yuichi Mozaki, Masato Yoneda, Koji Fujita, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Satoru Saito, Yoshiaki Inayama, Atsushi Nakajima

    PANCREAS   39 ( 1 )   E6 - E10   2010年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: Patients with autoimmune pancreatitis (AIP) sometimes present with Mikulicz disease (MD); however, the clinical features regarding these AIP patients with MD have not yet been fully elucidated. Our aim is to study the clinical differences between AIP with and without MD.
    Methods: Twenty-eight AIP patients were divided into 2 groups, one with MD and one without it. The following factors having a possible association with the presence or absence of MD were investigated: sex; serum IgG and IgG4 levels; the presence or absence of antinuclear auto-antibodies, jaundice, diabetes mellitus, swollen duodenal papilla, diffuse pancreatic swelling, spontaneous remission, and relapse.
    Results: The MD and non-MD groups consisted of 5 AIP and 23 AIP patients, respectively. The results of univariate analysis revealed that AIP patients presenting with MD were significantly associated with a younger onset, female predominance, high serum IgG4 titer, and diffuse pancreatic swelling (P &lt; 0.05). In 4 of the MD patients, onset preceded pancreatitis.
    Conclusions: Autoimmune pancreatitis patients presenting with MD tended to have different clinical features from the non-MD AIP patients, such as having an earlier onset, female tendency, and diffuse pancreatic swelling with a high titer of serum IgG4. Autoimmune pancreatitis with MD tended to precede gastroenterological events.

    DOI: 10.1097/MPA.0b013e3181bc119d

    Web of Science

    PubMed

    researchmap

  • Portal Vein Thrombosis Treated Using Danaparoid Sodium and Antithrombin III 査読

    T. Uchiyama, Hirokazu Takahashi, K. Hosono, H. Endo, T. Ahiyama, K. Yoneda, M. Inamori, Y. Abe, K. Kubota, S. Saito, A. Nakajima

    HEPATO-GASTROENTEROLOGY   57 ( 97 )   52 - 53   2010年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    A 45-year-old man under treatment for liver cirrhosis (LC) due to chronic hepatitis C and hemophilia A was seen in our emergency room because of a 10-kg weight gain in the previous week due to ascites. Portal vein thrombosis (PVT) was detected with computer tomography (CT) and ultrasonographic (US). Danaparoid sodium (DS) and antithrombin III (AT III) were administrated and doppler US images showed improvement of portal venous blood flow. DS or AT III may be safe and alternative therapies for PVT.

    Web of Science

    PubMed

    researchmap

  • Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis 査読

    Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Takeshi Shimamura, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    WORLD JOURNAL OF GASTROENTEROLOGY   16 ( 4 )   484 - 489   2010年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BAISHIDENG PUBLISHING GROUP INC  

    AIM: To test the hypothesis that the shape and length of Barrett's epithelium are associated with prevalence of erosive esophagitis.
    METHODS: A total study population comprised 869 patients who underwent endoscopy during a health checkup at our hospital. The presence and extent of Barrett's epithelium were diagnosed based on the Prague C & M Criteria. We originally classified cases of Barrett's epithelium into two types based on its shape, namely, flamelike and lotus-like Barrett's epithelium, and into two groups based on its length, its C extent &lt; 2 cm, and &gt;= 2 cm. Correlation of shape and length of Barrett's epithelium with erosive esophagitis was examined.
    RESULTS: Barrett's epithelium was diagnosed in 374 cases (43%). Most of these were diagnosed as short-segment Barrett's epithelium. The prevalence of erosive esophagitis was significantly higher in subjects with flame-like than lotus-like Barrett's epithelium, and in those with a C extent of &gt;= 2 cm than &lt; 2 cm.
    CONCLUSION: Flame-like rather than lotus-like Barrett's epithelium, and Barrett's epithelium with a longer segment were more strongly associated with erosive esophagitis. (C) 2010 Baishideng. All rights reserved.

    DOI: 10.3748/wjg.v16.i4.484

    Web of Science

    PubMed

    researchmap

  • Ulcerative Colitis with Multidrug-Resistant Pseudomonas aeruginosa Infection Successfully Treated with Bifidobacterium 査読

    Azusa Nagasaki, Hirokazu Takahashi, Mizue Iinuma, Takashi Uchiyama, Seitaro Watanabe, Tomoko Koide, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima

    DIGESTION   81 ( 3 )   204 - 205   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    A 71-year-old man was diagnosed with ulcerative colitis (UC) complicated by bacterial infections, and his active disease proved difficult to treat with steroid therapy or antibiotics. Although the patient&apos;s UC failed to respond to several types of induction therapy, his condition finally improved when treated using Bifidobacterium. Probiotics could be one of the treatment agents for induction of remission in UC. Copyright (C) 2010 S. Karger AG, Basel

    DOI: 10.1159/000236042

    Web of Science

    PubMed

    researchmap

  • Metastatic Tumor in the Colon from Renal Cell Carcinoma 査読

    Yuichi Nozaki, Masahiko Inamori, Koji Fujita, Masato Yoneda, Shingo Kato, Takashi Uchiyama, Kaori Suzuki, Seitaro Watanabe, Hironori Mawatari, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Kyoko Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Takeshi Shimamura, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Hisashi Oshiro, Yoshiaki Inayama, Atsushi Nakajima

    INTERNAL MEDICINE   49 ( 7 )   709 - 709   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.49.3233

    Web of Science

    PubMed

    researchmap

  • Ulcerative Colitis with Takayasu Disease 査読

    Yumi Asano, Sachie Morita, Kenta Iguchi, Hiromi Kasugai, Masahiko Inamori, Takashi Uchiyama, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima

    DIGESTION   82 ( 4 )   261 - 261   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000297160

    Web of Science

    PubMed

    researchmap

  • Recurrent Sigmoid Volvulus Treated by Colonoscopic Reduction 査読

    Shinya Ito, Akito Oshima, Masahiko Inamori, Takashi Uchiyama, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTION   82 ( 4 )   260 - 260   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000288508

    Web of Science

    PubMed

    researchmap

  • New Technique for Picking Up Large Colorectal Tumors during Endoscopic Submucosal Dissection 査読

    Hideyuki Chiba, Ken Ohata, Yusuke Sekino, Takafumi Ito, Yosuke Tsuji, Tomohiko Ohya, Masahiko Inamori, Atsushi Nakajima, Nobuyuki Matsuhashi

    DIGESTION   82 ( 1 )   66 - 67   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000283576

    Web of Science

    PubMed

    researchmap

  • Efficacy of Granulocytapheresis for the Treatment of Active Ulcerative Colitis and Avoidance of Systemic Corticosteroid Administration 査読

    Chikako Tokoro, Masahiko Inamori, Takasi Uchiyama, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Ayumu Goto, Hiroaki Yasuzaki, Yasunobu Abe, Reikei Matsuda, Daisuke Takahashi, Ichiro Kawana, Shinichiro Suzuki, Atsushi Nakajima

    DIGESTION   82 ( 1 )   37 - 38   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000276896

    Web of Science

    PubMed

    researchmap

  • Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions 査読

    H. Endo, K. Hosono, T. Fujisawa, H. Takahashi, M. Sugiyama, K. Yoneda, Y. Nozaki, K. Fujita, M. Yoneda, M. Inamori, K. Wada, H. Nakagama, A. Nakajima

    GUT   58 ( 12 )   1637 - 1643   2009年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:B M J PUBLISHING GROUP  

    Background and aims: The molecular mechanisms underlying the promotion of colorectal carcinogenesis by a high-fat diet (HFD) remain unclear. We investigated the role of the insulin-signal pathway and the c-Jun N-terminal kinase (JNK) pathway, which reportedly play crucial roles in insulin resistance, during colorectal carcinogenesis in the presence of hyperinsulinaemia induced by a HFD.
    Methods: Azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colonic epithelium were compared between mice fed a normal diet (ND) and mice fed a HFD. A western blot analysis was performed to elucidate the mechanism affecting colorectal carcinogenesis by a HFD.
    Results: The number of aberrant crypt foci and the colonic epithelial cell proliferative activity were significantly higher in the HFD group than in the ND group. While the plasma insulin level was significantly higher in the HFD group than in the ND group, a western blot analysis revealed the inactivation of Akt, which is located downstream of the insulin receptor, in the colonic epithelia of the HFD group. On the other hand, JNK activity was significantly higher in the HFD group than in the ND group. A JNK specific inhibitor significantly suppressed the increase in epithelial cell proliferation only under a HFD, but not under a ND.
    Conclusions: Colonic cell proliferation was promoted via the JNK pathway in the presence of a HFD but not in the presence of a ND. This novel mechanism may explain the involvement of the JNK pathway in the effect of dietary fat intake on colon carcinogenesis.

    DOI: 10.1136/gut.2009.183624

    Web of Science

    PubMed

    researchmap

  • Clinical Study of Upper Gastrointestinal Bleeding Associated with Low-Dose Aspirin in Japanese Patients 査読

    Kazuhisa Okada, Masahiko Inamori, Kento Imajo, Hideyuki Chiba, Takashi Nonaka, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Etsuo Hoshino, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 96 )   1665 - 1669   2009年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to clarify the prevalence and various clinical factors of upper gastrointestinal bleeding (UGIB) associated with low-dose aspirin (LDA) treatment.
    Methodology: There were 6,807 patients who were under treatment with LDA at our hospital between January 2003 and November 2007. They had kept taking the LDA or started treatment in the study period and kept taking the whole period of observation. Esophagogastroduodenoscopy (EGD) was performed 453 patients of these patients, and 71 were diagnosed as LDA-associated UGIB. We examined the prevalence and various clinical factors of UGIB associated with LDA treatment.
    Results: The occurrence rate of UGIB was 0.209 UGIB per 100 patient-years at least. The multivariate odds ratio of LDA-associated UGIB was 3.318 (95% confidence interval (CI) 1.650-6.671, p=0.0008) for a history of peptic ulcer, 0.086 (95% CI: 0.011-0.652, p=0.0176) for the use of a proton pump inhibitor (PPI) with LDA, and 0.253 (95% CI: 0.113-0.569, p=0.0009) for the use of a histamine type 2 receptor antagonist (H2RA) with LDA.
    Conclusions: Our results suggest that a history of peptic ulcer significantly increases the risk of LDA-associated UGIB. Regular use of a PPI or a H2RA effectively decreases the risk.

    Web of Science

    PubMed

    researchmap

  • Symptomatic gastric sarcoidosis with multiple antral ulcers 査読

    T. Akiyama, H. Endo, M. Inamori, H. Iida, K. Hosono, K. Fujita, M. Yoneda, H. Takahashi, A. Goto, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, K. Nagahama, Y. Inayama, A. Nakajima

    ENDOSCOPY   41   E159 - E159   2009年11月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-0029-1214690

    Web of Science

    PubMed

    researchmap

  • Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease 査読

    Masato Yoneda, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Wataru Tomeno, Seitaro Watanabe, Kunihiro Hosono, Hironori Mawatari, Hiroshi Iida, Koji Fujita, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Kensuke Kubota, Takeshi Shimamura, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima

    HEPATOLOGY RESEARCH   39 ( 10 )   963 - 971   2009年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Aim:
    Genetic factors as well as environmental factors play an important role in the development of non-alcoholic fatty liver disease (NAFLD). Recently, inducible nitric oxide synthase (iNOS) was significantly higher in the severest form of non-alcoholic steatohepatitis (NASH), and nitric oxide (NO) has been determined to play an important role in the process of fibrosis in NASH. In this study, we investigated iNOS gene polymorphisms for associations with NAFLD.
    Methods:
    A total of 115 NAFLD patients, consisting of 65 patients with NASH and 50 patients with simple steatosis, in whom a positive diagnosis had been made by liver biopsy, and 435 healthy control subjects, were recruited into this study.
    Results:
    We investigated 10 single nucleotide polymorphisms (SNP) of the iNOS gene, one of which, rs1060822, had the lowest P-value in the allele frequency model (P = 0.00078) with an odds ratio (95% confidence interval) of 0.49 (0.32-0.75). Four SNP, rs2297510, rs2297511, rs2797512 and rs1060822, were significantly associated with NAFLD, even when the most conservative Bonferroni&apos;s correction was applied. Linkage disequilibrium analysis revealed that SNP rs1060822 and three other SNP, rs2297510, rs2297511 and rs2797512, were in the same block. We also investigated associations between rs1060822 genotypes and the fibrosis index, and the results of the analysis revealed an additive increase in the fibrosis index and intrahepatic iNOS mRNA expression in the patients with the T allele of rs1060822.
    Conclusion:
    This is the first study to identify genetic variations in iNOS that may influence the risk of NAFLD and liver fibrosis in NAFLD.

    DOI: 10.1111/j.1872-034X.2009.00539.x

    Web of Science

    PubMed

    researchmap

  • The Continuous Real-Time C-13-Octanoate Breath Test for Patients with Nonalcoholic Steatohepatitis Using the BreathID System 査読

    Hironori Mawatari, Masahiko Inamori, Koji Fujita, Masato Yoneda, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 94-95 )   1436 - 1438   2009年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Hepatic mitochondrial beta-oxidation is considered to play a pivotal role in the pathogenesis of nonalcoholic steatohepatitis (NASH). The aim of this study was to determine whether there were differences between patients with NASH and healthy controls in a breath test with C-13-octanoate, a medium-chain fatty acid.
    Methodology: The subjects were 8 patients (5 men, 3 women, median age 46.5 years) with histologically proven NASH and 6 healthy controls (5 men, 1 women, and median age 27.8 years). The C-13 breath test was performed for 4 hours using the BreathID system with a 100mL of water, containing 100mg C-13-octanoate.
    Results: There were no significant differences between NASH patients and controls about all breath test; parameters.
    Conclusions: NASH-mediated changes in breath test parameters after ingestion of C-13-octanoate were not observed in our study. The present study findings suggest the possible preservation of C-13-octanoate metabolism (mitochondrial beta-oxidation) in patients with NASH.

    Web of Science

    PubMed

    researchmap

  • Dysfunctional Very-Low-Density Lipoprotein Synthesis and Release Is a Key Factor in Nonalcoholic Steatohepatitis Pathogenesis 査読

    Koji Fujita, Yuichi Nozaki, Koichiro Wada, Masato Yoneda, Yoko Fujimoto, Mihoyo Fujitake, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATOLOGY   50 ( 3 )   772 - 780   2009年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JOHN WILEY & SONS INC  

    The specific mechanisms of nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) pathogenesis remain unknown. In the present study we investigated the differences between NAFL and NASH in terms of liver lipid metabolites and serum lipoprotein. In all, 104 Japanese subjects (50 men and 54 postmenopausal women) with histologically verified NAFL disease (NAFLD) (51 with NAFL, 53 with NASH) were evaluated; all diagnoses were based on liver biopsy findings and the proposed diagnostic criteria. To investigate the differences between NAFL and NASH in humans, we carefully examined (1) lipid inflow in the liver, (2) lipid outflow from the liver, (3) very-low-density lipoprotein (VLDL) synthesis in the liver, (4) triglyceride (TG) metabolites in the liver, and (5) lipid changes and oxidative DNA damage. Most of the hepatic lipid metabolite profiles were similar in the NAFL and NASH groups. However, VLDL synthesis and lipid outflow from the liver were impaired, and surplus TGs might have been produced as a result of lipid oxidation and oxidative DNA damage in the NASH group. Conclusion: A growing body of literature suggests that a deterioration in fatty acid oxidation and VLDL secretion from the liver, caused by the impediment of VLDL synthesis, might induce serious lipid oxidation and DNA oxidative damage, impacting the degree of liver injury and thereby contributing to the progression of NASH. Therefore, dysfunctional VLDL synthesis and release may be a key factor in progression to NASH. (HEPATOLOGY 2009;50:772-780.)

    DOI: 10.1002/hep.23094

    Web of Science

    PubMed

    researchmap

  • Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease 査読

    Yuichi Nozaki, Koji Fujita, Masato Yoneda, Koichiro Wada, Yoshiyasu Shinohara, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Tetsuya Mizoue, Naohiko Masaki, Yoji Nagashima, Yasuo Terauchi, Atsushi Nakajima

    JOURNAL OF HEPATOLOGY   51 ( 3 )   548 - 556   2009年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome that is closely associated with multiple factors such as obesity, hyperlipidemia, type 2 diabetes mellitus and hypertension, making it difficult to treat NAFLD effectively using any monotherapy available to date. In this study, we propose a novel combination therapy for NAFLD comprising ezetimibe (EZ), a cholesterol absorption inhibitor, and acarbose (AC), an alpha-glucosidase inhibitor.
    Methods: C57BL/6J mice were divided into five treatment groups as follows: basal diet (1113), high-fat diet (HFD) only, HFD with EZ (5 mg/kg/day), HFD with AC (100 mg/kg/day), and HFD with both EZ and AC for 24 weeks.
    Results: Long-term combination therapy with EZ and AC significantly reduced steatosis, inflammation and fibrosis in the liver, compared with long-term monotherapy with either drug, in an HFD-induced NAFLD mouse model; the combination therapy also significantly increased the expression of microsomal triglyceride transfer protein (MTP) and peroxisome proliferators-activated receptor-alpha 1 (PPAR-alpha 1) in the liver, compared with either monotherapy, which may have led to the improvement in lipid metabolic disorder seen in this model.
    Conclusions: Combination therapy with EZ and AC for 24 weeks improved the histopathological findings in a mouse model of NAFLD. (C) 2009 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jhep.2009.05.017

    Web of Science

    PubMed

    researchmap

  • Management of Acute Lower Intestinal Bleeding: What Bowel Preparation Should be Required for Urgent Colonoscopy? 査読

    Kumiko Saito, Masahiko Inamori, Yusuke Sekino, Keiko Akimoto, Kaori Suzuki, Ayako Tomimoto, Nobutaka Fujisawa, Kensuke Kubota, Satoru Saito, Shigeru Koyama, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 94-95 )   1331 - 1334   2009年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The management of acute intestinal bleeding is not standardized. The aim of this study was to determine the most suitable method of bowel preparation for urgent colonoscopy.
    Methodology: One hundred and forty patients admitted with acute lower intestinal bleeding (ALIB) to our Hospital (April 1998 to March 2004) were studied. The preparation for colonoscopy consisted, usually, of oral administration of polyethylene glycol (PEG)-salt solution. For elderly patients or for those suspected of bleeding from a sigmoid colon lesion, colonoscopy was performed following glycerin enemas or water enemas. For patients with a suspected rectal lesion or soon after undergoing a polypectomy, colonoscopy was performed without any of the above procedures.
    Results: Ischemic colitis was the most common cause of bleeding. The overall cecal completion ratio was 41%, compared with 74% in the PEG group. The percentage of those in whom colonoscopy was impossible (poor preparation) was 16% overall, compared with 5% in the PEG group. Endoscopic hematemesis were performed successfully for 26 patients who were mainly postpolypectomy cases or had rectal ulcers.
    Conclusions: In urgent colonoscopy, the preparation with PEG-salt solution may improve the patient&apos;s outcome. In postpolypectomy patients and those with rectal ulcers preparation was not always needed.

    Web of Science

    PubMed

    researchmap

  • Gastrointestinal: Pachydermoperiostosis associated with Crohn&apos;s disease 査読

    K. Ohata, C. Niinami, T. Ohya, M. Inamori, A. Nakajima, N. Kurose, K. Yashiro

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   24 ( 9 )   1576 - 1576   2009年9月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    DOI: 10.1111/j.1440-1746.2009.05991.x

    Web of Science

    PubMed

    researchmap

  • 生活習慣病、肥満とバレット粘膜の関連について

    秋山 智之, 米田 正人, 稲森 正彦, 池田 多聞, 内山 崇, 秋本 恵子, 飯田 洋, 遠藤 宏樹, 細野 邦広, 藤田 浩司, 坂本 康成, 高橋 宏和, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 小山 茂, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A755 - A755   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Risk Factors for the Progression of Endoscopic Barrett's Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria 査読

    T. Akiyama, M. Inamori, K. Akimoto, H. Iida, H. Mawatari, H. Endo, T. Ikeda, Y. Nozaki, K. Yoneda, Y. Sakamoto, K. Fujita, M. Yoneda, H. Takahashi, S. Hirokawa, A. Goto, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, A. Nakajima

    DIGESTIVE DISEASES AND SCIENCES   54 ( 8 )   1702 - 1707   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Purpose To determine the prevalence and progression of Barrett's epithelium and associated risk factors in Japan. Methods The study population comprised 869 cases. Endoscopic Barrett's epithelium was diagnosed based on the Prague C & M Criteria. The correlations of clinical factors with the prevalence and progression of endoscopic Barrett's epithelium were examined. Results Endoscopic Barrett's epithelium was diagnosed in 374 cases (43%), in the majority of which the diagnosis was short-segment Barrett's esophagus. The progression of Barrett's epithelium was identified in 47 cases. In univariate and multiple logistic regression analyses, aging, smoking habit, and erosive esophagitis were significantly associated with the prevalence of Barrett's epithelium, whereas aging and erosive esophagitis, especially severe erosive esophagitis, were significant contributing factors to the progression of Barrett's epithelium. Conclusions Forty-three percent of the total study population was diagnosed as having endoscopic Barrett's epithelium. During the follow-up period, 12.6% of the cases with Barrett's epithelium exhibited progression which was associated with aging and severe erosive esophagitis.

    DOI: 10.1007/s10620-008-0537-y

    Web of Science

    PubMed

    researchmap

  • Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease 査読

    Masato Yoneda, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Shingo Kato, Koji Fujita, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima

    LIVER INTERNATIONAL   29 ( 7 )   1078 - 1085   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Background
    Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver injury in many countries. Genetic factors are important for the development of NAFLD, as well as environmental factors. Recently an angiotensin II type 1 receptor (AGTR1) has been recognized as important in the aetiology of fibrosis in the liver.
    Objective
    In this study we investigated the association between angiotensin II type 1 receptor gene polymorphism (ATGR1) and NAFLD.
    Methods
    One hundred and sixty-seven NAFLD patients [106 with nonalcoholic steatohepatitis (NASH) and 61 with simple steatosis] with a positive diagnosis by liver biopsy and 435 healthy control subjects were recruited in this study.
    Results:
    We investigated 12 single nucleotide polymorphisms (SNPs) of the ATGR1 gene, among which rs3772622 showed the lowest P-value of allele frequency model (P=0.0000012) with an odds ratio (95% confidence interval) of 1.95 (1.49-2.55). Five SNPs (rs3772622, rs3772633, rs2276736, rs3772630 and rs3772627) were significantly associated with NAFLD, even when the most conservative Bonferroni&apos;s correction was applied. Linkage disequilibrium analysis revealed that SNP rs3772622 and another four SNPs (rs3772633, rs2276736, rs3772630 and rs3772627) were in the same block. We investigated the association between rs3772622 genotypes and the fibrosis index. The results of the analysis revealed an additive increase of the fibrosis index in the patients with the A allele of rs3772622.
    Conclusions
    This is the first report to demonstrate the genetic variations in ATGR1 that may influence the risk of NAFLD and liver fibrosis in NAFLD.

    DOI: 10.1111/j.1478-3231.2009.01988.x

    Web of Science

    PubMed

    researchmap

  • Identification of Cystatin SN as a novel tumor marker for colorectal cancer 査読

    Kyoko Yoneda, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Masato Yoneda, Koji Fujita, Shingo Kato, Yuichi Nozaki, Yasushi Ichikawa, Hiroshi Uozaki, Masashi Fukayama, Takahiro Shimamura, Tatsuhiko Kodama, Hiroyuki Aburatani, Chihiro Miyazawa, Keisuke Ishii, Naoki Hosomi, Mina Sagara, Masazumi Takahashi, Hideyuki Ike, Hiroaki Saito, Akihiko Kusakabe, Atsushi Nakajima

    INTERNATIONAL JOURNAL OF ONCOLOGY   35 ( 1 )   33 - 40   2009年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPANDIDOS PUBL LTD  

    The goal of this study was to investigate Cystatin SN, a cysteine protease inhibitor, as a novel tumor marker for colorectal cancer (CRC). Gene expression profiles of mRNA from normal tissues and cancer cell lines were performed. Twenty-eight monoclonal antibodies for Cystatin SN were generated and serum Cystatin SN was quantified using ELISA in sera from 159 patients with CRC and 40 healthy controls. Cystatin SN was highly expressed in colon cancer cells. Employing a receiver-operating characteristic curve, we obtained an area under the curve of 0.708 for Cystatin SN, 0.819 for carcinoembryonic antigen (CEA) and 0.703 for carbohydrate antigen 19-9 (CA19-9). The combination assay of Cystatin SN, CEA and CA19-9 showed 62.9% sensitivity and 90.0% specificity. Especially, the sensitivity of the combination assay in stages I and IT detection, in which stages curative operation would be possible, was improved over that of the assay testing only for CEA and CA 19-9 (from 37.5 to 42.5% in stage I, from 49.0 to 60.8% in stage II). Furthermore, Western blot analysis revealed that Cystatin SN was increased in the urine from patients with CRC. Our results suggest the possibility of utilizing this novel tumor marker that can be tested in urine samples. These observations suggest that Cystatin SN in combination with CEA and CA19-9 is a useful tumor marker for detecting early stage CRC and that it is a unique urinary excretory protein, suggesting that Cystatin SN might be a novel candidate for use in mass screening for CRC.

    DOI: 10.3892/ijo_00000310

    Web of Science

    PubMed

    researchmap

  • A PROPOSAL FOR DIFFERENTIATION BETWEEN EARLY- AND ADVANCED-STAGE AUTOIMMUNE PANCREATITIS BY ENDOSCOPIC ULTRASONOGRAPHY 査読

    Kensuke Kubota, Shingo Kato, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Masami Ogawa, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Kantaro Hisatomi, Nobuyuki Matsuhashi, Atsushi Nakajima

    DIGESTIVE ENDOSCOPY   21 ( 3 )   162 - 169   2009年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Aim:
    We evaluated the characteristic endoscopic ultrasonography (EUS) findings of early autoimmune pancreatitis (AIP).
    Methods:
    Nineteen patients with AIP were identified from our database. We reviewed the following features of EUS as being potentially characteristic of early AIP: hyperechoic foci, hyperechoic strands, lobularity, hyperechoic pancreatic duct margins and reduced echogenicity. According to the Cambridge classification for chronic pancreatitis, we classified AIP into early AIP (Grades 0-2) and advanced AIP (Grades 3-5) and examined the histopathological findings in each stage of AIP.
    Results:
    There were nine cases of early AIP and 10 cases of advanced AIP. Five of the nine early cases of AIP showed spontaneous remission without corticosteroid therapy (P &lt; 0.05). The EUS findings were as follows (early vs advanced): hyperechoic foci, 100% (9/9) vs 100% (10/10); hyperechoic strands, 66.7% (6/9) vs 70% (7/10); lobularity, 77.8% (7/9) vs 20% (2/10); hyperechoic pancreatic duct margin, 88.9% (8/9) vs 30% (3/10); reduced echogenicity, 88.9% (8/9) vs 90% (9/10). Lobularity and hyperechoic pancreatic duct margin were detected at a significantly higher frequency in early AIP than in the advanced AIP patients (P &lt; 0.05). Regarding the histopathological findings, acinar cells were better preserved in the cases of early AIP, whereas acinar cells were reduced in number and replaced by massive fibrosis in the patients with advanced AIP.
    Conclusions:
    Lobularity and hyperechoic pancreatic duct margin are characteristic EUS features of early AIP, which has a more favorable prognosis, and shows a higher frequency of spontaneous remission and preservation of acinar cells, than advanced AIP.

    DOI: 10.1111/j.1443-1661.2009.00879.x

    Web of Science

    researchmap

  • Visceral obesity and the risk of Barrett&apos;s esophagus in Japanese patients with non-alcoholic fatty liver disease 査読

    Tomoyuki Akiyama, Masato Yoneda, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Tomoko Koide, Chikako Tokoro, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    BMC GASTROENTEROLOGY   9   56   2009年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: The association between obesity and the risk of Barrett&apos;s esophagus (BE) is unclear. Furthermore, the association between visceral obesity and the risk of BE is entirely unknown.
    Methods: We conducted a retrospective study in 163 patients with non-alcoholic fatty liver disease (NAFLD) who underwent both endoscopy and abdominal CT at an interval of less than a year at our institution. BE was endoscopically diagnosed based on the Prague C & M Criteria. The surface areas of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were calculated from CT images at the level of the umbilicus. The correlations between the BMI, VAT, and SAT and the risk of BE were examined by univariate and multivariate analyses.
    Results: Sixty-nine of the 163 study participants (42.3%) were diagnosed to have endoscopic BE, which was classified as short-segment BE (SSBE) in almost all of the cases. There were no significant differences in the age or gender distribution between the groups with and without BE. According to the results of the univariate analysis, VAT was significantly associated with the risk of BE; the BMI tended to be higher in the group with BE than in the group without BE, but this relation did not reach statistical significance. VAT was independently associated with the risk of BE even after adjustment for the BMI.
    Conclusion: In Japanese patients with NAFLD, obesity tended to be associated with the risk of BE, and this risk appeared to be mediated for the most part by abdominal visceral adiposity.

    DOI: 10.1186/1471-230X-9-56

    Web of Science

    PubMed

    researchmap

  • Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values 査読

    Hiroshi Iida, Masahiko Inamori, Yuichi Nozaki, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Atsushi Nakajima

    BMC GASTROENTEROLOGY   9   52   2009年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: The ideal medication for treatment of acid related diseases should have a rapid onset of action to promote hemostasis and resolution of symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion after a single oral administrations of lafutidine, is a newly synthesized H2-receptor antagonist, with mosapride 5 mg or lafutidine alone.
    Methods: Ten Helicobacter pylori negative male subjects participated in this randomized, two-way crossover study. Intragastric pH was monitored continuously for 4 hours after a single oral administration of lafutidine 10 mg or lafutidine 10 mg with mosapride 5 mg (the lafutidine being administrated one hour after the mosapride). Each administration was separated by a 7-day washout period.
    Results: The average pH during the 4-hour period after administration of lafutidine 10 mg with mosapride 5 mg was higher than after lafutidine 10 mg alone (median: 5.25 versus 4.58, respectively; p = 0.0318). During the 3-4 hour study period, lafutidine 10 mg with mosapride 5 mg provided a higher pH, compared to lafutidine 10 mg alone (median: 7.28 versus 6.42; p = 0.0208).
    Conclusion: In H. pylori negative healthy male subjects, an oral dose of lafutidine 10 mg with mosapride 5 mg more rapidly increased intragastric pH than lafutidine 10 mg alone.

    DOI: 10.1186/1471-230X-9-52

    Web of Science

    PubMed

    researchmap

  • Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma 査読

    Hiroyuki Kirikoshi, Satoru Saito, Masato Yoneda, Koji Fujita, Hironori Mawatari, Takashi Uchiyama, Takuma Higurashi, Ayumu Goto, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Takashi Sakaguchi, Norio Ueno, Atsushi Nakajima

    HEPATOLOGY RESEARCH   39 ( 6 )   553 - 562   2009年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Hepatocellular carcinoma (HCC) is one of the most commonly occurring malignances worldwide. Curative therapies such as resection, percutaneous ethanol injection (PEI) and radiofrequency ablation (RFA) have been applied to patients with early-stage HCC. Patients with more advanced cancers require local or systemic therapies. We present the results of our retrospective review conducted to evaluate whether transarterial chemoembolization (TACE) alone and combined TACE with percutaneous ablation for HCC exhibited superior efficacy to palliative treatment.
    The effects of TACE and of the combined therapies (TACE + PEI or TACE + RFA) on the long-term survival rates were evaluated in 268 untreated HCC patients by various statistical analyses.
    The cumulative survival rates in the TACE alone group were significantly superior to those in the palliative treatment group. Further, the cumulative survival rates in the combined TACE + PEI/RFA group were significantly superior to those in the TACE alone group. When the comparison among the groups was restricted to patients with two or three tumors fulfilling the Milan criteria, significantly greater prolongation of survival was observed in the combined TACE + PEI/RFA group than in the PEI/RFA alone group.
    The aforementioned treatment modalities yielded greater improvements of the survival rate and survival duration as compared to palliative treatment in HCC patients. Furthermore, in terms of the effect on the survival period, combined TACE + PEI/RFA therapy was more effective than TACE monotherapy, and also more effective than PEI or RFA monotherapy in cases with multiple tumors fulfilling the Milan criteria.

    DOI: 10.1111/j.1872-034X.2009.00490.x

    Web of Science

    PubMed

    researchmap

  • Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy 査読

    Hiroki Endo, Kunihiro Hosono, Masahiko Inamori, Yuichi Nozaki, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Tomohiko Ohya, Kantaro Hisatomi, Takuma Teratani, Nobuyuki Matsuhashi, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   44 ( 6 )   544 - 549   2009年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    The antithrombotic effects of low-dose aspirin (LDA) are well established, and it is used for primary and secondary prevention of cardiovascular events. However, the small intestinal toxicity of LDA remains unclear. The aim of this study was to review the characteristics of small bowel injury in long-term LDA users with capsule endoscopy (CE).
    We retrospectively reviewed all chronic LDA users (&gt; 3 months) who underwent CE for suspected small bowel diseases from May 2004 to May 2008 at two medical centers.
    At our institutions, a total of 22 patients (13 males and 9 females, mean age 66.3 years) taking LDA underwent a CE examination. The indications for CE were obscure gastrointestinal bleeding in 21 patients and 1 patient who had abdominal pain. Twenty-one patients (95.5%) had some small bowel mucosal injury. Small bowel erosions were identified in 14 patients (63.6%). This enteropathy was characterized by multiple petechiae, loss of villi, erosions, and ulcers with round, irregular, and punched-out shapes. Two patients had circumferential ulcers with stricture. In most patients, small bowel lesions were multifocal and were evenly distributed in the small bowel. No patients failed to pass the capsule.
    This is the first CE report that has studied the characteristics of small bowel injury in chronic LDA users. CE is useful to diagnose small bowel enteropathy associated with LDA.

    DOI: 10.1007/s00535-009-0040-z

    Web of Science

    PubMed

    researchmap

  • Does Postprandial Coffee Intake Enhance Gastric Emptying?: A Crossover Study using Continuous Real Time C-13 Breath Test (BreathID system) 査読

    Keiko Akimoto, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Tamon Ikeda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 91-92 )   918 - 920   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Coffee is one of the most popular beverages worldwide, however, few studies have examined the effects of coffee on the gastrointestinal system. The aim of this study was to determine whether there was a correlation between coffee intake and gastric emptying using a novel non-invasive technique for measuring gastric emptying with a continuous real time C-13 breath test (BreathID system: Oridion, Israel).
    Methodology: Six healthy male volunteers participated in this randomized, two-way crossover study. The subjects were randomly assigned to receive a test meal (200kcal per 200mL) plus postprandial 190mL black coffee or the test meal alone after fasting overnight. A C-13-acetic acid breath test was continuously performed using the BreathID system, which monitors gastric emptying, for 4 hours after the administration of the test meal. Using Oridion Research Software (13 version), the time for emptying of 50% of the labeled meals (T 1/2) and the analog to the scintigraphy lag time for 10% emptying of the labeled meal (T lag) were calculated. The parameters between two occasions were compared using the Wilcoxon signed-rank test.
    Results: After coffee intake the T 1/2 and T lag constant were significantly decreased.
    Conclusions: The decrease in the T 1/2 and T lag suggests the acceleration of gastric emptying. This study showed that postprandial coffee intake enhances gastric emptying, suggesting the potential use of coffee in clinical settings for patients with functional gastrointestinal disorders.

    Web of Science

    PubMed

    researchmap

  • Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan 査読

    Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Yasushi Rino, Atsushi Nakajima

    BMC GASTROENTEROLOGY   9   34   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: We aimed to estimate whether the macroscopic extent of gastric mucosal atrophy is associated with a risk for esophageal squamous cell carcinoma using a case-control study in Japanese subjects, a population known to have a high prevalence of CagA-positive H. pylori infection.
    Methods: Two hundred and fifty-three patients who were diagnosed as having esophageal squamous cell carcinoma, and 253 sex-and age-matched controls were enrolled in the present study. The macroscopic extent of gastric mucosal atrophy was evaluated based on the Kimura and Takemoto Classification. A conditional logistic regression model with adjustment for potential confounding factors was used to assess the associations.
    Results: Body gastritis, defined endoscopically, was independently associated with an increased risk for esophageal squamous cell carcinoma.
    Conclusion: Our findings suggest that macroscopic body gastritis may be a risk factor for esophageal squamous cell carcinoma in Japan. Further studies are needed to confirm these findings.

    DOI: 10.1186/1471-230X-9-34

    Web of Science

    PubMed

    researchmap

  • Abdominal Surgery Affects Small Bowel Transit Time and Completeness of Capsule Endoscopy 査読

    Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inamori, Tomohiko Ohya, Hiroshi Iida, Hironori Mawatari, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   54 ( 5 )   1066 - 1070   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    The aim of the study was to evaluate bowel dysmotility in patients with a history of abdominal surgery by measuring both gastric transit time and small bowel transit time during capsule endoscopy and assessing the completeness of the examination. The study included 26 patients who had undergone abdominal surgery (postoperative group) and 52 patients who had not (control group). The capsule reached the cecum in 50.0% of the postoperative group and 80.8% of the control group (P = 0.005). While there was no significant difference in gastric transit time between the two groups (P = 0.882), small bowel transit time was significantly longer in the postoperative group (338.3 +/- A 119.2 min) than in the control group (266.4 +/- A 110.8 min, P = 0.010). This is the first study to report that the small bowel transit time during capsule endoscopy is prolonged in patients who had a history of abdominal surgery, resulting in a lower frequency of complete examination.

    DOI: 10.1007/s10620-008-0467-8

    Web of Science

    PubMed

    researchmap

  • Correlation of the plasma level of insulin-like growth factor-1 with the number of aberrant crypt foci in male individuals 査読

    Hirokazu Takahashi, Tetsuji Takayama, Kunihiro Hosono, Kyoko Yoneda, Hiroki Endo, Yuichi Nozaki, Koji Fujita, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Hitoshi Nakagama, Atsushi Nakajima

    MOLECULAR MEDICINE REPORTS   2 ( 3 )   339 - 343   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPANDIDOS PUBL LTD  

    In human subjects, aberrant crypt foci (ACF) can be classified as dysplastic or non-dysplastic using magnifying colonoscopy. Dysplastic ACF are thought to be a biomarker for the risk of colorectal cancer (CRC). Hyperinsulinemia and insulin-like growth factor-1 (IGF-1) have also been reported to be associated with an increased risk of CRC. To clarify this association, we investigated the relationship between diabetes risk, IGF-1 and the number of dysplastic ACF. Assessment of the number of dysplastic ACF in the entire colorectum is technically difficult, and we imaged the lower rectum only. Blood collections were taken in the morning on the day of colonoscopy. A total of 512 ACF were counted in 84 male participants, and a correlation was demonstrated to exist between age, body mass index (BMI), fasting blood sugar (FBS), insulin, homeostasis model assessment-insulin resistance (HOMA-IR), plasma leptin levels, plasmal IGF-1 levels and the number of dysplastic ACF. A significant association between plasma IGF-1 levels and the number of dysplastic ACF was still demonstrable after adjustment for age, BMI, FBS, insulin, HOMA-IR and plasma leptin levels. Our findings suggest that increased plasma leptin and IGF-1 levels, hyperinsulinemia and insulin resistance may promote the growth of dysplastic ACF. The results of multiple regression analysis revealed that increased plasma IGF-1 levels are associated with the number of dysplastic ACF present, and may be an independent risk factor for CRC. In conclusion, elevated plasma IGF-1 may promote the growth of dysplastic ACF and play a key role in colon carcinogenesis in male individuals.

    DOI: 10.3892/mmr_00000105

    Web of Science

    PubMed

    researchmap

  • Clinical Characteristics of Patients with Gastric Perforation following Endoscopic Submucosal Resection for Gastric Cancer 査読

    Yasunobu Abe, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Satoru Hirokawa, Ayumu Goto, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 91-92 )   921 - 924   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to evaluate the risk factors of perforation during endoscopic submucosal dissection (ESD).
    Methodology: ESD was performed using a Flex knife in 64 patients with a total of 67 gastric tumors. Perforation occurred at the sites of a total of 4 lesions (5.9% [4/67]) for which conservative treatment had been effective. We evaluated several possible risk factors for perforation following ESD, such as tumor size, the location of the lesion, the operation time, and other clinical factors.
    Results: All the perforations occurred in the posterior wall of the gastric upper or middle body. In an analysis adjusted for age and sex, the tumor size (odds ratio (OR), 1.017; 95% confidence interval (CI), 1.004-1.030), the location of the lesion in an upper region (OR, 10.64; 95%CI, 1.160-10.00) and the operation time (OR, 1.017; 95%CI, 1.013-1.295) were significantly associated with the incidence of perforation. All perforations were transient, resolving within 7 days, and did not require surgical treatment.
    Conclusions: A large tumor size, the location of the lesion in an upper region, and a long operation time are risk factors for perforation following ESD.

    Web of Science

    PubMed

    researchmap

  • Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study 査読

    Hiroyuki Kirikoshi, Satoru Saito, Masato Yoneda, Koji Fujita, Hironori Mawatari, Takashi Uchiyama, Takuma Higurashi, Kento Imajo, Takashi Sakaguchi, Kazuhiro Atsukawa, Aya Sawabe, Akira Kanesaki, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Norio Ueno, Atsushi Nakajima

    BMC GASTROENTEROLOGY   9   29   2009年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: Spontaneous rupture is rare complication of hepatocellular carcinoma (HCC) with high mortality rate in cirrhotic cases. The aim of this study was to determine the factors influencing prognosis in cases of spontaneously ruptured HCC and to investigate the outcomes of the treatments employed, especially transcatheter arterial embolization (TAE).
    Methods: A retrospective multicenter study was conducted in 48 cirrhotic patients with spontaneous rupture of HCC. Conservative treatment was employed in 32 patients (ConT group) and TAE was performed in 16 patients (TAE group).
    Results: The median survival time (MST) in the ConT group was only 13.1 days and the survival rate was extremely poor: 59.4% at 7 days, 37.5% at 14 days, and 6.3% at 30 days. On the other hand, the MST in the TAE group was 244.8 days and the survival rate was 87.5% at 1 month, 56.3% at 3 months, 23.4% at 12 months, and 15.6% at 24 months. According to the results of univariate analyses, factors associated with poor hepatic function and poor suitability for TAE was important determinants of short-term death (less than 3 weeks) among the patients (p &lt; 0.05). On the other hand, among the patients in whom initial TAE was successfully performed (n = 15), a multivariate analysis showed that a maximum tumor size not exceeding 7 cm was the only independent factor determining long-term survival (p = 0.0130).
    Conclusion: Despite the inherent limitations of this retrospective study, TAE appears to be a useful treatment strategy for cirrhotic patients with spontaneous HCC rupture, as it yielded a longer survival period compared with conservative treatment in patients with ruptured HCC. Among the patients with ruptured HCC in whom initial TAE was successfully performed, the maximum tumor size was an important factor influencing survival.

    DOI: 10.1186/1471-230X-9-29

    Web of Science

    PubMed

    researchmap

  • Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres 査読

    Akiko Danjo, Kanako Yamaguchi, Kazuma Fujimoto, Toshihito Saitoh, Masahiko Inamori, Takashi Ando, Tomohiko Shimatani, Kyoichi Adachi, Fukunori Kinjo, Shiko Kuribayashi, Shoji Mitsufuji, Yasuhiro Fujiwara, Shigeki Koyama, Junichi Akiyama, Atsushi Takagi, Noriaki Manabe, Hiroto Miwa, Yasuyuki Shimoyama, Motoyasu Kusano

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   24 ( 4 )   633 - 638   2009年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    We compared endoscopic findings of the frequency scale for the symptoms of gastroesophageal reflux disease (FSSG), a written questionnaire developed in Japan, to that for the questionnaire for the diagnosis of reflux esophagitis (QUEST) for the diagnosis of reflux esophagitis.
    We registered 475 patients with untreated symptoms of upper abdominal pain (male/female: 252/223, average age 52.4 +/- 17.8 years). Subjects were assessed first with the FSSG and QUEST questionnaires, then by endoscopy, before allocation to a gastric ulcer (GU), duodenal ulcer (DU), gastroesophageal reflux disease (GERD) or functional dyspepsia (FD) group.
    On the basis of the endoscopic findings the diagnoses for the 475 subjects were as follows: FD 52.2%, DU 7.6%, GU 7.8%, and GERD 32.4% (Grade M 10.1%, Grade A + B 20.2%, Grade C + D 2.3%). There was no difference between the FSSG and QUEST in sensitivity, specificity or accuracy for any condition. The FSSG score rose with increasing endoscopic severity of GERD, but there was no correlation between the QUEST score and endoscopic severity. The FSSG total score was inferior to QUEST in terms of distinguishing GERD from other conditions, but when only the questions relating to reflux symptoms were used, the FSSG was able to distinguish GERD from other conditions as well as QUEST.
    The FSSG score reflects the severity of the endoscopic findings of GERD.

    DOI: 10.1111/j.1440-1746.2008.05747.x

    Web of Science

    PubMed

    researchmap

  • Aperitif Effects on Gastric Emptying: A Crossover Study Using Continuous Real-Time (13)C Breath Test (BreathID System) 査読

    M. Inamori, H. Iida, H. Endo, K. Hosono, T. Akiyama, K. Yoneda, K. Fujita, T. Iwasaki, H. Takahashi, M. Yoneda, A. Goto, Y. Abe, N. Kobayashi, K. Kubota, A. Nakajima

    DIGESTIVE DISEASES AND SCIENCES   54 ( 4 )   816 - 818   2009年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    The aim of this study was to determine whether there is a correlation between aperitif and gastric emptying. Ten healthy male volunteers participated in this randomized, two-way crossover study. Under two conditions (after drinking an aperitif versus not), the (13)C breath test was performed for 4 h with a liquid meal (200 kcal/200 ml) containing 100 mg (13)C acetate. We used 50 ml of umeshu as the aperitif. This is a traditional Japanese plum liqueur, and contains 7 ml alcohol (14%). In the aperitif group, T (1/2), T (lag), and T (peak) were significantly delayed [T (1/2) (132: 113-174) versus (112: 92-134) (P = 0.0069); T (lag) (80: 63-94) versus (55: 47-85) (P = 0.0069); and T (peak) (81: 62-96) versus (54: 34-84) (P = 0.0069), (median: range, aperitif versus control, min)]. Gastric emptying was significantly delayed in the aperitif group as compared with the control group. This study revealed that even a small amount of alcohol such as an aperitif may contribute to delayed gastric emptying.

    DOI: 10.1007/s10620-008-0427-3

    Web of Science

    PubMed

    researchmap

  • 飲水試験に関する基礎的研究 30分の休憩は最大飲水量を増やすか?

    秋本 恵子, 稲森 正彦, 冨本 彩子, 藤澤 信隆, 斎藤 久美子, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 秋山 智之, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 斎藤 聡, 小山 茂, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A336 - A336   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Early Effects of Intravenous Administrations of Lansoprazole and Famotidine on Intragastric pH 査読

    Hiroshi Iida, Masahiho Inamori, Keiko Akimoto, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Tomoyuki Akiyama, Tamon Ikeda, Yasunari Sakamoto, Koji Fujita, Kyoho Yoneda, Hirohazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 90 )   551 - 554   2009年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The ideal medication for treatment of acid related diseases should have a rapid onset of action to promote hemostasis. The aim of our study was to investigate the inhibitory effects on gastric acid secretion after single intravenous administrations of lansoprazole 30 mg and famotidine 20 mg.
    Methodology: Twelve Helicobacter pylori-negative male subjects participated in this randomized, two-way crossover study. Intragastric pH was monitored continuously for 4 hours after single intravenous administration of lansoprazole 30 mg or famotidine 20 mg.
    Results: The average pH during the 4-hour period after administration of famotidine was higher than after lansoprazole (median: 5.15 versus 3.55, respectively; p = 0.0376). During the 4-hour study period, famotidine 20 mg provided a longer duration of pH &gt; 3, 3.5, 4, 5, 6 and 7, compared to lansoprazole 30 mg (median: 73.6% versus 57.0%; p = 0.0414, 66.8% versus 47.8%; p = 0.0281, 60.8% versus 38.8%; p = 0.0150, 55.7% versus 29.7%; p = 0.0281, 45.0% versus 23.1%; p = 0.0414 and 23.9% versus 3.65%; p = 0.0076).
    Conclusions: In Helicobacter pylori-negative healthy male subjects, an intravenous dose of famotidine 20 mg more rapidly increases intragastric pH than lansoprazole 30 mg.

    Web of Science

    PubMed

    researchmap

  • 飲水試験に関する基礎的研究 nutrition induced accommodationを検出できるか?

    池田 多聞, 稲森 正彦, 秋山 智之, 内山 崇, 飯田 洋, 野崎 雄一, 細野 邦広, 遠藤 宏樹, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 廣川 智, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斎藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A336 - A336   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Gastrointestinal: Aneurysmal artery in a gastric ulcer after endoscopic hemostasis 査読

    Y. Abe, M. Inamori, T. Uchiyama, H. Iida, K. Akimoto, H. Mawatari, Y. Nozaki, K. Hosono, H. Endo, T. Akiyama, K. Yoneda, K. Fujita, M. Yoneda, H. Takahashi, A. Goto, N. Kobayashi, H. Kirikoshi, K. Kubota, S. Saito, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   24 ( 2 )   323 - 323   2009年2月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    DOI: 10.1111/j.1440-1746.2008.05765.x

    Web of Science

    PubMed

    researchmap

  • Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population 査読

    Hirokazu Takahashi, Tetsuji Takayama, Kyoko Yoneda, Hiroki Endo, Hiroshi Iida, Michiko Sugiyama, Koji Fujita, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Satoru Saito, Koichiro Wada, Hitoshi Nakagama, Atsushi Nakajima

    CANCER SCIENCE   100 ( 1 )   29 - 32   2009年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    The association between obesity and the risk of colorectal cancer (CRC) cannot be easily evaluated because CRC itself is associated with a gradual loss of bodyweight. Aberrant crypt foci (ACF) can be classified as dysplastic ACF or non-dysplastic ACF by magnifying colonoscopy, and dysplastic ACF are thought to be a biomarker of CRC. Ninety-four participants who underwent colonoscopy at Yokohama City University Hospital, Japan, were enrolled in the current study. We detected 557 ACF, including 67 dysplastic ACF (12.0%). Univariate regression analysis was conducted to determine correlations between the number of dysplastic ACF and various potential risk factors, including patient age, waist circumference, body mass index, visceral fat area (VFA), and plasma adiponectin level. The results of multiple regression analysis revealed that the number of dysplastic ACF correlated with age (correlation coefficient r = 0.212, P = 0.0383) and plasma adiponectin level (r = -0.201, P = 0.0371), even after adjustments for sex, waist circumference, body mass index, and VFA. Our univariate correlation analysis data showed a significant correlation with the number of dysplastic ACF with VFA (r = 0.238, P = 0.0209), no correlation with subcutaneous fat area, and an inverse correlation with the plasma level of adiponectin (r = -0.258, P = 0.0118). Thus, our results suggest that aging and visceral fat accumulation could correlate moderately with colorectal carcinogenesis. The novelty of our study lies in the finding that visceral fat accumulation and a low plasma adiponectin level may promote colorectal carcinogenesis; therefore, these obesity-related parameters may serve as novel targets for CRC prevention. (Cancer Sci 2009; 100: 29-32).

    DOI: 10.1111/j.1349-7006.2008.00994.x

    Web of Science

    PubMed

    researchmap

  • Gender Differences in the Age-stratified Prevalence of Erosive Esophagitis and Barrett&apos;s Epithelium in Japan 査読

    Tomoyuki Akiyama, Masahiko Inamori, Keiko Akimoto, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Kyoko Yoneda, Yasunari Sakamoto, Tamon Ikeda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 89 )   144 - 148   2009年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: In contrast to Western countries where erosive esophagitis (EE) is more prevalent in males, there is a high incidence of EE in elderly females in Japan. We aimed to examine the gender differences in the age-stratified prevalence of EE and Barrett&apos;s epithelium.
    Methodology: The study population comprised 869 cases (463 men and 406 women) who had undergone an upper endoscopy at the Gastroenterology Division of Yokohama City University Hospital between August 2005 and July 2006. EE was graded according to the Los Angeles Classification. Barrett&apos;s epithelium was diagnosed based on the Prague C & M Criteria.
    Results: In contrast to the decrease of the proportion of EE with aging in males, that in females remained constant. The results suggest that the suppressive effect of the increased gastric mucosal atrophy associated with aging was wiped out by the age-related effect of the increased incidence of hiatal hernia. The proportions of Barrett&apos;s epithelium in both males and females increased with aging.
    Conclusions: In Japan, the prevalence of elderly females complicated with hiatal hernia, which was partly due to osteoporosis and kyphosis, may affect the proportion of EE and probably Barrett&apos;s epithelium.

    Web of Science

    PubMed

    researchmap

  • Renal Dysfunction Caused by Oral Sodium Phosphate Tablets for Colonoscopy 査読

    Takashi Uchiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Masato Yoneda, Koji Fujita, Ayumu Goto, Yasunobu Abe, Norioshi Kobayashi, Hiroyuki Kirikoshi, Takeshi Shimamura, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTION   80 ( 3 )   159 - 159   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000227044

    Web of Science

    PubMed

    researchmap

  • Life Style-Related Disease and Colorectal Cancer 査読

    Hirokazu Takahashi, Masahiko Inamori

    INTERNAL MEDICINE   48 ( 3 )   121 - 121   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.48.1800

    Web of Science

    PubMed

    researchmap

  • Colonic Ulcers in a Patient Taking Low-Dose Aspirin 査読

    Hirofumi Hara, Kaori Suzuki, Yusuke Sekino, Keiko Akimoto, Ayako Tomimoto, Tomoyuki Akiyama, Nobutaka Fujisawa, Kumiko Saito, Masahiko Inamori, Kensuke Kubota, Atsushi Nakamura, Satoru Saito, Shigeru Koyama, Atsushi Nakajima

    DIGESTION   79 ( 4 )   251 - 251   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000213242

    Web of Science

    PubMed

    researchmap

  • Preparation with Oral Tablets of Sodium Phosphate (Visiclear (R)) Is Suitable for Colonoscopy but Not for Colonoscopy with Upper Endoscopy 査読

    Takashi Uchiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTION   79 ( 2 )   98 - 98   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000209218

    Web of Science

    PubMed

    researchmap

  • Penetration of the sigmoid colon to the posterior uterine wall secondary to diverticulitis: A case report 査読

    Tomoyuki Akiyama, Masahiko Inamori, Takeshi Shimamura, Hiroshi Iida, Hiroki Endo, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Hiroshi Kobayashi, Shoji Yamanaka, Yasushi Rino, Atsushi Nakajima

    Journal of Medical Case Reports   3   8957   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Introduction. Penetration of the colon to the posterior uterine wall secondary to diverticulitis is unusual, with diagnostic methods not yet established. Non-invasive imaging, such as computed tomography and magnetic resonance imaging may help to establish a proper diagnosis, but confirmation may be reached only after surgical exploration. Case presentation. We report the case of a 78-year-old Japanese woman who presented with a low grade fever and mild diarrhea which occurred two or three times a week. Computed tomography and magnetic resonance imaging demonstrated a capsular lesion including an air structure with a diameter of 5 cm, between the posterior aspect of the uterine body and the sigmoid colon. A gastrograffin enema and colonoscopy demonstrated a giant diverticulum of the sigmoid colon with no evidence of malignancy. These data confirmed the diagnosis of diverticulitis complicated by a giant diverticulum. Because of a relapsing fever after therapy with antibiotics, the patient had en bloc surgical treatment of the uterus, fallopian tubes, ovaries and sigmoid colon, the organs involved in the diverticulitis, followed by an uneventful recovery. Conclusion. This is a rare case report of penetration of the sigmoid colon to the posterior uterine wall secondary to diverticulitis. © 2009 Akiyama et al.
    licensee Cases Network Ltd.

    DOI: 10.4076/1752-1947-3-8957

    Scopus

    PubMed

    researchmap

  • Asymptomatic Hepatic Schistosomiasis Detected by Ultrasonograpy and Confirmed by Liver Biopsy 査読

    Yuichi Nozaki, Masahiko Inamori, Koji Fujita, Masato Yoneda, Takashi Uchiyama, Shingo Kato, Hironori Mawatari, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Tomoyuki Akiyama, Kyoko Yoneda, Hirokazu Takahashi, Ayumu Goto, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Hanako Kurai, Shoji Yamanaka, Atsushi Nakajima

    INTERNAL MEDICINE   48 ( 12 )   1109 - 1110   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.48.2229

    Web of Science

    researchmap

  • Dissecting Intramural Hematoma of the Esophagus in a Kendo Player Taking Low-Dose Aspirin 査読

    Hirofumi Hara, Eiji Sakai, Yasuhiro Inokuchi, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima

    INTERNAL MEDICINE   48 ( 24 )   2153 - 2154   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.48.2822

    Web of Science

    researchmap

  • Esophageal Granular Cell Tumor Treated by Endoscopic Mucosal Resection 査読

    Yasunori Sakamoto, Masahiko Inamori, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Kenichi Kawana, Naoki Hasagawa, Yukio Kakuta, Hajime Nagase, Atsushi Nakajima

    DIGESTION   80 ( 4 )   258 - 259   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000236031

    Web of Science

    PubMed

    researchmap

  • Importance of Multidetector Computed Tomography in the Diagnosis of a Small Intestinal Tumor 査読

    Seitaro Watanabe, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Tomoko Koide, Chikako Tokoro, Kunihiro Hosono, Hiroki Endo, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Nobuhiro Sugano, Yasushi Rino, Takashi Nakayama, Yoshiaki Inayama, Atsushi Nakajima

    DIGESTION   80 ( 4 )   247 - 247   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000235922

    Web of Science

    PubMed

    researchmap

  • Intravascular Lymphoma: Usefulness of Liver Biopsy in the Clinical Setting 査読

    Takuma Higurashi, Hirokazu Takahashi, Masahiko Inamori, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Hiroyuki Kirikoshi, Satoru Saito, Shoji Yamanaka, Atsushi Nakajima

    INTERNAL MEDICINE   48 ( 24 )   2155 - 2156   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.48.2823

    Web of Science

    researchmap

  • Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: A case report 査読

    Atsushi Nakajima, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shoji Yamanaka

    Journal of Medical Case Reports   2   391   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Introduction: The granulocyte-colony stimulating factor-producing tumor was first reported in 1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-colony stimulating factor is still rare. Case presentation: A 63-year-old man was admitted to our hospital with body weight loss (-10 kg during months) and upper abdominal pain from 3 weeks. Abdominal computed tomography demonstrated a pancreatic tumor 10 cm in size and multiple low-density areas in the liver. On admission, the peripheral leukocyte count was elevated to 91,500/mm3 and the serum concentration of granulocyte-colony stimulating factor was 134 pg/mL (normal, &lt
    18.1 pg/mL). Based on liver biopsy findings, the tumor was classified as an anaplastic pleomorphic-type carcinoma. Immunohistochemical staining showed that pancreatic carcinoma cells were positive for granulocyte-colony stimulating factor. The patient developed interstitial pneumonia, probably caused by granulocyte-colony stimulating factor, and died 11 days after admission. Conclusion: This is a rare case report of anaplastic pleomorphic-type carcinoma of the pancreas producing granulocyte-colony stimulating factor and confirmed by immunohistochemistry. © 2008 Nakajima et al
    licensee BioMed Central Ltd.

    DOI: 10.1186/1752-1947-2-391

    Scopus

    PubMed

    researchmap

  • Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett&apos;s epithelium in Japanese men 査読

    Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8   58   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: Evidence regarding the association between alcohol consumption and the gastro-esophageal reflux disease (GERD) spectrum has been conflicting. We examined the association between alcohol consumption and erosive esophagitis and Barrett&apos;s epithelium in Japanese men.
    Methods: The study population comprised 463 men subjects who had undergone an upper endoscopy at the Gastroenterology Division of Yokohama City University Hospital between August 2005 and July 2006. The presence of erosive esophagitis and Barrett&apos;s epithelium was diagnosed based on the Los Angeles Classification and the Prague C and M Criteria, respectively. We divided the study population into four groups: never drinkers, light drinkers ( less than 25.0 g of ethanol per day), moderate drinkers ( 25.0 to 50.0 g of ethanol per day), and heavy drinkers ( more than 50.0 g of ethanol per day). A linear regression of the logistic regression analysis was used to analyze the dose-response trends.
    Results: Compared with never drinkers, light drinkers ( less than 25.0 g ethanol per day), moderate drinkers ( 25.0 to 50.0 g per day), and heavy drinkers ( more than 50.0 g per day) had ORs for erosive esophagitis of 1.110 (95% CI: 0.553 - 2.228, p = 0.7688), 1.880 ( 95% CI: 1.015 - 3.484, p = 0.0445) and 1.988 ( 95% CI: 1.120 - 3.534, p = 0.0190), respectively. These groups had ORs for Barrett&apos;s epithelium of 1.278 ( 95% CI: 0.752 - 2.170, p = 0.3643), 1.458 ( 95% CI: 0.873 - 2.433, p = 0.1500), and 1.912 ( 95% CI: 1.185 - 3.086, p = 0.0079), respectively. The odds ratios/grams ( alcohol)/day of dose response trends for erosive esophagitis and Barrett&apos;s epithelium were 1.015 ( 95% CI: 1.004 - 1.026, p = 0.0066) and 1.012 ( 95% CI: 1.003 - 1.021, p = 0.0079), respectively.
    Conclusion: These findings suggest that alcohol consumption in Japanese men tends to be associated with an increased risk of erosive esophagitis and Barrett&apos;s epithelium.

    DOI: 10.1186/1471-230X-8-58

    Web of Science

    PubMed

    researchmap

  • Ingesting 500 ml of Polyethylene Glycol Solution During Capsule Endoscopy Improves the Image Quality and Completion Rate to the Cecum 査読

    Hiroki Endo, Yasuyuki Kondo, Masahiko Inamori, Tomohiko R. Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Masato Yoneda, Atsushi Nakajima, Nobuyuki Matsuhashi

    DIGESTIVE DISEASES AND SCIENCES   53 ( 12 )   3201 - 3205   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    The benefits of bowel preparation prior to capsule endoscopy (CE) are controversial. The aim of this study was to examine whether ingesting a small amount of polyethylene glycol (PEG) during, not before, the CE procedure improves the image quality and the cecal completion rate. A prospective single-blind controlled study was conducted including 59 patients. The initial 32 patients (group A) received no preparation, and the subsequent 27 patients (group B) ingested 500 ml of PEG starting 30 min after swallowing the capsule. The capsule reached the cecum in 65.6% of the patients in group A and 88.9% of the patients in group B (P = 0.038). The use of PEG during CE examination significantly improved the image quality, and this effect was more pronounced in the distal ileum. Ingesting a small amount of PEG during CE examination significantly improves both the CE image quality and the cecal completion rate.

    DOI: 10.1007/s10620-008-0292-0

    Web of Science

    PubMed

    researchmap

  • Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features 査読

    Kensuke Kubota, Shingo Kato, Tomoyuki Akiyama, Masato Yoneda, Koji Fujita, Masami Ogawa, Masahiko Inamori, Noritoshi Kobayashi, Satoru Saito, Yukio Kakuta, Hisashi Ohshiro, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   68 ( 6 )   1204 - 1208   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MOSBY-ELSEVIER  

    Background: Differentiating primary sclerosing cholangitis (PSC) and sclerosing cholangids caused by autoimmune pancreatitis (SC-AIP) is often challenging. Recently, endoscopic findings of the duodenal papilla in cases with AIP or PSC were reported by Unno and Parlak, although the endoscopic differentiation of these 2 conditions has not yet been fully clarified.
    Objective: Our purpose was to clarify, the endoscopic findings of the duodenal papilla in patients with SC-AIP and those with PSC and to determine criteria for the differentiation of these conditions.
    Design: Case series.
    Setting: Restrospective.
    Patients: Twenty-seven,en patients With SC-AIP and 12 patients with PSC who had undergone ERCP were identified from out database. We reviewed these records to determine whether the duodenal papillary findings (swollen papilla/normal papilla/small papilla) might be potentially useful for differentiating SC-AIP and PSC. Immunohistopathological findings for the duodenal papilla were also examined by using immunoglobulin G4 (IgG4) among the infiltrating plasma cells.
    Interventions: ERCP, biopsy specimen taken from duodenal papilla.
    Main Outcome Measurements: The presence of a swollen duodenal papilla with IgG4-positive plasma cells was useful for discriminating SC-AIP from with PSC.
    Results: A swollen duodenal papilla was observed in 63% (17/27) of the patients with SC-AIP, whereas there was no swelling of the duodenal papilla of the patients with PSC. A small papilla was recognized in 50% (6/12) of the patients with PSC. IgG4-positive plasma cells in the duodenal papilla were significantly detected in the patients with SC-AIP but not in the patients with PSC.
    Limitation: Single-center study.
    Conclusions: Characteristic duodenal endoscopic papillary features in patients with SC-AIP, such as a swollen duodenal papilla and positive immunostaining for IgG4, might be helpful for discriminating this condition from PSC.

    DOI: 10.1016/j.gie.2008.08.013

    Web of Science

    PubMed

    researchmap

  • Inhibition of Peroxisome Proliferator-Activated Receptor gamma Promotes Tumorigenesis Through Activation of the beta-Catenin/T Cell Factor (TCF) Pathway in the Mouse Intestine 査読

    Toshio Fujisawa, Michiko Sugiyama, Ayako Tomimoto, Koichiro Wada, Hiroki Endo, Hirokazu Takahashi, Kyoko Yoneda, Masato Yoneda, Masahiko Inamori, Satoru Saito, Yasuo Terauchi, Takashi Kadowaki, Naoto Tsuchiya, Hitoshi Nakagama, Atsushi Nakajima

    JOURNAL OF PHARMACOLOGICAL SCIENCES   108 ( 4 )   535 - 544   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Although peroxisome proliferator-activated receptor gamma (PPAR gamma) is strongly expressed in the intestinal epithelium, the role of PPAR gamma in intestinal tumorigenesis has not yet been elucidated. To address this issue, we investigated the effect of PPAR gamma, inhibition and its mechanism on intestinal tumorigenesis using a selective antagonist, T0070907. We treated Apc(Min/+) mice and carcinogen-induced colon cancer model C57BL/6 mico, with T0070907 and counted the number of spontaneous polyps and aberrant crypt foci and observed cell proliferation and beta-catenin protein in the colon epithelium. To investigate its mechanism, the changes of beta-catenin/TCF (T cell factor) transcriptional activity and location of beta-catenin induced by T0070907 were investigated in the colon cancer cell lines. T0070907 promoted polyp formation in the small intestine of Apc(Min/+) mice and aberrant crypt foci in the colon of C57BL/6 mice. PPAR gamma inhibition promoted cell proliferation and increased expressions of the c-myc and cyclin D1 genes and the beta-catenin protein in the colon epithelium. In vitro, cell proliferation was promoted, but it was inhibited by the transfection of dominant-negative Tcf4. T0070907 increased beta-catenin/TCF transcriptional activity and beta-catenin protein in the cytsol and nucleus, but relatively decreased it on the cell membrane. PPAR gamma antagonist promotes tumorigenesis in the small intestine and colon through stimulation of epithelial cell proliferation. beta-Catenin contributes to the promotion of tumorigenesis by PPAR gamma antagonist due to activation of TCF/LEF (lymphoid enhancer factor) transcriptional factor.

    DOI: 10.1254/jphs.08193FP

    Web of Science

    researchmap

  • Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis 査読

    Masato Yoneda, Hiroki Endo, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Tomoyuki Akiyama, Takuma Higurashi, Takashi Uchiyama, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Noritoshi Kobayashi, Naotaka Yamaguchi, Shiro Maeyama, Shogo Yamamoto, Shuichi Tsutsumi, Hiroyuki Aburatani, Koichiro Wada, Kikuko Hotta, Atsushi Nakajima

    HEPATOLOGY RESEARCH   38 ( 12 )   1204 - 1212   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim: Non-alcoholic steatohepatitis (NASH) is a subset of non-alcoholic fatty liver disease (NAFLD) and sometimes progresses to cirrhosis and liver failure. In this study we analyzed the expression profile of genes and biological pathways involved in NASH in comparison with non-NASH by gene set enrichment analysis (GSEA) employing a DNA microarray technique.
    Methods: mRNA from liver biopsy specimens was collected from a group of NASH patients and a group of non-NASH patients. We analyzed the relative abundance of mRNA using high-density oligonucleotide microarrays containing probes for 54 675 known genes, and investigated the pathogenetic mechanisms of NASH by means of a powerful technique for analyzing molecular profiling data, GSEA.
    Results: The results showed that the level of expression of 27 gene sets was significantly higher and the level of expression of 25 gene sets was significantly lower in the NASH samples than in the non-NASH samples. Based on these results we created an online, publicly available, searchable database containing the data for the gene expression profiles of the NASH patients (http://www2.genome.rcast.u-tokyo.ac.jp/__/NASH/NASH_GSEA2/).
    Conclusion: Our data revealed differences in expression of many gene sets that are involved in the pathogenesis of NASH.

    DOI: 10.1111/j.1872-034X.2008.00399.x

    Web of Science

    PubMed

    researchmap

  • Gastric ulcer following a thrombotic aneurysm of the splenic artery 査読

    K. Suzuki, H. Takahashi, N. Fujisawa, Y. Sekino, K. Akimoto, A. Tomimoto, K. Saito, M. Yoneda, M. Inamori, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, S. Koyama, A. Nakajima

    ENDOSCOPY   40   E193 - E194   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-2008-1077418

    Web of Science

    PubMed

    researchmap

  • Usefulness of Multidetector Computed Tomography for Detection of the Obstructive Point in a Patient with Ileus 査読

    Eiji Sakai, Hirokazu Takahashi, Masahiko Inamori, Hiroki Endo, Tomoyuki Akiyama, Keiko Akimoto, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   53 ( 12 )   3264 - 3264   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    DOI: 10.1007/s10620-008-0272-4

    Web of Science

    PubMed

    researchmap

  • Colonic Metastasis from Hepatocellular Carcinoma: Manifested by Gastrointestinal Bleeding 査読

    Yuichi Nozaki, Noritoshi Kobayashi, Takeshi Shimamura, Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Takeshi Sasaki, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   53 ( 12 )   3265 - 3266   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    DOI: 10.1007/s10620-008-0273-3

    Web of Science

    PubMed

    researchmap

  • Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition 査読

    T. Fujisawa, H. Endo, A. Tomimoto, M. Sugiyama, H. Takahashi, S. Saito, M. Inamori, N. Nakajima, M. Watanabe, N. Kubota, T. Yamauchi, T. Kadowaki, K. Wada, H. Nakagama, A. Nakajima

    GUT   57 ( 11 )   1531 - 1538   2008年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:B M J PUBLISHING GROUP  

    Background and aims: The effect of adiponectin on colorectal carcinogenesis has been proposed but not fully investigated. We investigated the effect of adiponectin deficiency on the development of colorectal cancer.
    Methods: We generated three types of gene-deficient mice ( adiponectin-deficient, adiponectin receptor 1-deficient, and adiponectin receptor 2-deficient) and investigated chemical-induced colon polyp formation and cell proliferation in colon epithelium. Western blot analysis was performed to elucidate the mechanism which affected colorectal carcinogenesis by adiponectin deficiency.
    Results: The numbers of colon polyps were significantly increased in adiponectin-deficient mice compared with wild-type mice fed a high-fat diet. However, no difference was observed between wild-type and adiponectin-deficient mice fed a basal diet. A significant increase in cell proliferative activity was also observed in the colonic epithelium of the adiponectin-deficient mice when compared with wild-type mice fed a high-fat diet; however, no difference was observed between wild-type and adiponectin-deficient mice fed a basal diet. Similarly, an increase in epithelial cell proliferation was observed in adiponectin receptor 1-deficient mice, but not in adiponectin receptor 2-deficient mice. Western blot analysis revealed activation of mammalian target of rapamycin, p70 S6 kinase, S6 protein and inactivation of AMP-activated protein kinase in the colon epithelium of adiponectin-deficient mice fed with high-fat diet.
    Conclusions: Adiponectin suppresses colonic epithelial proliferation via inhibition of the mammalian target of the rapamycin pathway under a high-fat diet, but not under a basal diet. These studies indicate a novel mechanism of suppression of colorectal carcinogenesis induced by a Western-style high-fat diet.

    DOI: 10.1136/gut.2008.159293

    Web of Science

    PubMed

    researchmap

  • Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH) 査読

    Masato Yoneda, Takashi Uchiyama, Shingo Kato, Hiroki Endo, Koji Fujita, Kyoko Yoneda, Hironori Mawatari, Hiroshi Iida, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Mina Sagara, Hiroyuki Aburatani, Tatsuhiko Kodama, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8   53   2008年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to differentiate between NASH and non-progressive NAFLD on the basis of the clinical findings alone.
    Aims: In this study we investigated the clinical usefulness of plasma Pentraxin3 (PTX3) levels to predict NASH. Plasma PTX3 was measured in 70 patients with histologically verified NAFLD (28 with non-NASH and 42 with NASH) and 10 healthy control subjects.
    Results: The plasma PTX3 level was significantly higher in the NASH cases than in the non-NASH cases (p = 0.0021) and control subjects (p = 0.045). And the plasma PTX3 level was significantly higher in the stages 3-4 NAFLD cases than in the stages 0-2 NAFLD cases (p&lt;0.0001). The PTX3 values were closely correlated with the stages of liver fibrosis (p&lt;0.0001, Kruskal-Wallis test). To detect NASH compared with non-NASH, the area under the curve for plasma PTX3 were 0.755, and to detect stages 3-4 NAFLD compared with stages 0-2 NAFLD, the area under the curve for plasma PTX3 were 0.850.
    Conclusion: This is the first study to demonstrate consistent and profound elevation of plasma PTX3 levels in NASH in comparison with non-NASH. The results suggest that plasma PTX3 levels may not only be laboratory values that differentiate NASH from non-NASH, but marker of the severity of hepatic fibrosis in NASH.

    DOI: 10.1186/1471-230X-8-53

    Web of Science

    PubMed

    researchmap

  • Gastrointestinal: Ascariasis 査読

    A. Suzuki, Y. Yabushita, H. Takahashi, M. Inamori, S. Nakao, K. Suzuki, H. Iida, H. Endo, T. Akiyama, T. Ikeda, Y. Sakamoto, K. Fujita, M. Yoneda, A. Goto, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   23 ( 11 )   1770 - 1770   2008年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/j.1440-1746.2008.05662.x

    Web of Science

    PubMed

    researchmap

  • Tumor fragment impacted at the major duodenal papilla causing obstructive jaundice in a patient with hepatocellular carcinoma 査読

    Noritoshi Kobayashi, Hiroyuki Kirikoshi, Takuma Higurashi, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   68 ( 5 )   999 - 1000   2008年11月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2008.04.023

    Web of Science

    PubMed

    researchmap

  • Gastrointestinal: Mantle cell lymphoma diagnosed by balloon enteroscopy 査読

    A. Yumori, H. Okubo, H. Takahashi, H. Iida, H. Mawatari, M. Yoneda, M. Inamori, Y. Abe, N. Kobayashi, H. Kirikoshi, K. Kubota, S. Saito, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   23 ( 10 )   1623 - 1623   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/j.1440-1746.2008.05630.x

    Web of Science

    PubMed

    researchmap

  • Acute appendicitis associated with Peutz-Jeghers-type hamartoma of the appendix 査読

    Hiroshi Iida, Masahiko Inamori, Yusuke Sekino, Hiroki Endo, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Noritoshi Kobayashi, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Hisashi Oshiro, Yasushi Rino, Atsushi Nakajma

    DIGESTIVE DISEASES AND SCIENCES   53 ( 10 )   2832 - 2833   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    DOI: 10.1007/s10620-008-0219-9

    Web of Science

    PubMed

    researchmap

  • Tumorous arteriovenous malformation in the jejunum missed by capsule endoscopy 査読

    Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inarnori, Tomohiko Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Koji Fujita, Masato Yoneda, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   68 ( 4 )   773 - 774   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2008.03.009

    Web of Science

    PubMed

    researchmap

  • Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility 査読

    Atsushi Nakajima, Ayako Tomimoto, Koji Fujita, Michiko Sugiyama, Hirokazu Takahashi, Ikuko Ikeda, Kunihiro Hosono, Hiroki Endo, Kyoko Yoneda, Hiroshi Iida, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Noriko Nakajima, Koichiro Wada, Yoji Nagashima, Hitoshi Nakagama

    CANCER SCIENCE   99 ( 10 )   1892 - 1900   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated transcription factor that has been implicated in the carcinogenesis and progression of various solid tumors, including pancreatic carcinomas. We aimed to clarify the role of this receptor in pancreatic cell motility in vitro and in metastasis in vivo. Cell motility was examined by assaying transwell migration and wound filling in Capan-1 and Panc-1 pancreatic cancer cells, with or without the PPAR gamma-specific inhibitor T0070907. A severe combined immunodeficiency xenograft metastasis model was used to examine the in vivo effect of PPAR gamma inhibition on pancreatic cancer metastasis. In both transwell-migration and wound-filling assays, inhibition of PPAR gamma activity suppressed pancreatic cell motility without affecting in vitro cell proliferation. Inhibition of PPAR gamma also suppressed liver metastasis in vivo in metastatic mice. In PPAR gamma-inhibited cells, p120 catenin accumulation was induced predominantly in cell membranes, and the Ras-homologous GTPases Rac1 and Cdc42 were inactive. Inhibition of PPAR gamma in pancreatic cancer cells decreased cell motility by altering p120ctn localization and by suppressing the activity of the Ras-homologous GTPases Rac1 and Cdc42. Based on these findings, PPAR gamma could function as a novel target for the therapeutic control of cancer cell invasion or metastasis. (Cancer Sci 2008; 99: 1892-1900)

    DOI: 10.1111/j.1349-7006.2008.00904.x

    Web of Science

    PubMed

    researchmap

  • Gastric Surgery is Not a Risk Factor for the Development or Progression of Barrett&apos;s Epithelium 査読

    Tomoyuki Akiyama, Masahiko Inamori, Keiko Akimoto, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Kyoko Yoneda, Tamon Ikeda, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Satoru Hirokawa, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Yasushi Rino, Atsushi Nahajima

    HEPATO-GASTROENTEROLOGY   55 ( 86-87 )   1899 - 1904   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Barrett&apos;s epithelium is currently believed to be related to acid gastroesophageal reflux. The aim was to determine the role of pancreatic-biliary reflux in the genesis of Barrett&apos;s epithelium.
    Methodology: The study population comprised 1055 cases (606 men and 449 women; median age, 67years) who had undergone an upper endoscopy at 67 the Gastroenterology Division of Yokohama City University Hospital between August 2005 and July 2006. The study population was composed of 869 cases with intact stomachs and 186 cases with distal-gastrectomies. The presence and the progression of Barrett&apos;s epithelium were diagnosed based on the Prague C & M Criteria. The correlations of clinical factors, including distal-gastrectomy, with the presence and the progression of Barrett&apos;s epithelium were examined.
    Results: The study demonstrated that 42.2% of the total population was diagnosed to have Barrett&apos;s epithelium and, in 12.6% of the cases with Barrett&apos;s epithelium, the progression of Barrett&apos;s epithelium was observed during the median 72 month follow-up. A distal gastrectomy was not significantly correlated with either the incidence or progression of Barrett&apos;s epithelium.
    Conclusions: This lack of association between gastric surgery and Barrett&apos;s epithelium suggests that pancreatic-biliary reflux with limited acid is not sufficient for the genesis of Barrett&apos;s epithelium.

    Web of Science

    PubMed

    researchmap

  • Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue 査読

    Kyoko Yoneda, Ayako Tomimoto, Hiroki Endo, Hiroshi Iida, Michiko Sugiyama, Hirokazu Takahashi, Hironori Mawatari, Yuichi Nozakv, Koji Fujita, Masato Yoneda, Masahiko Inamori, Noriko Nakajima, Koichiro Wada, Yoji Nagashima, Hitoshi Nakagama, Hiroshi Uozaki, Masashi Fukayama, Atsushi Nakajima

    ONCOLOGY REPORTS   20 ( 3 )   479 - 483   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PROFESSOR D A SPANDIDOS  

    Adiponectin is secreted by adipocytes and is a key hormone responsible for insulin sensitization. Recent studies have shown that plasma adiponectin is decreased in patients with breast, endometrial and gastric cancer. However, the effect of adiponectin on colorectal carcinogenesis is controversial. It is now well known that the adiponectin receptor exists in two isoforms, adiponectin receptor 1 (AdipoR1) and adiponectin receptor 2 (AdipoR2). We examined the expression of the adiponectin receptors on normal colon mucosa and colon cancer tissues in a human study using real-time RT-PCR, Western blotting and immunohistochemical staining. Adiponectin receptors, AdipoR1/AdipoR2, were expressed in normal colon epithelial and colon cancer cells. Furthermore, laser microdissection was pet-formed to confirm our results. These results suggest that adiponectin may exert some effects on normal colon epithelium or colon cancer cells directly through adiponectin receptors. Further studies are required to elucidate the function of the AdipoRs activated by adiponectin and the downstream mechanisms of AdipoRs in colon cancer cells.

    DOI: 10.3892/or_00000031

    Web of Science

    PubMed

    researchmap

  • Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) 査読

    Noritoshi Kobayashi, Takuma Higurashi, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Ayako Tomimoto, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima, Shoji Yamanaka, Yoshiaki Inayama

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY   15 ( 5 )   531 - 535   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    We report a rare case of adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) in which parathyroid hormone-related protein (PTH-rP) was identified as the causative factor of hypercalcemia. A 72-year-old Japanese man was admitted to our institution complaining of fever and abdominal pain. Abdominal computed tomography demonstrated a large tumor in the body of the pancreas, with multiple liver metastases. Both serum calcium and PTH-rP levels were elevated. No accumulation was observed on bone scan with technetium-99. The patient died of pneumonia 3 months after admission. Autopsy demonstrated that the neoplasm in the pancreas showed an abrupt histological transition from adenocarcinoma to squamous cell carcinoma. PTH-rP was identified in the primary pancreatic tumor cells by immunohistochemical examination and a reverse-transcription polymerase chain reaction (RTPCR) method. We concluded that PTH-rP was the causative factor of the HHM, based on the laboratory data, immunohistochemical examination, and messenger RNA (mRNA) expression. This is a very rare report of adenosquamous cell carcinoma of the pancreas associated with HHM.

    DOI: 10.1007/s00534-007-1258-x

    Web of Science

    PubMed

    researchmap

  • Chemotherapeutic treatment of priapism in metastatic rectal cancer. 査読

    Kitai Y, Takahashi H, Goto A, Iida H, Mawatari H, Fujita K, Yoneda M, Inamori M, Abe Y, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima A

    Case reports in gastroenterology   2   505 - 508   2008年9月

     詳細を見る

    出版者・発行元:3  

    DOI: 10.1159/000183537

    PubMed

    researchmap

  • Effective Treatment for Advanced Hepatocellular Carcinoma with Portal Venous Invasion using a Combination Therapy of Intra-arterial 5-Fluorouracil and Subcutaneous Pegylated-interferon-alpha-2b 査読

    Hironori Mawatari, Hiroyuki Kirikoshi, Masato Yoneda, Takuma Higurashi, Koji Fujita, Satoru Saito, Masahiko Inamori, Hirokazu Takahashi, Yasunobu Abe, Kensuke Kubota, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   55 ( 86-87 )   1776 - 1777   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Hepatocellular carcinoma with portal venous invasion has a poor prognosis. We report a case treated successfully by intra-arterial 5-fluorouracil with systemic peglated-interferon-alpha-2b instead of conventional interferon-alpha.
    A 66-year-old mail was admitted to our hospital, and diagnosed with hepatocellular carcinoma with portal venous invasion. Following informed consent,, he was treated with eight week cycles of combination chemotherapy using intra-arterial 5-fluorouracil (500mg/body/day i.a., days 1-5, 8-12 continuously) and pepylated-interferon-alpha-2b (100 mu g body s.c., days 1, 8). No significant side effects were observed during his therapy. After 4 cycles, computed tomography scan revealed a partial response of tumor reduction. This is the first report of advanced hepatocellular carcinoma effectively treated using subcutaneous pegylated-interferon-alpha-2b with intra-arterial 5-fluorouracil. While the conventional therapy of interferon-alpha with 5-fluorouracil has significant side effects, no significant side effects were observed in Our case. The use of subcutaneous pegylated-interferon-alpha-2b combined with intra-arterial 5-fluorouracil, may improve patients quality of life.

    Web of Science

    PubMed

    researchmap

  • Effects of Body Positions on Gastric Emptying with Enteral Nutrition: A Crossover Study using a Continuous Real Time (13)C Breath Test (BreathID system) 査読

    Tamon Ikeda, Masahiko Inamori, Nobutaka Fujisawa, Tomoyuki Iwasaki, Tomoyuki Akiyama, Keiko Akimoto, Hironori Mawatari, Hiroshi Iida, Hiroki Endo, Yuichi Nozaki, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Kyoko Yoneda, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   55 ( 86-87 )   1905 - 1907   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to determine whether there was a correlation between body positions and gastric emptying, using a novel non-invasive technique for measuring gastric emptying with a continuous real time (13)C breath test (BreathID system).
    Methodology: Ten healthy male volunteers participated in this randomized, two-way crossover study. On both occasions. the (13)C breath test was performed for 4 hours using the BreathID system with a liquid meal (200kcal per 200mL) containing 100mg (13)C-acetic acid. Subjects were randomly assigned to sit comfortable (the sitting position) or to lie supine (the lying position).
    Results: In the lying position, T 1/2 and T lag were significantly delayed. The gastric emptying coefficient was also decreased in lying position.
    Conclusions: This study showed that gastric emptying following a liquid meal was significantly delayed in the lying position compared to the sitting position, suggesting the potential use of these findings in the clinical setting for patients receiving enteral nutrition via the stomach.

    Web of Science

    PubMed

    researchmap

  • Gastric varices with remarkable collateral veins in valpronic Acid-induced chronic pancreatitis. 査読 国際誌

    Hattori Y, Higurashi T, Takahashi H, Inamori M, Abe Y, Rino Y, Nakajima A

    Case reports in gastroenterology   2 ( 2 )   279 - 282   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:2  

    DOI: 10.1159/000151288

    PubMed

    researchmap

  • Gastric inflammatory fibroid polyp treated by endoscopic submucosal dissection. 査読

    Hattori Y, Kobayashi S, Takahashi H, Yoneda M, Inamori M, Abe Y, Kubota K, Saito S, Nakajima A

    Case reports in gastroenterology   2   283 - 286   2008年8月

     詳細を見る

    出版者・発行元:2  

    DOI: 10.1159/000151330

    PubMed

    researchmap

  • Education and imaging - Gastrointestinal: Colonic spirochetosis 査読

    K. Tsuzawa, N. Fujisawa, Y. Sekino, K. Suzuki, K. Saito, S. Koyama, M. Tanaka, A. Wada, M. Inamori, K. Kubota, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   23 ( 7 )   1160 - 1160   2008年7月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2008.05493.x

    Web of Science

    PubMed

    researchmap

  • Clinicopathologic study of resected cases of primary carcinoma of the cystic duct 査読

    Kensuke Kubota, Yukio Kakuta, Yoshiaki Inayama, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima, Kazuya Sugimori, Kenichi Matuo, Takeda Kazunaga, Hiroshi Shimada

    HEPATO-GASTROENTEROLOGY   55 ( 85 )   1174 - 1178   2008年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: There have been few reports of primary carcinoma of the cystic duct (CCD) included in advanced cases. The aim of this study was to elucidate the clinical features of resected CCD.
    Methodology: Six cases of CCD were diagnosed in which the main carcinomatous component arose from the cystic bile duct, even if these carcinomas were accompanied by invasion beyond the cystic duct. Histopathologic findings (i.e., H.E. staining and cell proliferating potency assessed by ki-67 staining) were compared between the main lesion and invasive lesion of the CCD.
    Results: Abdominal ultrasonography revealed swelling of the gallbladder in 3 of the 6 patients, but not in the remaining 3, who were later diagnosed as having adenomyomatosis of the gallbladder, dyst-electasis due to the carcinomatous infiltration, and atrophic gallbladder, respectively. On computed tomography, 4 of the 6 cases with nodular-type lesions fulfilling Farrar's criteria, the tumors showed contrast enhancement. Direct cholangiography demonstrated unilateral obstruction of the common bile duct in 4 out of the 6 cases. Intraductal ultrasonography revealed CCD in only I of the 6 cases. Advanced CCD shows 2 patterns of invasion; the hepatic hilum pattern and the confluence invasive pattern. The hepatic hilum pattern of invasion tends to be associated with a poorer prognosis. Histopathological study revealed papillary and/or well differentiated adenocarcinoma in the cases where the lesion predominantly involved the cystic duct, whereas those lesions which extended beyond the cystic duct were composed of moderate and/or poorly differentiated tubular adenocarcinoma. The latter was associated with a high cellular proliferative activity as assessed by immunocytochemical examination for ki-67. Invasion of the perineural space was often observed in the cases with advanced CCD.
    Conclusions: CCD showed the hepatic hilum and/or confluence pattern of invasion when the tumor extended beyond the cystic duct. CCD extending beyond the cystic duct was associated with more aggressive characteristics of the tumors, with perineural infiltration and histopathologic features resembling those of pancreatic cancer. It is concluded that CCDs extending beyond the cystic duct are more aggressive and associated with a poorer prognosis.

    Web of Science

    PubMed

    researchmap

  • Association between PPARGCIA polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD) 査読

    Masato Yoneda, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Shingo Kato, Kunihiro Hosono, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8   27   2008年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: Genetic factors as well as environmental factors are important in the development of NAFLD and in this study we investigated associations between polymorphisms of peroxisome proliferators-activated receptor gamma coactivator 1 alpha polymorphism (PPARGC1A) and NAFLD.
    Aims: We recruited 115 patients with biopsy-proven NAFLD, 65 with NASH and 50 with simple steatosis, and 441 healthy control subjects and investigated 15 SNPs of PPARGC1A.
    Results: SNP rs2290602 had the lowest p value in the dominant mode (p = 0.00095), and the odds ratio for NAFLD (95% CI) was 2.73 (1.48-5.06). rs2290602 was significantly associated with NAFLD even when the most conservative Bonferroni&apos;s correction was applied (p = 0.0143). The frequency of the T allele of rs2290602 was significantly higher in the NASH patients than in the control subjects (p = 0.00093, allele frequency mode), and its frequency in the NASH patients tended to be higher than in the simple steatosis patients (p = 0.09). The results of the real-time RT-PCR study showed that intrahepatic mRNA expression of PPARGC1A was lower in the TT group than in the GG or GT group at SNP rs2290602 (p = 0.0454).
    Conclusion: This is the first study to demonstrate a significant association between genetic variations in PPARGC1A and NAFLD. This finding suggested that PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to etiology of NAFLD.

    DOI: 10.1186/1471-230X-8-27

    Web of Science

    PubMed

    researchmap

  • 下腹部腫瘤で発症し小腸内視鏡で診断し得たMantle cell lymphomaの1例

    大久保 秀則, 鈴木 裕史, 小林 智, 柳沢 昇吾, 村田 依子, 栗山 仁, 秦 康夫, 飯田 洋, 馬渡 弘典, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.1 )   878 - 878   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Rebleeding rate after interventional therapy directed by capsule endoscopy in patients with obscure gastrointestinal bleeding 査読

    Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inamori, Keiko Akimoto, Tomohiko Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Koji Fujita, Masato Yoneda, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8   12   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMED CENTRAL LTD  

    Background: The precise role of capsule endoscopy in the diagnostic algorithm of obscure gastrointestinal bleeding has yet to be determined. Despite the higher diagnostic yield of capsule endoscopy, the actual impact on clinical outcome remains poorly defined. The aim of this study was to evaluate the follow-up results of patients with obscure gastrointestinal bleeding to determine which management strategies after capsule endoscopy reduced rebleeding.
    Methods: All patients in whom the cause of obscure gastrointestinal bleeding was investigated between May 2004 and March 2007 were studied retrospectively. We evaluated the clinical outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy using the rebleeding rate as the primary outcome.
    Results: Seventy-seven patients with obscure gastrointestinal bleeding underwent capsule endoscopy. Capsule endoscopy identified clinically significant findings that were thought to be the sources of obscure gastrointestinal bleeding in 58.4% of the patients. The overall rebleeding rate was 36.4%. The rebleeding rate was significantly higher among patients with insignificant findings than among those with significant findings (p = 0.036). Among the patients in whom capsule endoscopy produced significant findings, the rebleeding rate of the patients who underwent therapeutic interventions was significantly lower than that in those who did not undergo intervention (9.5% vs 40.0%, p = 0.046).
    Conclusion: Follow-up and further aggressive interventions are necessary for patients with obscure gastrointestinal bleeding and significant capsule endoscopy findings to reduce the chance of rebleeding.

    DOI: 10.1186/1471-230X-8-12

    Web of Science

    PubMed

    researchmap

  • 長期経過観察中急激な形態変化を示したinflammatory fibroid polypの1例

    小林 智, 柳沢 昇吾, 村田 依子, 栗山 仁, 秦 康夫, 飯田 洋, 馬渡 弘典, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.1 )   899 - 899   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms 査読

    Noritoshi Kobayashi, Masahiko Inamori, Koji Fujita, Toshio Fujisawa, Nobutaka Fujisawa, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Harunobu Kawamura, Takeshi Shimamura, Hiroyuki Kirikoshi, Kensuke Kubota, Takashi Sakaguchi, Satoru Saito, Lawrence J. Saubermann, Atsushi Nakajima

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY   15 ( 2 )   169 - 177   2008年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Background/Purpose. Intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas have a favorable prognosis. However, invasive ductal carcinomas of the pancreas show a rapid progression. The aim of this study was to investigate gene mutations in pure pancreatic juice from IPMN patients and to define these genetic mutations in relation to the histopathological and clinical features of IPMNs.
    Methods. Twenty-two patients with IPMN, 21 patients with ductal carcinoma, and 20 patients with normal pancreas or chronic pancreatitis were recruited for this study. We measured the main pancreatic duct's largest diameter and the maximum size of a dilated branch was assessed by ultrasonography or endoscopic ultrasonography. Pure pancreatic juice was collected and was investigated for K-ras, p16, and p53 mutations.
    Results. Mutant K-ras gene was detected in 13 of the 22 patients (59.1%) with IPMNs. Different kinds of mutations were detected in the same patient in 4 cases. In the 13 patients with mutant K-ras gene, the diameter of the most dilated part of the main pancreatic duct was 2-8 mm ( average, 4.5 mm) and in 7 patients with wild-type K-ras gene, the diameter was 2 5 mm ( average, 2.7 mm). There was a significant difference in the diameter of the main pancreatic duct between patients with and without the mutant K-ras gene ( P = 0.0323).
    Conclusions. The incidence of K-ras mutation may be associated with the hypersecretion of mucin.

    DOI: 10.1007/s00534-007-1223-8

    Web of Science

    PubMed

    researchmap

  • Levovist ultrasonography imaging in intracystic hemorrhage of simple liver cyst 査読

    Tomoyuki Akiyama, Masahiko Inamori, Satoru Saito, Hirokazu Takahashi, Masato Yoneda, Koji Fujita, Toshio Fujisawa, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Michio Ueda, Kuniya Tanaka, Shinji Togo, Norio Ueno, Hiroshi Shimada, Atsushi Nakajima

    WORLD JOURNAL OF GASTROENTEROLOGY   14 ( 5 )   805 - 807   2008年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:W J G PRESS  

    The differential diagnosis between intracystic hemorrhage and cystadenocarcinoma of the liver is often difficult even with the use of various imaging modalities. A 73-year-old woman was admitted to our hospital with the complaint of right upper quadrant pain. Ultrasonography (US) demonstrated a heterogeneous echogenic cyst measuring 11 cm x 8 cm in size in S2 of the liver, indicated intracystic hemorrhage of simple liver cyst or cystadenocarcinoma, but the differential diagnosis was considerably difficult. Levovist (Schering, Berlin, Germany) US revealed no enhancement of the intracystic structures, suggesting a clot in the case of intracystic hemorrhage. An operation was performed and the resected lesion showed a solitary benign liver cyst, measuring 5.5 cm x 4.7 cm x 8.5 cm containing a large blood clot. The patient had an uneventful recovery after the surgery. Levovist US may play an important role in discrimination between intracystic hemorrhage of simple hepatic cysts and cystadenocarcinoma of the liver. (C) 2008 WJG. All rights reserved.

    DOI: 10.3748/wjg.14.805

    Web of Science

    PubMed

    researchmap

  • [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?]. 査読

    Kobayashi N, Fujita K, Fujisawa T, Takahashi H, Yoneda M, Abe Y, Inamori M, Kirikoshi H, Kubota K, Saito S, Nakajima A

    Gan to kagaku ryoho. Cancer & chemotherapy   35   65 - 70   2008年1月

     詳細を見る

    出版者・発行元:1  

    PubMed

    researchmap

  • Visceral fat and digestive disease 査読

    Masahiko Inamori, Tomoyuki Akiyama, Hirokazu Takahashi, Yasunobu Abe, Atsushi Nakajima

    Japanese Journal of Gastroenterology   105 ( 12 )   1722 - 1727   2008年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:12  

    DOI: 10.11405/nisshoshi.105.1722

    Scopus

    PubMed

    researchmap

  • Comparative Study of the Convenience of the QUEST and FSSG Questionnaires 査読

    M. Inamori, T. Akiyama, S. Kato, T. Uchiyama, H. Iida, H. Mawatari, K. Akimoto, H. Endo, K. Hosono, K. Yoneda, T. Ikeda, K. Fujita, Y. Sakamoto, M. Yoneda, H. Takahashi, A. Goto, S. Hirokawa, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, A. Nakajima

    PROCEEDINGS OF THE 11TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR DISEASES OF THE ESOPHAGUS   167 - 170   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:MEDIMOND S R L  

    We compared the convenience of the Quality-of-Life and Utility Evaluation Survey Technology (QUEST) questionnaire and the Frequency Scale for the Symptoms of Gastro-esophageal Reflux Disease (FSSG) questionnaire. The subjects were 40 healthy adult volunteers (22-52 years old). They were asked to complete the QUEST and FSSG themselves. The time required to complete the questionnaire, whether the subjects asked any questions as they filled in the questionnaires, and the questionnaire scores were analyzed. The comparison between the QUEST and FSSG revealed significant differences in the completion time (82.5 sec vs 42.5 sec, respectively: P &lt; 0.0001) and whether the subjects asked any questions (13 subjects vs 2 subjects, respectively: P=0.0031). The FSSG was more convenient to complete than the QUEST.

    Web of Science

    researchmap

  • The Role of Duodenogastroesophageal Reflux in Barrett&apos;s Esophagus 査読

    T. Akiyama, M. Inamori, S. Kato, T. Uchiyama, H. Iida, H. Mawatari, K. Akimoto, H. Endo, K. Hosono, Y. Nozaki, T. Ikeda, K. Yoneda, Y. Sakamoto, K. Fujita, H. Takahashi, M. Yoneda, A. Goto, S. Hirokawa, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, A. Nakajima

    PROCEEDINGS OF THE 11TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR DISEASES OF THE ESOPHAGUS   109 - 111   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:MEDIMOND S R L  

    The contribution of duodenogastroesophageal reflex (DGER) to the development of Barrett&apos;s esophagus (BE) has remained a controversial topic. Animal models suggest that bile reflex may result in BE. Clinical studies demonstrated that reflux played only it synergistic role in bile and it major role in the acidity of the refluxate, but the amount of bile reflex correlate with the severity of gastroesophageal reflex disease (GERD). Those studies which evaluated the association between previous gastric surgery, as it good model for both bile reflex and acid inhibition, and the development of BE have shown that gastric surgery does not pose any risk. DGER Without Simultaneous acid reflux does not cause BE, but the synergy between acid and DGER shows a graded increase in severity across the GERD spectrum, enhancing the damage to esophagus.0

    Web of Science

    researchmap

  • Severe large-intestine involvement in adult-onset Henoch-Schönlein purpura: successful treatment with factor XIII concentrate. 査読

    Hosono K, Endo H, Inamori M, Mawatari H, Iida H, Nozaki Y, Yoneda K, Akiyama T, Fujita K, Yoneda M, Takahashi H, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A

    Digestion   78 ( 1 )   9 - 9   2008年

     詳細を見る

    記述言語:英語   出版者・発行元:1  

    DOI: 10.1159/000151298

    Web of Science

    PubMed

    researchmap

  • Ulcerative colitis with positivity for proteinase 3-antineutrophil cytoplasmic antibody 査読

    Keiko Suzuki, Satoshi Nakao, Akihiro Suzuki, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTION   77 ( 3-4 )   157 - 158   2008年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000140976

    Web of Science

    PubMed

    researchmap

  • Antiphospholipid syndrome manifested by gastrointestinal bleeding: Can we overlook endoscopically revealed small lesions? 査読

    Satoshi Nakao, Keiko Akimoto, Masahiko Inamori, Akihiro Suzuki, Keiko Suzuki, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shoji Yamanaka, Atsushi Nakajima

    DIGESTION   77 ( 3-4 )   139 - 140   2008年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000127417

    Web of Science

    PubMed

    researchmap

  • Collagenous colitis in a Japanese woman: Successful treatment with mesalazine 査読

    Keiko Suzuki, Taiichi Kawabe, Hirokazu Takahashi, Satoshi Nakao, Akihiro Suzuki, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Hisashi Oshiro, Atsushi Nakajima

    DIGESTION   77 ( 3-4 )   155 - 156   2008年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000140975

    Web of Science

    PubMed

    researchmap

  • Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats 査読

    Koji Fujita, Masato Yoneda, Koichiro Wada, Hironori Mawatari, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Shiro Maeyama, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   52 ( 12 )   3455 - 3464   2007年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    The term nonalcoholic steatohepatitis (NASH) has recently been proposed to identify a fatty liver disease accompanied by diffuse fatty infiltration and inflammation. However, no drug therapy has been established for NASH as yet. In the present study, we demonstrate the effect of the angiotensin II type 1 receptor antagonist telmisartan on the development of NASH in a rat model. Telmisartan, but not the angiotensin receptor antagonist valsartan, markedly attenuated hepatic steatosis, inflammation, and fibrosis in these rats. The quantitative parameters of steatosis, inflammation, and fibrosis were also ameliorated by treatment with telmisartan. Compared with telmisartan, the peroxisome proliferator-activated receptor-gamma agonist pioglitazone attenuated hepatic steatosis and fibrosis of the liver to a similar degree. However, telmisartan, but not pioglitazone, dramatically decreased both subcutaneous and visceral fat. In conclusion, these results indicated that telmisartan should be the drug of first choice for the treatment of patients with NASH.

    DOI: 10.1007/s10620-007-9741-4

    Web of Science

    PubMed

    researchmap

  • Life style-related diseases of the digestive system: colorectal cancer as a life style-related disease: from carcinogenesis to medical treatment 査読

    Hirokazu Takahashi, Kyoko Yoneda, Ayako Tomimoto, Hiroki Endo, Toshio Fujisawa, Hiroshi Lida, Hironori Mawatari, Yuichi Nozaki, Tamon Ikeda, Tomoyuki Akiyama, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Satoru Saito, Atsushi Nakajima, Hitoshi Nakagarna

    JOURNAL OF PHARMACOLOGICAL SCIENCES   105 ( 2 )   129 - 132   2007年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Life style-related diseases are associated with an increased risk of colorectal cancer (CRC). Recently, an association has been demonstrated between obesity and CRC. CRC has been associated with markers of insulin or glucose control, and insulin resistance might be the unifying mechanism by which several risk factors affect colorectal carcinogenesis. We evaluated the association between the number of aberrant crypt foci (ACF) and obesity, insulin resistance, hyperlipidemia, and other factors of life style-related disease. As a result, age, body mass index (BMI), waist circumference, and visceral fat obesity were significantly associated with the number of ACF. These results suggest that visceral fat obesity is an important target for CRC prevention. Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a member of the nuclear receptor superfamily and is highly expressed in CRC. PPAR gamma ligand administration for 1 to 8 months significantly reduced the number of ACF in human subjects. PPAR gamma ligand is a promising candidate as a chemopreventive agent. Further investigation is needed to elucidate these mechanisms.

    DOI: 10.1254/jphs.FM0070022

    Web of Science

    researchmap

  • Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) 査読

    M. Yoneda, K. Fujita, M. Inamori, A. Nakajima, M. Yoneda, M. Tamano, H. Hiraishi

    GUT   56 ( 9 )   1330 - 1331   2007年9月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    DOI: 10.1136/gut.2007.126417

    Web of Science

    PubMed

    researchmap

  • Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients 査読

    M. Yoneda, S. Saito, T. Ikeda, K. Fujita, H. Mawatari, H. Kirikoshi, M. Inamori, Y. Nozaki, T. Akiyama, H. Takahashi, Y. Abe, K. Kubota, T. Iwasaki, Y. Terauchi, S. Togo, A. Nakajima

    JOURNAL OF VIRAL HEPATITIS   14 ( 9 )   600 - 607   2007年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL PUBLISHING  

    Insulin resistance (IR) is known to be associated with the visceral adipose tissue area. Elucidation of the relationship between hepatitis C virus (HCV) and IR is of great clinical relevance, because IR promotes liver fibrosis. In this study, we tested the hypothesis that HCV infection by itself may promote IR. We prospectively evaluated 47 patients with chronic HCV infection who underwent liver biopsy. Patients with obesity, type 2 diabetes mellitus (DM), or a history of alcohol consumption were excluded. IR was estimated by calculation of the modified homeostasis model of insulin resistance (HOMA-IR) index. Abdominal fat distribution was determined by computed tomography. Fasting blood glucose levels were within normal range in all the patients. The results of univariate analysis revealed a significant correlation between the quantity of HCV-RNA and the HOMA-IR (r = 0.368, P = 0.0291). While a significant correlation between the visceral adipose tissue area and the HOMA-IR was also observed in the 97 control, nondiabetic, non-HCV-infected patients (r = 0.398, P &lt; 0.0001), no such significant correlation between the visceral adipose tissue area and the HOMA-IR (r = 0.124, P = 0.496) was observed in the patients with HCV infection. Multiple regression analysis with adjustment for age, gender and visceral adipose tissue area revealed a significant correlation between the HCV-RNA and the HOMA-IR (P = 0.0446). HCV is directly associated with IR in a dose-dependent manner, independent of the visceral adipose tissue area. This is the first report to demonstrate the direct involvement of HCV and IR in patients with chronic HCV infection.

    DOI: 10.1111/j.1365-2893.2006.00836.x

    Web of Science

    PubMed

    researchmap

  • Early effects of peppermint oil on gastric emptying: a crossover study using a continuous real-time C-13 breath test (BreathID system) 査読

    Masahiko Inamori, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 7 )   539 - 542   2007年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Background. The aim of this study was to determine whether there was a correlation between peppermint oil and gastric emptying by using a novel noninvasive technique for measuring gastric emptying with a continuous real-time C-13 breath test (BreathID system, Oridion, Israel). Methods. Ten healthy male volunteers participated in this randomized, two-way crossover study. The subjects were randomly assigned to receive a test meal (200 kcal per 200 ml) containing 0.64 ml of peppermint oil or the test meal alone, after fasting overnight. A C-13-acetic acid breath test was continuously performed with the BreathID system, which monitors gastric emptying, for 4 h after the administration of the test meal. Using Oridion Research Software (beta version), the time for emptying of 50% of the labeled meals (T 1/2), the analog to the scintigraphy lag time for 10% emptying of the labeled meal (T lag), the gastric emptying coefficient (GEC), and the regression-estimated constants (beta and kappa) were calculated. The parameters between two occasions were compared using the Wilcoxon signed-rank test. Results. After peppermint oil intake, the T lag and beta constant were significantly decreased. No significant differences in T 1/2, GEC, or kappa were observed between the two occasions. Conclusions. The decrease in the T lag and beta constant suggests acceleration of gastric emptying during the early phase. This study showed that peppermint oil enhances gastric emptying, suggesting the potential use of peppermint oil in clinical settings for patients with functional gastrointestinal disorders.

    DOI: 10.1007/s00535-007-2067-3

    Web of Science

    researchmap

  • High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH 査読

    Masato Yoneda, Hironori Mawatari, Koji Fujita, Hiroshi Iida, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 7 )   573 - 582   2007年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Background. The changes in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However, it has remained difficult to differentiate between NASH and nonprogressive NAFLD by clinical examination. We investigated the interrelationships between serum high-sensitivity C-reactive protein (hs-CRP) and the pathogenesis and progression of NASH. Methods. Hs-CRP was measured in 100 patients with histologically verified NAFLD (29 with steatosis and 71 with NASH), and a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was performed to measure the intrahepatic mRNA expressions of CRP and interleukin (IL)-6. Results. The results of a multiple regression analysis revealed that in comparison with cases of steatosis, hs-CRP was significantly elevated (P = 0.0048) in cases of NASH. Furthermore, among patients with NASH, hs-CRP was significantly elevated in those with advanced fibrosis compared with that in those with mild fibrosis (P = 0.0384), even after adjustment for age, sex, presence of diabetes, body mass index, visceral fat area, subcutaneous fat area, homeostasis model assessment for insulin resistance, high-density lipoprotein cholesterol, triglyceride, and low-density lipoprotein cholesterol. The results of the RT-PCR analysis showed that intrahepatic mRNA expression of CRP, but not IL-6, was increased in patients with NASH compared with those with steatosis (P = 0.0228). Conclusions. This is the first report to demonstrate consistent and profound elevation of hs-CRP in cases of NASH compared with in cases of simple nonprogressive steatosis. Our results suggest that hs-CRP may be a clinical feature that not only distinguishes NASH from simple nonprogressive steatosis but also indicates the severity of hepatic fibrosis in cases of NASH.

    DOI: 10.1007/s00535-007-2060-x

    Web of Science

    PubMed

    researchmap

  • Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment? 査読

    Masahiko Inamori, Keiko Akimoto, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 6 )   510 - 511   2007年6月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    DOI: 10.1007/s00535-007-2024-1

    Web of Science

    researchmap

  • Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage 査読

    Masato Yoneda, Hironori Mawatari, Koji Fujita, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 5 )   375 - 381   2007年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Background. The changes in nonalcoholic fatty liver disease range over a wide spectrum, extending, from simple steatosis to nonalcoholic steatohepatitis (NASH). We investigated the clinical usefulness of the type IV collagen 7s domain and hyaluronic acid for predicting the severity of fibrosis before progression to the cirrhotic stage in NASH patients. Methods. The type IV collagen 7s domain and hyaluronic acid were measured in 72 patients with histologically verified NASH. Results. In a univariate analysis, marked elevation of hyaluronic acid and the type IV collagen 7s domain was observed in the NASH patients with advanced fibrosis compared with those with mild fibrosis (P = 0.0028, P = 0.0006, respectively). For detection of NASH with advanced fibrosis, the area under the receiver-operating characteristic curves for type IV collagen 7s domain and hyaluronic acid were 0.767 and 0.754, respectively. However, multiple regression analysis revealed that the type IV collagen 7s domain, but not hyaluronic acid, was significantly elevated in patients with advanced fibrosis even after adjustment for age, sex, platelet count, prothrombin time, aspartate aminotransferase/alanine aminotransferase ratio, body mass index, and presence of underlying type 2 diabetes mellitus, all of which have previously been reported as useful predictors of advanced fibrosis in patients with NASH (P = 0.0127, P = 0.2804, respectively). Conclusions. This is the first report to demonstrate a consistent and profound elevation of the type IV collagen 7s domain in NASH patients with advanced fibrosis (before progression to the stage of cirrhosis) compared with those with mild fibrosis.

    DOI: 10.1007/s00535-007-2014-3

    Web of Science

    PubMed

    researchmap

  • Lupus Enteritis Detected by Capsule Endoscopy 査読

    Hiroki Endo, Yasuyuki Kondo, Kei Kawagoe, Tomohiko R. Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Masato Yoneda, Masahiko Inamori, Atsushi Nakajima, Nobuyuki Matsuhashi

    INTERNAL MEDICINE   46 ( 18 )   1621 - 1622   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.46.0137

    Web of Science

    researchmap

  • Protein-losing gastroenteropathy in a patient with pityriasis rubra pilaris 査読

    Takamitsu Sato, Hitomi Sakai, Hiroshi Iida, Masahiko Inamori, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Norio Ueno, Yoshihiro Takeshita, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   98 - 98   2007年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000102964

    Web of Science

    PubMed

    researchmap

  • Usefulness of transnasal ultrathin endoscopy for the placement of a postpyloric decompression tube 査読

    Hiroki Endo, Masahiko Inamori, Takayuki Murakami, Kenichi Yoshida, Takuma Higurashi, Hiroshi Iida, Hirokazu Takahashi, Tomoyuki Akiyama, Keiko Akimoto, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima

    DIGESTION   75 ( 4 )   181 - 181   2007年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000107937

    Web of Science

    PubMed

    researchmap

  • Protein-losing gastroenteropathy and gastric polyps: Successful treatment by Helicobacter pylori eradication 査読

    Takamitsu Sato, Gaku Chiguchi, Masahiko Inamori, Hitomi Sakai, Nobutaka Fujisawa, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Norio Ueno, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   99 - 99   2007年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000102965

    Web of Science

    PubMed

    researchmap

  • Balloon-occluded retrograde transvenous obliteration for gastric varices with plural draining veins: Effectiveness of coil embolization for collaterals 査読

    Masato Yoneda, Masahiko Inamori, Tomoyuki Iwasaki, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Yasunobu Abe, Kensuke Kubota, Norio Ueno, Masato Shiiba, Aya Abe, Toshiyuki Nagashima, Tomio Inoue, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   100 - 100   2007年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    DOI: 10.1159/000102966

    Web of Science

    PubMed

    researchmap

  • Gastrointestinal: Rectal polyp associated with schistosomiasis 査読

    Y. Abe, M. Inamori, K. Fujita, T. Fujisawa, N. Fujisawa, M. Yoneda, H. Takahashi, T. Ikeda, K. Hara, T. Akiyama, H. Kawamura, A. Kato, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, T. Sasaki, Y. Inayama, N. Ueno, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   21 ( 7 )   1216 - 1216   2006年7月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2006.04557.x

    Web of Science

    PubMed

    researchmap

  • Blastocystis hominis infection in patient with regular dialysis 査読

    Miho Hayashi, Masahiko Inamori, Kouki Goto, Tomoyuki Akiyama, Kouji Fujita, Ikuko Ikeda, Toshio Fujisawa, Hirokazu Takahashi, Masato Yoneda, Kouji Hara, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima, Yumiko Hamada, Hiroyuki Fukutomi, Hideyuki Satsuta

    JOURNAL OF GASTROENTEROLOGY   41 ( 6 )   605 - 606   2006年6月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    DOI: 10.1007/s00535-006-1817-y

    Web of Science

    PubMed

    researchmap

  • mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis 査読

    M Inamori, T Shimamura, H Nagase, Y Abe, T Umezawa, A Nakajima, T Saito, N Ueno, K Tanaka, H Sekihara, JI Togawa, H Kaifu, H Tsuboi, H Kayama, S Tominaga

    HEPATO-GASTROENTEROLOGY   53 ( 69 )   361 - 365   2006年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Nitric oxide (NO) production is elevated in the intestine and may contribute to intestinal injury during inflammation. However, how the expression of inducible NO synthase (iNOS) mRNA and endothelial NO synthase (eNOS) mRNA in the esophageal mucosa contribute to mucosal damage caused by reflux esophagitis remains unknown. Since vascular endothelial growth factor (VEGF) exerts its action on microcirculation, contributing to angiogenesis and inflammation, we examined the role of VEGF together with NOS and eNOS on development of reflux esophagitis.
    Methodology: The mRNA expression levels of NOS, eNOS and VEGF were measured in biopsy specimens from 25 patients with reflux esophagitis, using TaqMan PCR and reverse transcription PCR.
    Results: The expression of NOS mRNA in the esophageal mucosa increased parallel to the severity of the esophagitis. There were no significant differences between both eNOS and VEGF mRNA expression levels and the severity of the esophagitis. The existence of gastric mucosal atrophy, hiatus hernia, therapy and Helicobacter pylori infection did not affect the levels of mRNA expression.
    Conclusions: The accumulation of NO, produced by NOS, was considered to be related to the exacerbation of reflux esophagitis. Therapeutic intervention that reduces NO production may thus be of use in preventing development of esophageal mucosal injury in patients with reflux esophagitis.

    Web of Science

    PubMed

    researchmap

  • Pleural effusions following endoscopic injection sclerotherapy for cirrhotic patients with esophageal varices 査読

    H Kayama, M Inamori, JI Togawa, T Shimamura, Y Tokita, T Umezawa, T Sakaguchi, M Naitoh, H Nagase, A Nakajima, T Saito, S Tominaga, N Ueno, K Tanaka, H Sekihara

    HEPATO-GASTROENTEROLOGY   53 ( 69 )   376 - 380   2006年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Endoscopic injection sclerotherapy is in widespread use for patients with esophageal varices. It is well known that pleural effusions are among complications following endoscopic sclerotherapy. However, there are few studies regarding the proportion of patients developing pleural effusions after sclerotherapy.
    Methodology: Between August 1991 and September 1998, 575 endoscopic injection sclerotherapies were carried out in 128 patients. Chest radiographs were obtained prior to and 24 hours after all procedures. We also obtained other clinical data from all patients.
    Results: In total, 17.7% of post-sclerotherapy patients were diagnosed as having small amounts of pleural effusions. Logistic regression revealed pleural effusions after sclerotherapy to be associated with ascites, chest pain for 24 hours, total volume of sclerosant and submucosal injection of more than 4mL of sclerosant. In parallel with injection of an increasing amount of submucosal sclerosant, the proportion of patients with pleural effusion increased.
    Conclusions: Pleural, effusions were related to ascites, chest pain for 24 hours, total sclerosant.

    Web of Science

    PubMed

    researchmap

  • [Clinical features of long time survivors with unresectable pancreatic cancer treated by gemcitabine alone]. 査読

    Kobayashi N, Fujita K, Fujisawa T, Takahashi H, Fujisawa N, Yoneda M, Abe Y, Inamori M, Kawamura H, Kirikoshi H, Shimamura T, Kubota K, Sakaguchi T, Saito S, Nakajima A

    Gan to kagaku ryoho. Cancer & chemotherapy   33   207 - 212   2006年2月

     詳細を見る

    出版者・発行元:2  

    PubMed

    researchmap

  • Gastrointestinal: Gastrointestinal metastases from malignant melanoma 査読

    M Inamori, N Ueno, K Fujita, T Fujisawa, N Fujisawa, M Yoneda, H Takahashi, T Ikeda, H Kawamura, Y Abe, A Kato, H Kirikoshi, N Kobayashi, T Shimamura, K Kubota, S Saito, T Sakaguchi, S Yamanaka, Y Inayama, A Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   21 ( 1 )   327 - 327   2006年1月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2006.04239.x

    Web of Science

    PubMed

    researchmap

  • [Enterostatin, galanin, and GRP]. 査読

    Nagase H, Inamori M

    Nihon rinsho. Japanese journal of clinical medicine   63 Suppl 8   524 - 527   2005年8月

     詳細を見る

  • Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? 査読

    M Inamori, JI Togawa, T Iwasaki, Y Ozawa, T Kikuchi, K Muramatsu, G Chiguchi, S Matsumoto, H Kawamura, Y Abe, H Kirikoshi, N Kobayashi, T Shimamura, K Kubota, T Sakaguchi, S Saito, N Ueno, A Nakajima

    JOURNAL OF GASTROENTEROLOGY   40 ( 5 )   453 - 458   2005年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Background Medication for the relief of heartburn should have the rapid onset of action required for on-demand use. We studied the inhibition of gastric acid secretion by lafutidine and rabeprazole, given in single doses to fasting and postprandial subjects. Methods. A total of 22 healthy male, Helicobacter pylori-negative volunteers participated in this randomized, two-way crossover study. They were randomly assigned to receive a single oral dose of 10mg lafutidine or 20mg rabeprazole after fasting overnight (12 subjects, fasting study) or after eating a test meal (noodles, 364kcal; protein, 10.1g; fat, 16g; carbohydrates, 44.9g; NaCl, 1.1g; 10 subjects, postprandial study). Intragastric pH was monitored continuously for 6h after treatment. The other drug was given after a washout period of at least 7 days, and intragastric pH was similarly monitored. Results. In the fasting study, lafutidine sustained pH at &gt; 3 and &gt; 4 during the second, third, fourth, fifth, and sixth hours of the study for significantly longer than rabeprazole. During the first 6h after treatment, lafutidine sustained pH at more than 2, 3, 3.5, 4, 5, 6, and 7 longer than rabeprazole. In the postprandial study, lafutidine sustained pH &gt; 3 and &gt; 4 for longer periods than rabeprazole during the third, fourth, fifth, and sixth hours of the study. During the first 6h after treatment, lafutidine sustained pH at more than 2, 3, 3.5, 4, 5, 6, and 7 longer than rabeprazole. Conclusions. Lafutidine 10mg produces a prompter rise in intragastric pH than rabeprazole 20mg in fasting and postprandial Helicobacter pylori-negative male subjects.

    DOI: 10.1007/s00535-005-1569-0

    Web of Science

    PubMed

    researchmap

  • Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy 査読

    J Togawa, M Inamori, N Fujisawa, H Takahashi, M Yoneda, H Kawamura, Y Abe, H Kirikoshi, N Kobayashi, T Sakaguchi, T Takamura, A Nakajima, N Ueno, H Sekihara

    HEPATO-GASTROENTEROLOGY   52 ( 62 )   645 - 648   2005年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Triple therapy consisting of lansoprazole, amoxicillin, and clarithromycin (LAC regimen) is widely used to eradicate Helicobacter pylori in Japan. However, the need for appropriate treatment after failure of initial therapy to eradicate H. pylori has been increasing. We therefore assessed the efficacy of a combination of rabeprazole, amoxicillin, and faropenem for second-line eradication therapy.
    Methodology: The subjects were 116 patients positive for H. pylori infection. Patients initially received lansoprazole 60mg/day, amoxicillin 1500mg/day and clarithromycin 400mg/day in two divided doses for 7 days. Patients in whom eradication treatment failed were given rabeprazole 20mg/day and amoxicillin 1500mg/day in two divided doses, and faropenem 600mg/day in three divided doses (RAF regimen) for 7 consecutive days. H. pylori status was assessed by the C-13-urea breath test combined with rapid urease test or H. pylori culture method 8 weeks after completion of therapy. Susceptibility to clarithromycin was determined by the agar dilution method, and genetic polymorphism of CYP2C19 was analyzed by polymerase chain reaction-restriction fragment length polymorphism.
    Results: The initial H. pylori eradication rate with the LAC regimen was 76.4% (84/110). Assessment of the CYP2C19 genotypes of the patients in whom eradication therapy failed revealed that homozygous,extensive metabolizers accounted for 70.0%. (16/23) and heterozygous extensive metabolizers, for 30.0% (7/23), with no poor metabolizers. The acquired resistance rate for clarithromycin was 52.0% (12/23), The success rate of re-eradication with the RAF regimen was 91.3% (21/23) with no serious adverse effects.
    Conclusions: Triple therapy comprising rabeprazole, amoxicillin, and faropenem is effective for second-line eradication treatment of H. pylori infection, regardless of the genetic polymorphism of CYP2C19 or the presence of resistance to clarithromycin.

    Web of Science

    PubMed

    researchmap

  • Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H-2 receptor antagonist effective as initial treatment? 査読

    M Inamori, J Togawa, G Chiguchi, Y Abe, T Kikuchi, K Muramatsu, H Kawamura, N Kobayashi, H Kirikoshi, T Shimamura, T Sakaguchi, T Takamura, N Ueno, A Nakajima

    JOURNAL OF GASTROENTEROLOGY   40 ( 2 )   213 - 214   2005年2月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    DOI: 10.1007/s00535-004-1521-8

    Web of Science

    PubMed

    researchmap

  • Percutaneous transhepatic gallbladder stenting for recurrent acute acalculous cholecystitis after failed endoscopic attempt 査読

    K Kubota, Y Abe, M Inamori, H Kawamura, H Kirikoshi, N Kobayashi, S Saito, N Ueno, A Nakajima

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY   12 ( 4 )   286 - 289   2005年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    Endoscopic gallbladder stenting is useful palliative therapy for acute cholecystitis in high-risk patients. Although the success rate of endoscopic gallbladder stenting is 79%-100%, an alternative method has not been reported. We succeeded in employing a method for percutaneous gallbladder stenting (PTGS) and herein describe this new method. A patient with acute acalculous cholecystitis related to ischemic atherosclerotic vascular disease, cholangitis due to Lemmel syndrome, and severe congestive heart failure underwent PTGS through the cystic duct from the gallbladder to the duodenal papilla, because an endoscopic method failed in the treatment of Lemmel syndrome. Because we were unable to place endoscopic transpapillary gallbladder drainage, percutaneous transhepatic gallbladder drainage (PTGBD) was performed and both the cholecystitis and cholangitis ceased. PTGS was performed as an alternative to endoscopic gallbladder stenting. Access to the cystic duct and gallbladder was obtained by the PTGBD route, using a guidewire (0.035-inch diameter) and seeking catheter (6.5 Fr) under fluoroscopic control. A 7-Fr 12-cm double-pigtail biliary polyethylene stent was placed. The patient remained asymptomatic for 3 months after the PTGS until he died, of an acute recurrent myocardial infarction. This new PTGS placement is an alternative treatment for symptomatic gallbladder disease in patients with increased operative risk when the endoscopic method is unsuccessful.

    DOI: 10.1007/s00534-005-0989-9

    Web of Science

    PubMed

    researchmap

  • 眼球摘出術10年後に肝,膵,心転移を認めた悪性黒色腫の1剖検例

    澤辺 文, 窪田 賢輔, 柳沢 昇吾, 稲森 正彦, 河村 晴信, 桐越 博之, 島村 健, 小林 規俊, 斉藤 聡, 中島 敦

    日本内科学会関東地方会   523回   21 - 21   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 膵癌との鑑別に苦慮した急性膵炎後の肉芽性病変の1例

    小林 規俊, 稲森 正彦, 関原 久彦, 大川 伸一, 宮川 薫, 玉井 拙夫, 政木 隆博, 廣川 智, 多羅尾 和郎, 杉政 征夫, 武宮 省治, 林 宏行, 亀田 陽一

    膵臓:The Journal of Japan Pancreas Society   19 ( 1 )   75 - 81   2004年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本膵臓学会  

    69歳男性。突然の心窩部痛及び背部痛を主訴とした。腹部超音波、腹部CTで膵鈎部に腫瘤を認めた。臨床経過より急性膵炎の修復過程と考えられたが、膵癌も完全には否定できず、膵頭十二指腸切除術を施行した。腫瘤は、病理組織学的にリンパ球、組織球からなる炎症性の結節性病変であり、悪性所見はなかった。また、病変周囲の膵実質には強い炎症が認められたが、膵体部など離れた部分では膵実質の炎症は認められなかった。以上より、急性膵炎後の修復過程に発生した肉芽腫病変と診断した。術後経過は良好で、現在外来通院中である。

    J-GLOBAL

    researchmap

  • The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH 査読

    Y Abe, M Inamori, J Togawa, T Kikuchi, K Muramatsu, G Chiguchi, H Kawamura, N Kobayashi, H Kirikoshi, T Sakaguchi, T Takamura, A Nakajima, N Ueno, H Sekihara

    JOURNAL OF GASTROENTEROLOGY   39 ( 1 )   21 - 25   2004年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER-VERLAG TOKYO  

    Background The ideal medication for the treatment of acid-related diseases, for example, hemorrhagic ulcers and stress-related gastric bleeding, should have a rapid onset of action to promote hemostasis and alleviate symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion after single intravenous administrations of omeprazole 20 mg and famotidine 20 mg. Methods. Ten healthy Helicobacter pylori-negative male subjects participated in this randomized, double-masked, two-way crossover study. Intragastric pH was monitored continuously for 4 h after a single intravenous administration of omeprazole 20 mg and after a single intravenous administration of famotidine 20 mg. The administration of the two agents was separated by a 7-day washout period. Results. In all ten subjects, the length of time that intragastric pH remained over 3, during the 0- to 3- and 0- to 4-h study periods, was greater after famotidine treatment than after treatment with omeprazole, and famotidine increased the average pH during the 0 to 3- and 0 to 4-h study periods significantly more than omeprazole did. During the 4-h study period, famotidine provided a longer duration of pH of more than 2, 3, 3.5, 4, 5, 6, and 7, compared to omeprazole. Conclusions. In Helicobacter pylori-negative healthy male subjects, an intravenous dose of 20 mg famotidine increased intragastric pH more rapidly than intravenous omeprazole 20 mg.

    DOI: 10.1007/s00535-003-1240-6

    Web of Science

    PubMed

    researchmap

  • Accumulation of 18F-fluoro-2-deoxy-D-glucose (FDG) in tumor-forming pancreatitis decreased with recovery from the pancreatitis

    Noritoshi Kobayashi, Fujisawa Nobutaka, Hirokazu Takahashi, Masato Yoneda, Koji Fujita, Toshio Fujisawa, Takashi Ogura, Yasunobu Abe, Masahiko Inamori, Harunobu Kawamura, Hiroyuki Kirikoshi, Takeshi Shimamura, Kensuke Kubota, Takashi Sakaguchi, Satoru Saito, Atsushi Nakajima, Norio Ueno, Katsumi Morita

    Yokohama Medical Journal   55 ( 3 )   91 - 96   2004年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    A 52-year old man was admitted to the hospital because of epigastralgia after heavy drinking. Computer tomography (CT) revealed segmental pancreas swelling suggestive of pancreas head carcinoma. We evaluated this pancreas head mass by 18F-fluorodexyglucose positron emission tomography (FDG-PET) using the standardized uptake value (SUV). Accumulation of FDG in this mass was very high and the SUV was 6. 61. We could not completely role out a malignant lesion but treated the case as acute pancreatitis because of the clinical symptoms. We followed this mass for 6 months by CT and FDG-PET. The pancreas head mass gradually diminished in size and finally vanished from the CT findings. FDG-PET accumulation also decreased with the recovery from acute pancreatitis. FDG-PET is a useful and sensitive means for evaluating pancreas carcinoma. But FDG accumulation also occurs in acute, chronic, tumor-forming, and autoimmune-related case of pancreatitis. So it is important to follow up a pancreas mass when observed by FDG-PET.

    Scopus

    researchmap

  • Severe ulceration of the stomach after endoscopic injection sclerotherapy 査読

    M Inamori, J Togawa, H Kawamura, Y Abe, H Naitoh, H Nagase, A Nakajima, T Saito, S Tominaga, N Ueno, K Tanaka, H Sekihara

    ENDOSCOPY   35 ( 12 )   1082 - 1082   2003年12月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-2003-44588

    Web of Science

    PubMed

    researchmap

  • Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: Which is suitable for on-demand therapy? 査読

    M Inamori, JI Togawa, H Takahashi, M Yoneda, N Fujisawa, T Iwasaki, Y Ozawa, T Kikuchi, K Muramatsu, G Chiguchi, S Matsumoto, H Kawamura, Y Abe, H Kirikoshi, N Kobayashi, T Sakaguchi, T Takamura, A Nakajima, N Ueno, H Sekihara

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   18 ( 9 )   1034 - 1038   2003年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL PUBLISHING ASIA  

    Background and Aims: An ideal medication for heartburn should have the rapid onset of action needed for on-demand treatment. However, assessment of the onset of action of proton pump inhibitors has been largely subjective. We compared the inhibitory effect on gastric acid secretion of a single oral dose of omeprazole with that of rabeprazole.
    Methods: Fourteen Helicobacter pylori -negative men participated in this randomized, double-masked, two-way cross-over study. Intragastric pH was monitored continuously for 6 h after a single, randomly assigned 20 mg oral dose of either omeprazole or rabeprazole. After a 7-day washout period, the other drug was administered. Each patient's S-mephenytoin 4'-hydroxylase (CYP2C19 ) genotype was determined by polymerase chain reaction-restriction fragment length polymorphism.
    Results: Intragastric pH and pH holding time did not differ between treatments when the data were analyzed for the whole group without stratifying for CYP2C19 status. In CYP2C19 homozygous and heterozygous extensive metabolizers (10 subjects), rabeprazole maintained the intragastric at pH &gt; 3 and&gt; 4 for longer than omeprazole during both the 5 and 6 h study periods, and the average pH during the 6 h study period was higher with rabeprazole than with omeprazole. In these extensive metabolizers, rabeprazole maintained the pH &gt; 2,&gt; 3,&gt; 3.5 and&gt; 4 for longer during the 6 h study period than did omeprazole.
    Conclusions: In H. pylori -negative men who are CYP2C19 homozygous or heterozygous extensive metabolizers, the intragastric pH after a single dose of 20 mg rabeprazole is higher during first 5-6 h than that after a single dose of 20 mg omeprazole. (C) 2003 Blackwell Publishing Asia Pty Ltd.

    DOI: 10.1046/j.1440-1746.2003.03126.x

    Web of Science

    PubMed

    researchmap

  • Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification 査読

    M Inamori, J Togawa, H Nagase, Y Abe, T Umezawa, A Nakajima, T Saito, N Ueno, K Tanaka, H Sekihara, H Kaifu, H Tsuboi, H Kayama, S Tominaga, H Nagura

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   18 ( 2 )   172 - 176   2003年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL PUBLISHING ASIA  

    Background: Recent studies have shown that the number of patients with reflux esophagitis is increasing in Japan, but the prevalence and risk factors associated with reflux esophagitis in Japanese patients are not well defined.
    Methods: By using all endoscopic records in the Katta General Hospital from April through to September 1999, we identified 392 patients. We examined the Los Angeles classification, peptic ulcer, gastric mucosal atrophy, hiatal hernia and other medical variable factors for their contribution to esophagitis in the patients.
    Results: Patients (13.8%) were diagnosed as having reflux esophagitis with a mucosal break. In a multivariate analysis, reflux esophagitis was associated with hiatal hernia (odds ratio (OR) 2.276, 95% confidence interval (CI) 1.164-4.450), with patients over 65 years of age (OR 2.521, 95% CI 1.238-5.134) and the open type of gastric mucosal atrophy (OR 0.420, 95% CI 0.225-0.785). There was no significant difference between esophagitis and Helicobacter pylori infection and peptic ulcer.
    Conclusions: We observed that age, hiatal hernia and a lower rate of gastric mucosal atrophy were associated with the proportion of mucosal breaks accompanying esophagitis. (C) 2003 Blackwell Publishing Asia Pty Ltd.

    DOI: 10.1046/j.1440-1746.2003.02932.x

    Web of Science

    PubMed

    researchmap

  • Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance 査読

    JI Togawa, H Nagase, K Tanaka, M Inamori, A Nakajima, N Ueno, T Saito, H Sekihara

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   17 ( 12 )   1291 - 1298   2002年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL PUBLISHING ASIA  

    Background and Aims: The natural immunomodulator, lactoferrin, is widespread among various biological fluids and is known to exert an anti-inflammatory effect. However, there has been only one study that examined the mode of action of lactoferrin in reducing intestinal damage. We investigated the therapeutic role of lactoferrin and its effect on the levels of pro-inflammatory and anti-inflammatory cytokines, by using a rat model of dextran sulfate sodium (DSS) induced-colitis.
    Methods: Male Sprague-Dawley rats were given distilled drinking water containing 2.5% (wt/vol) synthetic DSS ad libitum. Bovine lactoferrin was given once daily through gavage, starting 3 days before beginning the DSS administration, until death. The whole colon was removed to be examined macroscopically and histologically. Myeloperoxidase activity, and pro-inflammatory and anti-inflammatory cytokines in the colonic tissue were also measured.
    Results: Dextran sulfate sodium-induced colitis was attenuated by oral administration of lactoferrin in a dose-dependent manner, as reflected by improvement in clinical disease activity index, white blood cell count and hemoglobin concentration, macroscopic and histological scores, and myeloperoxidase activity. Reduced inflammation in response to lactoferrin was correlated with the significant induction of the anti-inflammatory cytokines, interleukin-4 and interleukin-10, and with significant reductions in the proinflammatory cytokines, tumor necrosis factor, interleukin-1, and interleukin-6.
    Conclusions: We concluded that oral administration of lactoferrin exerts a protective effect against the development of colitis in rats via modulation of the immune system and correction of cytokine imbalance. Lactoferrin has potential as a new therapeutic agent for inflammatory bowel disease. (C) 2002 Blackwell Publishing Asia Pty Ltd.

    DOI: 10.1046/j.1440-1746.2002.02868.x

    Web of Science

    PubMed

    researchmap

  • Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance 査読

    J Togawa, H Nagase, K Tanaka, M Inamori, T Umezawa, A Nakajima, M Naito, S Sato, T Saito, H Sekihara

    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY   283 ( 1 )   G187 - G195   2002年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER PHYSIOLOGICAL SOC  

    Natural immunomodulator lactoferrin is known to exert an anti-inflammatory effect. However, there have been no studies that examine the mode of action of lactoferrin in reducing intestinal damage. We investigated the effect of lactoferrin on a trinitrobenzenesulfonic acid (TNBS)-induced colitis model in rats. Bovine lactoferrin was given once daily through gavage, starting 3 days before (preventive mode) or just after TNBS administration (treatment mode) until death. The distal colon was removed to be examined. Colitis was attenuated by lactoferrin via both modes in a dose-dependent manner, as reflected by improvement in macroscopic and histological scores and myeloperoxidase activity. Lactoferrin caused significant induction of the anti-inflammatory cytokines interleukin (IL)-4 and IL-10, significant reductions in the proinflammatory cytokines tumor necrosis factor-alpha and IL-1beta, and downregulation of the nuclear factor-kappaB pathway. We concluded that lactoferrin exerts a protective effect against colitis in rats via modulation of the immune system and correction of cytokine imbalance. Lactoferrin has potential as a new therapeutic agent for inflammatory bowel disease.

    DOI: 10.1152/ajpgi.00331.2001

    Web of Science

    PubMed

    researchmap

  • [Bleeding gastric varices associated with pancreatic arteriovenous malformation]. 査読

    Inamori M, Kayama H, Tsuboi H, Togawa J, Endo Y, Kaifu H, Tominaga S, Oikawa H, Nagura H, Naitoh M, Saitoh T, Tanaka K, Sekihara H

    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology   98 ( 5 )   569 - 571   2001年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:5  

    DOI: 10.11405/nisshoshi1964.98.569

    PubMed

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2001269357

  • A case of mitochondrial cardiomyopathy with heart failure, sick sinus syndrome and diabetes mellitus : Mitochondrial DNA adenine-to-guanine transition at 3243 of mitochondrial tRNA(LEU(UUR)) gene 査読

    M. Inamori, T. Ishigami, N. Takahashi, K. Hibi, K. Ashino, S. Sumita, K. Tamura, H. Ochiai, S. Umemura, M. Ishii, S. Tanaka, H. Sekihara, Y. Inayama

    Journal of Cardiology   30 ( 6 )   341 - 347   1997年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:6  

    A 42-year-old woman with diabetes mellitus lost consciousness and was transferred to the Yokohama City University Hospital. Blood chemistry findings indicated low blood sugar levels and chest X-ray examination revealed cardiomegaly and bilateral pleural effusions. These clinical abnormalities were corrected by treatment with glucose, diuretics, angiotensin convening enzyme inhibitor and digitalis. Cardiological laboratory examinations were performed after admission. Electrocardiography revealed first degree atrioventricular block and incomplete right bundle branch block. Ultrasonography showed lower grade of ejection fraction and diffuse hypokinesis of the cardiac wall. After admission, sinus arrest suddenly occurred. The diagnosis was sick sinus syndrome. Scintigraphy using iodine-123 betamethyl-p-iodophenyl-pentadecanoic acid showed abnormal mottled defects. Coronary angiography found no significant stenosis of the coronary artery. Electron microscopy showed abnormally shaped mitochondrial accumulations in an endomyocardial biopsy specimen. Mitochondrial DNA amplification by polymerase chain reaction followed by restriction enzyme Apa I digestion revealed adenine-to-guanine transition at 3243 of the mitochondrial tRNA(LEU(UUR)) gene.

    Scopus

    PubMed

    researchmap

▼全件表示

書籍等出版物

  • 11th World Congress of the International Society for Diseases of the Esophagus

    MEDIMOND  2008年  ( ISBN:9788875874650

     詳細を見る

MISC

  • 摂食嚥下障害により経口摂取困難となった患者の予後予測因子:急性期病院退院後コホート研究

    西口翔, 西口翔, 秋山美代, 三浦由紀子, 菅谷渚, 稲森正彦

    日本病院総合診療医学会雑誌(Web)   20   2024年

     詳細を見る

  • 急性疾患後の摂食嚥下障害患者の90日後転帰

    西口翔, 菅谷渚, 秋山美代, 稲森正彦

    日本老年医学会雑誌(Web)   60   2023年

     詳細を見る

  • e-learningを利用した初期研修医に対する漢方医学教育の試み

    畝田 一司, 石上 友章, 伊藤 亜希, 稲森 正彦, 西巻 滋

    医学教育   51 ( Suppl. )   207 - 207   2020年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 卒後教育として内科医に行う,実技指導を交えた小外科講義の教育効果

    袴田智伸, 國司洋佑, 吉江浩一郎, 福澤邦康, 岩田悠里, 稲森正彦, 日下部明彦, 太田光泰

    月刊地域医学   34 ( 12 )   2020年

     詳細を見る

  • 医学部1年生に対する早期医療体験実習の学習者評価に関する検討

    飯田 洋, 岩田 悠里, 藤田 浩司, 日下部 明彦, 太田 光泰, 西巻 滋, 稲森 正彦

    医学教育   50 ( Suppl. )   198 - 198   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 内科医に対する小外科講義の教育効果について

    袴田智伸, 國司洋佑, 福澤邦康, 吉江浩一郎, 安田優, 日下部明彦, 稲森正彦, 太田光泰

    日本プライマリ・ケア連合学会学術大会抄録集   10th (Web)   2019年

     詳細を見る

  • 終末期がん患者のセクシュアリティについての苦悩に医療者は備えているか?

    日下部明彦, 平野和恵, 馬渡弘典, 森田千雅子, 奈良健, 結束貴臣, 松浦哲也, 吉見明香, 後藤歩, 稲森正彦, 稲森正彦, 太田光泰

    日本在宅医療学会学術集会プログラム・抄録集   29th   165   2018年10月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Elsevier Reviewの使用経験 解剖学分野において

    岩田 悠里, 飯田 洋, 稲森 正彦, 日下部 明彦, 太田 光泰, 原 良紀, 藤田 浩司, 西巻 滋, 前田 愼, 船越 健悟

    医学教育   49 ( Suppl. )   218 - 218   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • Elsevier Reviewの使用経験 解剖学分野において

    岩田 悠里, 飯田 洋, 稲森 正彦, 日下部 明彦, 太田 光泰, 原 良紀, 藤田 浩司, 西巻 滋, 前田 愼, 船越 健悟

    医学教育   49 ( Suppl. )   218 - 218   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • Googleフォームを用いた試験運用の経験

    稲森 正彦, 岩田 悠里, 飯田 洋正, 日下部 明彦, 太田 光泰, 原 良紀, 藤田 浩司, 西巻 滋

    医学教育   49 ( Suppl. )   221 - 221   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 医学部新入生に対する多職種連携への理解を深める試み

    飯田 洋, 岩田 悠里, 藤田 浩司, 日下部 明彦, 太田 光泰, 西巻 滋, 稲森 正彦

    医学教育   49 ( Suppl. )   158 - 158   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 医学部新入生に対する多職種連携への理解を深める試み

    飯田 洋, 岩田 悠里, 藤田 浩司, 日下部 明彦, 太田 光泰, 西巻 滋, 稲森 正彦

    医学教育   49 ( Suppl. )   158 - 158   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 慢性便秘症と大腸内視鏡の難易度についての検討

    稲生 優海, 松浦 瑞恵, 飯田 洋, 野中 敬, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   113 ( 臨増大会 )   A761 - A761   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 【誰も教えてくれなかった-慢性便秘の診かた】 ケース別対応 高齢者の慢性便秘

    稲生 優海, 稲森 正彦, 中島 淳

    Medicina   53 ( 9 )   1391 - 1394   2016年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    <ポイント>年齢とともに,便秘の有訴者率は上昇する.加齢が便秘に与える影響は,腸管神経系の変化,骨盤底機能障害に加え,さまざまな生活環境要因が考えられる.適切な病態評価を行い,併存症や薬剤の副作用に留意しながら,生活環境に合わせて,包括的な治療にあたることが重要である.(著者抄録)

    researchmap

  • 消化器内視鏡治療における外科と内科のコラボレーション 当院における十二指腸非乳頭部上皮性腫瘍に対する内視鏡治療の現状と問題点

    野中 敬, 稲森 正彦, 遠藤 宏樹, 利野 靖, 中島 淳

    Progress of Digestive Endoscopy   89 ( Suppl. )   s94 - s94   2016年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • The Efficacy and Safety of Deep Sedation With a Combination of Propofol and Dexmedetomidine Hydrochloride Under the Guidance of Gastroenterologists for Gastric Endoscopic Submucosal Dissection

    Takashi Nonaka, Kenji Kanoshima, Yumi Inoh, Hidenori Ohkubo, Takuma Higurashi, Hiroshi Iida, Hiroki Endo, Masahiko Inamori, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   83 ( 5 )   AB434 - AB435   2016年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • Efficacy and Safety of Novel Class of Acid Suppressants: P-Cab-Based Amoxicillin and Metronidazole 1 Week Triple Therapy as Second Line Eradication of H. pylori in Japan. A Multicenter Study

    Soichiro Sue, Isao Arima, Hirohumi Kuwashima, Katuyuki Sanga, Hiroyuki Oka, Yuniba Ishii, Masatomo Kanno, Masahiro Terada, Yuri Iwata, Yasuhiro Inokuchi, Takehide Fukuchi, Kazuto Komatu, Makoto Naito, Ichiro Kawana, Hiroshi Okazaki, Toshifumi Saito, Yosuke Kunishi, Akihiko Ikeda, Shigeru Iwase, Manabu Morimoto, Daisuke Takahashi, Atsushi Kokawa, Takeshi Sato, Eri Kameta, Yasuaki Ishii, Hiroaki Kaneko, Haruo Miwa, Tomohiko Sasaki, Toshihide Tamura, Masaaki Kondo, Masahiko Inamori, Wataru Shibata, Shin Maeda

    GASTROENTEROLOGY   150 ( 4 )   S880 - S880   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • Efficacy and Safety of Novel Class of Acid Suppressants: P-Cab-Based Amoxicillin and Clarithromycin 1 Week Triple Therapy as First Line Eradication of H. pylori in Japan. A Multicenter Study

    Soichiro Sue, Isao Arima, Hirohumi Kuwashima, Katuyuki Sanga, Hiroyuki Oka, Yuniba Ishii, Masatomo Kanno, Masahiro Terada, Yuri Iwata, Yasuhiro Inokuchi, Takehide Fukuchi, Kazuto Komatu, Makoto Naito, Ichiro Kawana, Hiroshi Okazaki, Toshifumi Saito, Yosuke Kunishi, Akihiko Ikeda, Shigeru Iwase, Manabu Morimoto, Daisuke Takahashi, Atsushi Kokawa, Takeshi Sato, Eri Kameta, Yasuaki Ishii, Hiroaki Kaneko, Haruo Miwa, Tomohiko Sasaki, Toshihide Tamura, Masaaki Kondo, Masahiko Inamori, Wataru Shibata, Shin Maeda

    GASTROENTEROLOGY   150 ( 4 )   S880 - S880   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 当院における機能性消化管障害に併存する疾患の実態

    稲生 優海, 大熊 幹二, 鹿野島 健二, 松浦 瑞恵, 飯田 洋, 野中 敬, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   113 ( 臨増総会 )   A371 - A371   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院におけるHelicobacter pylori除菌診療の現状

    野中 敬, 稲生 優海, 日暮 琢磨, 大久保 秀則, 飯田 洋, 遠藤 宏樹, 稲森 正彦, 中島 淳

    胃病態機能研究会誌   48   43 - 43   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 消化管疾患に対する内科医と外科医のコラボレーション 当院における十二指腸非乳頭部上皮性腫瘍に対する腹腔鏡内視鏡合同手術の経験

    野中 敬, 稲森 正彦, 山田 貴允, 大島 貴, 利野 靖, 栗田 祐介, 稲生 優海, 梅沢 翔太郎, 冬木 晶子, 内山 詩織, 日暮 琢磨, 大久保 秀則, 飯田 洋, 遠藤 宏樹, 中島 淳

    神奈川医学会雑誌   43 ( 1 )   136 - 136   2016年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 上部ESDにおけるTroubleShooting この局面こうして乗り越えた ESD治療困難部位に対するGIF-2TQ260Mと糸付きクリップ併用の有用性

    野中 敬, 稲生 優海, 鹿野島 健二, 大熊 幹二, 梅沢 翔太郎, 冬木 晶子, 内山 詩織, 日暮 琢磨, 大久保 秀則, 飯田 洋, 遠藤 宏樹, 稲森 正彦, 中島 淳

    Progress of Digestive Endoscopy   88 ( Suppl. )   s99 - s99   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 当院における便秘薬処方の実態調査

    稲生 優海, 鹿野島 健二, 松浦 瑞恵, 飯田 洋, 野中 敬, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   112 ( 臨増大会 )   A917 - A917   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 消化器機能性疾患における内視鏡の役割 健常成人ボランティアにおけるルビプロストンの胃・小腸への影響 カプセル内視鏡を用いて

    松浦 瑞惠, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   112 ( 臨増大会 )   A805 - A805   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • ルビプロストン内服における悪心と上部消化管の通過時間に関する検討 13C呼気試験法を用いて

    川名 憲一, 松浦 瑞惠, 稲生 優海, 鹿野島 健二, 飯田 洋, 野中 敬, 中島 淳, 稲森 正彦, 永瀬 肇

    日本消化器病学会雑誌   112 ( 臨増大会 )   A832 - A832   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 本学における東洋医学教育について

    稲森 正彦, 石上 友章, 畝田 一司, 飯田 洋, 五嶋 良郎

    医学教育   46 ( Suppl. )   178 - 178   2015年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 卒前教育として消化器内視鏡教育を行う意義と工夫に関する検討

    飯田 洋, 鹿野島 健二, 稲生 優海, 松浦 瑞恵, 冬木 晶子, 内山 詩織, 大久保 秀則, 日暮 琢磨, 遠藤 宏樹, 野中 敬, 後藤 歩, 稲森 正彦, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   57 ( Suppl.1 )   952 - 952   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Slow Transit Constipationとは 本邦における認知調査のまとめ

    冬木 晶子, 大久保 秀則, 稲生 優海, 稲森 正彦, 中島 淳, 高尾 良彦

    日本大腸肛門病学会雑誌   68 ( 4 )   285 - 285   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本大腸肛門病学会  

    researchmap

  • 消化器疾患の機能検査法と機能に基づいた治療戦略 消化管機能障害患者の胃排出能の検討 13C呼気テストを用いて

    松浦 瑞恵, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   112 ( 臨増総会 )   A250 - A250   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 機能性ディスペプシア診療の現状と将来 機能性消化管障害のフォローに内視鏡検査は必要か 医師アンケート結果から

    松浦 瑞恵, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   112 ( 臨増総会 )   A197 - A197   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 食道表在癌の診断と治療 課題と展開 プロポフォール・デクスメデトミジン併用鎮静法は食道ESDを容易にする

    野中 敬, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   112 ( 臨増総会 )   A121 - A121   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 横浜市西部地区における大腸憩室自験例101例よりみた日本人における大腸憩室の変遷

    多羅尾 和郎, 関野 雄典, 野中 敬, 稲森 正彦, 中島 淳, 前田 慎

    日本消化器病学会雑誌   112 ( 臨増総会 )   A469 - A469   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • よく使う日常治療薬の正しい使い方 慢性便秘の治療薬の使い方

    中島 淳, 稲生 優海, 冬木 晶子, 大久保 秀則, 飯田 洋, 稲森 正彦

    レジデントノート   16 ( 15 )   2873 - 2878   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)羊土社  

    <薬の使い方のポイント・注意点>・慢性便秘とは排便回数の減少および排便困難症状を呈する便通異常の病態である ・多くの患者は硬便、残便感、過度の怒責、頻回便といった排便困難症状を訴える ・便秘治療のゴールは排便回数の是正よりは患者の愁訴の改善である ・酸化マグネシウムは便秘治療に最も使われる治療薬であるが、高マグネシウム血症に注意しなければならないため、用法用量を守ることに加え、高齢者などで腎機能が低下している場合減量しなければならない。また併用注意薬を熟知しなければならない ・刺激性下剤(センナ、ダイオウなど)は漫然と毎日投与し習慣性や依存性をきたさないように注意する。排便が数日ない場合の頓用使用に関しては非常に有効である ・漢方薬は便秘に伴う腹部膨満や腹痛の対処にきわめて有効であるばかりでなく作用のマイルドなものから強いものまでラインナップが豊富である ・慢性便秘の治療で常に心がけなければならないのは、背景に大腸がんのような器質性疾患がないか、甲状腺機能低下症や強皮症のような全身疾患による症候性便秘ではないかを念頭におき除外診断を怠らないことである ・通常の治療でコントロールが難しい場合、あるいは難治性便秘は専門医にコンサルトする(著者抄録)

    researchmap

  • 気道音モニタリングが有用であったESD中に喉頭痙攣を合併した一例

    野中 敬, 原田 紳介, 宮下 徹也, 稲生 優海, 鹿野島 健二, 松浦 瑞恵, 日暮 琢磨, 大久保 秀則, 飯田 洋, 遠藤 宏樹, 稲森 正彦, 後藤 隆久, 中島 淳

    神奈川医学会雑誌   42 ( 1 )   115 - 115   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 胃平坦隆起性病変におけるNBI拡大内視鏡診断

    野中 敬, 稲生 優海, 鹿野島 健二, 松浦 瑞恵, 飯田 洋, 中島 淳, 稲森 正彦

    胃病態機能研究会誌   47   22 - 22   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 機能性消化管障害のフォローに内視鏡検査は必要か 医師アンケート結果から

    松浦 瑞惠, 稲生 優海, 鹿野島 健二, 飯田 博, 野中 敬, 中島 淳, 稲森 正彦

    胃病態機能研究会誌   47   65 - 65   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 経口血糖降下薬の胃排出に与える影響の検討

    鹿野島 健二, 稲生 優海, 松浦 瑞江, 飯田 洋, 野中 敬, 中島 淳, 稲森 正彦

    胃病態機能研究会誌   47   57 - 57   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • ESD治療困難例に対するコツと工夫 ESD治療困難例に対するScope選択の工夫 GIF-2TQ260Mの有用性

    野中 敬, 稲生 優海, 鹿野島 健二, 松浦 瑞恵, 日暮 琢磨, 大久保 秀則, 飯田 洋, 遠藤 宏樹, 稲森 正彦, 中島 淳

    神奈川医学会雑誌   42 ( 1 )   121 - 121   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 炭酸水による胃排出への影響

    稲生 優海, 鹿野島 健二, 松浦 瑞惠, 飯田 洋, 野中 敬, 中島 淳, 稲森 正彦

    胃病態機能研究会誌   47   54 - 54   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 消化管運動と薬剤 経口糖尿病薬が胃排出に与える影響の検討

    鹿野島 健二, 稲森 正彦, 中島 淳

    日本臨床生理学会雑誌   44 ( 4 )   48 - 48   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床生理学会  

    researchmap

  • 炭酸水の胃排出に与える効果について

    松浦 瑞惠, 飯田 洋, 野中 敬, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   111 ( 臨増大会 )   A845 - A845   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 酸分泌抑制薬の胃内pH立ち上がりに関する検討

    飯田 洋, 稲森 正彦, 稲生 優海, 鹿野島 健二, 松浦 瑞恵, 内山 詩織, 酒井 英嗣, 大久保 秀則, 日暮 琢磨, 遠藤 宏樹, 野中 敬, 後藤 歩, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳, 前田 愼, 後藤 英司

    日本消化器病学会雑誌   111 ( 臨増大会 )   A847 - A847   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Upper G.I.Cancer 食道・胃癌 食道表在癌の内視鏡診断と治療の進歩

    野中 敬, 稲森 正彦, 中島 淳

    癌と化学療法   41 ( 9 )   1082 - 1086   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)癌と化学療法社  

    researchmap

  • 腹腔鏡下整復術により根治を得た食道裂孔ヘルニアの一例

    有本 純, 山田 英司, 関野 雄典, 酒井 英嗣, 大久保 秀則, 日暮 琢磨, 飯田 洋, 細野 邦広, 野中 敬, 高橋 宏和, 古出 智子, 稲森 正彦, 前田 愼, 中島 淳, 遠藤 宏樹

    Progress of Digestive Endoscopy   85 ( Suppl. )   s119 - s119   2014年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 動画で見る消化管ESDのさらなる工夫 食道ESDにおけるプロポフォール・デクスメデトミジン併用静脈麻酔の有用性に関する検討

    野中 敬, 宮下 徹也, 有本 純, 松浦 瑞恵, 日暮 琢磨, 飯田 洋, 遠藤 宏樹, 古出 智子, 高橋 宏和, 芝田 渉, 稲森 正彦, 中島 淳, 前田 愼, 後藤 隆久

    Progress of Digestive Endoscopy   85 ( Suppl. )   s83 - s83   2014年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • Location of Diverticular Disease and Irritable Bowel Syndrome: A Multicenter Prospective Study in Japan

    Eri Uchida, Shiori Uchiyama, Eiji Yamada, Eiji Sakai, Hidenori Ohkubo, Takuma Higurashi, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Shin Maeda, Atsushi Nakajima

    GASTROENTEROLOGY   146 ( 5 )   S224 - S224   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • Lubiprostone Decreases Small-Bowel Transit Time and Improves Visualization of the Small Bowel in Capsule Endoscopy: A Double-Blind, Placebo-Controlled 3-Way Crossover Study

    Mizue Matsuura, Hiroshi Iida, Takashi Nonaka, Atsushi Nakajima, Shin Maeda, Masahiko Inamori

    GASTROENTEROLOGY   146 ( 5 )   S358 - S358   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 胃平坦隆起性病変におけるNBI拡大内視鏡診断 腺腫と癌を鑑別し得る所見とは?

    野中 敬, 稲森 正彦, 前田 愼, 本多 靖, 厚川 和裕, 高橋 久雄, 有本 純, 松浦 瑞枝, 日暮 琢磨, 飯田 洋, 遠藤 宏樹, 古出 智子, 高橋 宏和, 芝田 渉, 中島 淳

    Gastroenterological Endoscopy   56 ( Suppl.1 )   1090 - 1090   2014年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 健常成人男性におけるルビプロストンによる胃・小腸通過時間への影響 カプセル内視鏡を用いて

    松浦 瑞惠, 内山 詩織, 山田 英司, 日暮 琢磨, 大久保 秀則, 酒井 英嗣, 飯田 洋, 遠藤 宏樹, 野中 敬, 高橋 宏和, 古出 智子, 稲森 正彦, 中島 淳, 前田 愼

    Gastroenterological Endoscopy   56 ( Suppl.1 )   1156 - 1156   2014年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 大腸憩室出血の診断・治療における造影CT検査の有用性

    内山 詩織, 日暮 琢磨, 永瀬 肇, 松浦 瑞恵, 酒井 英嗣, 大久保 秀則, 飯田 洋, 遠藤 宏樹, 野中 敬, 高橋 宏和, 古出 智子, 芝田 渉, 稲森 正彦, 中島 淳, 前田 愼, 水城 啓

    Gastroenterological Endoscopy   56 ( Suppl.1 )   1119 - 1119   2014年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 胸焼け患者に対するRoxatidine単回内服投与の効果に関する検討

    飯田 洋, 石井 研, 有本 純, 松浦 瑞恵, 内山 詩織, 山田 英司, 酒井 英嗣, 大久保 秀則, 日暮 琢磨, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 後藤 歩, 桐越 博之, 窪田 賢輔, 斉藤 聡, 稲森 正彦, 中島 淳, 前田 愼, 後藤 英司

    Gastroenterological Endoscopy   56 ( Suppl.1 )   1299 - 1299   2014年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 胃平坦隆起性病変の内視鏡診断 通常観察とNBI併用拡大観察における検討

    野中 敬, 稲森 正彦, 前田 愼, 本多 靖, 厚川 和裕, 松浦 瑞枝, 日暮 琢磨, 飯田 洋, 遠藤 宏樹, 古出 智子, 高橋 宏和, 芝田 渉, 高橋 久雄, 中島 淳

    日本消化器病学会雑誌   111 ( 臨増総会 )   A379 - A379   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 横浜西部地区で注腸レ線にて発見された大腸憩室症100例の解析

    多羅尾 和郎, 関野 雄典, 野中 敬, 稲森 正彦, 中島 淳, 前田 愼, 朴 鉉鋒, 坪川 雅哉, 棗田 豊, 池上 匡

    神奈川医学会雑誌   41 ( 1 )   74 - 75   2014年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 隆起型を呈する胃腺腫と胃癌の内視鏡的診断に関する検討

    野中 敬, 石井 研, 松浦 瑞恵, 日暮 琢磨, 飯田 洋, 遠藤 宏樹, 古出 智子, 高橋 宏和, 芝田 渉, 後藤 英司, 中島 淳, 稲森 正彦, 前田 愼

    神奈川医学会雑誌   41 ( 1 )   78 - 79   2014年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 呼気法による胃排出の遅延は近胃弛緩能の増強を表すか?

    秋本 恵子, 関野 雄典, 飯田 洋, 野中 敬, 稲森 正彦, 中島 淳, 前田 愼

    安定同位体と生体ガス: 医学応用   5 ( 1 )   34 - 40   2013年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本安定同位体・生体ガス医学応用学会  

    健常男性10名を対象に無作為割り付け交差試験法(スマトリプタン50mg内服および非内服後の13C標識栄養流動食摂取)による13C連続呼気試験を行った。スマトリプタン内服により栄養流動食摂取後の呼気中13Cの計算上の半減時間・計算最大値到達時間・実測最大値到達時間は有意に延長し、胃排出遅延を認めた。次に健常男女5名ずつ(年齢中央値20歳)を対象に無作為割り付け交差試験法(スマトリプタン50mg内服および非内服後の13C標識栄養流動食摂取)による超音波検査を行った。超音波検査では試験食を100mL摂取毎に近位胃の最大断面積を測定し、その後被験者を体位変換し前庭部収縮能の評価を行った。試験食摂取後の近位胃の断面積はいずれも投薬群で有意に増大したが、前庭部収縮率や収縮周期、運動指数に有意差は認めなかった。以上のことから、スマトリプタンによる胃排出遅延の機序が前庭部収縮の抑制ではなく、近位胃弛緩能の増強を介したものであることが示された。

    researchmap

  • 食道静脈瘤破裂時の輸血を契機に発見された先天性ハプトグロビン欠損症の1例

    東 文香, 飯田 洋, 米田 正人, 高橋 宏和, 稲森 正彦, 桐越 博之, 中島 淳, 前田 愼, 斉藤 聡, 上條 亜紀

    日本内科学会雑誌   102 ( 11 )   2980 - 2982   2013年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    74歳女。原発性胆汁性肝硬変のため外来通院中であった。黒色便と吐血のため救急搬送され、食道静脈瘤破裂の診断で内視鏡的静脈瘤結紮術を施行した。入院翌日に赤血球濃厚液(RCC)を輸血し、明らかな副作用は認めなかったが、輸血後8日に溶血性貧血を認め、精査の結果、間接Coombs試験陽性、不規則抗体陽性が判明した。1ヵ月後に食道静脈瘤破裂のため再入院となり、再びRCCの輸血を開始したところ、開始直後から発熱と呼吸困難が出現した。輸血の副作用の精査で血清ハプトグロビン(Hp)が検出限界以下、抗Hp抗体が陽性を示し、核酸増幅検査では通常認められる476bpのバンドが本例にはなく、Hpdel遺伝子特異的な増幅断片を示す315bpに濃厚なバンドを認めた。Hp遺伝子欠失アリルが検出され、先天性Hp欠損症の診断に至った。

    DOI: 10.2169/naika.102.2980

    researchmap

  • Helicobacter pylori(Hp)陰性健常成人におけるProton Pump inhibitor(PPI)間の夜間酸分泌抑制力の比較検討:Izumo night pH study

    古田賢司, 木幡幸恵, 藤原靖弘, 杉本光繁, 古田隆久, 岩切龍一, 稲森正彦, 河村修, 草野元康, 加藤元嗣, 岩切勝彦, 竹内利寿, 樋口和秀, 泙誠一, 直良浩司, 木下芳一, 藤本一眞, 荒川哲男

    日本消化器病学会雑誌   110 ( 臨増大会 )   A907 - A907   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    J-GLOBAL

    researchmap

  • Influence of pretreatment with rabeprazole on Helicobacter pylori eradication and quality of life for peptic ulcer patients: randomized controlled clinical trial

    M. Inamori, H. Iida, T. Nonaka, A. Nakajima, S. Maeda, E. Gotoh, C. Tokoro

    NEUROGASTROENTEROLOGY AND MOTILITY   25   40 - 40   2013年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • EsomeprazokeとOmeprazoleの単回経口投与における胃内pHの立ち上がりに関する検討

    飯田 洋, 山田 英司, 大久保 秀則, 日暮 琢磨, 酒井 英嗣, 細野 邦広, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 米田 正人, 後藤 歩, 桐越 博之, 窪田 賢輔, 斉藤 聡, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   110 ( 臨増大会 )   A889 - A889   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 逆流性食道炎患者におけるエソメプラゾール投与後の満足度検討

    松浦 瑞惠, 関野 雄典, 日暮 琢磨, 大久保 秀則, 山田 英司, 飯田 洋, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 後藤 歩, 井田 智則, 日下部 明彦, 中島 淳, 前田 愼, 後藤 英司, 稲森 正彦

    日本消化器病学会雑誌   110 ( 臨増大会 )   A879 - A879   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 慢性便秘患者に対するルビプロストンの使用経験 満足度調査アンケートより

    稲森 正彦, 松浦 瑞惠, 関野 雄典, 日暮 琢磨, 大久保 秀則, 山田 英司, 飯田 洋, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 後藤 歩, 井田 智則, 日下部 明彦, 中島 淳, 前田 愼, 後藤 英司

    日本消化器病学会雑誌   110 ( 臨増大会 )   A949 - A949   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 平坦隆起性病変におけるNBI併用拡大観察を用いた胃腺腫と胃癌の鑑別に関する検討

    野中 敬, 関野 雄典, 飯田 洋, 遠藤 宏樹, 古出 智子, 高橋 宏和, 後藤 英司, 前田 慎, 中島 淳, 稲森 正彦

    Gastroenterological Endoscopy   55 ( Suppl.2 )   2778 - 2778   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 【Helicobacter pylori感染症の臨床試験-いま、明らかにされるべきことは何か-】 動脈硬化・糖尿病などの生活習慣病とHelicobacter pyloriの関連

    飯田 洋, 稲森 正彦, 中島 淳

    Helicobacter Research   17 ( 4 )   312 - 315   2013年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)先端医学社  

    Helicobacter pylori(H.pylori)感染が動脈硬化に影響し生活習慣病に関連しているという報告は、冠動脈疾患と脳血管疾患について散見される。H.pylori感染は糖尿病、脂質異常症、高血圧、喫煙などの既知の冠動脈疾患の危険因子とは独立した危険因子である。血管疾患におけるH.pylori感染が危険因子として果たす役割としては、感染によりインスリン抵抗性が出現することと、また低比重リポ蛋白コレステロール(LDL-C)値が上昇することが認められている。さらにその詳細な機序については不明であるが、生活習慣病の増加が問題化しているわが国では、H.pylori感染は生活習慣病の更なる増悪因子となっている可能性がある。また除菌後に体重増加や脂質異常症の発症がみられる報告があることより、除菌治療と生活習慣病との関連にも注意しなければならない。今後、H.pylori感染とその除菌治療は、生活習慣病との関連を考慮に入れた前向き研究が期待されるものである。(著者抄録)

    researchmap

  • 上部消化管内視鏡検査における教育支援 画像因子の定量化

    森 由美, 稲森 正彦, 井上 祥, 吉川 奈緒美, 松浦 瑞惠, 関野 雄典, 飯田 洋, 野中 敬, 井田 智則, 日下部 明彦, 中島 淳, 前田 愼, 後藤 英司

    医学教育   44 ( Suppl. )   161 - 161   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 肝胆膵領域の癌患者における消化器症状の検討 FSSGとGSRSを用いて

    松浦 瑞惠, 坂本 康成, 稲森 正彦, 飯田 洋, 野中 敬, 後藤 英司, 中島 淳, 前田 愼

    胃病態機能研究会誌   45   54 - 54   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 本邦における慢性偽性腸閉塞の疫学調査(報告症例を交えて)

    飯田 洋, 稲森 正彦, 関野 雄典, 大久保 秀則, 野中 敬, 後藤 英司, 佐藤 元, 中島 淳

    神奈川医学会雑誌   40 ( 2 )   292 - 292   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 逆流性食道炎患者におけるエソメプラゾール投与後の満足度の検討 PPI切り替え後の自己記入式問診における患者満足度の検討

    吉川 奈緒美, 稲森 正彦, 松浦 端恵, 内山 詩織, 山田 英司, 日暮 琢磨, 大久保 秀則, 酒井 英嗣, 飯田 洋, 遠藤 宏樹, 野中 敬, 高橋 宏和, 古出 智子, 芝田 渉, 井田 智則, 日下部 明彦, 後藤 英司, 中島 淳, 前田 愼

    消化器の臨床   16 ( 3 )   321 - 328   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ヴァンメディカル  

    既存のプロトンポンプ阻害薬(PPI)を投与されているにもかかわらず、胸やけあるいは酸逆流症状のいずれかが残存する患者30例を対象にエソメプラゾールに切り替え、患者満足度を検討した。切り替え前後の症状について比較した結果、症状の強さおよび症状の頻度、双方の質問項目すべてにおいて有意な改善が認められた。また、エソメプラゾールに対する満足度は「満足している」と「やや満足している」を合わせると73.3%であった。既存のPPIで症状が残存している患者においてはエソメプラゾールに変更する治療法も一選択肢と考えられた。(著者抄録)

    researchmap

  • 【原因不明消化管出血の診断と治療】 原因不明消化管出血における小腸血管性病変・潰瘍性病変のリスクファクター

    酒井 英嗣, 遠藤 宏樹, 佐藤 高光, 山田 英二, 大久保 秀則, 日暮 琢磨, 高橋 宏和, 飯田 洋, 野中 敬, 古出 智子, 河村 晴信, 稲森 正彦, 中島 淳

    消化器内科   56 ( 5 )   472 - 476   2013年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 【カプセル内視鏡の現状と展望】 カプセル内視鏡が診断に有用な疾患 薬剤性小腸潰瘍 NSAIDを中心に

    遠藤 宏樹, 酒井 英嗣, 日暮 琢磨, 大久保 秀則, 山田 英司, 飯田 洋, 野中 敬, 古出 智子, 稲森 正彦, 高橋 宏和, 中島 淳

    胃と腸   48 ( 4 )   457 - 463   2013年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    カプセル内視鏡によって,NSAIDs起因性小腸粘膜傷害の現状が明らかになってきた.NSAIDsは,小腸にびらん,潰瘍,絨毛欠損や出血など多彩な病変を引き起こし,原因不明の消化管出血の一因となりうる.また,NSAIDs長期服用者においては,小腸に輪状潰瘍・膜様狭窄という特徴的な所見を来すことがあり,カプセル内視鏡検査に注意を要することがある.NSAIDs起因性小腸潰瘍に対しては休薬が確実な治療であるが,治療後の評価もカプセル内視鏡ならば,簡便かつ低侵襲で行うことが可能である.カプセル内視鏡はNSAIDs起因性小腸粘膜傷害の診断や治療評価に有用であると考えられる.(著者抄録)

    DOI: 10.11477/mf.1403113775

    researchmap

  • 【何がわかる?CT&MRI】 腹部(消化管)MRI MRIを用いた消化管疾患診断学の近年の進歩

    大久保 秀則, 冬木 晶子, 飯田 洋, 稲森 正彦, 高原 太郎, 中島 淳

    診断と治療   101 ( 4 )   565 - 570   2013年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)診断と治療社  

    researchmap

  • 食道静脈瘤破裂時の輸血を契機に発見された先天性ハプトグロビン欠損症の1例

    東 文香, 飯田 洋, 米田 正人, 高橋 宏和, 稲森 正彦, 桐越 博之, 中島 淳, 前田 愼, 上條 亜紀, 斉藤 聡

    日本内科学会関東地方会   595回   33 - 33   2013年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 本邦における慢性偽性腸閉塞の疫学調査 報告症例を交えて

    飯田 洋, 稲森 正彦, 関野 雄典, 大久保 秀則, 野中 敬, 後藤 英司, 佐藤 元, 中島 淳

    神奈川医学会雑誌   40 ( 1 )   72 - 72   2013年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 大うつ病合併NAFLD患者の臨床的特徴、治療効果反応の検討

    米田 正人, 今城 健人, 中島 淳, 留野 渉, 小川 祐二, 桐越 博之, 芝田 渉, 窪田 賢輔, 稲森 正彦, 前田 慎, 遠藤 宏樹, 斉藤 聡

    日本消化器病学会雑誌   110 ( 臨増総会 )   A332 - A332   2013年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃粘膜下腫瘍に対する腹腔鏡・内視鏡合同胃局所切除術の検討

    渥美 陽介, 佐藤 勉, 利野 靖, 飯田 洋, 古出 智子, 稲森 正彦, 中島 淳, 前田 愼, 長谷川 慎一, 玉川 洋, 大島 貴, 湯川 寛夫, 吉川 貴己, 今田 敏夫, 益田 宗孝

    日本胃癌学会総会記事   85回   222 - 222   2013年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本胃癌学会  

    researchmap

  • Social Networking Service(SNS)を用いた医育機関からの情報発信

    稲森 正彦, 関野 雄典, 飯田 洋, 遠藤 宏樹, 野中 敬, 古出 智子, 日下部 明彦, 中島 淳, 前田 愼, 後藤 英司

    日本内科学会雑誌   102 ( Suppl. )   244 - 244   2013年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    researchmap

  • 消化管機能性疾患への応用を念頭に、健常ボランティアを対象とした研究を組み立てる場合の問題点について

    稲森 正彦, 関野 雄典, 飯田 洋, 野中 敬, 日下部 明彦, 遠藤 宏樹, 古出 智子, 高橋 宏和, 中島 淳, 前田 愼, 井上 祥, 後藤 栄司

    臨床薬理   43 ( Suppl. )   S320 - S320   2012年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床薬理学会  

    researchmap

  • 胃粘膜下腫瘍に対する腹腔鏡・内視鏡合同胃局所切除術の検討

    渥美 陽介, 利野 靖, 佐藤 勉, 山田 六平, 飯田 洋, 古出 智子, 稲森 正彦, 中島 淳, 前田 愼, 藤川 寛人, 長谷川 慎一, 大島 貴, 湯川 寛夫, 今田 敏夫, 益田 宗孝

    日本癌治療学会誌   47 ( 3 )   1475 - 1475   2012年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本癌治療学会  

    researchmap

  • 胃粘膜下腫瘍に対する腹腔鏡・内視鏡合同胃局所切除術の検討

    渥美 陽介, 利野 靖, 佐藤 勉, 山田 六平, 飯田 洋, 古出 智子, 稲森 正彦, 中島 淳, 前田 愼, 山奥 公一朗, 長谷川 慎一, 大島 貴, 湯川 寛夫, 今田 敏夫, 益田 宗孝

    日本消化器外科学会雑誌   45 ( Suppl.2 )   266 - 266   2012年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器外科学会  

    researchmap

  • 満腹と膨満 日本人は区別しているか

    坂本 康成, 稲森 正彦, 井上 祥, 飯沼 端恵, 関野 雄典, 飯田 洋, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 米田 正人, 日下部 明彦, 後藤 英司, 中島 淳, 前田 愼, 本郷 道夫

    横浜医学   63 ( 4 )   589 - 595   2012年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    【目的】近年、機能性消化管障害の診療等で症状の評価が見直されている。同じように&quot;腹がふくれる&quot;症状を表す言葉に満腹と膨満があるが、その区別の詳細は不明である。本研究の目的は、日本人が満腹と膨満をどのように区別しているかを調べることである。【方法】健常男性17名を対象とし、腹部症状の定量的評価の方法として、Boeckxstaensの飲水試験を行った。飲水試験で得られる問診表をはじめとする情報を解析し、満腹感と膨満感の関連につき考察した。【結果】最大飲水量の中央値は1350mLであった。満腹感と膨満感について問診表における推移を解析すると、満腹感優位型(29.4%)、膨満感優位型(23.5%)、満腹感先行型(11.7%)、膨満感先行型(29.4%)、同等型(5.8%)に分類された。最大飲水量とBMIのみ正の相関が認められた(P=0.0445)。満腹、膨満、嘔気は全員に出現し、その閾値容量は各々相関していた。【結論】満腹感と膨満感は個々により捉え方が異なる可能性が示唆された。(著者抄録)

    researchmap

  • スマトリプタン内服は、近位胃の弛緩を介して胃排出を遅延させる 13C BreathID systemと飲水超音波法を用いて

    関野 雄典, 飯田 洋, 野中 敬, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   109 ( 臨増大会 )   A779 - A779   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 機能性消化管疾患診療における問診票の検討 GerdQとFSSGを用いて(第2報)

    野中 敬, 山田 英司, 酒井 英嗣, 大久保 秀則, 日暮 琢磨, 関野 雄典, 渡邉 誠太郎, 飯田 洋, 遠藤 宏樹, 古出 智子, 高橋 宏和, 後藤 歩, 桐越 博之, 小林 規俊, 窪田 賢輔, 斎藤 聡, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   109 ( 臨増大会 )   A767 - A767   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • ランソプラゾールが原因と考えられたcollagenous colitisの1例

    佐藤 瑞希, 佐藤 高光, 飯田 洋, 野中 敬, 古出 智子, 稲森 正彦, 前田 愼, 遠藤 宏樹, 高橋 宏和, 中島 淳

    日本内科学会関東地方会   590回   50 - 50   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • Rabeprazoleの胃内pHの立ち上がりに関するmosaprideの効果についての検討

    飯田 洋, 山田 英司, 関野 雄典, 酒井 英嗣, 日暮 琢磨, 細野 邦広, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 後藤 歩, 阿部 泰伸, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   109 ( 臨増大会 )   A777 - A777   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Assessment of cine-MRI as a novel diagnostic modality for chronic intestinal pseudo-obstruction (CIPO)

    H. Ohkubo, E. Yamada, E. Sakai, T. Higurashi, H. Iida, Y. Sekino, H. Endo, H. Takahashi, M. Inamori, A. Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   24   173 - 173   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • An epidemiologic survey of chronic intestinal pseudo-obstruction (CIPO) and evaluation of the newly proposed diagnostic criteria

    H. Ohkubo, E. Yamada, E. Sakai, T. Higurashi, Y. Sekino, H. Iida, H. Endo, H. Takahashi, M. Inamori, A. Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   24   101 - 101   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 機能性胃疾患の病態における基礎と臨床の接点 ラモセトロン塩酸塩0.1mg経口投与の胃排出能に及ぼす影響に関する検討

    野中 敬, 日下部 明彦, 関野 雄典, 飯田 洋, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    胃病態機能研究会誌   44   31 - 31   2012年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • カプセル内視鏡および小腸内視鏡で観察し得た小腸多発潰瘍の1例

    土谷 一泉, 藤井 徹朗, 飯田 洋, 古出 智子, 稲森 正彦, 阿部 泰伸, 馬渡 弘典, 米田 正人, 小林 規俊, 斉藤 聡, 前田 愼, 遠藤 宏樹, 細野 邦広, 高橋 宏和, 窪田 賢輔, 中島 淳

    Progress of Digestive Endoscopy   80 ( 2 )   116,10 - 117,10   2012年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    80歳女性。数十年来の貧血と4年前から指摘されている便潜血陽性を主訴に近医を受診、鉄欠乏性貧血と低蛋白血症が認められたが、上・下部消化管内視鏡検査では異常所見はみられなかった。また、鉄剤投与により貧血は改善傾向はみられたが、便潜血陽性は持続しており、そのためカプセル内視鏡を施行したところ、回腸に全周性の潰瘍性病変が認められた。以後、精査目的で著者らの施設へ紹介となったが、入院後、シングルバルーン小腸内視鏡(SBE)でBauhin弁から約60cm口側に管腔狭窄を伴う浅い輪状潰瘍が確認され、スコープ通過は不可能であった。一方、出血は認めず、回盲部も正常であったものの、狭窄の口側は拡張しており、本狭窄の3cmほど口側にも潰瘍狭窄が観察され、SBEからの造影検査では計4ヶ所の狭窄病変が確認された。だが、輪状潰瘍の生検では病理所見上で非特異的な慢性炎症細胞浸潤のみで肉芽腫は認めず、一般培養検査、抗酸菌培養検査は陰性であった。以上より、本症例は非特異性多発性小腸潰瘍症(CNSU)が最も疑わしいと考えらたが、八尾らが提唱する診断基準(案)からすると本症例をCNSUと確定診断するにはやや根拠が乏しいと考えられた。

    DOI: 10.11641/pde.80.2_116

    researchmap

  • 【肥満と消化器疾患】 病的肥満患者に対する内視鏡的胃内バルーン留置術の効果

    関野 雄典, 稲森 正彦, 中島 淳

    消化器内科   54 ( 6 )   694 - 698   2012年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    病的肥満患者に対する内視鏡的胃内バルーン留置術の効果について検討した。対象は8名で、身長169.5cm、体重117.6kg、BMIは44.0kg/m2、超過体重は平均54.4kgであった。手技は大きな合併症なく施行され、治療成績はそれぞれ中央値で、体重減少が8.6kg、BMI減少が2.8kg/m2、超過体重減少率が14.9%であった。体重、肝臓容量は治療開始後の1ヵ月間で有意に減少し、2ヵ月目以降は横ばいとなったが、治療期間を通じて有意に減少した。一方、内臓脂肪断面積は治療開始1ヵ月で減少傾向を示したものの、6ヵ月間を通じての変化に有意差を認めなかった。また、肝酵素、糖代謝、脂質代謝に関しては有意な変化を認めなかった。

    researchmap

  • Efficacy of Probiotic Treatment on Small Bowel Injury in Chronic Low-Dose Aspirin Users: A Pilot Randomized Controlled Trial

    Hiroki Endo, Takuma Higurashi, Eiji Sakai, Kunihiro Hosono, Hidenori Ohkubo, Eiji Yamada, Yusuke Sekino, Hiroshi Iida, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Atsushi Nakajima

    GASTROENTEROLOGY   142 ( 5 )   S736 - S736   2012年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 肥満症に対する内視鏡治療の最前線 日本人患者に対する内視鏡的胃内バルーン留置術の効果

    関野 雄典, 稲森 正彦, 中島 淳

    Gastroenterological Endoscopy   54 ( Suppl.1 )   1050 - 1050   2012年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Capsule Endoscopic Findings of Ulcerative Colitis Patients

    Takuma Higurashi, Hiroki Endo, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Yusuke Sekino, Hiroshi Iida, Tomoko Koide, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   75 ( 4 )   256 - 256   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • 当院における内視鏡的胃十二指腸ステント留置術の現状

    小林 規俊, 佐藤 高光, 加藤 真吾, 渡邉 誠太郎, 細野 邦広, 稲森 正彦, 前田 愼, 中島 淳, 遠藤 格, 窪田 賢輔

    Gastroenterological Endoscopy   54 ( Suppl.1 )   1095 - 1095   2012年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 消化管 残された課題 難治性便秘

    中島 淳, 大久保 秀則, 稲森 正彦

    日本消化器病学会雑誌   109 ( 臨増総会 )   A208 - A208   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • シタグリプチンによる胃排出能に及ぼす影響に関する検討

    野中 敬, 藤井 徹朗, 加藤 真吾, 山田 英司, 酒井 英嗣, 大久保 秀則, 日暮 琢磨, 関野 雄典, 渡邉 誠太郎, 飯田 洋, 細野 邦広, 遠藤 宏樹, 米田 正人, 古出 智子, 高橋 宏和, 阿部 泰伸, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   109 ( 臨増総会 )   A280 - A280   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 瘻孔閉鎖を目的とした胃瘻カテーテル抜去の現状と閉鎖不全への対策

    古出 智子, 佐藤 孝光, 山田 英司, 加藤 真吾, 酒井 英嗣, 大久保 秀則, 日暮 琢磨, 後藤 歩, 日下部 明彦, 関野 雄典, 飯田 洋, 野中 敬, 細野 邦広, 遠藤 宏樹, 高橋 宏和, 阿部 泰伸, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   109 ( 臨増総会 )   A251 - A251   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 本邦における慢性偽性腸閉塞の疫学調査『慢性特発性偽性腸閉塞症(CIIP)の我が国における疫学・診断・治療の実態調査(厚生労働省難治性疾患克服研究事業)』研究班報告

    飯田 洋, 稲森 正彦, 藤井 徹朗, 加藤 真吾, 山田 英司, 関野 雄典, 酒井 英嗣, 日暮 琢磨, 大久保 秀則, 遠藤 宏樹, 細野 邦広, 野中 敬, 古出 智子, 高橋 宏和, 後藤 歩, 阿部 泰伸, 後藤 英司, 佐藤 元, 中島 淳

    日本消化器病学会雑誌   109 ( 臨増総会 )   A224 - A224   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 漢方治療のエビデンス 慢性偽性腸閉塞症に対する大健中湯の使用 本邦初の国内実態調査の結果から

    稲森 正彦, 飯田 洋, 関野 雄典, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 阿部 泰伸, 前田 愼, 中島 淳

    日本内科学会雑誌   101 ( Suppl. )   342 - 342   2012年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    researchmap

  • 逆流性食道炎がBarrett食道の発生・伸展・形状に及ぼす影響 (特集 逆流性食道炎とBarrett食道)

    秋山 智之, 稲森 正彦, 中島 淳

    消化器内科   54 ( 2 )   185 - 191   2012年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:科学評論社  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2012164925

  • 胃粘膜下腫瘍に対する腹腔鏡・内視鏡合同胃局所切除術の検討

    佐藤 勉, 利野 靖, 山田 六平, 古出 智子, 阿部 泰伸, 稲森 正彦, 中島 淳, 前田 愼, 山奥 公一朗, 藤川 寛人, 稲垣 大輔, 大島 貴, 湯川 寛夫, 今田 敏夫, 益田 宗孝

    日本胃癌学会総会記事   84回   360 - 360   2012年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本胃癌学会  

    researchmap

  • 酸分泌抑制薬による胃機能への影響に関する検討

    野中 敬, 藤井 徹朗, 加藤 真吾, 山田 英司, 酒井 英嗣, 大久保 秀則, 日暮 琢磨, 関野 雄典, 渡邉 誠太郎, 飯田 洋, 細野 邦広, 遠藤 宏樹, 米田 正人, 古出 智子, 高橋 宏和, 阿部 泰伸, 前田 愼, 中島 淳, 後藤 英司, 稲森 正彦

    神奈川医学会雑誌   39 ( 1 )   79 - 79   2012年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 内視鏡的胃内バルーン留置術(IGB)の治療成績

    関野 雄典, 飯田 洋, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 阿部 泰伸, 前田 愼, 中島 淳, 稲森 正彦, 滝端 正博, 寺内 康夫, 後藤 英司

    神奈川医学会雑誌   39 ( 1 )   87 - 88   2012年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 小腸のpHを測る試み

    飯田 洋, 稲森 正彦, 関野 雄典, 内山 崇, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 中島 淳, 前田 愼

    神奈川医学会雑誌   39 ( 1 )   69 - 70   2012年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 腹腔鏡・内視鏡合同胃局所切除術(胃全層切開法)で切除した胃粘膜下腫瘍の1例

    菅野 健児, 利野 靖, 湯川 寛夫, 山田 六平, 佐藤 勉, 益田 宗孝, 稲森 正彦, 阿部 泰伸, 古出 智子, 中島 淳, 前田 愼, 大島 貴, 比企 直樹, 今田 敏夫

    神奈川医学会雑誌   39 ( 1 )   79 - 80   2012年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • Dose Transnasal Endoscopy for Percutaneous Endoscopic Gastrostomy Decrease Local Infection?

    Tomoko Koide, Masahiko Inamori

    DIGESTION   85 ( 2 )   156 - 156   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:KARGER  

    Web of Science

    researchmap

  • 慢性偽性腸閉塞症患者におけるミトコンドリア病診療の実態

    関野 雄典, 稲森 正彦, 飯田 洋, 坂本 康成, 野中 敬, 児矢野 繁, 中島 淳

    診断と治療   99 ( 12 )   2151 - 2157   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)診断と治療社  

    researchmap

  • 慢性偽性腸閉塞症

    中島 淳, 大久保 秀則, 飯田 洋, 高橋 宏和, 稲森 正彦

    消化器医学   9   15 - 27   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)アークメディア  

    偽性腸閉塞症は、腸管の蠕動運動が障害されることにより、機械的な閉塞機転がないにも拘わらず腹部膨満、腹痛、嘔吐などの腸閉塞症状を引き起こす疾患である。慢性偽性腸閉塞症の分類・病態、疫学、診断、治療法について概説し、小児領域と成人発症との疾患概念の違いについて述べた。シネMRIの応用により、腸管の運動や拡張程度、癒着、腸管内容物などが詳細にわかるようになってきた。

    researchmap

  • 内視鏡的に回収したスプーン誤飲の1例

    池川 健, 高橋 宏和, 遠藤 宏樹, 古出 智子, 所 知加子, 稲森 正彦, 阿部 泰伸, 後藤 歩, 嶌村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 川名 一朗, 前田 愼, 中島 淳

    Progress of Digestive Endoscopy   79 ( 2 )   52 - 53   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    30歳女性。スプーン誤飲を主訴に著者らの施設へ受診となった。腹部単純X線では胃内にスプーンの陰影が認められたが、縦隔気腫や遊離ガスはみられなかった。更に緊急上部消化管内視鏡を施行するも、胃内残渣多量でスプーンを発見することは困難であった。しかし翌日、上部消化管内視鏡にて十二指腸下行脚のスプーンが確認され、スネアを用いて摘出した。尚、スプーン(全長11cm、幅2.5cm)抜去後に粘膜損傷や出血、縦隔・皮下気腫、気胸などの合併症は認められなかった。

    DOI: 10.11641/pde.79.2_52

    researchmap

  • 食道・胃良性疾患に対する内視鏡外科の適応 胃粘膜下腫瘍に対する腹腔鏡・内視鏡合同胃局所切除術(胃全層切開法)

    利野 靖, 湯川 寛夫, 佐藤 勉, 山田 六平, 稲森 正彦, 阿部 泰伸, 古出 智子, 中島 淳, 前田 愼, 大島 貴, 今田 敏夫, 益田 宗孝

    日本内視鏡外科学会雑誌   16 ( 7 )   225 - 225   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内視鏡外科学会  

    researchmap

  • カプセル内視鏡及び小腸内視鏡が診断に有用であった非特異性多発性小腸潰瘍症の1例

    土谷 一泉, 藤井 徹朗, 飯田 洋, 古出 智子, 稲森 正彦, 阿部 泰伸, 渡邉 誠太郎, 馬渡 弘典, 米田 正人, 嶌村 健, 小林 規俊, 桐越 博之, 斉藤 聡, 川名 一朗, 前田 愼, 遠藤 宏樹, 細野 邦広, 高橋 宏和, 窪田 賢輔, 中島 淳

    Progress of Digestive Endoscopy   80 ( 1 )   106 - 106   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 腹腔鏡・内視鏡合同胃局所切除術(胃全層切開法)で切除した胃粘膜下腫瘍の2例

    利野 靖, 湯川 寛夫, 山田 六平, 佐藤 勉, 稲森 正彦, 阿部 泰伸, 古出 智子, 中島 淳, 前田 愼, 大島 貴, 比企 直樹, 今田 敏夫, 益田 宗孝

    横浜医学   62 ( 4 )   519 - 524   2011年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    腹腔鏡下でのwedge resectionが胃粘膜下腫瘍(SMT)のひとつであるgastrointestinal stromal tumor(GIST)の治療に広く行われるようになってきている。それにもかかわらず、SMTの胃の占拠部位や大きさで、的確な腹腔鏡手術の手技を選択するガイドラインは存在しない。腹腔鏡・内視鏡合同胃局所切除術(LECS)は占拠部位や大きさに影響されない手技である。これは内視鏡でendoscopic submucosal dissection(ESD)の手技を用いて腫瘍周囲の粘膜および粘膜下層を切開し、続いて腹腔鏡下で漿膜筋層を内視鏡で切開した線に沿って3/4周切開していく。SMTを腹腔内へ反転させ、自動縫合器を用いて胃の切開部を縫合しつつ、SMTを切除する手技である。われわれはGISTの治療のひとつとしてLECSを選択することとした。これまで2例のGIST症例に施行した。1例目は体下部で幽門に近い部位の5cmを超える症例で、2例目は噴門直下の症例であった。2例とも術後経過は問題なかった。GIST治療のLECSは安全であり、手術時間、出血量も問題ないものと考えられた。さらに手術困難と言われている胃食道移行部や幽門近傍でも応用可能な手技と考えられた。(著者抄録)

    researchmap

  • Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply

    Takashi Nonaka, Masahiko Inamori

    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY   17 ( 4 )   435 - 435   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KOREAN SOC NEUROGASTERONTEROL & MOTILITY  

    DOI: 10.5056/jnm.2011.17.4.435

    Web of Science

    researchmap

  • 胃食道逆流症に対し、腹腔鏡下噴門形成術手術が著効した1例

    利野 靖, 小澤 荘司, 飯田 洋, 湯川 寛夫, 山田 六平, 佐藤 勉, 菅野 伸洋, 稲垣 大輔, 藤川 寛人, 山奥 公一郎, 稲福 賢司, 稲森 正彦, 中島 淳, 前田 愼, 高 錫健, 益田 宗孝, 今田 敏夫

    横浜医学   62 ( 4 )   533 - 537   2011年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    食道裂孔ヘルニアにより生じる胃食道逆流症(GERD)は外科的治療の対象となる。日本消化器病学会から診療ガイドラインでも、PPI投与が無効な場合、外科治療が示されている。現在、腹腔鏡手術が世界中で施行されるようになっている。逆流防止手術には全周性のNissen噴門形成術と非全周性のToupet噴門形成術などがある。われわれは術後の通過障害の発生頻度が少ないToupet噴門形成術を選択した。症例 65歳、男性。主訴 胸焼け。4年間PPI投与を続けたが、症状が改善しない症例に腹腔鏡下Toupet噴門形成術を施行した。術後症状は改善し、PPI投与も不要となった。(著者抄録)

    researchmap

  • Sumatriptan intake delays gastric emptying: a crossover study using a continuous real-time C-13 breath test (breath system)

    Y. Sekino, Y. Sakamoto, H. Iida, T. Akiy-Ama, T. Nonaka, T. Ikeda, E. Gotoh, S. Maeda, A. Nakajima, M. Inamori

    NEUROGASTROENTEROLOGY AND MOTILITY   23   40 - 40   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • The correlation between gastric transit time evaluated with capsule endoscopy and gastric emptying evaluated with using continuous real time 13C breath test (breathed system)

    M. Inamori, Y. Sekino, H. Iida, T. Akiy-Ama, Y. Sakamoto, T. Nonaka, T. Ikeda, S. Maeda, A. Nakajima, E. Gotoh

    NEUROGASTROENTEROLOGY AND MOTILITY   23   37 - 38   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Rabeprazoleの胃内pHの立ち上がりに関するクエン酸mosaprideの効果についての検討

    飯田 洋, 山田 英司, 関野 雄典, 酒井 英嗣, 日暮 琢磨, 細野 邦広, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 後藤 歩, 阿部 泰伸, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   108 ( 臨増大会 )   A790 - A790   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • ラモセトロン塩酸塩内服と胃排出能の関係について 13C Breath ID systemによる呼気試験を用いて

    坂本 康成, 山田 英司, 関野 雄典, 内山 崇, 酒井 英嗣, 日暮 琢磨, 大久保 秀則, 飯田 洋, 細野 邦広, 遠藤 宏樹, 野中 敬, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   108 ( 臨増大会 )   A790 - A790   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • BMI階層化による大腸腺腫およびaberrant crypt fociの比較検討

    高橋 宏和, 藤井 哲郎, 山田 英司, 大久保 秀則, 日暮 琢磨, 酒井 英嗣, 飯田 洋, 細野 邦広, 遠藤 宏樹, 古出 智子, 稲森 正彦, 阿部 泰伸, 前田 愼, 中島 淳

    日本消化器病学会雑誌   108 ( 臨増大会 )   A869 - A869   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • スマトリプタン内服は胃排出を遅延させる 13C Breath ID systemによる呼気試験を用いて

    野中 敬, 山田 英司, 関野 雄典, 内山 崇, 酒井 英嗣, 日暮 琢磨, 大久保 秀則, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   108 ( 臨増大会 )   A790 - A790   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸血管拡張症の臨床的特徴、消化管出血の危険因子(症例対象研究)

    関野 雄典, 山田 英司, 内山 崇, 酒井 英嗣, 日暮 琢磨, 飯田 洋, 細野 邦弘, 遠藤 宏樹, 野中 敬, 坂本 康成, 高橋 宏和, 古出 智子, 所 知加子, 後藤 歩, 阿部 泰伸, 後藤 英司, 前田 愼, 中島 淳, 稲森 正彦

    Gastroenterological Endoscopy   53 ( Suppl.2 )   2652 - 2652   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Early effects of ramosetron on gastric emptying: a crossover study using a continuous real-time C-13 breath test (breath ID system)

    T. Nonaka, Y. Sakamoto, Y. Sekino, H. Iida, T. Akiyama, T. Ikeda, E. Gotoh, S. Maeda, A. Nakajima, M. Inamori

    NEUROGASTROENTEROLOGY AND MOTILITY   23   39 - 39   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Helicobacter pylori感染と食道扁平上皮癌罹患の関係

    所 知加子, 稲森 正彦, 古出 智子, 後藤 歩, 阿部 泰伸, 河島 菜々子, 亀田 英里, 吉村 築, 菱木 智, 池原 孝, 篠原 正夫, 中島 淳, 前田 愼

    日本消化器病学会雑誌   108 ( 臨増大会 )   A779 - A779   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 肥満と消化器疾患 病的肥満患者に対する内視鏡的胃内バルーン留置術の効果

    関野 雄典, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   108 ( 臨増大会 )   A431 - A431   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院における消化管カルチノイド52例の臨床的検討

    古出 智子, 関野 雄典, 酒井 英嗣, 日暮 琢磨, 山田 英司, 大久保 秀則, 飯田 洋, 細野 邦広, 遠藤 宏樹, 野中 敬, 高橋 宏和, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 後藤 英司, 利野 靖, 遠藤 格, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   108 ( 臨増大会 )   A870 - A870   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • より簡便な質問紙を求めて(第2報)

    野中 敬, 関野 雄典, 飯田 洋, 遠藤 宏樹, 高橋 宏和, 古出 智子, 阿部 泰伸, 前田 愼, 中島 淳, 稲森 正彦

    胃病態機能研究会誌   43   47 - 47   2011年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 【小腸疾患の診断と治療の進歩】 非侵襲的かつ連続的に小腸の画像とpHを同時に測定する機器「pHカプセル」の開発

    飯田 洋, 関野 雄典, 馬渡 弘典, 野中 敬, 遠藤 宏樹, 稲森 正彦, 中島 淳

    消化器内科   53 ( 1 )   7 - 11   2011年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    小腸の機能異常の解析手段の一つとして開発した、小腸の画像とpHを同時に測定する非侵襲的連続小腸内pH測定装置「pHカプセル」を紹介し、健常成人男性ボランティア5名を対象とした小腸の生理的な状態の画像とpH測定結果を提示した。「pHカプセル」は嚥下後、全員盲腸に到達し、全小腸の画像観察、pH測定が可能であった。5名中2名は排便時に「pHカプセル」の排出を確認し、他の3名も後日腹部X線で体内からの排出が確認された。腸管内pHの推移は、十二指腸に入ると非常に急峻な上昇を認め2以下から7になり、肛門側に向かい徐々に上昇し、回腸末端では8強であった。十二指腸球部から盲腸に到達するまでの平均pHは7.56であった。以上、pHカプセルで小腸画像より確実に解剖学的位置とその場所のpHをモニターできることが確認された。

    researchmap

  • メタボ時代の上部消化管疾患を探る 体重減少は症状の軽減に関与するか Frequency Scale for the Symptoms of GERD(FSSG)を用いた検討

    野中 敬, 坂本 康成, 岩崎 知之, 関野 雄典, 飯田 洋, 遠藤 宏樹, 高橋 宏和, 古出 智子, 阿部 泰伸, 後藤 栄司, 前田 眞, 中島 淳, 稲森 正彦

    胃病態機能研究会誌   43   26 - 26   2011年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 胃瘻管理および胃瘻交換の問題点と工夫 大学病院における胃瘻のフォローと地域連携

    古出 智子, 細野 邦広, 内山 崇, 関野 雄典, 酒井 英嗣, 飯田 洋, 遠藤 宏樹, 坂本 康成, 野中 敬, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 前田 愼, 中島 淳, 後藤 英司, 日下部 明彦, 稲森 正彦

    Progress of Digestive Endoscopy   79 ( 1 )   74 - 74   2011年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 進行膵癌による十二指腸狭窄に対して、Niti-Sステント留置が有効であった2例

    桑原 大輔, 小林 規俊, 窪田 賢輔, 島村 健, 渡邊 誠太郎, 加藤 真吾, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 藤田 浩司, 米田 正人, 高橋 宏和, 古出 智子, 所 知加子, 稲森 正彦, 阿部 泰伸, 桐越 博之, 斎藤 聡, 中島 淳, 前田 愼

    Progress of Digestive Endoscopy   79 ( 1 )   104 - 104   2011年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 内視鏡的に摘出したスプーン誤飲の1例

    池川 健, 高橋 宏和, 遠藤 宏樹, 古出 智子, 所 知加子, 稲森 正彦, 阿部 泰伸, 加藤 真吾, 渡邉 誠太郎, 馬渡 弘典, 米田 正人, 後藤 歩, 嶌村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 川名 一朗, 前田 愼, 中島 淳

    Progress of Digestive Endoscopy   79 ( 1 )   103 - 103   2011年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 【明日の診療に漢方をいかす 西洋医学と漢方医学の融合】 日常診療でまず使ってみたい漢方ベストチョイス15 FD 六君子湯

    稲森 正彦, 中島 淳

    診断と治療   99 ( 5 )   765 - 769   2011年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)診断と治療社  

    researchmap

  • 食後のアルコール摂取が消化管知覚に与える影響について 飲水試験を用いて

    稲森 正彦, 関野 雄典, 飯田 洋, 坂本 康成, 藤田 浩司, 米田 正人, 中島 淳

    アルコールと医学生物学   30   72 - 75   2011年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)響文社  

    食後のアルコール摂取が消化管知覚に与える影響について飲水試験を用いて検討した。消化器症状がない20〜34歳の男性健常ボランティア8例を対象としてクロスオーバー研究を実施した。8時間の絶飲食後、400kcal/400mLの試験食を5分間で摂取後少量のアルコール(梅酒50mL)を摂取もしくは水50mLを5分間で摂取し、毎分100mLのストローによる飲水試験を実施した。最大飲水量は、アルコール群では1200mL、コントロール群では1000mLで、アルコール群で有意に多かった。症状の問診表では差を認めなかった。

    researchmap

  • 胃粘膜下腫瘍に対する切除時の工夫について

    利野 靖, 村上 仁志, 稲森 正彦, 阿部 泰伸, 高橋 宏和, 所 知加子, 古出 智子, 湯川 寛夫, 山田 六平, 佐藤 勉, 松浦 仁, 菅野 伸洋, 大島 貴, 益田 宗孝, 今田 敏夫

    日本胃癌学会総会記事   83回   323 - 323   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本胃癌学会  

    researchmap

  • 胃ろうカテーテル抜去後のろう孔閉鎖不全に対し、内視鏡的アルゴンプラズマ凝固とクリップによる縫縮が有効であった2例

    古出 智子, 稲森 正彦, 加藤 真吾, 内山 崇, 関野 雄典, 酒井 英嗣, 今城 健人, 鈴木 香峰理, 飯田 洋, 渡辺 誠太郎, 遠藤 宏樹, 細野 邦広, 坂本 康成, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 中島 淳, 前田 愼, 日下部 明彦

    日本消化器病学会雑誌   108 ( 臨増総会 )   A358 - A358   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 小腸の画像とpHを同時に測定する試み(第2報)

    飯田 洋, 関野 雄典, 酒井 英嗣, 内山 崇, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 米田 正人, 所 知加子, 後藤 歩, 阿部 泰伸, 窪田 賢輔, 斎藤 聡, 前田 愼, 中島 淳, 稲森 正彦

    日本消化器病学会雑誌   108 ( 臨増総会 )   A279 - A279   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • ESDで診断された胃壁内病変の3例

    阿部 泰伸, 遠藤 宏樹, 飯田 洋, 関野 雄典, 内山 崇, 酒井 英嗣, 細野 邦宏, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳, 前田 愼

    Gastroenterological Endoscopy   53 ( Suppl.1 )   845 - 845   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 【なぜ胃や腸は痛くなるのか? 機能性消化管疾患の病態と診療】 機能性消化管疾患の各論 Pseudo-obstruction

    中島 淳, 坂本 康成, 飯田 洋, 関野 雄典, 稲森 正彦

    Modern Physician   31 ( 3 )   331 - 335   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)新興医学出版社  

    ●Pseudo-obstruction(偽性腸閉塞)は機械的閉塞機転が認められないのにもかかわらず腸閉塞症状(腹部膨満、腹痛、嘔吐など)を示す疾患である。●その病態はfunctional disorderではなく、消化管の神経・筋・カハール介在細胞などの変性などによる腸管の蠕動運動の減弱によるmotility disorderである。●欧米ではマノメーター、シンチグラフィーを用いた診断が普及しているが我が国では実地診療でこれらの検査法が普及しておらず、厚労省研究班で本邦で実施可能な診断基準案が策定された。(著者抄録)

    researchmap

  • EUSによる分枝型IPMNの良悪性の鑑別について

    小林 規俊, 窪田 賢輔, 島村 健, 渡邊 誠太郎, 加藤 真吾, 坂本 康成, 遠藤 宏樹, 藤田 浩司, 古出 智子, 米田 正人, 高橋 宏和, 所 知加子, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斎藤 聡, 川名 一朗, 中島 淳, 前田 愼, 遠藤 格

    日本消化器病学会雑誌   108 ( 臨増総会 )   A300 - A300   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 漢方治療のエビデンス 慢性偽性腸閉塞症に対する大建中湯の使用 本邦初の国内実態調査の結果から

    稲森 正彦, 飯田 洋, 関野 雄典, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 阿部 泰伸, 前田 愼, 中島 淳

    日本内科学会雑誌   100 ( Suppl. )   166 - 166   2011年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    researchmap

  • カプセル内視鏡を契機に発見されたサイトメガロウイルス起因性出血性小腸潰瘍の1例

    酒井 英嗣, 遠藤 宏樹, 内山 崇, 細野 邦広, 古出 智子, 高橋 宏和, 所 知加子, 阿部 泰伸, 稲森 正彦, 中島 淳, 菅野 伸洋, 利野 靖, 大城 久, 稲山 嘉明

    栄養-評価と治療   28 ( 1 )   90 - 90   2011年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカルレビュー社  

    researchmap

  • 私はこう治療する 経皮内視鏡的胃瘻造設術(PEG)--一般内科医が知るべきこと

    古出 智子, 稲森 正彦, 日下部 明彦

    診断と治療   99 ( 1 )   164 - 169   2011年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:診断と治療社  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2011088782

  • 胃瘻カテーテルの抜去閉鎖を行った症例の検討:問題点の提示

    古出智子, 稲森正彦, 内山崇, 関野雄典, 酒井英嗣, 飯田洋, 細野邦広, 遠藤宏樹, 坂本康成, 米田正人, 高橋宏和, 所知加子, 安崎弘晃, 後藤歩, 阿部泰伸, 小林規俊, 窪田賢輔, 中島淳, 前田愼, 日下部明彦

    日本消化管学会総会学術集会プログラム・抄録集   7th   2011年

     詳細を見る

  • 慢性偽性腸閉塞症の内科的診断・治療の現状-厚労省研究班の調査結果を踏まえて-

    坂本康成, 関野雄典, 飯田洋, 遠藤宏樹, 藤田浩司, 米田正人, 高橋宏和, 古出智子, 所知加子, 安崎弘晃, 後藤歩, 河部泰伸, 嶌村健, 小林規俊, 桐越博之, 窪田賢輔, 斉藤聡, 前田愼, 中島淳, 稲森正彦

    日本消化管学会総会学術集会プログラム・抄録集   7th   2011年

     詳細を見る

  • 経鼻内視鏡 スクリーニング検査での有用性及び応用法の現状(ESD、イレウス管挿入、PEG、ERCPなど) 経鼻内視鏡を用いた内視鏡的胃瘻造設術は合併症を軽減させたか?

    古出 智子, 稲森 正彦, 加藤 真吾, 酒井 英嗣, 関野 雄典, 内山 崇, 渡辺 誠太郎, 飯田 洋, 細野 邦弘, 遠藤 宏樹, 坂本 康成, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 中島 淳, 前田 愼, 日下部 明彦

    Progress of Digestive Endoscopy   78 ( 1 )   62 - 62   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 内視鏡的切除を施行した十二指腸乳頭部Gangliocytic paragangliomaの一例

    高橋 碧, 小林 規俊, 窪田 賢輔, 渡邊 誠太郎, 稲森 正彦, 阿部 泰伸, 島村 健, 川名 一朗, 前田 愼, 中島 淳

    Progress of Digestive Endoscopy   78 ( 1 )   98 - 98   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 慢性偽性腸閉塞症のわが国の報告例のまとめと新たに提唱された診断基準案についての検討

    飯田 洋, 稲森 正彦, 坂本 康成, 大和 滋, 中島 淳

    診断と治療   98 ( 11 )   1879 - 1883   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)診断と治療社  

    偽性腸閉塞は、腸管に機械的な通過障害がないにも拘らず、臨床的に腸管閉塞の症状を呈する臨床的症候群である。慢性偽性腸閉塞(CIP)のうち、原因不明のものが慢性特発性偽性腸閉塞(CIIP)である。CIIPの疾患概念、分類、病態について概説し、CIPの臨床的特徴、診断と検査、診断基準案について述べた。日本のCIP症例において、中島らの診断基準案は感度85.9%と有用であった。

    researchmap

  • EUSによるearly-and advanced-stageの自己免疫性膵炎診断の提言

    窪田 賢輔, 加藤 真吾, 秋山 智之, 藤田 浩司, 米田 正人, 高橋 宏和, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 斉藤 聡, 久富 勘太郎, 松橋 信行, 中島 淳

    Gastroenterological Endoscopy   52 ( 9 )   2745 - 2754   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    ERCP、超音波内視鏡(EUS)を行った自己免疫膵炎(AIP)19例を対象とし、Cambridge Gradeにより早期(Grade 1・2)と進行期(Grade 3・4・5)に分類してEUS所見を検討した。治療として、血性IgG4値が135mg/dl以上の陽性例にはステロイド治療を行い、全例治療に良好に反応した。一方、ステロイド非投与の5例は、膵酵素阻害剤や抗生物質投与で4例が改善し、1例は自然緩解した。また、EUS所見により早期と診断した9例では5例がステロイド治療を行うことなく緩解したが、進行期例では自然緩解例はなかった。再燃は全体で21.2%に認め、1例は早期、3例は進行期で、ステロイド治療施行例であった。早期9例、進行期10例のEUS所見についてみたところ、年齢、性別、血清において両群で有意差は認めなかった。病期との関連が考えられる所見をみると、lobularityとhyperechoic duct marginは早期群で有意に高頻度に認めた。AIPの病理所見に対応したEUS所見についてみたところ、早期例では線維化は小葉内と小葉間に認め、膵腺房の小葉構造は保たれていた。進行期例では膵腺房の小葉構造は脱落し、著明な線維化に置き換わっていた。

    researchmap

  • 大腸癌治療・予防の新しい分子標的としてのレプチンシグナル経路の解析

    内山 崇, 高橋 宏和, 遠藤 宏樹, 細野 邦広, 飯田 洋, 坂本 康成, 藤田 浩司, 古出 智子, 米田 正人, 所 知加子, 阿部 泰伸, 稲森 正彦, 桐越 博之, 小林 規俊, 嶋村 健, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A851 - A851   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 本邦における慢性偽性腸閉塞の121例の症例報告のまとめ

    飯田 洋, 稲森 正彦, 渡邉 誠太郎, 内山 崇, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 米田 正人, 所 知加子, 後藤 歩, 阿部 泰伸, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 大和 滋, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A824 - A824   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 高齢者のC型慢性肝炎(1型・高ウイルス量)に対するPeg-IFN+RBV療法のSVR予測における肝生検とASTの有用性

    馬渡 弘典, 米田 正人, 藤田 浩司, 野崎 雄一, 加藤 真吾, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 島村 健, 小林 規俊, 窪田 賢輔, 桐越 博之, 中島 淳, 斉藤 聡

    肝臓   51 ( Suppl.2 )   A594 - A594   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • NASHにおける繊維化発症のメカニズムについて IL-13/TGF-βの役割

    島村 健, 藤澤 俊夫, 加藤 真吾, 渡辺 誠太郎, 藤田 浩司, 米田 正人, 高橋 宏和, 安崎 弘晃, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 川名 一郎, 窪田 賢輔, 斎藤 聡, 市川 靖史, 前田 愼, 中島 淳, Puri R

    日本消化器病学会雑誌   107 ( 臨増大会 )   A909 - A909   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • PPIとH2RAの単回経口投与における胃内pHの立ち上がりに関する検討

    飯田 洋, 稲森 正彦, 加藤 真吾, 内山 崇, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 坂本 康成, 藤田 浩司, 古出 智子, 高橋 宏和, 米田 正人, 所 知加子, 後藤 歩, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A805 - A805   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • ドンペリドンによる胃排出能の変化について Breath ID systemを用いた連続呼気採取による評価

    坂本 康成, 稲森 正彦, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 細野 邦広, 藤田 浩司, 米田 正人, 高橋 宏和, 古出 智子, 所 知加子, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 嶋村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A779 - A779   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 慢性偽性腸閉塞症 内科的診断・治療の現状

    坂本 康成, 稲森 正彦, 加藤 真吾, 内山 崇, 飯田 洋, 関野 雄典, 酒井 英嗣, 細野 邦広, 遠藤 宏樹, 藤田 浩司, 米田 正人, 高橋 宏和, 古出 智子, 所 知加子, 後藤 歩, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A823 - A823   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院で経験した悪性黒色腫の胃転移5症例の検討

    所 知加子, 稲森 正彦, 内山 崇, 飯田 洋, 鈴木 香峰理, 細野 邦広, 遠藤 宏樹, 坂本 康成, 米田 正人, 高橋 宏和, 古出 智子, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 川名 一朗, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A807 - A807   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 急性腹症で発症した異物性胃潰瘍の1例

    梅沢 翔太郎, 高橋 宏和, 内山 崇, 飯田 洋, 坂本 康成, 細野 邦広, 遠藤 宏樹, 古出 智子, 所 知加子, 阿部 泰伸, 稲森 正彦, 加藤 真吾, 渡辺 誠太郎, 藤田 浩司, 米田 正人, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.2 )   2415 - 2415   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 【機能性消化管異常症 消化管を一本の管としてみる】 便通の悩み(IBSから難病・偽性腸閉塞まで) 偽性腸閉塞(急性を除く)の診断と治療の実際

    坂本 康成, 稲森 正彦, 飯田 洋, 中島 淳

    診断と治療   98 ( 9 )   1461 - 1466   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)診断と治療社  

    researchmap

  • 胃瘻より内視鏡で止血術を行った1例

    内山 崇, 高橋 宏和, 飯田 洋, 遠藤 宏樹, 細野 邦広, 坂本 康成, 藤田 浩司, 古出 智子, 米田 正人, 所 知加子, 阿部 泰伸, 稲森 正彦, 桐越 博之, 小林 規俊, 嶌村 健, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.2 )   2469 - 2469   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 胃ろうの閉鎖を行った症例の検討

    古出 智子, 稲森 正彦, 日下部 明彦, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 米田 正人, 高橋 宏和, 所 知加子, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 嶌村 健, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.2 )   2459 - 2459   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 低分化腺癌と浸潤性微小乳頭癌成分を有した巨大胆管のう胞腺癌の1例

    本多 靖, 米田 正人, 藤田 浩司, 加藤 真吾, 馬渡 弘典, 内山 崇, 今城 健人, 留野 渉, 小林 規俊, 窪田 賢輔, 桐越 博之, 高橋 宏和, 稲森 正彦, 細野 邦弘, 遠藤 宏樹, 大城 久, 山中 正二, 稲山 嘉明, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A892 - A892   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Acoustic Radiation Force Impulse imaging(ARFI)とフィブロスキャンを用いたNAFLD患者での肝脂肪化、炎症、線維化の比較検討

    米田 正人, 今城 健人, 鈴木 香峰理, 野崎 雄一, 藤田 浩司, 細野 邦広, 遠藤 宏樹, 前田 慎, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増大会 )   A911 - A911   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • どのように対処するのか? 臨床で遭遇する下部消化管運動障害への対処法を語る

    中島 淳, 藤本 一眞, 大和 滋, 洲崎 文男, 稲森 正彦

    Pharma Medica   28 ( 9 )   95 - 100   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカルレビュー社  

    researchmap

  • 大腸憩室出血症例の検討

    鈴木 香峰理, 稲森 正彦, 内山 詩織, 今城 健人, 留野 渉, 酒井 英嗣, 山田 英司, 谷田 恵美子, 秋山 智之, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 高橋 宏和, 古出 智子, 所 知加子, 阿部 泰伸, 川口 実, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.2 )   2499 - 2499   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 一酸化窒素はNAFL形成を促進させるが、NASH進展を抑制する NAFLD病態における一酸化窒素の多様な作用とその機序について

    野崎 雄一, 藤田 浩司, 篠原 義康, 米田 正人, 馬渡 弘典, 今城 健人, 桐越 博之, 稲森 正彦, 斉藤 聡, 中島 淳

    G.I.Research   18 ( 4 )   372 - 373   2010年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)先端医学社  

    researchmap

  • Can we discriminate between "Manpuku'' (satiety) and "Bouman'' (epigastric bloating)?

    Y. Sakamoto, M. Inamori, H. Iida, T. Ikeda, A. Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   22   26 - 26   2010年8月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • Early effects of oral administrations of omeprazole with mosapride on intragastric pH

    H. Iida, M. Inamori, T. Akiyama, Y. Sakamoto, A. Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   22   63 - 63   2010年8月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • チューインガムによる胃排出能、飲水許容量の変化 連続呼気採取法と飲水試験を用いた評価

    坂本 康成, 稲森 正彦, 飯田 洋, 渡邉 誠太郎, 細野 邦広, 遠藤 宏樹, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 中島 淳

    神奈川医学会雑誌   37 ( 2 )   262 - 262   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 六君子湯の飲水許容量への効果の検討

    関野 雄典, 稲森 正彦, 飯田 洋, 坂本 康成, 細野 邦広, 遠藤 宏樹, 藤田 浩司, 米田 正人, 高橋 宏和, 古出 智子, 所 知加子, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 嶌村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳, 前田 愼

    胃病態機能研究会誌   42   40 - 40   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 飲水・呼気試験による酸分泌抑制薬と胃許容能、排出能の検討

    坂本 康成, 稲森 正彦, 関野 雄典, 飯田 洋, 細野 邦広, 遠藤 宏樹, 藤田 浩司, 米田 正人, 高橋 宏和, 古出 智子, 所 知加子, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 嶌村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳, 前田 愼

    胃病態機能研究会誌   42   37 - 37   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • 当院における内視鏡的胃ろう造設術の現況

    古出 智子, 稲森 正彦, 内山 崇, 渡邊 誠太郎, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 高橋 宏和, 所 知加子, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 中島 淳, 日下部 明彦

    神奈川医学会雑誌   37 ( 2 )   260 - 260   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 無線式pHモニタリングの当施設における使用経験

    飯田 洋, 稲森 正彦, 内山 崇, 渡邊 誠太郎, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 中島 淳

    神奈川医学会雑誌   37 ( 2 )   259 - 259   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • プロトンポンプ阻害剤先行投与によるHelicobacter pyloriの除菌率への影響

    所 知加子, 稲森 正彦, 飯田 洋, 坂本 康成, 細野 邦広, 遠藤 宏樹, 古出 智子, 高橋 宏和, 安崎 弘晃, 小川 真実, 阿部 泰伸, 川名 一朗, 中島 淳, 松田 玲圭, 高橋 大介

    神奈川医学会雑誌   37 ( 2 )   263 - 263   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 【機能性消化管障害 視えない疾患への挑戦】 機能性ディスペプシアの病態と治療 機能性ディスペプシアの病態

    坂本 康成, 稲森 正彦, 中島 淳

    カレントテラピー   28 ( 6 )   542 - 546   2010年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ライフメディコム  

    researchmap

  • 【小腸・大腸内視鏡 こんな時どうする 検査編】 小腸内視鏡 診断能向上に向けて カプセル内視鏡の前処置 全小腸を鮮明に観察するための工夫

    遠藤 宏樹, 細野 邦広, 酒井 英嗣, 日暮 琢磨, 飯田 洋, 高橋 宏和, 稲森 正彦, 松橋 信行, 中島 淳

    Intestine   14 ( 3 )   283 - 288   2010年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本メディカルセンター  

    researchmap

  • 内視鏡的治療からみた悪性胆管狭窄と良性胆管狭窄の違い 肝移植後胆管狭窄症例を中心に

    小林 規俊, 窪田 賢輔, 島村 健, 渡邊 誠太郎, 加藤 真吾, 内山 崇, 鈴木 香峰理, 飯田 洋, 馬渡 弘典, 細野 邦広, 坂本 康成, 遠藤 宏樹, 野崎 雄一, 藤田 浩司, 米田 正人, 稲森 正彦, 桐越 博之, 斉藤 聡, 武田 和永, 遠藤 格, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.1 )   971 - 971   2010年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • A New Noninvasive Modality for Recording Sequential Images and the pH of the Small Bowel

    Hiroshi Iida, Masahiko Inamori, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   71 ( 5 )   AB319 - AB319   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • Leptin signaling regulates colorectal tumor growth through Stat3 signaling: Tumor growth induced by dietary intake

    Hiroki Endo, Kunihiro Hosono, Takashi Uchiyama, Hirokazu Takahashi, Masahiko Inamori, Atsushi Nakajima

    CANCER RESEARCH   70   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM10-2479

    Web of Science

    researchmap

  • 非アルコール性脂肪性肝疾患(NAFLD)における脾体積の検討 早期非アルコール性脂肪性肝炎(NASH)の診断におけるspleen-body indexの有用性について

    鈴木 香峰理, 桐越 博之, 米田 正人, 馬渡 弘典, 藤田 浩司, 野崎 雄一, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 島村 健, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    アルコールと医学生物学   29   126 - 129   2010年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)響文社  

    2002年〜2007年に肝生検を施行した非アルコール性脂肪性肝疾患(NAFLD)患者のうち、病理組織学的に単純性脂肪肝(SFL)診断された22例(男性5例、女性17例、平均44.2歳)と線維化ステージ1または2の軽度線維化非アルコール性脂肪性肝炎(NASH)と診断された62例(男性35例、女性27例、平均49.3歳)を対象に、軽度線維化NASHとSFLの脾サイズを比較し、両者の鑑別における脾サイズの有用性について検討した。また、両者のspleen-body index(SBI)を比較検討した。軽度線維化NASHで有意に高値であったものは皮下脂肪、AST、フェリチン、CRPであった。またSBIについてはSFL群におけるSBI平均値は15.83、軽度線維化NASH群におけるSBI平均値は18.69で有意に軽度線維化NASH群においてSBIが高かった。ROC曲線の曲線下面積は0.661でoptimal cut off値16.25、感度66.1%、特異度68.2%、陽性的中率85.4%、陰性的中率41.7%であった。軽度線維化NASHを規定する因子として単変量解析で有意差を認めた項目を用い、ロジスティック回帰分析を行ったところ、性別およびSBIが独立してNASH軽度線維化を規定する因子として認められた。

    researchmap

  • 分枝型IPMN診断におけるEUSの役割について

    小林 規俊, 窪田 賢輔, 島村 健, 渡邊 誠太郎, 加藤 真吾, 鈴木 香峰里, 内山 崇, 飯田 洋, 馬渡 弘典, 坂本 康成, 細野 邦広, 遠藤 宏樹, 野崎 雄一, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.1 )   1075 - 1075   2010年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • HDL-free cholesterolとC型慢性肝炎(genotype1・高ウイルス量)に対する治療抵抗性との関係

    馬渡 弘典, 斉藤 聡, 篠原 義康, 米田 正人, 藤田 浩司, 野崎 雄一, 桐越 博之, 加藤 真吾, 遠藤 宏樹, 細野 邦広, 坂本 康成, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 窪田 賢輔, 中島 淳

    肝臓   51 ( Suppl.1 )   A298 - A298   2010年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Capsule Endoscopy Findings in the Small Intestine of HIV Carrier

    Kunihiro Hosono, Hiroki Endo, Takashi Uchiyama, Kaori Suzuki, Hiroshi Iida, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Atsuhisa Ueda, Tomoyuki Miura, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   71 ( 5 )   AB370 - AB370   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • 経鼻内視鏡における最適な挿入ルートの検討

    細野 邦広, 稲森 正彦, 内山 崇, 渡邉 誠太郎, 鈴木 香峰理, 飯田 洋, 遠藤 宏樹, 野崎 雄一, 坂本 康成, 藤田 浩司, 高橋 宏和, 米田 正人, 古出 智子, 所 知加子, 阿部 泰伸, 嶌村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.1 )   1003 - 1003   2010年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • PEG造設・交換の手技と工夫 内視鏡的胃ろう造設術後の早期合併症の検討 造設方法の差異を中心に

    古出 智子, 稲森 正彦, 中島 淳

    Gastroenterological Endoscopy   52 ( Suppl.1 )   901 - 901   2010年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • NAFLDと肝血流 eNOSは体内脂肪分布を制御する

    野崎 雄一, 藤田 浩司, 米田 正人, 篠原 義康, 馬渡 弘典, 今城 健人, 桐越 博之, 高橋 宏和, 古出 智子, 所 知加子, 安崎 弘晃, 阿部 泰伸, 小林 規俊, 島村 健, 稲森 正彦, 川名 一朗, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A226 - A226   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 【初診外来における初期診療】 異物の誤飲

    坂本 康成, 稲森 正彦, 中島 淳

    診断と治療   98 ( Suppl. )   363 - 366   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)診断と治療社  

    researchmap

  • 小腸疾患の診断と治療法の進歩 非侵襲的かつ連続的に小腸の画像とpHを同時に測定する機器「pHカプセル」の開発

    飯田 洋, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A152 - A152   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 難治性GERDの治療戦略 難治性胃食道逆流症の治療戦略

    稲森 正彦, 阿部 泰伸, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A137 - A137   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 酸分泌抑制薬と胃許容能、胃排出能について 飲水試験、呼気試験を用いた検討

    坂本 康成, 稲森 正彦, 飯田 洋, 細野 邦広, 遠藤 宏樹, 藤田 浩司, 古出 智子, 米田 正人, 高橋 宏和, 所 知加子, 安崎 弘晃, 後藤 歩, 阿部 泰伸, 嶌村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A259 - A259   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 内視鏡的胃ろう造設術後の出血に関する検討

    古出 智子, 稲森 正彦, 日下部 明彦, 加藤 真吾, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 藤田 浩司, 高橋 宏和, 米田 正人, 所 知加子, 後藤 歩, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A250 - A250   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 酸分泌抑制薬の前投与によるHelicobacter pyloriの除菌率への影響 プロトンポンプ阻害薬とH2受容体拮抗薬の差異は?

    所 知加子, 稲森 正彦, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 藤田 浩司, 古出 智子, 高橋 宏和, 米田 正人, 後藤 歩, 安崎 弘晃, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 松田 玲圭, 高橋 大介, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A300 - A300   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 一酸化窒素(NO)はNAFL形成を促進させるが、NASH進展を抑制する NAFLD病態におけるNOの多様な作用とその機序について

    野崎 雄一, 藤田 浩司, 米田 正人, 篠原 義康, 今城 健人, 馬渡 弘典, 桐越 博之, 稲森 正彦, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A225 - A225   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸憩室症の存在部位と内臓脂肪との関連性についての検討

    渡邉 誠太郎, 稲森 正彦, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 鈴木 香峰理, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 阿部 泰伸, 桐越 博之, 小林 規俊, 嶌村 健, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A208 - A208   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 肝腫瘍、膵腫瘍の予後因子としてのFOXP3+制御性T細胞について

    小林 規俊, 平岡 伸介, 窪田 賢輔, 渡邊 誠太郎, 加藤 真吾, 島村 健, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 野崎 雄一, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A233 - A233   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • カプセル内視鏡で確認した潰瘍性大腸炎の小腸病変

    日暮 琢磨, 遠藤 宏樹, 内山 詩織, 城野 文武, 小島 拓人, 千葉 宙門, 村瀬 貴之, 柳沢 昇吾, 細野 邦広, 谷 理恵, 稲森 正彦, 川名 憲一, 永瀬 肇, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A437 - A437   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NASH患者に対するエゼチミブの有用性 6ヵ月投与による肝組織改善効果のパイロットスタディー

    米田 正人, 藤田 浩司, 野崎 雄一, 遠藤 宏樹, 加藤 真吾, 細野 邦広, 高橋 宏和, 鈴木 香峰理, 内山 崇, 坂本 康成, 飯田 洋, 馬渡 弘典, 小林 規俊, 島村 健, 阿部 泰伸, 稲森 正彦, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A227 - A227   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院における分枝型IPMNの切除例および経過観察例の検討

    小林 規俊, 窪田 賢輔, 渡邊 誠太郎, 加藤 真吾, 島村 健, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 野崎 雄一, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 遠藤 格, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A234 - A234   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸憩室出血症例の検討

    鈴木 香峰理, 秋山 智之, 稲森 正彦, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 坂本 康成, 高橋 宏和, 古出 智子, 所 知加子, 阿部 泰伸, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 小山 茂, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A391 - A391   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸腫瘍進展における糖尿病関連因子の相関解析

    高橋 宏和, 細野 邦広, 内山 崇, 飯田 洋, 遠藤 宏樹, 野崎 雄一, 坂本 康成, 藤田 浩司, 米田 正人, 古出 智子, 所 知加子, 後藤 歩, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   107 ( 臨増総会 )   A361 - A361   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 食事、生活指導により消化器症状は変化するか? Fスケールを用いた研究

    坂本 康成, 稲森 正彦, 飯田 洋, 岩崎 知之, 内山 崇, 秋山 智之, 池田 多聞, 細野 邦広, 遠藤 宏樹, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 中島 淳

    神奈川医学会雑誌   37 ( 1 )   63 - 64   2010年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 胃排出と薬の速効性 pHモニタリングを用いた研究

    飯田 洋, 稲森 正彦, 内山 崇, 秋山 智之, 池田 多聞, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 中島 淳

    神奈川医学会雑誌   37 ( 1 )   65 - 65   2010年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 胃食道逆流症患者に対するon demand therapy 維持療法における臨床的観察

    稲森 正彦, 飯田 洋, 内山 崇, 秋山 智之, 池田 多聞, 細野 邦広, 遠藤 宏樹, 坂本 康成, 古出 智子, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 中島 淳

    神奈川医学会雑誌   37 ( 1 )   64 - 64   2010年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 当施設における無線式pHモニタリングの使用経験

    飯田洋, 稲森正彦, 加藤真吾, 内山崇, 渡邊誠太郎, 細野邦広, 遠藤宏樹, 坂本康成, 藤田浩司, 古出智子, 高橋宏和, 米田正人, 所知加子, 後藤歩, 阿部泰伸, 小林規俊, 桐越博之, 窪田賢輔, 斉藤聡, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   6th   2010年

     詳細を見る

  • 子宮頸癌による癌性イレウスに対し,経皮内視鏡的胃瘻造設術後に経胃瘻的にイレウス管挿入を試みた一例

    渡邉誠太郎, 稲森正彦, 留野渉, 加藤真吾, 内山崇, 藤田浩司, 古出智子, 高橋宏和, 米田正人, 所知加子, 小川真実, 阿部泰伸, 嶌村健, 小林規俊, 桐越博之, 窪田賢輔, 斉藤聡, 川名一朗, 上野規男, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   6th   2010年

     詳細を見る

  • 内視鏡的に吸引除去し得た食道異物の2例

    坂本康成, 稲森正彦, 飯田洋, 渡邉誠太郎, 遠藤宏樹, 細野邦広, 高橋宏和, 古出智子, 米田正人, 所知加子, 小川真実, 阿部泰伸, 嶌村健, 小林規俊, 桐越博之, 窪田賢輔, 斉藤聡, 川名一朗, 上野規男, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   6th   2010年

     詳細を見る

  • 内視鏡的一括切除が可能であった盲腸への逸脱を認めた巨大小腸ポリープの1例

    嶌村 健, 姜 正広, 坂本 康成, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 古出 智子, 所 知加子, 高橋 宏和, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 川名 一郎, 稲山 嘉明, 中島 淳

    Progress of Digestive Endoscopy   76 ( 1 )   121 - 121   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 自己免疫性膵炎の診断と治療効果判定にVater乳頭部の内視鏡的、免疫組織学的所見が有用であった1例

    石田 修一, 窪田 賢輔, 馬渡 弘典, 阿部 泰伸, 稲森 正彦, 小林 規俊, 斉藤 聡, 大城 久, 山中 正二, 中島 淳

    Progress of Digestive Endoscopy   75 ( 2 )   126,10 - 127,10   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    症例は63歳、男性。膵腫大、膵管狭細像に加え、Vater乳頭部腫大と同部位でのIgG4陽性形質細胞浸潤を認め、自己免疫性膵炎と診断された。これらの所見は、いずれもステロイド治療開始後より改善を認めた。自己免疫性膵炎における診断、治療効果の判定の補助にVater乳頭部所見と、同部位へのIgG4陽性形質細胞浸潤の程度が有用であることが示唆された。(著者抄録)

    DOI: 10.11641/pde.75.2_126

    researchmap

  • 十二指腸静脈瘤に対し内視鏡的静脈瘤結紮術が奏効した1例

    加藤 真吾, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 所 知加子, 古出 智子, 坂本 康成, 飯田 洋, 細野 邦弘, 遠藤 宏樹, 中島 淳

    Progress of Digestive Endoscopy   75 ( 2 )   78,4 - 79,4   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    十二指腸静脈瘤は稀な疾患であるが、一度出血をきたすと止血が困難で時に致命的となる。治療法の選択は確立されていないが、侵襲性が低く、簡便かつ迅速に行える内視鏡的治療は緊急時の第一選択として期待される。今回、内視鏡的静脈瘤結紮術(Endoscopic Variceal Ligation;EVL)が奏効した十二指腸静脈瘤の症例を経験したので報告する。(著者抄録)

    DOI: 10.11641/pde.75.2_78

    researchmap

  • 消化器内視鏡偶発症に対するトラブルシューティング 胃瘻損傷時の胃壁固定を用いたリカバリー

    古出 智子, 稲森 正彦, 加藤 真吾, 内山 崇, 渡邊 誠太郎, 飯田 洋, 遠藤 宏樹, 細野 邦広, 藤田 浩司, 米田 正人, 高橋 宏和, 所 知加子, 後藤 歩, 阿部 泰伸, 嶌村 健, 小林 規俊, 窪田 賢輔, 佐藤 晶子, 日下部 明彦, 中島 淳

    Progress of Digestive Endoscopy   76 ( 1 )   81 - 81   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • NAFLDと肝血流 血管内皮型一酸化窒素合成酵素(eNOS)は体内脂肪分布を制御する

    野崎 雄一, 藤田 浩司, 米田 正人, 馬渡 弘典, 篠原 義康, 今城 健人, 高橋 宏和, 阿部 泰伸, 島村 健, 桐越 博之, 小林 規俊, 稲森 正彦, 窪田 賢輔, 斉藤 聡, 中島 淳

    肝臓   50 ( Suppl.3 )   A734 - A734   2009年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 非アルコール性脂肪性肝疾患(NAFLD)における脾サイズの検討 NASH診断におけるspleen-body index(SBI)の有用性について

    鈴木 香峰理, 桐越 博之, 米田 正人, 馬渡 弘典, 野崎 雄一, 藤田 浩司, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 島村 健, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    肝臓   50 ( Suppl.3 )   A739 - A739   2009年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Management of Acute Lower Intestinal Bleeding: What Bowel Preparation Should be Required for Urgent Colonoscopy?

    Kumiko Saito, Masahiko Inamori, Yusuke Sekino, Keiko Akimoto, Kaori Suzuki, Ayako Tomimoto, Nobutaka Fujisawa, Kensuke Kubota, Satoru Saito, Shigeru Koyama, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 94-95 )   1331 - 1334   2009年9月

     詳細を見る

    記述言語:英語   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The management of acute intestinal bleeding is not standardized. The aim of this study was to determine the most suitable method of bowel preparation for urgent colonoscopy.
    Methodology: One hundred and forty patients admitted with acute lower intestinal bleeding (ALIB) to our Hospital (April 1998 to March 2004) were studied. The preparation for colonoscopy consisted, usually, of oral administration of polyethylene glycol (PEG)-salt solution. For elderly patients or for those suspected of bleeding from a sigmoid colon lesion, colonoscopy was performed following glycerin enemas or water enemas. For patients with a suspected rectal lesion or soon after undergoing a polypectomy, colonoscopy was performed without any of the above procedures.
    Results: Ischemic colitis was the most common cause of bleeding. The overall cecal completion ratio was 41%, compared with 74% in the PEG group. The percentage of those in whom colonoscopy was impossible (poor preparation) was 16% overall, compared with 5% in the PEG group. Endoscopic hematemesis were performed successfully for 26 patients who were mainly postpolypectomy cases or had rectal ulcers.
    Conclusions: In urgent colonoscopy, the preparation with PEG-salt solution may improve the patient&apos;s outcome. In postpolypectomy patients and those with rectal ulcers preparation was not always needed.

    Web of Science

    researchmap

  • 6歳小児の感染性膵仮性嚢胞に対し、direct endoscopic drainageを施行した一例

    加藤 真吾, 窪田 賢輔, 小林 規俊, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 野崎 雄一, 遠藤 宏樹, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.2 )   2300 - 2300   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 開腹生検によっても膵癌の確定診断に至らなかった症例の検討

    小林 規俊, 窪田 賢輔, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 野崎 雄一, 米田 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 遠藤 格, 稲山 嘉明, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A931 - A931   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • IPMNの多段階発がんにおけるFOXP3+制御性T細胞の変化についての検討

    小林 規俊, 窪田 賢輔, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 野崎 雄一, 米田 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 上田 倫夫, 遠藤 格, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A922 - A922   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • metallic stent逸脱に対し、内視鏡的抜去が可能であった膵癌の2例

    加藤 真吾, 窪田 賢輔, 小林 規俊, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 野崎 雄一, 遠藤 宏樹, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.2 )   2272 - 2272   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 十二指腸球部に穿破をきたした胆嚢がんの一例

    石戸 岳仁, 小林 規俊, 窪田 賢輔, 加藤 真吾, 山本 晴美, 内山 崇, 飯田 洋, 馬渡 弘典, 米田 恭子, 遠藤 宏樹, 野崎 雄一, 藤田 浩司, 米田 正人, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 遠藤 格, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.2 )   2294 - 2294   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 急激に進行した食道静脈瘤破裂に対する内視鏡治療後に脳梗塞を起した1例

    竹中 麻起, 内山 崇, 高橋 宏和, 阿部 泰伸, 加藤 真吾, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 細野 邦広, 秋山 智之, 米田 恭子, 藤田 浩司, 米田 正人, 稲森 正彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.2 )   2208 - 2208   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • ディスペプシア症状と内視鏡 早期飽満感に対応する内視鏡所見はなにか? 問診表と内視鏡所見の対比

    稲森 正彦, 阿部 泰伸, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A674 - A674   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • わが国におけるアスピリン、NSAID消化管傷害の現況と対策 低用量アスピリンによる小腸粘膜傷害の評価 病変の特徴、剤型による違いにせまる

    遠藤 宏樹, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A560 - A560   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸ポリープ、大腸癌の診断に血清レプチン値は有用か

    内山 崇, 高橋 宏和, 飯田 洋, 遠藤 宏樹, 細野 邦弘, 秋山 智之, 阿部 泰伸, 稲森 正彦, 加藤 真吾, 渡辺 誠太郎, 馬渡 弘典, 米田 恭子, 野崎 雄一, 藤田 浩司, 米田 正人, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A853 - A853   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 生活習慣病からみた大腸癌の新たな化学発癌予防 抗糖尿病薬メトホルミンを用いた検討

    細野 邦広, 高橋 宏和, 加藤 真吾, 内山 嵩, 鈴木 香峰理, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 坂本 康成, 米田 恭子, 藤田 浩司, 米田 正人, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A839 - A839   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院で経験した無症候性に診断された日本住血吸虫症の3例

    竹前 久美, 米田 正人, 野崎 雄一, 留野 渉, 藤田 浩司, 内山 崇, 遠藤 宏樹, 飯田 洋, 馬渡 弘典, 細野 邦彦, 高橋 宏和, 加藤 真吾, 秋山 智之, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A094 - A094   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 経腸栄養剤の固形化による胃排出能の変化及びモサプリドの与える影響について BreathID systemを用いた検討

    池田 多聞, 稲森 正彦, 秋本 恵子, 飯田 洋, 遠藤 宏樹, 細野 邦広, 秋山 智之, 藤田 浩司, 坂本 康成, 米田 正人, 高橋 宏和, 後藤 歩, 廣川 智, 内山 崇, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A779 - A779   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • H2受容体拮抗薬投与初期における胃内pHに関する検討 mint oilの効果について

    飯田 洋, 稲森 正彦, 加藤 真吾, 内山 崇, 細野 邦広, 遠藤 宏樹, 米田 恭子, 秋山 智之, 藤田 浩司, 坂本 康成, 高橋 宏和, 米田 正人, 後藤 歩, 廣川 智, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A763 - A763   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 十二指腸静脈瘤破裂に対し3度のEVLが必要であった1例

    高橋 宏和, 阿部 泰伸, 稲森 正彦, 留野 渉, 渡辺 誠太郎, 加藤 真吾, 内山 崇, 藤田 浩司, 米田 正人, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A793 - A793   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 満腹感と膨満感を日本人は区別しているのか?(第2報)

    坂本 康成, 稲森 正彦, 飯田 洋, 加藤 真吾, 内山 崇, 細野 邦広, 遠藤 宏樹, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 後藤 歩, 廣川 智, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増大会 )   A779 - A779   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Telmisartan投与が推奨されるNASH背景病態の検討

    藤田 浩司, 野崎 雄一, 留野 渉, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 坂本 康成, 細野 邦広, 遠藤 宏樹, 米田 正人, 高橋 宏和, 稲森 正彦, 阿部 泰伸, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斎藤 聡, 中島 淳

    肝臓   50 ( Suppl.2 )   A553 - A553   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • HBs抗体陽性でALTが軽度異常を示したB型肝炎の1例

    馬渡 弘典, 斉藤 聡, 桐越 博之, 米田 正人, 藤田 浩司, 野崎 雄一, 飯田 洋, 篠原 義康, 秋山 智之, 内山 崇, 加藤 真吾, 遠藤 宏樹, 米田 恭子, 細野 邦広, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 窪田 賢輔, 中島 淳

    肝臓   50 ( Suppl.2 )   A504 - A504   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • The Continuous Real-Time C-13-Octanoate Breath Test for Patients with Nonalcoholic Steatohepatitis Using the BreathID System

    Hironori Mawatari, Masahiko Inamori, Koji Fujita, Masato Yoneda, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   56 ( 94-95 )   1436 - 1438   2009年9月

     詳細を見る

    記述言語:英語   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Hepatic mitochondrial beta-oxidation is considered to play a pivotal role in the pathogenesis of nonalcoholic steatohepatitis (NASH). The aim of this study was to determine whether there were differences between patients with NASH and healthy controls in a breath test with C-13-octanoate, a medium-chain fatty acid.
    Methodology: The subjects were 8 patients (5 men, 3 women, median age 46.5 years) with histologically proven NASH and 6 healthy controls (5 men, 1 women, and median age 27.8 years). The C-13 breath test was performed for 4 hours using the BreathID system with a 100mL of water, containing 100mg C-13-octanoate.
    Results: There were no significant differences between NASH patients and controls about all breath test; parameters.
    Conclusions: NASH-mediated changes in breath test parameters after ingestion of C-13-octanoate were not observed in our study. The present study findings suggest the possible preservation of C-13-octanoate metabolism (mitochondrial beta-oxidation) in patients with NASH.

    Web of Science

    researchmap

  • Risk Factors for the Progression of Endoscopic Barrett's Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria

    T. Akiyama, M. Inamori, K. Akimoto, H. Iida, H. Mawatari, H. Endo, T. Ikeda, Y. Nozaki, K. Yoneda, Y. Sakamoto, K. Fujita, M. Yoneda, H. Takahashi, S. Hirokawa, A. Goto, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, A. Nakajima

    DIGESTIVE DISEASES AND SCIENCES   54 ( 8 )   1702 - 1707   2009年8月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    Purpose To determine the prevalence and progression of Barrett's epithelium and associated risk factors in Japan. Methods The study population comprised 869 cases. Endoscopic Barrett's epithelium was diagnosed based on the Prague C & M Criteria. The correlations of clinical factors with the prevalence and progression of endoscopic Barrett's epithelium were examined. Results Endoscopic Barrett's epithelium was diagnosed in 374 cases (43%), in the majority of which the diagnosis was short-segment Barrett's esophagus. The progression of Barrett's epithelium was identified in 47 cases. In univariate and multiple logistic regression analyses, aging, smoking habit, and erosive esophagitis were significantly associated with the prevalence of Barrett's epithelium, whereas aging and erosive esophagitis, especially severe erosive esophagitis, were significant contributing factors to the progression of Barrett's epithelium. Conclusions Forty-three percent of the total study population was diagnosed as having endoscopic Barrett's epithelium. During the follow-up period, 12.6% of the cases with Barrett's epithelium exhibited progression which was associated with aging and severe erosive esophagitis.

    DOI: 10.1007/s10620-008-0537-y

    Web of Science

    researchmap

  • Adiponectin and signal pathways in obesity-induced colon cancer Reply

    H. Endo, T. Fujisawa, H. Takahashi, M. Inamori, A. Nakajima

    GUT   58 ( 8 )   1169 - 1170   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:B M J PUBLISHING GROUP  

    Web of Science

    researchmap

  • Authors' reply

    H. Endo, T. Fujisawa, H. Takahashi, M. Inamori, A. Nakajima

    Gut   58 ( 8 )   1169 - 1170   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)  

    Scopus

    researchmap

  • 下部胆管にskip lesionを有した早期十二指腸乳頭部癌の一例

    加藤 真吾, 窪田 賢輔, 小川 真実, 稲森 正彦, 遠藤 格, 稲山 嘉明, 中島 淳

    胆道   23 ( 3 )   531 - 531   2009年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本胆道学会  

    researchmap

  • 満腹感と膨満感を日本人は区別しているのか?

    稲森 正彦, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦宏, 遠藤 宏樹, 野崎 雄一, 秋山 智之, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 廣川 智, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    神奈川医学会雑誌   36 ( 2 )   270 - 270   2009年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 胃排出を速くする事により酸分泌抑制薬の効き始めを速くする試み

    飯田 洋, 稲森 正彦, 内山 崇, 遠藤 宏樹, 細野 邦広, 秋山 智之, 後藤 歩, 高橋 宏和, 阿部 泰伸, 中島 淳

    胃病態機能研究会誌   41   27 - 27   2009年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • NSAIDs(アスピリンを含む)に起因する消化管病変の実態並びにそれに対する取り組みについて 出血を認めた低用量アスピリン起因性小腸潰瘍のカプセル内視鏡診断

    遠藤 宏樹, 稲森 正彦, 中島 淳

    神奈川医学会雑誌   36 ( 2 )   276 - 276   2009年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy

    Hiroki Endo, Kunihiro Hosono, Masahiko Inamori, Yuichi Nozaki, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Tomohiko Ohya, Kantaro Hisatomi, Takuma Teratani, Nobuyuki Matsuhashi, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   44 ( 6 )   544 - 549   2009年6月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    The antithrombotic effects of low-dose aspirin (LDA) are well established, and it is used for primary and secondary prevention of cardiovascular events. However, the small intestinal toxicity of LDA remains unclear. The aim of this study was to review the characteristics of small bowel injury in long-term LDA users with capsule endoscopy (CE).
    We retrospectively reviewed all chronic LDA users (&gt; 3 months) who underwent CE for suspected small bowel diseases from May 2004 to May 2008 at two medical centers.
    At our institutions, a total of 22 patients (13 males and 9 females, mean age 66.3 years) taking LDA underwent a CE examination. The indications for CE were obscure gastrointestinal bleeding in 21 patients and 1 patient who had abdominal pain. Twenty-one patients (95.5%) had some small bowel mucosal injury. Small bowel erosions were identified in 14 patients (63.6%). This enteropathy was characterized by multiple petechiae, loss of villi, erosions, and ulcers with round, irregular, and punched-out shapes. Two patients had circumferential ulcers with stricture. In most patients, small bowel lesions were multifocal and were evenly distributed in the small bowel. No patients failed to pass the capsule.
    This is the first CE report that has studied the characteristics of small bowel injury in chronic LDA users. CE is useful to diagnose small bowel enteropathy associated with LDA.

    DOI: 10.1007/s00535-009-0040-z

    Web of Science

    researchmap

  • 色素拡大観察にて診断しえた粘膜内Barrett腺癌の1例

    秋山 智之, 坂本 康成, 内山 崇, 飯田 洋, 細野 邦広, 遠藤 宏樹, 米田 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斎藤 聡, 中山 崇, 稲山 嘉明, 中島 淳

    Progress of Digestive Endoscopy   75 ( 1 )   94 - 94   2009年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 十二指腸静脈瘤破裂に対し2度のEVLが奏功した1例

    加藤 真吾, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 野崎 雄一, 秋山 智之, 米田 恭子, 藤田 浩司, 米田 正人, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   75 ( 1 )   81 - 81   2009年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 経鼻内視鏡の現状と問題点 経鼻内視鏡の位置づけ 医療者側の評価

    細野 邦広, 稲森 正彦, 内山 崇, 加藤 真吾, 飯田 洋, 遠藤 宏樹, 秋山 智之, 池田 多聞, 米田 恭子, 坂本 康成, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斎藤 聡, 中島 淳

    Progress of Digestive Endoscopy   75 ( 1 )   76 - 76   2009年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • Abdominal Surgery Affects Small Bowel Transit Time and Completeness of Capsule Endoscopy

    Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inamori, Tomohiko Ohya, Hiroshi Iida, Hironori Mawatari, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   54 ( 5 )   1066 - 1070   2009年5月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    The aim of the study was to evaluate bowel dysmotility in patients with a history of abdominal surgery by measuring both gastric transit time and small bowel transit time during capsule endoscopy and assessing the completeness of the examination. The study included 26 patients who had undergone abdominal surgery (postoperative group) and 52 patients who had not (control group). The capsule reached the cecum in 50.0% of the postoperative group and 80.8% of the control group (P = 0.005). While there was no significant difference in gastric transit time between the two groups (P = 0.882), small bowel transit time was significantly longer in the postoperative group (338.3 +/- A 119.2 min) than in the control group (266.4 +/- A 110.8 min, P = 0.010). This is the first study to report that the small bowel transit time during capsule endoscopy is prolonged in patients who had a history of abdominal surgery, resulting in a lower frequency of complete examination.

    DOI: 10.1007/s10620-008-0467-8

    Web of Science

    researchmap

  • Natural history of human aberrant crypt foci after colorectal polypectomy

    Hirokazu Takahashi, Kunihiro Hosono, Hiroki Endo, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Yoshinobu Kubota, Hitoshi Nakagama, Atsushi Nakajima

    CANCER RESEARCH   69   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER ASSOC CANCER RESEARCH  

    Web of Science

    researchmap

  • Hepatic Arterial Infusion Chemotherapy (HAIC) with Interferon Is Very Useful for Unresectable Hepatocellular Carcinoma (HCC)

    Hiroyuki Kirikoshi, Satoru Saito, Masato Yoneda, Koji Fujita, Hironori Mawatari, Hiroshi Lida, Takashi Uchiyama, Yuichi Nozaki, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima

    GASTROENTEROLOGY   136 ( 5 )   A861 - A861   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • Dysfunctional VLDL Synthesis and Release Is a Key Factor in Non-Alcoholic Steatohepatitis(NASH) Progression

    Koji Fujita, Yuichi Nozaki, Masato Yoneda, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Hiroyuki Kirikoshi, Yasunobu Abe, Hiroshi Iida, Hironori Mawatari, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    GASTROENTEROLOGY   136 ( 5 )   A848 - A848   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • Plasma IGF-1 Is Correlated with Dysplastic Aberrant Crypt Foci in Men

    Hirokazu Takahashi, Kunihiro Hosono, Hiroki Endo, Kyoko Yoneda, Tomoyuki Akiyama, Masahiko Inamori, Yasunobu Abe, Shingo Kato, Takashi Uchiyama, Hiroshi Iida, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Masato Yoneda, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    GASTROENTEROLOGY   136 ( 5 )   A752 - A752   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • Follow-Up Study of the Progression of Non-Alcoholic Steatohepatitis (NASH) in An Inducible Nitric Oxide Synthase (iNOS)-Knockout Mouse Model 査読

    Nozaki Yuchi, Fujita Koji, Yoneda Masato, Wada Koichiro, Shinohara Yoshiyasu, Mawatari Hironori, Takahashi Hirokazu, Inamori Masahiko, Kobayashi Noritoshi, Kirikoshi Hiroyuki, Kubota Kensuke, Saito Satoru, Nagashima Yoji, Nakajima Atsushi

    GASTROENTEROLOGY   136 ( 5 )   A848   2009年5月

  • Evaluation of Clinical Symptoms of Gastroesopahgeal Disease with the Questionnaire Is Critical for Treatment with Proton Pump Inhibitor: 146 Patients in Japan Multi Center Trial with the Endoscopic Examination and Questionnaire.

    Yasuhisa Sakata, Kazuma Fujimoto, Yasuhiro Fujiwara, Masahiko Inamori, Junji Tanaka, Tomohiko Shimatani, Junichi Akiyama, Takashi Ando, Noriaki Manabe, Fukunori Kinjo, Ryuzo Deguchi, Motoyasu Kusano

    GASTROENTEROLOGY   136 ( 5 )   A286 - A287   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 膵動静脈奇形の内視鏡所見についての検討

    加藤 真吾, 小林 規俊, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 野崎 雄一, 遠藤 宏樹, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   846 - 846   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 肝移植後胆管狭窄に対する内視鏡的治療に関する検討

    小林 規俊, 窪田 賢輔, 加藤 真吾, 小川 真実, 馬渡 弘典, 飯田 洋, 内山 崇, 米田 恭子, 遠藤 宏樹, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 上野 規男, 武田 和永, 遠藤 格, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   845 - 845   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • NAFLD病態形成にeNOS由来NOは関与しているか?

    野崎 雄一, 藤田 浩司, 米田 正人, 馬渡 弘典, 内山 崇, 篠原 義康, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 長嶋 洋治, 中島 淳

    肝臓   50 ( Suppl.1 )   A212 - A212   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • HDL中のリン脂質測定はC型慢性肝炎・genotype 1型のPEG-IFN+RBV療法における治療前効果予測因子となり得る

    馬渡 弘典, 斉藤 聡, 佐々木 裕樹, 米田 正人, 藤田 浩司, 篠原 義康, 野崎 雄一, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 中島 淳

    肝臓   50 ( Suppl.1 )   A148 - A148   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 進行肝細胞癌に対する、PEG-IFNα2b併用5-FU肝動注化学療法

    桐越 博之, 馬渡 弘典, 米田 正人, 藤田 浩司, 日暮 琢磨, 内山 崇, 飯田 洋, 野崎 雄一, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 後藤 歩, 小林 規俊, 窪田 賢輔, 上野 規男, 斉藤 聡, 中島 淳

    肝臓   50 ( Suppl.1 )   A276 - A276   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 上部消化管内視鏡検査後に溶血発作を認めた1例

    内山 崇, 稲森 正彦, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   959 - 959   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 胃瘻カテーテル交換に伴う偶発症とその対策 胃瘻カテーテル交換後の細径内視鏡による経カテーテル的胃内留置確認と瘻孔損傷時の胃壁固定具を用いたリカバリー

    稲森 正彦, 内山 崇, 細野 邦広, 飯田 洋, 遠藤 宏樹, 秋山 智之, 藤田 浩司, 米田 恭子, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 日下部 明彦, 小林 規俊, 窪田 賢輔, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   1043 - 1043   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 糖尿病患者に発症した虚血性胃炎の1症例

    細野 邦広, 稲森 正彦, 加藤 真吾, 遠藤 宏樹, 藤田 浩司, 高橋 宏和, 阿部 泰伸, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   959 - 959   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 【ミトコンドリアがおもしろい!消化管疾患へのアプローチ】 ミトコンドリア病と消化管機能障害の関連を探る MELAS自験例の考察より

    稲森 正彦, 中島 淳

    G.I.Research   17 ( 2 )   119 - 122   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)先端医学社  

    胃排出能を測定し得たMELAS患者自験例の臨床経過を提示する。上下部内視鏡ともに残渣が残っていたが、BreathID systemを用いた胃排出能の測定ではほぼ正常であった。偽性腸閉塞との関連では、MELASなどに特徴的なヘテロプラスミーによる臨床表現型の多様性について考察する。(著者抄録)

    researchmap

  • C型慢性肝炎患者におけるインスリン抵抗性の変化

    斉藤 聡, 馬渡 弘典, 桐越 博之, 米田 正人, 藤田 浩司, 野崎 雄一, 飯田 洋, 内山 崇, 加藤 真吾, 篠原 義康, 遠藤 宏樹, 細野 邦広, 阿部 泰伸, 稲森 正彦, 高橋 宏和, 小林 規俊, 窪田 賢輔, 中島 淳

    肝臓   50 ( Suppl.1 )   A380 - A380   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • カプセル内視鏡の新展開 低用量アスピリン起因性の小腸粘膜傷害発生の検討 健常ボランティアに対しカプセル内視鏡を用いたクロスオーバー試験

    遠藤 宏樹, 稲森 正彦, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   774 - 774   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 内視鏡を用いた消化器機能検査 カプセル内視鏡における胃通過時間の意義 呼気法による胃排出能測定との比較

    稲森 正彦, 遠藤 宏樹, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   657 - 657   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 当院におけるB型慢性肝炎と肝癌発癌の検討

    内山 崇, 斉藤 聡, 加藤 真吾, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 細野 邦広, 秋山 智之, 藤田 浩司, 米田 恭子, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 中島 淳

    肝臓   50 ( Suppl.1 )   A311 - A311   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Incidence of Small Bowel Injury Induced By Low-Dose Aspirin: A Crossover Study Using Capsule Endoscopy in Healthy Volunteers

    Hiroki Endo, Kunihiro Hosono, Masahiko Inamori, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   69 ( 5 )   AB211 - AB211   2009年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • 出血を認めた低用量アスピリン起因性小腸粘膜傷害のカプセル内視鏡診断

    遠藤 宏樹, 細野 邦広, 稲森 正彦, 飯田 洋, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳, 松橋 信行

    Gastroenterological Endoscopy   51 ( Suppl.1 )   840 - 840   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Aberrant crypt fociの自然史に対する解析

    高橋 宏和, 細野 邦広, 遠藤 宏樹, 米田 恭子, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 野崎 雄一, 秋山 智之, 藤田 浩司, 米田 正人, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   832 - 832   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • プロトンポンプ阻害薬維持療法中の胃食道逆流症患者におけるH2受容体拮抗薬の意義

    稲森 正彦, 秋山 智之, 中島 淳

    Gastroenterological Endoscopy   51 ( Suppl.1 )   855 - 855   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Barrett粘膜の形状・長さと逆流性食道炎の分布の関連性について

    秋山 智之, 稲森 正彦, 野崎 雄一, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 米田 恭子, 米田 正人, 高橋 宏和, 後藤 歩, 藤田 浩司, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斎藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A373 - A373   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 内臓脂肪およびアディポサイトカインの大腸発癌に関する解析

    高橋 宏和, 細野 邦広, 中島 淳, 米田 恭子, 遠藤 宏樹, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 野崎 雄一, 秋山 智之, 藤田 浩司, 米田 正人, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男

    日本消化器病学会雑誌   106 ( 臨増総会 )   A269 - A269   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃食道逆流症の維持療法のあり方 on demand therapyを中心に

    稲森 正彦, 阿部 泰伸, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A252 - A252   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • チューインガムはdistention induced accommodationに影響するか? 飲水試験を用いた研究

    坂本 康成, 稲森 正彦, 加藤 真吾, 飯田 洋, 内山 崇, 野崎 雄一, 後藤 歩, 細野 邦広, 遠藤 宏樹, 秋山 智之, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斎藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A336 - A336   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 進行肝細胞癌に対する、IFN併用肝動注化学療法の有用性 low dose FP療法との比較検討

    桐越 博之, 米田 正人, 藤田 浩司, 馬渡 弘典, 日暮 琢磨, 内山 崇, 野崎 雄一, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 後藤 歩, 小林 規俊, 窪田 賢輔, 坂口 隆, 上野 規男, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A282 - A282   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • iNOS欠損マウスモデルでのNAFLD病態進展の経時的追跡

    野崎 雄一, 藤田 浩司, 米田 正人, 飯田 洋, 馬渡 弘典, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 長嶋 洋治, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A206 - A206   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 肝ミクロソームTG輸送蛋白(MTTP)がNAFLD病態進展に与える影響

    藤田 浩司, 野崎 雄一, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 細野 邦広, 秋山 智之, 米田 恭子, 池田 多聞, 米田 正人, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斎藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A205 - A205   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • IPMNの多段階発がんにおけるFOXP3+制御性T細胞の変化についての検討

    小林 規俊, 窪田 賢輔, 小川 真実, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A246 - A246   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 膵癌におけるSema4D/PlexinB1/METの発現とその機能解析

    加藤 真吾, 小林 規俊, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦弘, 野崎 雄一, 遠藤 宏樹, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A245 - A245   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 小腸癌の診断に冠状断CT像が有用であった1例

    飯田 洋, 稲森 正彦, 加藤 真吾, 内山 崇, 馬渡 弘典, 遠藤 宏樹, 細野 邦広, 秋山 智之, 米田 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 菅野 信洋, 利野 靖, 稲山 嘉明, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A398 - A398   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大量の胸水を契機に発症し、2度のEUS下ドレナージ術が有効であった慢性膵炎の一例

    大森 尚子, 小林 規俊, 窪田 賢輔, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 遠藤 宏樹, 野崎 雄一, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A496 - A496   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NASH診断、進行度判定における炎症マーカー高感度CRPとPentraxin3の臨床有用性に対する比較検討

    米田 正人, 加藤 真吾, 内山 崇, 飯田 洋, 馬渡 弘典, 細野 邦広, 野崎 雄一, 遠藤 宏樹, 米田 恭子, 藤田 浩司, 高橋 宏和, 留野 渉, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 前山 史朗, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A206 - A206   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • C型慢性肝炎に対しインターフェロン治療中にShewanella putrefasciensによる敗血症を合併し救命しえた先天性胆道閉鎖症術後の1例

    濱口 冴香, 留野 渉, 小川 祐二, 加藤 真吾, 米田 恭子, 遠藤 宏樹, 野崎 雄一, 飯田 洋, 馬渡 弘典, 内山 崇, 藤田 浩司, 米田 正人, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A413 - A413   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 健康診断で偶発的に発見された肝血管筋脂肪腫の1例

    小川 祐二, 留野 渉, 谷口 礼央, 加藤 真吾, 内山 崇, 日暮 琢磨, 馬渡 弘典, 飯田 洋, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 小林 規俊, 阿部 泰伸, 稲森 正彦, 桐越 博之, 坂口 隆, 窪田 賢輔, 齋藤 聡, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A370 - A370   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 日本人男性における飲酒と逆流性食道炎、Barrett粘膜の関連について

    秋山 智之, 稲森 正彦, 藤田 浩司, 米田 正人, 中島 淳

    アルコールと医学生物学   28   1 - 2   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)響文社  

    2005年8月〜2006年7月に上部内視鏡検査を受けた男性463例を対象に、飲酒量が逆流性食道炎に及ぼす影響について検討した。21%に逆流性食道炎を認め、ロサンゼルス分類グレードA〜Bの軽症例が19.4%を占め、グレードC〜Dの重症例はまれ(1.5%)であった。Barrett粘膜は45.6%に認め、殆どが環状面長3cm未満のSSBEが占め(45.1%)、3cm以上のLSBEはまれ(0.4%)であった。非飲酒群と常飲群を比較検討した結果、プロフィール分布は単変量解析で、喫煙歴のみ有意差を認め、年齢、BMIでは認めなかった。逆流性食道炎分布について非飲酒群、中等度飲酒群、多量飲酒群を比べた結果、有意なリスク増大を認めた。また、Barrett粘膜分布について非飲酒群と多量飲酒群を比べ有意なリスク増大を認めた。飲酒量増加が逆流性食道炎やBarrett粘膜の罹患率上昇のリスクとなる可能性が示唆された。

    researchmap

  • 下血が発見の契機となった高齢発症gastrointestinal stromal tumor(GIST)の1例

    内山 崇, 高橋 宏和, 加藤 真吾, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 細野 邦弘, 秋山 智之, 藤田 浩司, 米田 恭子, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 利野 靖, 中島 淳

    日本消化器病学会雑誌   106 ( 臨増総会 )   A457 - A457   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 造影エコーが診断に有用であった門脈血栓症の1例

    高橋 宏和, 桐越 博之, 米田 正人, 稲森 正彦, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    超音波医学   36 ( 1 )   76 - 76   2009年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本超音波医学会  

    researchmap

  • Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population

    Hirokazu Takahashi, Tetsuji Takayama, Kyoko Yoneda, Hiroki Endo, Hiroshi Iida, Michiko Sugiyama, Koji Fujita, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Satoru Saito, Koichiro Wada, Hitoshi Nakagama, Atsushi Nakajima

    CANCER SCIENCE   100 ( 1 )   29 - 32   2009年1月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    The association between obesity and the risk of colorectal cancer (CRC) cannot be easily evaluated because CRC itself is associated with a gradual loss of bodyweight. Aberrant crypt foci (ACF) can be classified as dysplastic ACF or non-dysplastic ACF by magnifying colonoscopy, and dysplastic ACF are thought to be a biomarker of CRC. Ninety-four participants who underwent colonoscopy at Yokohama City University Hospital, Japan, were enrolled in the current study. We detected 557 ACF, including 67 dysplastic ACF (12.0%). Univariate regression analysis was conducted to determine correlations between the number of dysplastic ACF and various potential risk factors, including patient age, waist circumference, body mass index, visceral fat area (VFA), and plasma adiponectin level. The results of multiple regression analysis revealed that the number of dysplastic ACF correlated with age (correlation coefficient r = 0.212, P = 0.0383) and plasma adiponectin level (r = -0.201, P = 0.0371), even after adjustments for sex, waist circumference, body mass index, and VFA. Our univariate correlation analysis data showed a significant correlation with the number of dysplastic ACF with VFA (r = 0.238, P = 0.0209), no correlation with subcutaneous fat area, and an inverse correlation with the plasma level of adiponectin (r = -0.258, P = 0.0118). Thus, our results suggest that aging and visceral fat accumulation could correlate moderately with colorectal carcinogenesis. The novelty of our study lies in the finding that visceral fat accumulation and a low plasma adiponectin level may promote colorectal carcinogenesis; therefore, these obesity-related parameters may serve as novel targets for CRC prevention. (Cancer Sci 2009; 100: 29-32).

    DOI: 10.1111/j.1349-7006.2008.00994.x

    Web of Science

    researchmap

  • 胃瘻カテーテル迷入後の胃壁固定を用いた加療

    稲森 正彦, 内山 崇, 加藤 真吾, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 細野 邦弘, 秋山 智之, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 日下部 明彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    神奈川医学会雑誌   36 ( 1 )   65 - 66   2009年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • Clinical study of gastroduodenal disorders associated with Low-dose aspirin in Japanese patients.

    INAMORI Masahiko

    Hepatogastroenterology   2009年

     詳細を見る

  • Incidence of Small Bowel Injury Induced by Low-Dose Aspirin: A Crossover Study Using Capsule Endoscopy in Healthy Volunteers 査読

    Hiroki Endo, Kunihiro Hosono, Masahiko Inamori, Shingo Kato, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Nobuyuki Matsuhashi, Atsushi Nakajima

    DIGESTION   79 ( 1 )   44 - 51   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:KARGER  

    Background and Aims: Small intestinal toxicity of low-dose aspirin remains unclear. The purpose of this capsule endoscopy study was to assess the incidence of small bowel injury in healthy volunteers treated with short-term low-dose aspirin. Methods: Healthy subjects were randomly assigned to receive low-dose aspirin for 14 days (Aspirin group) or no drugs for 14 days (Control group). The two treatment occasions were separated by a washout period of at least 4 weeks. All subjects underwent capsule endoscopy at the end of each treatment period. Results: After 2 weeks of treatment, the percentages of subjects with small bowel pathology were 80% in the Aspirin group compared with 20% in the Control group (p = 0.023). The incidence of small bowel mucosal breaks in the Aspirin group was higher than that in the Control group, although the difference was not significant (30 vs. 0%; p = 0.210). Conclusions: This is the first pilot study using capsule endoscopy to report on the relation between small bowel injury and low-dose aspirin. Among the healthy subjects, the short-term administration of low-dose aspirin was associated with a mild mucosal inflammation of the small bowel. Copyright (c) 2009 S. Karger AG, Basel

    DOI: 10.1159/000204465

    Web of Science

    PubMed

    researchmap

  • H2受容体拮抗薬の立ち上がりに関する検討:モサプリドの上乗せ効果について

    飯田洋, 稲森正彦, 加藤慎吾, 内山崇, 馬渡弘典, 細野邦広, 野崎雄一, 遠藤宏樹, 米田恭子, 秋山智之, 藤田浩司, 高橋宏和, 米田正人, 阿部泰伸, 小林規俊, 桐越博之, 窪田賢輔, 斉藤聡, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   5th (Web)   2009年

     詳細を見る

  • PLASMA LEVEL OF INSULIN-LIKE GROWTH FACTOR-1 AND LEPTIN ARE ASSOCIATED WITH RECTAL ABERRANT CRYPT FOCI IN MEN

    H. Takahashi, K. Hosono, T. Uchiyama, H. Iida, H. Endo, M. Inamori, Y. Abe, A. Nakajima, H. Nakagama

    ANNALS OF ONCOLOGY   20   71 - 71   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:OXFORD UNIV PRESS  

    Web of Science

    researchmap

  • 膜様狭窄で発症し2度のSBEにて診断しえた小腸MALTomaの1例

    高橋宏和, 阿部泰伸, 稲森正彦, 加藤真吾, 内山崇, 飯田洋, 馬渡弘典, 細野邦広, 遠藤宏樹, 野崎雄一, 秋山智之, 米田恭子, 藤田浩司, 米田正人, 小林規俊, 桐越博之, 窪田賢輔, 斉藤聡, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   5th (Web)   2009年

     詳細を見る

  • メトホルミンによる大腸ポリープ抑制作用の解析-発癌モデルマウスにおける検討-

    細野邦広, 遠藤宏樹, 加藤真吾, 内山崇, 飯田洋, 馬渡弘典, 野崎雄一, 秋山智之, 米田恭子, 藤田浩司, 米田正人, 高橋宏和, 稲森正彦, 阿倍泰伸, 桐越博之, 小林規俊, 窪田賢輔, 斉藤聡, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   5th (Web)   2009年

     詳細を見る

  • カプセル内視鏡を用いた低用量アスピリン起因性小腸傷害の検討:ボランティアにおける傷害発生頻度と常用患者における病変の特徴

    遠藤宏樹, 細野邦広, 稲森正彦, 加藤真吾, 野崎雄一, 米田恭子, 藤田浩司, 高橋宏和, 米田正人, 阿部泰伸, 桐越博之, 小林規俊, 窪田賢輔, 斎藤聡, 松橋信行, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   5th (Web)   2009年

     詳細を見る

  • Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: A case report

    Atsushi Nakajima, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shoji Yamanaka

    Journal of Medical Case Reports   2 ( 2 )   2008年12月

     詳細を見る

    記述言語:英語  

    Introduction: The granulocyte-colony stimulating factor-producing tumor was first reported in 1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-colony stimulating factor is still rare. Case presentation: A 63-year-old man was admitted to our hospital with body weight loss (-10 kg during months) and upper abdominal pain from 3 weeks. Abdominal computed tomography demonstrated a pancreatic tumor 10 cm in size and multiple low-density areas in the liver. On admission, the peripheral leukocyte count was elevated to 91,500/mm3 and the serum concentration of granulocyte-colony stimulating factor was 134 pg/mL (normal, &lt
    18.1 pg/mL). Based on liver biopsy findings, the tumor was classified as an anaplastic pleomorphic-type carcinoma. Immunohistochemical staining showed that pancreatic carcinoma cells were positive for granulocyte-colony stimulating factor. The patient developed interstitial pneumonia, probably caused by granulocyte-colony stimulating factor, and died 11 days after admission. Conclusion: This is a rare case report of anaplastic pleomorphic-type carcinoma of the pancreas producing granulocyte-colony stimulating factor and confirmed by immunohistochemistry. © 2008 Nakajima et al
    licensee BioMed Central Ltd.

    DOI: 10.1186/1752-1947-2-391

    Scopus

    researchmap

  • 治療の効果判定にVater乳頭部生検が有用であった自己免疫性膵炎の一例

    石田 修一, 窪田 賢輔, 小林 規俊, 加藤 真吾, 稲森 正彦, 阿部 泰伸, 斎藤 聡, 稲山 嘉昭, 山中 正二, 中島 淳

    Progress of Digestive Endoscopy   74 ( 1 )   102 - 102   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett&apos;s epithelium in Japanese men

    Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8 ( 1 )   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:BIOMED CENTRAL LTD  

    Background: Evidence regarding the association between alcohol consumption and the gastro-esophageal reflux disease (GERD) spectrum has been conflicting. We examined the association between alcohol consumption and erosive esophagitis and Barrett&apos;s epithelium in Japanese men.
    Methods: The study population comprised 463 men subjects who had undergone an upper endoscopy at the Gastroenterology Division of Yokohama City University Hospital between August 2005 and July 2006. The presence of erosive esophagitis and Barrett&apos;s epithelium was diagnosed based on the Los Angeles Classification and the Prague C and M Criteria, respectively. We divided the study population into four groups: never drinkers, light drinkers ( less than 25.0 g of ethanol per day), moderate drinkers ( 25.0 to 50.0 g of ethanol per day), and heavy drinkers ( more than 50.0 g of ethanol per day). A linear regression of the logistic regression analysis was used to analyze the dose-response trends.
    Results: Compared with never drinkers, light drinkers ( less than 25.0 g ethanol per day), moderate drinkers ( 25.0 to 50.0 g per day), and heavy drinkers ( more than 50.0 g per day) had ORs for erosive esophagitis of 1.110 (95% CI: 0.553 - 2.228, p = 0.7688), 1.880 ( 95% CI: 1.015 - 3.484, p = 0.0445) and 1.988 ( 95% CI: 1.120 - 3.534, p = 0.0190), respectively. These groups had ORs for Barrett&apos;s epithelium of 1.278 ( 95% CI: 0.752 - 2.170, p = 0.3643), 1.458 ( 95% CI: 0.873 - 2.433, p = 0.1500), and 1.912 ( 95% CI: 1.185 - 3.086, p = 0.0079), respectively. The odds ratios/grams ( alcohol)/day of dose response trends for erosive esophagitis and Barrett&apos;s epithelium were 1.015 ( 95% CI: 1.004 - 1.026, p = 0.0066) and 1.012 ( 95% CI: 1.003 - 1.021, p = 0.0079), respectively.
    Conclusion: These findings suggest that alcohol consumption in Japanese men tends to be associated with an increased risk of erosive esophagitis and Barrett&apos;s epithelium.

    DOI: 10.1186/1471-230X-8-58

    Web of Science

    researchmap

  • Gastric ulcer following a thrombotic aneurysm of the splenic artery

    K. Suzuki, H. Takahashi, N. Fujisawa, Y. Sekino, K. Akimoto, A. Tomimoto, K. Saito, M. Yoneda, M. Inamori, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, S. Koyama, A. Nakajima

    ENDOSCOPY   40 ( Suppl 2 )   E193 - E194   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-2008-1077418

    Web of Science

    researchmap

  • Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features

    Kensuke Kubota, Shingo Kato, Tomoyuki Akiyama, Masato Yoneda, Koji Fujita, Masami Ogawa, Masahiko Inamori, Noritoshi Kobayashi, Satoru Saito, Yukio Kakuta, Hisashi Ohshiro, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   68 ( 6 )   1204 - 1208   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    Background: Differentiating primary sclerosing cholangitis (PSC) and sclerosing cholangids caused by autoimmune pancreatitis (SC-AIP) is often challenging. Recently, endoscopic findings of the duodenal papilla in cases with AIP or PSC were reported by Unno and Parlak, although the endoscopic differentiation of these 2 conditions has not yet been fully clarified.
    Objective: Our purpose was to clarify, the endoscopic findings of the duodenal papilla in patients with SC-AIP and those with PSC and to determine criteria for the differentiation of these conditions.
    Design: Case series.
    Setting: Restrospective.
    Patients: Twenty-seven,en patients With SC-AIP and 12 patients with PSC who had undergone ERCP were identified from out database. We reviewed these records to determine whether the duodenal papillary findings (swollen papilla/normal papilla/small papilla) might be potentially useful for differentiating SC-AIP and PSC. Immunohistopathological findings for the duodenal papilla were also examined by using immunoglobulin G4 (IgG4) among the infiltrating plasma cells.
    Interventions: ERCP, biopsy specimen taken from duodenal papilla.
    Main Outcome Measurements: The presence of a swollen duodenal papilla with IgG4-positive plasma cells was useful for discriminating SC-AIP from with PSC.
    Results: A swollen duodenal papilla was observed in 63% (17/27) of the patients with SC-AIP, whereas there was no swelling of the duodenal papilla of the patients with PSC. A small papilla was recognized in 50% (6/12) of the patients with PSC. IgG4-positive plasma cells in the duodenal papilla were significantly detected in the patients with SC-AIP but not in the patients with PSC.
    Limitation: Single-center study.
    Conclusions: Characteristic duodenal endoscopic papillary features in patients with SC-AIP, such as a swollen duodenal papilla and positive immunostaining for IgG4, might be helpful for discriminating this condition from PSC.

    DOI: 10.1016/j.gie.2008.08.013

    Web of Science

    researchmap

  • Ingesting 500 ml of Polyethylene Glycol Solution During Capsule Endoscopy Improves the Image Quality and Completion Rate to the Cecum

    Hiroki Endo, Yasuyuki Kondo, Masahiko Inamori, Tomohiko R. Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Masato Yoneda, Atsushi Nakajima, Nobuyuki Matsuhashi

    DIGESTIVE DISEASES AND SCIENCES   53 ( 12 )   3201 - 3205   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    The benefits of bowel preparation prior to capsule endoscopy (CE) are controversial. The aim of this study was to examine whether ingesting a small amount of polyethylene glycol (PEG) during, not before, the CE procedure improves the image quality and the cecal completion rate. A prospective single-blind controlled study was conducted including 59 patients. The initial 32 patients (group A) received no preparation, and the subsequent 27 patients (group B) ingested 500 ml of PEG starting 30 min after swallowing the capsule. The capsule reached the cecum in 65.6% of the patients in group A and 88.9% of the patients in group B (P = 0.038). The use of PEG during CE examination significantly improved the image quality, and this effect was more pronounced in the distal ileum. Ingesting a small amount of PEG during CE examination significantly improves both the CE image quality and the cecal completion rate.

    DOI: 10.1007/s10620-008-0292-0

    Web of Science

    researchmap

  • Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis

    Masato Yoneda, Hiroki Endo, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Tomoyuki Akiyama, Takuma Higurashi, Takashi Uchiyama, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Noritoshi Kobayashi, Naotaka Yamaguchi, Shiro Maeyama, Shogo Yamamoto, Shuichi Tsutsumi, Hiroyuki Aburatani, Koichiro Wada, Kikuko Hotta, Atsushi Nakajima

    HEPATOLOGY RESEARCH   38 ( 12 )   1204 - 1212   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Aim: Non-alcoholic steatohepatitis (NASH) is a subset of non-alcoholic fatty liver disease (NAFLD) and sometimes progresses to cirrhosis and liver failure. In this study we analyzed the expression profile of genes and biological pathways involved in NASH in comparison with non-NASH by gene set enrichment analysis (GSEA) employing a DNA microarray technique.
    Methods: mRNA from liver biopsy specimens was collected from a group of NASH patients and a group of non-NASH patients. We analyzed the relative abundance of mRNA using high-density oligonucleotide microarrays containing probes for 54 675 known genes, and investigated the pathogenetic mechanisms of NASH by means of a powerful technique for analyzing molecular profiling data, GSEA.
    Results: The results showed that the level of expression of 27 gene sets was significantly higher and the level of expression of 25 gene sets was significantly lower in the NASH samples than in the non-NASH samples. Based on these results we created an online, publicly available, searchable database containing the data for the gene expression profiles of the NASH patients (http://www2.genome.rcast.u-tokyo.ac.jp/__/NASH/NASH_GSEA2/).
    Conclusion: Our data revealed differences in expression of many gene sets that are involved in the pathogenesis of NASH.

    DOI: 10.1111/j.1872-034X.2008.00399.x

    Web of Science

    researchmap

  • Inhibition of Peroxisome Proliferator-Activated Receptor gamma Promotes Tumorigenesis Through Activation of the beta-Catenin/T Cell Factor (TCF) Pathway in the Mouse Intestine

    Toshio Fujisawa, Michiko Sugiyama, Ayako Tomimoto, Koichiro Wada, Hiroki Endo, Hirokazu Takahashi, Kyoko Yoneda, Masato Yoneda, Masahiko Inamori, Satoru Saito, Yasuo Terauchi, Takashi Kadowaki, Naoto Tsuchiya, Hitoshi Nakagama, Atsushi Nakajima

    JOURNAL OF PHARMACOLOGICAL SCIENCES   108 ( 4 )   535 - 544   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Although peroxisome proliferator-activated receptor gamma (PPAR gamma) is strongly expressed in the intestinal epithelium, the role of PPAR gamma in intestinal tumorigenesis has not yet been elucidated. To address this issue, we investigated the effect of PPAR gamma, inhibition and its mechanism on intestinal tumorigenesis using a selective antagonist, T0070907. We treated Apc(Min/+) mice and carcinogen-induced colon cancer model C57BL/6 mico, with T0070907 and counted the number of spontaneous polyps and aberrant crypt foci and observed cell proliferation and beta-catenin protein in the colon epithelium. To investigate its mechanism, the changes of beta-catenin/TCF (T cell factor) transcriptional activity and location of beta-catenin induced by T0070907 were investigated in the colon cancer cell lines. T0070907 promoted polyp formation in the small intestine of Apc(Min/+) mice and aberrant crypt foci in the colon of C57BL/6 mice. PPAR gamma inhibition promoted cell proliferation and increased expressions of the c-myc and cyclin D1 genes and the beta-catenin protein in the colon epithelium. In vitro, cell proliferation was promoted, but it was inhibited by the transfection of dominant-negative Tcf4. T0070907 increased beta-catenin/TCF transcriptional activity and beta-catenin protein in the cytsol and nucleus, but relatively decreased it on the cell membrane. PPAR gamma antagonist promotes tumorigenesis in the small intestine and colon through stimulation of epithelial cell proliferation. beta-Catenin contributes to the promotion of tumorigenesis by PPAR gamma antagonist due to activation of TCF/LEF (lymphoid enhancer factor) transcriptional factor.

    DOI: 10.1254/jphs.08193FP

    Web of Science

    researchmap

  • Usefulness of Multidetector Computed Tomography for Detection of the Obstructive Point in a Patient with Ileus

    Eiji Sakai, Hirokazu Takahashi, Masahiko Inamori, Hiroki Endo, Tomoyuki Akiyama, Keiko Akimoto, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   53 ( 12 )   3264 - 3264   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:SPRINGER  

    DOI: 10.1007/s10620-008-0272-4

    Web of Science

    researchmap

  • Colonic Metastasis from Hepatocellular Carcinoma: Manifested by Gastrointestinal Bleeding

    Yuichi Nozaki, Noritoshi Kobayashi, Takeshi Shimamura, Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Takeshi Sasaki, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   53 ( 12 )   3265 - 3266   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:SPRINGER  

    DOI: 10.1007/s10620-008-0273-3

    Web of Science

    researchmap

  • Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease 査読

    K. Fujita, Y. Nozaki, K. Wada, M. Yoneda, H. Endo, H. Takahashi, T. Iwasaki, M. Inamori, Y. Abe, N. Kobayashi, H. Kirikoshi, K. Kubota, S. Saito, Y. Nagashima, A. Nakajima

    GUT   57 ( 11 )   1583 - 1591   2008年11月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    Objective: No effective drugs have been developed to date to prevent or treat non-alcoholic fatty liver disease ( NAFLD), although diet modification and exercise to improve obesity have been attempted. Therefore, development of a novel drug/strategy to treat NAFLD is urgently needed. In the present study, a novel concept is proposed for the treatment of NAFLD.
    Methods: Fisher 344 male rats were given a choline-deficient, L-amino acid-defined ( CDAA) diet or a high-fat high-calorie ( HF/HC) diet with or without the antiplatelet agents, aspirin, ticlopidine or cilostazol for 16 weeks. Liver steatosis, inflammation and fibrosis, and the possible mechanisms involved were investigated.
    Results: All three antiplatelet drugs, namely aspirin, ticlopidine and cilostazol, significantly attenuated liver steatosis, inflammation and fibrosis in the CDAA diet group. Of the three agents, cilostazol was the most effective, and the drug also suppressed HF/HC diet-induced liver steatosis. Cilostazol appeared to exert its beneficial effect against NAFLD by suppressing mitogen-activated protein kinase activation induced by oxidative stress and platelet-derived growth factor via intercepting signal transduction from Akt to c-Raf.
    Conclusion: Antiplatelet agents, especially cilostazol, offer the promise of becoming key agents for the treatment of NAFLD.

    DOI: 10.1136/gut.2007.144550

    Web of Science

    PubMed

    researchmap

  • Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition

    T. Fujisawa, H. Endo, A. Tomimoto, M. Sugiyama, H. Takahashi, S. Saito, M. Inamori, N. Nakajima, M. Watanabe, N. Kubota, T. Yamauchi, T. Kadowaki, K. Wada, H. Nakagama, A. Nakajima

    GUT   57 ( 11 )   1531 - 1538   2008年11月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    Background and aims: The effect of adiponectin on colorectal carcinogenesis has been proposed but not fully investigated. We investigated the effect of adiponectin deficiency on the development of colorectal cancer.
    Methods: We generated three types of gene-deficient mice ( adiponectin-deficient, adiponectin receptor 1-deficient, and adiponectin receptor 2-deficient) and investigated chemical-induced colon polyp formation and cell proliferation in colon epithelium. Western blot analysis was performed to elucidate the mechanism which affected colorectal carcinogenesis by adiponectin deficiency.
    Results: The numbers of colon polyps were significantly increased in adiponectin-deficient mice compared with wild-type mice fed a high-fat diet. However, no difference was observed between wild-type and adiponectin-deficient mice fed a basal diet. A significant increase in cell proliferative activity was also observed in the colonic epithelium of the adiponectin-deficient mice when compared with wild-type mice fed a high-fat diet; however, no difference was observed between wild-type and adiponectin-deficient mice fed a basal diet. Similarly, an increase in epithelial cell proliferation was observed in adiponectin receptor 1-deficient mice, but not in adiponectin receptor 2-deficient mice. Western blot analysis revealed activation of mammalian target of rapamycin, p70 S6 kinase, S6 protein and inactivation of AMP-activated protein kinase in the colon epithelium of adiponectin-deficient mice fed with high-fat diet.
    Conclusions: Adiponectin suppresses colonic epithelial proliferation via inhibition of the mammalian target of the rapamycin pathway under a high-fat diet, but not under a basal diet. These studies indicate a novel mechanism of suppression of colorectal carcinogenesis induced by a Western-style high-fat diet.

    DOI: 10.1136/gut.2008.159293

    Web of Science

    researchmap

  • Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

    Masato Yoneda, Takashi Uchiyama, Shingo Kato, Hiroki Endo, Koji Fujita, Kyoko Yoneda, Hironori Mawatari, Hiroshi Iida, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Mina Sagara, Hiroyuki Aburatani, Tatsuhiko Kodama, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8 ( 1 )   2008年11月

     詳細を見る

    記述言語:英語   出版者・発行元:BIOMED CENTRAL LTD  

    Background: The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to differentiate between NASH and non-progressive NAFLD on the basis of the clinical findings alone.
    Aims: In this study we investigated the clinical usefulness of plasma Pentraxin3 (PTX3) levels to predict NASH. Plasma PTX3 was measured in 70 patients with histologically verified NAFLD (28 with non-NASH and 42 with NASH) and 10 healthy control subjects.
    Results: The plasma PTX3 level was significantly higher in the NASH cases than in the non-NASH cases (p = 0.0021) and control subjects (p = 0.045). And the plasma PTX3 level was significantly higher in the stages 3-4 NAFLD cases than in the stages 0-2 NAFLD cases (p&lt;0.0001). The PTX3 values were closely correlated with the stages of liver fibrosis (p&lt;0.0001, Kruskal-Wallis test). To detect NASH compared with non-NASH, the area under the curve for plasma PTX3 were 0.755, and to detect stages 3-4 NAFLD compared with stages 0-2 NAFLD, the area under the curve for plasma PTX3 were 0.850.
    Conclusion: This is the first study to demonstrate consistent and profound elevation of plasma PTX3 levels in NASH in comparison with non-NASH. The results suggest that plasma PTX3 levels may not only be laboratory values that differentiate NASH from non-NASH, but marker of the severity of hepatic fibrosis in NASH.

    DOI: 10.1186/1471-230X-8-53

    Web of Science

    researchmap

  • Gastrointestinal: Ascariasis

    A. Suzuki, Y. Yabushita, H. Takahashi, M. Inamori, S. Nakao, K. Suzuki, H. Iida, H. Endo, T. Akiyama, T. Ikeda, Y. Sakamoto, K. Fujita, M. Yoneda, A. Goto, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   23 ( 11 )   1770 - 1770   2008年11月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/j.1440-1746.2008.05662.x

    Web of Science

    researchmap

  • Tumor fragment impacted at the major duodenal papilla causing obstructive jaundice in a patient with hepatocellular carcinoma

    Noritoshi Kobayashi, Hiroyuki Kirikoshi, Takuma Higurashi, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   68 ( 5 )   999 - 1000   2008年11月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2008.04.023

    Web of Science

    researchmap

  • INFLUENCE OF AGTR1 POLYMORPHISMS IN JAPANESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

    Mosato Yoneda, Yuichi Nozaki, Kikuko Hotta, Hironori Mawatari, Hiroshi Iida, Takashi Uchiyama, Kyoko Yoneda, Hiroki Endo, Shingo Kato, Kunihiro Hosono, Koji Fujita, Takuma Higurashi, Hiroyuki Kirikoshi, Kensuke Kubota, Noritoshi Kobayashi, Masahiko Inamori, Satoru Saito, Atsushi Nakajima

    HEPATOLOGY   48 ( 4 )   634A - 634A   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

  • 肝細胞癌(HCC)破裂 生存率と長期予後に寄与する因子の検討(3施設共同研究)

    桐越 博之, 斉藤 聡, 米田 正人, 藤田 浩司, 内山 崇, 篠原 義康, 今城 健人, 坂口 隆, 厚川 和裕, 澤邉 文, 金崎 章, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 窪田 賢輔, 上野 規男, 中島 淳

    肝臓   49 ( Suppl.3 )   A754 - A754   2008年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 非アルコール性脂肪性肝障害(nonalcoholic fatty liver disease:NAFLD)や非アルコール性脂肪性肝炎(NASH)と糖尿病との関連

    野崎 雄一, 米田 正人, 藤田 浩司, 中村 昭伸, 内山 崇, 馬渡 弘典, 飯田 洋, 遠藤 宏樹, 秋山 智之, 米田 恭子, 高橋 宏和, 桐越 博之, 小林 規俊, 阿部 泰伸, 稲森 正彦, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本病態栄養学会誌   11 ( 3 )   255 - 260   2008年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病態栄養学会  

    非アルコール性脂肪性肝障害(nonalcoholic fatty liver disease:NAFLD)はメタボリックシンドロームとの関係が深く、メタボリックシンドロームの肝での表現形と考えられている。NAFLDの中でも約1割に当たる非アルコール性脂肪性肝炎(nonalcoholic steatohepatitis:NASH)は肝硬変に進展し、発癌もきたしうることから、その病態・病因や治療法の解明が望まれている。今回、NAFLDやNASHについて、インスリン抵抗性や糖尿病合併との病態進行の機序に関して検討を行った。肝生検にてNAFLDと診断された100例(単純性脂肪肝29例、NASH71例)を対象として、NASH症例は線維化軽度症例と線維化高度症例の2群に分類した。臨床データをもとに、単純性脂肪肝とNASHを規定する因子、さらにNASHの線維化高度症例を規定する因子について検討を行った。単純性脂肪肝とNASHを規定する因子に関する単変量解析では、皮下脂肪、AST、血清フェリチン、高感度CRP、ヒアルロン酸に有意差を認めた。糖尿病の有無を加えてロジスティック回帰分析を行ったところ、高感度CRP、Body Mass Index(BMI)、中性脂肪、糖尿病の有無が独立した因子として認められた。またNASHの線維化高度症例を規定する因子に関する単変量解析では、高感度CRPとヒアルロン酸、IV型コラーゲン7Sが有意差を示し、糖尿病の有無を加えたロジスティック回帰分析では、IV型コラーゲン7Sと糖尿病の有無が独立した因子として認められた。NAFLDにおいて単純性脂肪肝からNASHへの進展や、NASHにおける肝線維化進展には糖尿病の有無が強く影響することが示された。糖尿病を中心とした栄養療法は慢性肝疾患の進展を抑制するという新たな局面を迎えていると思われる。(著者抄録)

    researchmap

  • VLDL中のTriglyceridesはC型慢性肝炎・群別1型のPEG-IFN+RBV療法における治療前効果予測因子となり得る

    馬渡 弘典, 斉藤 聡, 佐々木 裕樹, 藤田 浩司, 野崎 雄一, 篠原 義康, 米田 正人, 桐越 博之, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 窪田 賢輔, 中島 淳

    肝臓   49 ( Suppl.3 )   A710 - A710   2008年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 造影エコーが診断に有用であった門脈血栓症の1例

    高橋 宏和, 桐越 博之, 米田 正人, 稲森 正彦, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本超音波医学会関東甲信越地方会学術集会抄録集   20回   55 - 55   2008年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(社)日本超音波医学会-関東甲信越地方会  

    researchmap

  • 当院におけるB型慢性肝炎に対するlamivudine治療の実際

    内山 崇, 斉藤 聡, 加藤 真吾, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 細野 邦弘, 秋山 智則, 藤田 浩司, 米田 恭子, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 小林 則俊, 窪田 賢輔, 中島 淳

    肝臓   49 ( Suppl.3 )   A752 - A752   2008年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • ペグインターフェロン・リバビリン治療1年半後に再燃したC型慢性肝炎患者の検討

    篠原 義康, 斉藤 聡, 馬渡 弘典, 桐越 博之, 米田 正人, 藤田 浩司, 野崎 雄一, 内山 崇, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 窪田 賢輔, 中島 淳

    肝臓   49 ( Suppl.3 )   A732 - A732   2008年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • EFFECT OF EZETIMIBE ADMINISTERED IN COMBINATION WITH ACARBOSE AGAINST THE DEVELOPMENT OF NAFLD

    Yuichi Nozaki, Koji Fujita, Masato Yoneda, Shingo Kato, Takashi Uchiyama, Hiroshi Iido, Hironori Mawatari, Kunihiro Hosono, Hiroki Endo, Tomoyuki Akiyoma, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Yosunobu Abe, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Atsushi Nakojima

    HEPATOLOGY   48 ( 4 )   838A - 838A   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

  • THE COMPARISON OF THE TRANS-ARTERIAL CHEMOEMBOLIZATION (TACE) MONOTHERAPY AND THE COMBINED TACE WITH PERCUTANEOUS LOCAL THERAPY FOR HEPATOCELLULAR CARCINOMA (HCC)

    Hiroyuki Kirikoshi, Satoru Saito, Masato Yonedo, Koji Fujita, Hironori Mawatari, Yuichi Nozaki, Takashi Uchiyama, Tamon Ikeda, Kunihiro Hosono, Tomoyuki Akiyama, Hiroki Endo, Kyoko Yoneda, Masahiko Inamori, Hirokazu Takahashi, Hiroshi Iida, Shingo Kato, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima

    HEPATOLOGY   48 ( 4 )   967A - 968A   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

  • Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility

    Atsushi Nakajima, Ayako Tomimoto, Koji Fujita, Michiko Sugiyama, Hirokazu Takahashi, Ikuko Ikeda, Kunihiro Hosono, Hiroki Endo, Kyoko Yoneda, Hiroshi Iida, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Noriko Nakajima, Koichiro Wada, Yoji Nagashima, Hitoshi Nakagama

    CANCER SCIENCE   99 ( 10 )   1892 - 1900   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated transcription factor that has been implicated in the carcinogenesis and progression of various solid tumors, including pancreatic carcinomas. We aimed to clarify the role of this receptor in pancreatic cell motility in vitro and in metastasis in vivo. Cell motility was examined by assaying transwell migration and wound filling in Capan-1 and Panc-1 pancreatic cancer cells, with or without the PPAR gamma-specific inhibitor T0070907. A severe combined immunodeficiency xenograft metastasis model was used to examine the in vivo effect of PPAR gamma inhibition on pancreatic cancer metastasis. In both transwell-migration and wound-filling assays, inhibition of PPAR gamma activity suppressed pancreatic cell motility without affecting in vitro cell proliferation. Inhibition of PPAR gamma also suppressed liver metastasis in vivo in metastatic mice. In PPAR gamma-inhibited cells, p120 catenin accumulation was induced predominantly in cell membranes, and the Ras-homologous GTPases Rac1 and Cdc42 were inactive. Inhibition of PPAR gamma in pancreatic cancer cells decreased cell motility by altering p120ctn localization and by suppressing the activity of the Ras-homologous GTPases Rac1 and Cdc42. Based on these findings, PPAR gamma could function as a novel target for the therapeutic control of cancer cell invasion or metastasis. (Cancer Sci 2008; 99: 1892-1900)

    DOI: 10.1111/j.1349-7006.2008.00904.x

    Web of Science

    researchmap

  • Acute appendicitis associated with Peutz-Jeghers-type hamartoma of the appendix

    Hiroshi Iida, Masahiko Inamori, Yusuke Sekino, Hiroki Endo, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Noritoshi Kobayashi, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Hisashi Oshiro, Yasushi Rino, Atsushi Nakajma

    DIGESTIVE DISEASES AND SCIENCES   53 ( 10 )   2832 - 2833   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:SPRINGER  

    DOI: 10.1007/s10620-008-0219-9

    Web of Science

    researchmap

  • Gastrointestinal: Mantle cell lymphoma diagnosed by balloon enteroscopy

    A. Yumori, H. Okubo, H. Takahashi, H. Iida, H. Mawatari, M. Yoneda, M. Inamori, Y. Abe, N. Kobayashi, H. Kirikoshi, K. Kubota, S. Saito, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   23 ( 10 )   1623 - 1623   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/j.1440-1746.2008.05630.x

    Web of Science

    researchmap

  • Tumorous arteriovenous malformation in the jejunum missed by capsule endoscopy

    Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inarnori, Tomohiko Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Koji Fujita, Masato Yoneda, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   68 ( 4 )   773 - 774   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2008.03.009

    Web of Science

    researchmap

  • Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM)

    KOBAYASHI NORITOSHI, HIGURASHI TAKUMA, IIDA HIROSHI, MAWATARI HIRONORI, ENDO HIROKI, NOZAKI YUICHI, TOMIMOTO AYAKO, YONEDA KYOKO, AKIYAMA TOMOYUKI, FUJITA KOJI, TAKAHASHI HIROKAZU, YONEDA MASATO, INAMORI MASAHIKO, ABE YASUNOBU, KIRIKOSHI HIROYUKI, KUBOTA KENSUKE, SAITO SATORU, UENO NORIO, NAKAJIMA ATSUSHI, YAMANAKA SHOJI, INAYAMA YOSHIAKI

    Journal of hepato-biliary-pancreatic surgery   15 ( 5 )   531 - 535   2008年9月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • 非肥満NASH患者に対するVit.E+EPL併用療法の有用性

    藤田 浩司, 野崎 雄一, 加藤 慎吾, 内山 崇, 馬渡 弘典, 飯田 洋, 遠藤 宏樹, 秋山 智之, 米田 恭子, 米田 正人, 高橋 宏和, 廣川 智, 後藤 歩, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A849 - A849   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • EzetimibeによるNAFLD病態の改善効果に関する検討

    野崎 雄一, 藤田 浩司, 米田 正人, 留野 渉, 加藤 真吾, 馬渡 弘典, 飯田 洋, 遠藤 宏樹, 秋山 智之, 米田 恭子, 高橋 宏和, 後藤 歩, 廣川 智, 阿部 泰伸, 稲森 正彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A849 - A849   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 先天性門脈欠損症の臨床的特徴について

    小林 規俊, 内山 崇, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    肝臓   49 ( Suppl.2 )   A600 - A600   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 当科におけるHCC破裂症例の検討

    桐越 博之, 米田 正人, 藤田 浩司, 内山 崇, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 窪田 賢輔, 坂口 隆, 上野 規男, 斉藤 聡, 中島 淳

    肝臓   49 ( Suppl.2 )   A589 - A589   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 当科における80歳以上超高齢症例におけるESDの検討

    阿部 泰伸, 飯田 洋, 馬渡 弘典, 内山 崇, 遠藤 宏樹, 野崎 雄一, 秋山 智之, 米田 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 小林 規俊, 桐越 博之, 稲森 正彦, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.2 )   2304 - 2304   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • NASH病態形成におけるiNOS由来Nitoric Oxideの意義

    野崎 雄一, 藤田 浩司, 米田 正人, 留野 渉, 内山 崇, 馬渡 弘典, 飯田 洋, 細野 邦広, 遠藤 宏樹, 秋山 智之, 米田 恭子, 高橋 宏和, 後藤 歩, 阿部 泰伸, 稲森 正彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A833 - A833   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • C型慢性肝炎治療におけるインスリン抵抗性、脂質、飲酒量による治療効果予測の検討

    斉藤 聡, 馬渡 弘典, 米田 正人, 桐越 博之, 藤田 浩司, 野崎 雄一, 窪田 賢輔, 小林 規俊, 稲森 正彦, 阿部 泰伸, 高橋 宏和, 廣川 智, 米田 恭子, 秋山 智之, 飯田 洋, 遠藤 宏樹, 中島 淳

    肝臓   49 ( Suppl.2 )   A539 - A539   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • C型慢性肝炎におけるウイルス量と血中VLDLコレステロールとの検討

    馬渡 弘典, 斉藤 聡, 藤田 浩司, 米田 正人, 野崎 雄一, 桐越 博之, 飯田 洋, 秋山 智之, 池田 多聞, 米田 恭子, 内山 崇, 遠藤 宏樹, 稲森 正彦, 阿部 泰伸, 小林 規俊, 窪田 賢輔, 留野 渉, 高橋 宏和, 中島 淳

    肝臓   49 ( Suppl.2 )   A535 - A535   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 食道から見た慢性胃炎の評価

    稲森 正彦, 秋山 智之, 飯田 洋, 遠藤 宏樹, 細野 邦宏, 米田 恭子, 高橋 宏和, 阿部 泰伸, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.2 )   2387 - 2387   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 門脈血栓による胃静脈瘤破裂に対しヒストアクリル局注法を繰り返し止血を得た1例

    谷口 礼央, 高橋 宏和, 飯田 洋, 阿部 泰伸, 稲森 正彦, 加藤 真吾, 内山 崇, 馬渡 弘典, 藤田 浩司, 米田 正人, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.2 )   2322 - 2322   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • アルコール摂取量と逆流性食道炎、Barrett粘膜の発生リスクに関する検討

    秋山 智之, 稲森 正彦, 内山 崇, 飯田 洋, 馬渡 弘典, 野崎 雄一, 米満 恭子, 遠藤 宏樹, 池田 多聞, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 廣川 智, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斎藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A746 - A746   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 軽症糖尿病患者の体重減少は消化器症状の軽減に関与するか Frequency Scale for the Symptoms of GERD(FSSG)を用いた検討

    稲森 正彦, 岩崎 知之, 秋山 智之, 飯田 洋, 高橋 宏和, 阿部 泰伸, 遠藤 宏樹, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A743 - A743   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 血友病Aに発症した門脈血栓症に対しAT3およびダナパロイドナトリウム併用療法が有効であった1例

    留野 渉, 高橋 宏和, 飯田 洋, 阿部 泰伸, 稲森 正彦, 加藤 真吾, 内山 崇, 馬渡 弘典, 藤田 浩司, 米田 正人, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A873 - A873   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NASH診断、線維化進行判定におけるPentraxin3の有効性についての検討

    加藤 真吾, 米田 正人, 内山 崇, 留野 渉, 馬渡 弘典, 飯田 洋, 野崎 雄一, 遠藤 宏樹, 米田 恭子, 藤田 浩司, 高橋 宏和, 小林 規俊, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 前山 史朗, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A850 - A850   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NAFLD,NASH発症におけるアンジオテンシンIIタイプ1受容体(AGTR1)の遺伝子多型解析

    米田 正人, 内山 崇, 留野 渉, 加藤 真吾, 馬渡 弘典, 飯田 洋, 野崎 雄一, 遠藤 宏樹, 藤田 浩司, 高橋 宏和, 小林 規俊, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 前山 史朗, 堀田 紀久子, 上野 規男, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A846 - A846   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃過形成ポリープの癌化、1切除例

    飯田 洋, 阿部 泰伸, 稲森 正彦, 内山 崇, 馬渡 弘典, 秋本 恵子, 遠藤 宏樹, 秋山 智之, 米田 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 利野 靖, 大城 久, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A775 - A775   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 高血圧のみを合併したNASH患者に対するARBの有用性

    藤田 浩司, 野崎 雄一, 内山 崇, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 細野 邦広, 秋山 智之, 米田 恭子, 米田 正人, 高橋 宏和, 後藤 歩, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増大会 )   A849 - A849   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM)

    Noritoshi Kobayashi, Takuma Higurashi, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Ayako Tomimoto, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima, Shoji Yamanaka, Yoshiaki Inayama

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY   15 ( 5 )   531 - 535   2008年9月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    We report a rare case of adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) in which parathyroid hormone-related protein (PTH-rP) was identified as the causative factor of hypercalcemia. A 72-year-old Japanese man was admitted to our institution complaining of fever and abdominal pain. Abdominal computed tomography demonstrated a large tumor in the body of the pancreas, with multiple liver metastases. Both serum calcium and PTH-rP levels were elevated. No accumulation was observed on bone scan with technetium-99. The patient died of pneumonia 3 months after admission. Autopsy demonstrated that the neoplasm in the pancreas showed an abrupt histological transition from adenocarcinoma to squamous cell carcinoma. PTH-rP was identified in the primary pancreatic tumor cells by immunohistochemical examination and a reverse-transcription polymerase chain reaction (RTPCR) method. We concluded that PTH-rP was the causative factor of the HHM, based on the laboratory data, immunohistochemical examination, and messenger RNA (mRNA) expression. This is a very rare report of adenosquamous cell carcinoma of the pancreas associated with HHM.

    DOI: 10.1007/s00534-007-1258-x

    Web of Science

    PubMed

    researchmap

  • Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue

    Kyoko Yoneda, Ayako Tomimoto, Hiroki Endo, Hiroshi Iida, Michiko Sugiyama, Hirokazu Takahashi, Hironori Mawatari, Yuichi Nozakv, Koji Fujita, Masato Yoneda, Masahiko Inamori, Noriko Nakajima, Koichiro Wada, Yoji Nagashima, Hitoshi Nakagama, Hiroshi Uozaki, Masashi Fukayama, Atsushi Nakajima

    ONCOLOGY REPORTS   20 ( 3 )   479 - 483   2008年9月

     詳細を見る

    記述言語:英語   出版者・発行元:PROFESSOR D A SPANDIDOS  

    Adiponectin is secreted by adipocytes and is a key hormone responsible for insulin sensitization. Recent studies have shown that plasma adiponectin is decreased in patients with breast, endometrial and gastric cancer. However, the effect of adiponectin on colorectal carcinogenesis is controversial. It is now well known that the adiponectin receptor exists in two isoforms, adiponectin receptor 1 (AdipoR1) and adiponectin receptor 2 (AdipoR2). We examined the expression of the adiponectin receptors on normal colon mucosa and colon cancer tissues in a human study using real-time RT-PCR, Western blotting and immunohistochemical staining. Adiponectin receptors, AdipoR1/AdipoR2, were expressed in normal colon epithelial and colon cancer cells. Furthermore, laser microdissection was pet-formed to confirm our results. These results suggest that adiponectin may exert some effects on normal colon epithelium or colon cancer cells directly through adiponectin receptors. Further studies are required to elucidate the function of the AdipoRs activated by adiponectin and the downstream mechanisms of AdipoRs in colon cancer cells.

    DOI: 10.3892/or_00000031

    Web of Science

    researchmap

  • Effects of Body Positions on Gastric Emptying with Enteral Nutrition: A Crossover Study using a Continuous Real Time (13)C Breath Test (BreathID system)

    Tamon Ikeda, Masahiko Inamori, Nobutaka Fujisawa, Tomoyuki Iwasaki, Tomoyuki Akiyama, Keiko Akimoto, Hironori Mawatari, Hiroshi Iida, Hiroki Endo, Yuichi Nozaki, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Kyoko Yoneda, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATO-GASTROENTEROLOGY   55 ( 86-87 )   1905 - 1907   2008年9月

     詳細を見る

    記述言語:英語   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: The aim of this study was to determine whether there was a correlation between body positions and gastric emptying, using a novel non-invasive technique for measuring gastric emptying with a continuous real time (13)C breath test (BreathID system).
    Methodology: Ten healthy male volunteers participated in this randomized, two-way crossover study. On both occasions. the (13)C breath test was performed for 4 hours using the BreathID system with a liquid meal (200kcal per 200mL) containing 100mg (13)C-acetic acid. Subjects were randomly assigned to sit comfortable (the sitting position) or to lie supine (the lying position).
    Results: In the lying position, T 1/2 and T lag were significantly delayed. The gastric emptying coefficient was also decreased in lying position.
    Conclusions: This study showed that gastric emptying following a liquid meal was significantly delayed in the lying position compared to the sitting position, suggesting the potential use of these findings in the clinical setting for patients receiving enteral nutrition via the stomach.

    Web of Science

    researchmap

  • Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b

    Hironori Mawatari, Hiroyuki Kirikoshi, Masato Yoneda, Takuma Higurashi, Koji Fujita, Satoru Saito, Masahiko Inamori, Hirokazu Takahashi, Yasunobu Abe, Kensuke Kubota, Atsushi Nakajima

    Hepato-Gastroenterology   55 ( 86-87 )   1776 - 1777   2008年9月

     詳細を見る

    記述言語:英語  

    Hepatocellular carcinoma with portal venous invasion has a poor prognosis. We report a case treated successfully by intra-arterial 5-fluorouracil with systemic pegylated-interferon-alpha-2b instead of conventional interferon-alpha. A 66-year-old man was admitted to our hospital, and diagnosed with hepatocellular carcinoma with portal venous invasion. Following informed consent, he was treated with eight week cycles of combination chemotherapy using intra-arterial 5-fluorouracil (500mg/body/day i.a., days 1-5, 8-12 continuously) and pegylated-interferon-alpha-2b (100μg body s.c,, days 1, 8). No significant side effects were observed during his therapy. After 4 cycles, computed tomography scan revealed a partial response of tumor reduction. This is the first report of advanced hepatocellular carcinoma effectively treated using subcutaneous pegylated-interferon-alpha-2b with intra-arterial 5-fluorouracil. While the conventional therapy of interferon-alpha with 5-fluorouracil has significant side effects, no significant side effects were observed in our case. The use of subcutaneous pegylated-interferon-alpha-2b combined with intra-arterial 5-flourouracil, may improve patients' quality of life. © H.G.E. Update Medical Publishing S.A., Athens-Stuttgart.

    Scopus

    PubMed

    researchmap

  • 大腸腫瘍のない男性における耐糖能異常および血清IGF-1とdysplastic aberrant crypt fociの解析(Abnormal glucose tolerance and plasma IGF-1 correlate with dysplastic aberrant crypt foci in colorectal tumor free male)

    高橋 宏和, 細野 邦広, 米田 恭子, 遠藤 宏樹, 野崎 雄一, 秋山 智之, 藤田 浩司, 米田 正人, 稲森 正彦, 阿部 泰伸, 斉藤 聡, 中島 淳

    日本癌学会総会記事   67回   381 - 381   2008年9月

     詳細を見る

    記述言語:英語   出版者・発行元:日本癌学会  

    researchmap

  • Gastric Surgery is Not a Risk Factor for the Development or Progression of Barrett&apos;s Epithelium

    Tomoyuki Akiyama, Masahiko Inamori, Keiko Akimoto, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Kyoko Yoneda, Tamon Ikeda, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Satoru Hirokawa, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Yasushi Rino, Atsushi Nahajima

    HEPATO-GASTROENTEROLOGY   55 ( 86-87 )   1899 - 1904   2008年9月

     詳細を見る

    記述言語:英語   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Barrett&apos;s epithelium is currently believed to be related to acid gastroesophageal reflux. The aim was to determine the role of pancreatic-biliary reflux in the genesis of Barrett&apos;s epithelium.
    Methodology: The study population comprised 1055 cases (606 men and 449 women; median age, 67years) who had undergone an upper endoscopy at 67 the Gastroenterology Division of Yokohama City University Hospital between August 2005 and July 2006. The study population was composed of 869 cases with intact stomachs and 186 cases with distal-gastrectomies. The presence and the progression of Barrett&apos;s epithelium were diagnosed based on the Prague C & M Criteria. The correlations of clinical factors, including distal-gastrectomy, with the presence and the progression of Barrett&apos;s epithelium were examined.
    Results: The study demonstrated that 42.2% of the total population was diagnosed to have Barrett&apos;s epithelium and, in 12.6% of the cases with Barrett&apos;s epithelium, the progression of Barrett&apos;s epithelium was observed during the median 72 month follow-up. A distal gastrectomy was not significantly correlated with either the incidence or progression of Barrett&apos;s epithelium.
    Conclusions: This lack of association between gastric surgery and Barrett&apos;s epithelium suggests that pancreatic-biliary reflux with limited acid is not sufficient for the genesis of Barrett&apos;s epithelium.

    Web of Science

    researchmap

  • 逆流性食道炎、バレット粘膜と飲酒 日本人男性における検討

    秋山 智之, 稲森 正彦, 藤田 浩司, 米田 正人, 中島 淳

    日本アルコール・薬物医学会雑誌   43 ( 4 )   438 - 438   2008年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本アルコール・アディクション医学会  

    researchmap

  • Education and imaging - Gastrointestinal: Colonic spirochetosis

    K. Tsuzawa, N. Fujisawa, Y. Sekino, K. Suzuki, K. Saito, S. Koyama, M. Tanaka, A. Wada, M. Inamori, K. Kubota, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   23 ( 7 )   1160 - 1160   2008年7月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2008.05493.x

    Web of Science

    researchmap

  • 苦痛のない上部消化管内視鏡検査(経鼻内視鏡検査を含む) 大学病院における経鼻内視鏡の導入経験

    稲森 正彦, 秋山 智之, 遠藤 宏樹, 飯田 洋, 馬渡 弘典, 野崎 雄一, 冨本 彩子, 藤田 浩司, 米田 恭子, 米田 正人, 高橋 宏和, 後藤 歩, 廣川 智, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斎藤 聡, 中島 淳

    神奈川医学会雑誌   35 ( 2 )   249 - 249   2008年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • Clinicopathologic study of resected cases of primary carcinoma of the cystic duct

    Kensuke Kubota, Yukio Kakuta, Yoshiaki Inayama, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima, Kazuya Sugimori, Kenichi Matuo, Takeda Kazunaga, Hiroshi Shimada

    HEPATO-GASTROENTEROLOGY   55 ( 85 )   1174 - 1178   2008年7月

     詳細を見る

    記述言語:英語   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: There have been few reports of primary carcinoma of the cystic duct (CCD) included in advanced cases. The aim of this study was to elucidate the clinical features of resected CCD.
    Methodology: Six cases of CCD were diagnosed in which the main carcinomatous component arose from the cystic bile duct, even if these carcinomas were accompanied by invasion beyond the cystic duct. Histopathologic findings (i.e., H.E. staining and cell proliferating potency assessed by ki-67 staining) were compared between the main lesion and invasive lesion of the CCD.
    Results: Abdominal ultrasonography revealed swelling of the gallbladder in 3 of the 6 patients, but not in the remaining 3, who were later diagnosed as having adenomyomatosis of the gallbladder, dyst-electasis due to the carcinomatous infiltration, and atrophic gallbladder, respectively. On computed tomography, 4 of the 6 cases with nodular-type lesions fulfilling Farrar's criteria, the tumors showed contrast enhancement. Direct cholangiography demonstrated unilateral obstruction of the common bile duct in 4 out of the 6 cases. Intraductal ultrasonography revealed CCD in only I of the 6 cases. Advanced CCD shows 2 patterns of invasion; the hepatic hilum pattern and the confluence invasive pattern. The hepatic hilum pattern of invasion tends to be associated with a poorer prognosis. Histopathological study revealed papillary and/or well differentiated adenocarcinoma in the cases where the lesion predominantly involved the cystic duct, whereas those lesions which extended beyond the cystic duct were composed of moderate and/or poorly differentiated tubular adenocarcinoma. The latter was associated with a high cellular proliferative activity as assessed by immunocytochemical examination for ki-67. Invasion of the perineural space was often observed in the cases with advanced CCD.
    Conclusions: CCD showed the hepatic hilum and/or confluence pattern of invasion when the tumor extended beyond the cystic duct. CCD extending beyond the cystic duct was associated with more aggressive characteristics of the tumors, with perineural infiltration and histopathologic features resembling those of pancreatic cancer. It is concluded that CCDs extending beyond the cystic duct are more aggressive and associated with a poorer prognosis.

    Web of Science

    researchmap

  • 胃排出能から見た食後愁訴症候群 BreathID systemを用いた解析

    稲森 正彦, 飯田 洋, 遠藤 宏樹, 細野 邦広, 秋山 智之, 米田 恭子, 高橋 宏和, 阿部 泰伸, 中島 淳

    胃病態機能研究会誌   40   15 - 15   2008年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • Association between PPARGCIA polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)

    Masato Yoneda, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Shingo Kato, Kunihiro Hosono, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8   2008年6月

     詳細を見る

    記述言語:英語   出版者・発行元:BIOMED CENTRAL LTD  

    Background: Genetic factors as well as environmental factors are important in the development of NAFLD and in this study we investigated associations between polymorphisms of peroxisome proliferators-activated receptor gamma coactivator 1 alpha polymorphism (PPARGC1A) and NAFLD.
    Aims: We recruited 115 patients with biopsy-proven NAFLD, 65 with NASH and 50 with simple steatosis, and 441 healthy control subjects and investigated 15 SNPs of PPARGC1A.
    Results: SNP rs2290602 had the lowest p value in the dominant mode (p = 0.00095), and the odds ratio for NAFLD (95% CI) was 2.73 (1.48-5.06). rs2290602 was significantly associated with NAFLD even when the most conservative Bonferroni&apos;s correction was applied (p = 0.0143). The frequency of the T allele of rs2290602 was significantly higher in the NASH patients than in the control subjects (p = 0.00093, allele frequency mode), and its frequency in the NASH patients tended to be higher than in the simple steatosis patients (p = 0.09). The results of the real-time RT-PCR study showed that intrahepatic mRNA expression of PPARGC1A was lower in the TT group than in the GG or GT group at SNP rs2290602 (p = 0.0454).
    Conclusion: This is the first study to demonstrate a significant association between genetic variations in PPARGC1A and NAFLD. This finding suggested that PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to etiology of NAFLD.

    DOI: 10.1186/1471-230X-8-27

    Web of Science

    researchmap

  • アレルギー機序を背景に発症した自己免疫性膵炎の一例

    阿部 真也, 窪田 賢輔, 石川 公, 馬渡 弘典, 阿部 泰伸, 稲森 正彦, 小林 規俊, 斎藤 聡, 大城 久, 中島 淳

    Progress of Digestive Endoscopy   73 ( 1 )   97 - 97   2008年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • Barrett粘膜およびBarrett食道の診断 Barrett粘膜の内視鏡的診断と経過観察におけるThe Prague C&M Criteriaの有用性

    秋山 智之, 稲森 正彦, 内山 崇, 池田 多聞, 秋本 恵子, 馬渡 弘典, 飯田 洋, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 廣川 智, 後藤 歩, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斎藤 聡, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   73 ( 1 )   70 - 70   2008年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 小腸疾患の診断・治療へのアプローチ 各種小腸内視鏡のすみわけはいかにすべきか 原因不明の消化管出血患者に対するカプセル内視鏡検査後のマネージメント

    遠藤 宏樹, 松橋 信行, 稲森 正彦, 秋本 恵子, 内山 崇, 飯田 洋, 馬渡 弘典, 野崎 雄一, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 小林 規俊, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    Progress of Digestive Endoscopy   73 ( 1 )   66 - 66   2008年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 診療の秘訣 若年女性の逆流性食道炎をみたら

    稲森 正彦, 中島 淳

    Modern Physician   28 ( 5 )   774 - 774   2008年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)新興医学出版社  

    researchmap

  • Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)

    M. Yoneda, M. Yoneda, H. Mawatari, K. Fujita, H. Endo, H. Iida, Y. Nozaki, K. Yonemitsu, T. Higurashi, H. Takahashi, N. Kobayashi, H. Kirikoshi, Y. Abe, M. Inamori, K. Kubota, S. Saito, M. Tamano, H. Hiraishi, S. Maeyama, N. Yamaguchi, S. Togo, A. Nakajima

    DIGESTIVE AND LIVER DISEASE   40 ( 5 )   371 - 378   2008年5月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE INC  

    Background. Liver fibrosis is the main predictor of the progression of nonalcoholic fatty liver disease. Transient elastography (FibroScan), which measures liver stiffness, is a novel, noninvasive method to assess liver fibrosis.
    Aim. We investigated the usefulness of liver stiffness measurement in the evaluation of liver fibrosis in nonalcoholic fatty liver disease patients.
    Study population. A total of 97 nonalcoholic fatty liver disease patients.
    Methods. Transient elastography was performed for liver stiffness measurement in 97 nonalcoholic fatty liver disease patients. And the relationship between histological parameters and liver stiffness measurement was studied by multivariate analysis. Moreover, we investigated the relationship between liver stiffness measurement and the serum levels of hyaluronic acid and type IV collagen 7s domain.
    Results. The liver stiffness was well correlated with the stage of liver fibrosis (Kruskal-Wallis test p&lt;0.0001). The areas under the receiver-operating characteristic curves were 0.927 for &gt;= F1, 0.865 for &gt;= F2, 0.904 for &gt;= F3, 0.991 for &gt;= F4. Only fibrosis stage was correlated significantly with liver stiffness measurement by multiple regression analysis. Liver stiffness was also strongly correlated with the serum levels of type IV collagen 7s domain (r = 0.525, p &lt; 0.0001) and hyaluronic acid (r = 0.457, p &lt; 0.0001).
    Conclusions. Our results show a significant correlation between liver stiffness measurement and fibrosis stage in nonalcoholic fatty liver disease patients, as confirmed by the results of liver biopsy, which remains the gold standard for evaluation of the severity of liver fibrosis in patients with nonalcoholic steatohepatitis. (C) 2007 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.

    DOI: 10.1016/j.dld.2007.10.019

    Web of Science

    researchmap

  • Rebleeding rate after interventional therapy directed by capsule endoscopy in patients with obscure gastrointestinal bleeding

    Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inamori, Keiko Akimoto, Tomohiko Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Koji Fujita, Masato Yoneda, Atsushi Nakajima

    BMC GASTROENTEROLOGY   8 ( 1 )   2008年4月

     詳細を見る

    記述言語:英語   出版者・発行元:BIOMED CENTRAL LTD  

    Background: The precise role of capsule endoscopy in the diagnostic algorithm of obscure gastrointestinal bleeding has yet to be determined. Despite the higher diagnostic yield of capsule endoscopy, the actual impact on clinical outcome remains poorly defined. The aim of this study was to evaluate the follow-up results of patients with obscure gastrointestinal bleeding to determine which management strategies after capsule endoscopy reduced rebleeding.
    Methods: All patients in whom the cause of obscure gastrointestinal bleeding was investigated between May 2004 and March 2007 were studied retrospectively. We evaluated the clinical outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy using the rebleeding rate as the primary outcome.
    Results: Seventy-seven patients with obscure gastrointestinal bleeding underwent capsule endoscopy. Capsule endoscopy identified clinically significant findings that were thought to be the sources of obscure gastrointestinal bleeding in 58.4% of the patients. The overall rebleeding rate was 36.4%. The rebleeding rate was significantly higher among patients with insignificant findings than among those with significant findings (p = 0.036). Among the patients in whom capsule endoscopy produced significant findings, the rebleeding rate of the patients who underwent therapeutic interventions was significantly lower than that in those who did not undergo intervention (9.5% vs 40.0%, p = 0.046).
    Conclusion: Follow-up and further aggressive interventions are necessary for patients with obscure gastrointestinal bleeding and significant capsule endoscopy findings to reduce the chance of rebleeding.

    DOI: 10.1186/1471-230X-8-12

    Web of Science

    researchmap

  • Association between Ppargc1a polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)

    Masato Yoneda, Koji Fujita, Yuichi Nozaki, Hiroyuki Kirikoshi, Atsushi Nakajima

    GASTROENTEROLOGY   134 ( 4 )   A781 - A781   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    DOI: 10.1186/1471-230X-8-27

    Web of Science

    researchmap

  • Sclerosing cholangitis affecting the hilar bile duct is associated with a cancer risk in cases with autoimmune pancreatitis

    Kensuke Kubota, Masahiko Inamori, Hironori Mawatari, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   67 ( 5 )   AB325 - AB326   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • 当院における経鼻内視鏡の使用経験 医療者側から見た有効例の評価

    稲森 正彦, 秋山 智之, 遠藤 宏樹, 秋本 恵子, 飯田 洋, 馬渡 弘典, 野崎 雄一, 坂本 康成, 藤田 浩司, 米田 恭子, 池田 多聞, 米田 正人, 高橋 宏和, 後藤 歩, 廣川 智, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.1 )   859 - 859   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • カプセル内視鏡通過時間と小腸病変の関連

    遠藤 宏樹, 松橋 信行, 秋本 恵子, 大谷 友彦, 柳川 達郎, 朝山 雅子, 久富 勘太郎, 寺谷 卓馬, 米田 正人, 稲森 正彦, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.1 )   844 - 844   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 胃瘻カテーテル交換時偶発症の現状 胃瘻カテーテル交換時のろう孔損傷の2例 胃壁固定を用いたリカバリーの有用性

    稲森 正彦, 内山 崇, 飯田 洋, 遠藤 宏樹, 秋山 智之, 藤田 浩司, 米田 恭子, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 日下部 明彦, 小林 規俊, 窪田 賢輔, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.1 )   1012 - 1012   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 肝細胞癌の胆管浸潤部が壊死をきたし、胆道内に落下し、乳頭部にて閉塞をきたした一例

    小林 規俊, 桐越 博之, 窪田 賢輔, 日暮 琢磨, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 冨本 彩子, 米田 恭子, 秋山 智之, 藤田 浩司, 高橋 宏和, 米田 正人, 阿部 泰伸, 稲森 正彦, 斉藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   50 ( Suppl.1 )   904 - 904   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 治療前半のリバビリン減量はC型慢性肝炎群別1型の再燃を生じる可能性がある

    馬渡 弘典, 斉藤 聡, 池田 多門, 米田 正人, 桐越 博之, 藤田 浩司, 飯田 洋, 秋山 智之, 遠藤 宏樹, 米田 恭子, 廣川 智, 後藤 歩, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 小林 規俊, 窪田 賢輔, 中島 淳

    肝臓   49 ( Suppl.1 )   A307 - A307   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 私の処方 逆流性食道炎/胃食道逆流症の症状に対する酸分泌抑制薬の使い分け

    稲森 正彦, 中島 淳

    Modern Physician   28 ( 4 )   581 - 581   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)新興医学出版社  

    researchmap

  • Novel diagnostic approach for NASH using [11c] choline dynamic PET imaging

    Koji Fujita, Yuichi Nozaki, Masato Yoneda, Hiroyuld Kirikoshi, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    GASTROENTEROLOGY   134 ( 4 )   A782 - A782   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 【胃癌のすべて】 胃癌の治療 早期胃癌の内視鏡的治療 レーザー治療(適応と成績、合併症)

    野崎 雄一, 阿部 泰伸, 藤田 浩司, 米田 正人, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 秋山 智之, 米田 恭子, 高橋 宏和, 小林 規俊, 桐越 博之, 稲森 正彦, 窪田 賢輔, 斉藤 聡, 川口 実, 中島 淳

    消化器外科   31 ( 5 )   696 - 700   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)へるす出版  

    researchmap

  • Feasibility of percutaneous transhepato-cholecystic biliary interventions after failed endoscopic attempt

    Kensuke Kubota, Masahiko Inamori, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   67 ( 5 )   AB161 - AB161   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • Visceral fat obesity and abnormal glucose tolerance correlate with dysplastic aberrant crypt foci in colorectal tumor free male

    Hirokazu Takahashi, Kyoko Yoneda, Hiroki Endo, Hiroshi Iida, Tomoyuki Akiyama, Yasunobu Abe, Masahiko Inamori, Atsushi Nakajima

    GASTROENTEROLOGY   134 ( 4 )   A26 - A27   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • Three clinicopathological subtypes of autoimmune pancreatitis stratified by the duodenal papillary findings and the serum IgG4

    Kensuke Kubota, Masahiko Inamori, Atsushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   67 ( 5 )   AB326 - AB326   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms

    Noritoshi Kobayashi, Masahiko Inamori, Koji Fujita, Toshio Fujisawa, Nobutaka Fujisawa, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Harunobu Kawamura, Takeshi Shimamura, Hiroyuki Kirikoshi, Kensuke Kubota, Takashi Sakaguchi, Satoru Saito, Lawrence J. Saubermann, Atsushi Nakajima

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY   15 ( 2 )   169 - 177   2008年3月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    Background/Purpose. Intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas have a favorable prognosis. However, invasive ductal carcinomas of the pancreas show a rapid progression. The aim of this study was to investigate gene mutations in pure pancreatic juice from IPMN patients and to define these genetic mutations in relation to the histopathological and clinical features of IPMNs.
    Methods. Twenty-two patients with IPMN, 21 patients with ductal carcinoma, and 20 patients with normal pancreas or chronic pancreatitis were recruited for this study. We measured the main pancreatic duct's largest diameter and the maximum size of a dilated branch was assessed by ultrasonography or endoscopic ultrasonography. Pure pancreatic juice was collected and was investigated for K-ras, p16, and p53 mutations.
    Results. Mutant K-ras gene was detected in 13 of the 22 patients (59.1%) with IPMNs. Different kinds of mutations were detected in the same patient in 4 cases. In the 13 patients with mutant K-ras gene, the diameter of the most dilated part of the main pancreatic duct was 2-8 mm ( average, 4.5 mm) and in 7 patients with wild-type K-ras gene, the diameter was 2 5 mm ( average, 2.7 mm). There was a significant difference in the diameter of the main pancreatic duct between patients with and without the mutant K-ras gene ( P = 0.0323).
    Conclusions. The incidence of K-ras mutation may be associated with the hypersecretion of mucin.

    DOI: 10.1007/s00534-007-1223-8

    Web of Science

    PubMed

    researchmap

  • 胃排出能を評価したMELASの1例 BreathID systemを用いて

    坂本 康成, 稲森 正彦, 秋山 智之, 岩崎 知之, 池田 多聞, 後藤 歩, 馬渡 弘典, 野崎 雄一, 遠藤 宏樹, 廣川 智, 藤田 浩司, 米田 正人, 高橋 宏和, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 大川 伸一, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A292 - A292   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • BreathID systemにて胃排出能を測定したアクロメガリーの1症例

    秋本 恵子, 稲森 正彦, 秋山 智之, 馬渡 弘典, 飯田 洋, 米田 恭子, 岩崎 知之, 遠藤 宏樹, 坂本 康成, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 松橋 信行, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A292 - A292   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 逆流性食道炎、Barrett粘膜の年代的推移における性差

    秋山 智之, 稲森 正彦, 飯田 洋, 秋本 恵子, 遠藤 宏樹, 坂本 康成, 池田 多聞, 米田 恭子, 野崎 雄一, 廣川 智, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A319 - A319   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 超音波内視鏡下膵嚢胞ドレナージが有効であった自己免疫性膵炎の一例

    馬渡 弘典, 窪田 賢輔, 関野 雄典, 飯田 洋, 藤田 浩司, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 斉藤 聡, 中島 淳, 大城 久

    日本消化器病学会雑誌   105 ( 臨増総会 )   A318 - A318   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 肝血管腫を合併し貧血にて高齢発見されたOsler-Rendu-Weber病の1例

    内山 崇, 飯田 洋, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 澤邉 文, 谷田 恵美子, 細野 邦広, 馬渡 弘典, 米田 正人, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A291 - A291   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 酸分泌抑制薬静注投与による胃排出能の変化について BreathID systemを用いた検討

    稲森 正彦, 秋山 智之, 秋本 恵子, 飯田 洋, 遠藤 宏樹, 坂本 康成, 池田 多聞, 野崎 雄一, 廣川 智, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A322 - A322   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 塩酸イトプリドによる胃排出能の変化について BreathID systemを用いた評価

    池田 多聞, 稲森 正彦, 秋本 恵子, 飯田 洋, 遠藤 宏樹, 秋山 智之, 坂本 康成, 米田 恭子, 馬渡 弘典, 廣川 智, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A321 - A321   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Angelman症候群に合併し非典型的側副血行路を示した胃静脈瘤の1例

    日暮 琢磨, 高橋 宏和, 飯田 洋, 阿部 泰伸, 稲森 正彦, 馬渡 弘典, 米田 正人, 廣川 智, 後藤 歩, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 金成 正信, 利野 靖, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A419 - A419   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • プロトンポンプ阻害薬とH2受容体拮抗薬の単回経静脈投与における胃内pHの立ち上がりに関する検討

    飯田 洋, 稲森 正彦, 遠藤 宏樹, 秋本 恵子, 馬渡 弘典, 坂本 康成, 秋山 智之, 池田 多聞, 米田 恭子, 野崎 雄一, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A347 - A347   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • カプセル内視鏡を用いた小腸潰瘍患者における通過時間の検討

    遠藤 宏樹, 松橋 信行, 秋本 恵子, 川越 圭, 大谷 友彦, 柳川 達郎, 朝山 雅子, 久富 勘太郎, 寺谷 卓馬, 米田 正人, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A198 - A198   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 交換時に用いる胃ろうボタンの長さに関する検討

    稲森 正彦, 日下部 明彦, 廣川 智, 秋山 智之, 秋本 恵子, 池田 多聞, 坂本 康成, 飯田 洋, 遠藤 宏樹, 米田 恭子, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A288 - A288   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 抗血小板薬のNAFLD病態改善効果 NAFLD病態モデルラットを用いた検討

    藤田 浩司, 野崎 雄一, 米田 正人, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 秋山 智之, 米田 恭子, 高橋 宏和, 後藤 歩, 廣川 智, 阿部 泰伸, 稲森 正彦, 小林 規俊, 島村 健, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A261 - A261   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 消化器症状の成り立ちに関する検討:食後愁訴症候群の症状を中心に

    稲森 正彦, 阿部 泰伸, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A171 - A171   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NAFLD病態形成におけるiNOS由来Nitric Oxideの意義

    野崎 雄一, 藤田 浩司, 米田 正人, 遠藤 宏樹, 馬渡 弘典, 飯田 洋, 米田 恭子, 秋山 智之, 高橋 宏和, 廣川 智, 後藤 歩, 小林 規俊, 稲森 正彦, 桐越 博之, 阿部 泰伸, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   105 ( 臨増総会 )   A239 - A239   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Levovist ultrasonography imaging in intracystic hemorrhage of simple liver cyst

    Tomoyuki Akiyama, Masahiko Inamori, Satoru Saito, Hirokazu Takahashi, Masato Yoneda, Koji Fujita, Toshio Fujisawa, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Michio Ueda, Kuniya Tanaka, Shinji Togo, Norio Ueno, Hiroshi Shimada, Atsushi Nakajima

    WORLD JOURNAL OF GASTROENTEROLOGY   14 ( 5 )   805 - 807   2008年2月

     詳細を見る

    記述言語:英語   出版者・発行元:W J G PRESS  

    The differential diagnosis between intracystic hemorrhage and cystadenocarcinoma of the liver is often difficult even with the use of various imaging modalities. A 73-year-old woman was admitted to our hospital with the complaint of right upper quadrant pain. Ultrasonography (US) demonstrated a heterogeneous echogenic cyst measuring 11 cm x 8 cm in size in S2 of the liver, indicated intracystic hemorrhage of simple liver cyst or cystadenocarcinoma, but the differential diagnosis was considerably difficult. Levovist (Schering, Berlin, Germany) US revealed no enhancement of the intracystic structures, suggesting a clot in the case of intracystic hemorrhage. An operation was performed and the resected lesion showed a solitary benign liver cyst, measuring 5.5 cm x 4.7 cm x 8.5 cm containing a large blood clot. The patient had an uneventful recovery after the surgery. Levovist US may play an important role in discrimination between intracystic hemorrhage of simple hepatic cysts and cystadenocarcinoma of the liver. (C) 2008 WJG. All rights reserved.

    DOI: 10.3748/wjg.14.805

    Web of Science

    researchmap

  • Life style-related disease and colorectal cancer.

    INAMORI Masahiko

    Internal Medicine   2008年

  • Severe Large-Intestine Involvement in Adult-Onset Henoch-Schonlein Purpura: Successful Treatment with Factor XIII Concentrate

    Kunihiro Hosono, Hiroki Endo, Masahiko Inamori, Hironori Mawatari, Hiroshi lida, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTION   78 ( 1 )   9 - 9   2008年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000151298

    Web of Science

    researchmap

  • Nitric oxide plays a crucial role in the development/progression of nonalcoholic steathepatitis (NASH) in the choline deficient, l-amino acid-deficient (CDAA) diet-fed rat model.

    INAMORI Masahiko

    Alcohol Clin Exp Res.   2008年

     詳細を見る

  • Gender differences in the age-stratified prevalence of erosive esophagitis and Barrett’s epithelium in Japan.

    INAMORI Masahiko

    Hepatogastroenterology   2008年

     詳細を見る

  • Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH.

    INAMORI Masahiko

    Hepatogastroenterology   2008年

     詳細を見る

  • 幽門側胃切除術後症例におけるBarrett粘膜の発生,伸展の観察-The Prague C&M Criteriaを用いて-

    秋山智之, 稲森正彦, 飯田洋, 秋本恵子, 池田多聞, 坂本康成, 遠藤宏樹, 高橋宏和, 阿部泰伸, 馬渡弘典, 藤田浩司, 米田正人, 後藤歩, 廣川智, 野崎雄一, 米田恭子, 小林規俊, 窪田賢輔, 利野靖, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   4th (Web)   2008年

     詳細を見る

  • The outcome of transarterial chemoembolization (TACE) monotherapy and combined TACE with percutaneus ethanol injection (PEI) or radiofrequency ablation (RFA) therapy for hepatocellular carcinoma (HCC).

    INAMORI Masahiko

    Hepatology Research   2008年

     詳細を見る

  • Aneurysmal artery in a gastric ulcer following endoscopic hemostasis.

    INAMORI Masahiko

    J Gastroenterol Hepatol   2008年

     詳細を見る

  • Does postprandial coffee intake enhance gastric emptying?: a crossover study using continuous real time 13C breath test (BreathID system).

    INAMORI Masahiko

    Hepatogastroenterology   2008年

     詳細を見る

  • Clinical characteristics of patients with gastric perforation following endoscopic submucosal resection for gastric cancer.

    INAMORI Masahiko

    Hepatogastroenterology   2008年

     詳細を見る

  • Gastric Varices with Remarkable Collateral Veins in Valpronic Acid-Induced Chronic Pancreatitis 国際誌

    INAMORI Masahiko

    Case Rep Gastroenterol   2 ( 2 )   279 - 82   2008年

     詳細を見る

    記述言語:英語  

    Valproic acid (VPA) is a commonly prescribed and approved treatment for epilepsy, including Angelman syndrome, throughout the world. However, the long-term administration of drugs like VPA is associated with the possible development of gastric varices and splenic obstruction as a result of chronic pancreatitis. Such cases can be difficult to treat using endoscopy or interventional radiology because of hemodynamic abnormalities; therefore, surgical treatment is often necessary.

    DOI: 10.1159/000151288

    PubMed

    researchmap

  • Antiphospholipid syndrome manifested by gastrointestinal bleeding: Can we overlook endoscopically revealed small lesions?

    Satoshi Nakao, Keiko Akimoto, Masahiko Inamori, Akihiro Suzuki, Keiko Suzuki, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shoji Yamanaka, Atsushi Nakajima

    DIGESTION   77 ( 3-4 )   139 - 140   2008年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000127417

    Web of Science

    researchmap

  • Collagenous colitis in a Japanese woman: Successful treatment with mesalazine

    Keiko Suzuki, Taiichi Kawabe, Hirokazu Takahashi, Satoshi Nakao, Akihiro Suzuki, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Hisashi Oshiro, Atsushi Nakajima

    DIGESTION   77 ( 3-4 )   155 - 156   2008年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000140975

    Web of Science

    researchmap

  • Ulcerative colitis with positivity for proteinase 3-antineutrophil cytoplasmic antibody

    Keiko Suzuki, Satoshi Nakao, Akihiro Suzuki, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTION   77 ( 3-4 )   157 - 158   2008年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000140976

    Web of Science

    researchmap

  • Chemotherapeutic Treatment of Priapism in Metastatic Rectal Cancer.

    INAMORI Masahiko

    Case Rep Gastroenterol   2   2008年

     詳細を見る

  • 早期胃癌を合併した自己免疫性膵炎の1例

    稲森 正彦

    Gastroenterological Endoscopy   50 ( 8 )   1736 - 1742   2008年

  • 切除不能膵癌に対するGemcitabine単独化学療法の適切な治療効果判定法についての検討

    稲森 正彦

    癌と化学療法   35 ( 1 )   2008年

     詳細を見る

  • Gastric Inflammatory Fibroid Polyp Treated by Endoscopic Submucosal Dissection.

    INAMORI Masahiko

    Case Rep Gastroenterol   2   2008年

     詳細を見る

  • 自己免疫性膵炎に併発した膵尾部癌の1例

    稲森 正彦

    膵臓   23 ( 5 )   608 - 614   2008年

     詳細を見る

    記述言語:日本語   出版者・発行元:Japan Pancreas Society  

    症例は66歳男性,閉塞性黄疸で発症したAutoimmune pancreatitis(AIP)が,1年6ヶ月のステロイド維持療法後,3年後に閉塞性黄疸で再発した.ステロイド再投与後,AIPは改善したが,その6ヶ月後,脳内出血で再入院した.7ヶ月後CA19-9 364U/m<i>l</i>と急上昇し,PET/CTで膵尾部癌,多発肝転移,骨盤転移と診断された.画像診断で膵炎所見は改善し,血清IgG4値も330から30mg/d<i>l</i>に改善した.抗癌剤投与が行われたが無効であった.最近,AIPの膵癌併発例が散見されるようになった.これまでAIPは予後良好の膵炎と認識されてきたが,今後は,膵炎症状の消退後も癌の存在を常に念頭に起き,ステロイドの長期投与の併発症に注意しながら,厳重に長期観察を行うことが肝要と考えられた.<br>

    DOI: 10.2958/suizo.23.608

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2009022177

  • 胃食道逆流症に対するon-demand therapyに適した薬剤の検討

    稲森正彦, 秋山智之, 飯田洋, 秋本恵子, 冨本彩子, 米田恭子, 馬渡弘典, 遠藤宏樹, 野崎雄一, 藤田浩司, 高橋宏和, 米田正人, 後藤あゆむ, 阿部泰伸, 池田多聞, 小林規俊, 坂本康成, 窪田賢輔, 斉藤聡, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   4th (Web)   2008年

     詳細を見る

  • ヒト大腸におけるアディポネクチンレセプター1および2(AdipoR1およびAdipoR2)の発現解析

    米満恭子, 高橋宏和, 日暮琢磨, 飯田洋, 馬渡弘典, 野崎雄一, 遠藤宏樹, 冨本彩子, 秋山智之, 藤田浩司, 米田正人, 稲森正彦, 阿部泰伸, 桐越博之, 小林規俊, 窪田賢輔, 斉藤聡, 上野規男, 中島淳

    日本消化管学会総会学術集会プログラム・抄録集   4th (Web)   2008年

     詳細を見る

  • Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats

    Koji Fujita, Masato Yoneda, Koichiro Wada, Hironori Mawatari, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Shiro Maeyama, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Atsushi Nakajima

    DIGESTIVE DISEASES AND SCIENCES   52 ( 12 )   3455 - 3464   2007年12月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    The term nonalcoholic steatohepatitis (NASH) has recently been proposed to identify a fatty liver disease accompanied by diffuse fatty infiltration and inflammation. However, no drug therapy has been established for NASH as yet. In the present study, we demonstrate the effect of the angiotensin II type 1 receptor antagonist telmisartan on the development of NASH in a rat model. Telmisartan, but not the angiotensin receptor antagonist valsartan, markedly attenuated hepatic steatosis, inflammation, and fibrosis in these rats. The quantitative parameters of steatosis, inflammation, and fibrosis were also ameliorated by treatment with telmisartan. Compared with telmisartan, the peroxisome proliferator-activated receptor-gamma agonist pioglitazone attenuated hepatic steatosis and fibrosis of the liver to a similar degree. However, telmisartan, but not pioglitazone, dramatically decreased both subcutaneous and visceral fat. In conclusion, these results indicated that telmisartan should be the drug of first choice for the treatment of patients with NASH.

    DOI: 10.1007/s10620-007-9741-4

    Web of Science

    researchmap

  • Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) (vol 56, pg 1330, 2007)

    Masato Yoneda, Masashi Yoneda, Koji Fujita, Masahiko Inamori, Masaya Tamano, Hideyuki Hiriishi, Atsushi Nakajima

    GUT   56 ( 12 )   1800 - 1800   2007年12月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    DOI: 10.1136/gut.2007.126417corr1

    Web of Science

    researchmap

  • Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis

    Kensuke Kubota, Hiroshi Iida, Toshio Fujisawa, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Satoru Saito, Hisashi Ohshiro, Yukio Kakuta, Atushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   66 ( 6 )   1142 - 1151   2007年12月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    Background: The rates of spontaneous remission and relapse of autoimmune pancreatitis (AIP) are not known.
    Objective: To study the clinicopathologic factors predictive of remission and relapse in cases of AIP.
    Design: Retrospective study.
    Patients: Of the 20 patients with AIP, complete response to steroid therapy was recognized in 12 patients, and the remaining 8 patients improved without steroid therapy. Seven patients experienced a relapse.
    Results: Patients who were seronegative for immunoglobulin (Ig) G4, had no obstructive jaundice, no diabetes mellitus, no swelling of the duodenal papilla, negative staining of the duodenal papilla for IgG4, and focal pancreatic swelling showed a greater tendency toward spontaneous remission (P &lt;.05). The results of multivariate analysis revealed that negative staining of the duodenal papilla for IgG4 was the only independent predictor of spontaneous remission of AIP (odds ratio [OR] 1.395, P =.0304). Seropositivity for IgG4, diffuse swelling of the pancreas, and the presence of stricture in the lower part of the bile duct were significantly associated with a relapse of AIP (P &lt;.05) according to the results of univariate analysis, whereas the results of multivariate analysis revealed only diffuse pancreatic swelling as an independent predictor of a relapse of AIP (OR 26.197, P =.0331).
    Conclusions: Endoscopic findings are of useful prognostic value, because patients with AIP and with negative staining of the duodenal papilla for IgG4 appeared to have a higher frequency of remission without steroid therapy. Patients with AIP and with diffuse pancreatic swelling were found to be at an increased risk of relapse after the initial steroid administration.

    DOI: 10.1016/j.gie.2007.06.059

    Web of Science

    researchmap

  • 当院における内視鏡シミュレーターシステムの使用経験 アンケート調査の結果からの問題点

    窪田 賢輔, 日暮 琢磨, 馬渡 弘典, 野崎 雄一, 遠藤 宏樹, 宮本 彩子, 米田 恭子, 秋山 智之, 飯田 洋, 藤田 浩二, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 斉藤 聡, 中島 淳

    Progress of Digestive Endoscopy   72 ( 1 )   103 - 103   2007年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • ERCPおよび関連手技の合併症対策 新型precut knifeの使用経験 その安全性、有用性について

    窪田 賢輔, 日暮 琢磨, 馬渡 弘典, 野崎 雄一, 遠藤 宏樹, 冨本 彩子, 米田 恭子, 秋山 智之, 飯田 洋, 藤田 浩司, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 斉藤 聡, 中島 淳

    Progress of Digestive Endoscopy   72 ( 1 )   62 - 62   2007年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model

    Ikuko Ikeda, Ayako Tomimoto, Koichiro Wada, Toshio Fujisawa, Koji Fujita, Kyoko Yonemitsu, Yuichi Nozaki, Hiroki Endo, Hirokazu Takahashi, Masato Yoneda, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Yoji Nagashima, Hitoshi Nakagama, Atsushi Nakajima

    CLINICAL CANCER RESEARCH   13 ( 21 )   6527 - 6531   2007年11月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER ASSOC CANCER RESEARCH  

    Purpose: The risk of colorectal cancer is increased inpatients with inflammatory bowel diseases, especially those with ulcerative colitis (UC). Although 5-aminosalicylic acid (5-ASA) is widely used in the treatment of UC to suppress the colitic inflammation, no studies have. been conducted to examine the chemopreventive effect of 5-ASA, given in the remission phase of colitis, against colitis- associated cancer using animal models. We therefore investigated the possible inhibition by peroxisome proliferator-activated receptor-gamma (PPAR gamma) ligands and 5-ASA of colitis-associated colon carcinogenesis in a mouse model.
    Experimental Design: A dextran sodium sulfate/azoxymethane-induced mouse colon cancer model was used, and the chemopreventive effects of 5-ASA and PPAR-gamma ligands, given in the remission phase of colitis, against colitis-related colon carcinogenesis, were evaluated.
    Results: The number of neoplasms in the mice treated with 5-ASA was significantly lower than that in the control mice. In addition, the size of the neoplasms in treated mice was also significantly smaller than that in the control mice. In contrast, no significant suppression in the number or size of the tumors was observed in the mice treated with PPAR gamma ligands. The proliferating cell nuclear antigen - labeling index in the tumor cells of the 5-ASA-treated mice was significantly smaller than that in the control, indicating that 5-ASA reduced tumor cell proliferation.
    Conclusion: Our results revealed that 5-ASA given in the remission phase of colitis significantly suppressed the development of colitis-associated cancer in a mouse model, which indicates the clinical importance of adopting chemopreventive strategies even in UC patients in remission.

    DOI: 10.1158/1078-0432.CCR-07-1208

    Web of Science

    researchmap

  • Life style-related diseases of the digestive system: colorectal cancer as a life style-related disease: from carcinogenesis to medical treatment

    Hirokazu Takahashi, Kyoko Yoneda, Ayako Tomimoto, Hiroki Endo, Toshio Fujisawa, Hiroshi Lida, Hironori Mawatari, Yuichi Nozaki, Tamon Ikeda, Tomoyuki Akiyama, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Satoru Saito, Atsushi Nakajima, Hitoshi Nakagarna

    JOURNAL OF PHARMACOLOGICAL SCIENCES   105 ( 2 )   129 - 132   2007年10月

     詳細を見る

    記述言語:英語   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Life style-related diseases are associated with an increased risk of colorectal cancer (CRC). Recently, an association has been demonstrated between obesity and CRC. CRC has been associated with markers of insulin or glucose control, and insulin resistance might be the unifying mechanism by which several risk factors affect colorectal carcinogenesis. We evaluated the association between the number of aberrant crypt foci (ACF) and obesity, insulin resistance, hyperlipidemia, and other factors of life style-related disease. As a result, age, body mass index (BMI), waist circumference, and visceral fat obesity were significantly associated with the number of ACF. These results suggest that visceral fat obesity is an important target for CRC prevention. Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a member of the nuclear receptor superfamily and is highly expressed in CRC. PPAR gamma ligand administration for 1 to 8 months significantly reduced the number of ACF in human subjects. PPAR gamma ligand is a promising candidate as a chemopreventive agent. Further investigation is needed to elucidate these mechanisms.

    DOI: 10.1254/jphs.FM0070022

    Web of Science

    researchmap

  • Aperitif effects on drinking capacity: a crossover study with water drinking test

    Masahiko Inamori, Tomoyuki Akiyama, Atsushi Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   19   53 - 53   2007年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BLACKWELL PUBLISHING  

    Web of Science

    researchmap

  • Effects of body positions on gastric emptying: a crossover study using a continuous real time 13C breath test (Breathid system)

    Tomoyuki Akiyama, Masahiko Inamori, Atsushi Nakajima

    NEUROGASTROENTEROLOGY AND MOTILITY   19   53 - 53   2007年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BLACKWELL PUBLISHING  

    Web of Science

    researchmap

  • High sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

    Yuichi Nozaki, Masato Yoneda, Takuma Higurashi, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Ayako Tomimoto, Kyoto Yonemitsu, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masahiko Inamori, Noritoshi Kobayashi, Yasunobu Abe, Kensuke Kubota, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima

    HEPATOLOGY   46 ( 4 )   735A - 735A   2007年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

  • Novel therapeutic approach for nafld using antiplatelet agents in an animal model

    Koji Fujita, Masato Yoneda, Yuichi Nozaki, Hiroshi Iida, Takuma Higurashi, Hironori Mawatari, Hiroki Endo, Ayako Tomimoto, Kyoko Yoneda, Tomoyuki Akiyama, Hirokazu Takahashi, Ayumu Goto, Satoru Hirokawa, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    HEPATOLOGY   46 ( 4 )   762A - 763A   2007年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

  • Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients

    M. Yoneda, S. Saito, T. Ikeda, K. Fujita, H. Mawatari, H. Kirikoshi, M. Inamori, Y. Nozaki, T. Akiyama, H. Takahashi, Y. Abe, K. Kubota, T. Iwasaki, Y. Terauchi, S. Togo, A. Nakajima

    JOURNAL OF VIRAL HEPATITIS   14 ( 9 )   600 - 607   2007年9月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    Insulin resistance (IR) is known to be associated with the visceral adipose tissue area. Elucidation of the relationship between hepatitis C virus (HCV) and IR is of great clinical relevance, because IR promotes liver fibrosis. In this study, we tested the hypothesis that HCV infection by itself may promote IR. We prospectively evaluated 47 patients with chronic HCV infection who underwent liver biopsy. Patients with obesity, type 2 diabetes mellitus (DM), or a history of alcohol consumption were excluded. IR was estimated by calculation of the modified homeostasis model of insulin resistance (HOMA-IR) index. Abdominal fat distribution was determined by computed tomography. Fasting blood glucose levels were within normal range in all the patients. The results of univariate analysis revealed a significant correlation between the quantity of HCV-RNA and the HOMA-IR (r = 0.368, P = 0.0291). While a significant correlation between the visceral adipose tissue area and the HOMA-IR was also observed in the 97 control, nondiabetic, non-HCV-infected patients (r = 0.398, P &lt; 0.0001), no such significant correlation between the visceral adipose tissue area and the HOMA-IR (r = 0.124, P = 0.496) was observed in the patients with HCV infection. Multiple regression analysis with adjustment for age, gender and visceral adipose tissue area revealed a significant correlation between the HCV-RNA and the HOMA-IR (P = 0.0446). HCV is directly associated with IR in a dose-dependent manner, independent of the visceral adipose tissue area. This is the first report to demonstrate the direct involvement of HCV and IR in patients with chronic HCV infection.

    DOI: 10.1111/j.1365-2893.2006.00836.x

    Web of Science

    researchmap

  • 便秘が発見の契機となった強大な糞石の1例

    内山 崇, 酒井 英嗣, 日暮 琢磨, 飯田 洋, 遠藤 宏樹, 野崎 雄一, 冨本 彩子, 秋山 智之, 藤田 浩司, 米田 恭子, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   49 ( Suppl.2 )   2366 - 2366   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 小腸内視鏡で診断され治療経過を追えたLymphomaの1例

    日暮 琢磨, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 冨本 彩子, 秋山 智之, 藤田 浩司, 米田 恭子, 米田 正人, 後藤 歩, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   49 ( Suppl.2 )   2335 - 2335   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 日本人における非アルコール性脂肪性肝炎(NASH)の診断における血清フェリチン値測定の有用性の検討

    野崎 雄一, 米田 正人, 藤田 浩司, 遠藤 宏樹, 飯田 洋, 馬渡 弘典, 秋本 恵子, 冨本 彩子, 米満 恭子, 秋山 智之, 後藤 歩, 廣川 智, 高橋 宏和, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 上野 規男, 斉藤 聡, 中島 淳

    肝臓   48 ( Suppl.2 )   A474 - A474   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • NAFLD患者の肝線維化測定におけるフィブロスキャンの有用性の検討

    米田 正人, 馬渡 弘典, 飯田 洋, 野崎 雄一, 遠藤 宏樹, 藤田 浩司, 高橋 宏和, 米満 恭子, 稲森 正彦, 小林 規俊, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 玉野 正也, 米田 政志, 平石 秀幸, 前山 史朗, 斉藤 聡, 上野 規男, 中島 淳

    肝臓   48 ( Suppl.2 )   A474 - A474   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 非典型的画像で切除した限局性結節性過形成の一例

    佐藤 圭, 馬渡 弘典, 藤田 浩司, 米田 正人, 桐越 博之, 武田 和永, 遠藤 格, 日暮 琢磨, 野崎 雄一, 飯田 洋, 秋本 恵子, 冨本 彩子, 米満 恭子, 秋山 智之, 高橋 宏和, 稲森 正彦, 阿部 泰伸, 窪田 賢輔, 斉藤 聡, 中島 淳

    肝臓   48 ( Suppl.2 )   A468 - A468   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 日本人における非アルコール性脂肪性肝炎(NASH)の診断における血清フェリチン値測定の有用性の検討

    米田 正人, 藤田 浩司, 稲森 正彦, 野崎 雄一, 中島 淳, 岩崎 知之, 寺内 康夫, 前山 史朗

    アルコールと医学生物学   27   154 - 159   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)響文社  

    日本人の非アルコール性脂肪性肝炎(NASH)患者における血清フェリチン値を測定し、NASH患者のフェリチン高値がHFE遺伝子変異、インスリン抵抗性と関与しているのか、またNASH診断における診断マーカーとしてなりうるか検討した。日本人NASH患者においても血清フェリチン値は高値で、また血清フェリチン高値は肝障害、肝線維化と関与することが示唆された。日本人においてもNASH患者のフェリチン高値とにはHFE遺伝子変異の関与は否定的であることが示唆された。196ng/ml場合はNASH診断における特異度76.5%、陽性的中率が88.9%と高値で、NASHを強く疑う所見と考え肝生検による診断確定を進めるべきである。しかし感度64.2%、陰性的申率43.1%と低いことから血清フェリチン値が低値であることからNASHを否定はできず、他の方法との併用が必要であることが示唆された。

    researchmap

  • 非アルコール性脂肪性肝炎患者の線維化進展症例(Stage 3)の診断における肝線維化マーカーの検討。4型コラーゲンとヒアルロン酸はどちらが有用か?

    馬渡 弘典, 米田 正人, 藤田 浩司, 桐越 博之, 斉藤 聡, 日暮 琢磨, 野崎 雄一, 飯田 洋, 秋本 恵子, 冨本 彩子, 米満 恭子, 秋山 智之, 高橋 宏和, 稲森 正彦, 阿部 泰伸, 窪田 賢輔, 中島 淳

    肝臓   48 ( Suppl.2 )   A475 - A475   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 血清Choline測定によるNASHの新しい診断法

    藤田 浩司, 野崎 雄一, 米田 正人, 稲森 正彦, 桐越 博之, 斉藤 聡, 中島 淳, 和田 孝一郎, 前山 史朗

    アルコールと医学生物学   27   197 - 202   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)響文社  

    動物モデルとヒト双方におけるコリン代謝を含めた肝脂質代謝排泄系を測定解析した。食餌中に全くコリン代謝物を有しないCDAAモデルは、対照コントロール群と比較して血清中・肝組織中のコリン代謝物含量は約1/2に減少した。HF/HCモデルは対照群と比較して血清中・肝組織中のコリン代謝物含量は約2倍に増加した。NASH病態進展の2nd hitには脂質排泄能の低下に伴う余剰脂肪の蓄積・停滞・酸化等が関与していることが示唆された。ヒトNAFLD病態における血清コリン代謝物値を測定し、コリンのみ病態進展に伴う血清値の増加を認めた。単純性脂肪肝とNASHの鑑別において、感度85%、陽性的中率80%であった。繊維化・病態の進展に伴い血清コリン値の有意な増加を認めた。特に肝硬変では顕著で、血清コリン値&gt;12ug/mlを超える症例は肝硬変である可能性が高いことが示唆された。

    researchmap

  • 回虫症が原因と考えられ診断に苦慮した消化管出血の一例

    薮下 泰宏, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 冨本 彩子, 秋山 智之, 藤田 浩司, 米田 恭子, 米田 正人, 後藤 歩, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増大会 )   A633 - A633   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 十二指腸乳頭部過誤腫の1例

    飯田 洋, 窪田 賢輔, 藤澤 俊郎, 稲森 正彦, 斉藤 聡, 中島 淳, 加藤 生真, 稲山 嘉明

    日本消化器病学会雑誌   104 ( 臨増大会 )   A618 - A618   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Gemcitabine/IL-4 cytotoxin併用療法における膵臓がん動物モデルでの抗腫瘍効果について

    島村 健, 中島 淳, 藤澤 聡郎, 藤田 浩二, 米田 正人, 高橋 宏和, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 増野 雄治, 宮崎 信彦, 姜 正広, 中原 成浩, 佐藤 仁一, Syed Husain, Raj Puri

    日本消化器病学会雑誌   104 ( 臨増大会 )   A733 - A733   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • メトフォルミンによるAPC Minマウスのポリープの形成抑制効果の検討

    冨本 彩子, 藤澤 聡郎, 米満 恭子, 高橋 宏和, 藤田 浩司, 遠藤 宏樹, 野崎 雄一, 秋山 智之, 馬渡 弘典, 飯田 洋, 米田 正人, 廣川 智, 後藤 歩, 阿部 泰伸, 稲森 正彦, 小林 規俊, 桐越 博之, 窪田 憲輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増大会 )   A643 - A643   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃食道逆流症診療の検証 医療者、患者両方の視点より

    稲森 正彦, 斎藤 聡, 中島 淳, 森實 敏夫

    日本消化器病学会雑誌   104 ( 臨増大会 )   A576 - A576   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 日本人のBarrett粘膜 The Prague C&M Criteriaを用いて

    秋山 智之, 稲森 正彦, 秋本 恵子, 坂本 康成, 池田 多聞, 藤田 浩司, 藤澤 聡郎, 飯田 洋, 馬渡 弘典, 後藤 歩, 富本 彩子, 米満 恭子, 米田 正人, 高橋 宏和, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増大会 )   A574 - A574   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 食後のコーヒー飲用による胃排出能の変化について Breath ID systemを用いた連続呼気採取による評価

    秋本 恵子, 稲森 正彦, 秋山 智之, 坂本 康成, 飯田 洋, 馬渡 弘典, 冨本 彩子, 米満 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 後藤 歩, 中戸川 満智子, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 上野 規男, 松橋 信行, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増大会 )   A608 - A608   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • チューインガムによる胃排出能の変化について Breath ID systemを用いた連続呼気採取による評価

    坂本 康成, 稲森 正彦, 秋本 恵子, 秋山 智之, 飯田 洋, 馬渡 弘典, 冨本 彩子, 米満 恭子, 藤田 浩司, 高橋 宏和, 米田 正人, 後藤 歩, 中戸川 満智子, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 上野 規男, 大川 伸一, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増大会 )   A606 - A606   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 肝転移巣より退形成膵管癌と診断された巨大G-CSF産生腫瘍の1例

    木村 麻里江, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 飯田 洋, 馬渡 弘典, 遠藤 宏樹, 野崎 雄一, 冨本 彩子, 秋山 智之, 藤田 浩司, 米田 恭子, 米田 正人, 後藤 歩, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増大会 )   A754 - A754   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)

    M. Yoneda, K. Fujita, M. Inamori, A. Nakajima, M. Yoneda, M. Tamano, H. Hiraishi

    GUT   56 ( 9 )   1330 - 1331   2007年9月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:B M J PUBLISHING GROUP  

    DOI: 10.1136/gut.2007.126417

    Web of Science

    researchmap

  • 胆道疾患へのIVR的アプローチ 胆道閉塞性疾患における経皮および経乳頭的胆嚢管アプローチの有用性

    窪田 賢輔, 飯田 洋, 小川 真実, 稲森 正彦, 小林 規俊, 斉藤 聡, 中島 淳

    胆道   21 ( 3 )   361 - 361   2007年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本胆道学会  

    researchmap

  • High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

    Masato Yoneda, Hironori Mawatari, Koji Fujita, Hiroshi Iida, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 7 )   573 - 582   2007年7月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    Background. The changes in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However, it has remained difficult to differentiate between NASH and nonprogressive NAFLD by clinical examination. We investigated the interrelationships between serum high-sensitivity C-reactive protein (hs-CRP) and the pathogenesis and progression of NASH. Methods. Hs-CRP was measured in 100 patients with histologically verified NAFLD (29 with steatosis and 71 with NASH), and a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was performed to measure the intrahepatic mRNA expressions of CRP and interleukin (IL)-6. Results. The results of a multiple regression analysis revealed that in comparison with cases of steatosis, hs-CRP was significantly elevated (P = 0.0048) in cases of NASH. Furthermore, among patients with NASH, hs-CRP was significantly elevated in those with advanced fibrosis compared with that in those with mild fibrosis (P = 0.0384), even after adjustment for age, sex, presence of diabetes, body mass index, visceral fat area, subcutaneous fat area, homeostasis model assessment for insulin resistance, high-density lipoprotein cholesterol, triglyceride, and low-density lipoprotein cholesterol. The results of the RT-PCR analysis showed that intrahepatic mRNA expression of CRP, but not IL-6, was increased in patients with NASH compared with those with steatosis (P = 0.0228). Conclusions. This is the first report to demonstrate consistent and profound elevation of hs-CRP in cases of NASH compared with in cases of simple nonprogressive steatosis. Our results suggest that hs-CRP may be a clinical feature that not only distinguishes NASH from simple nonprogressive steatosis but also indicates the severity of hepatic fibrosis in cases of NASH.

    DOI: 10.1007/s00535-007-2060-x

    Web of Science

    PubMed

    researchmap

  • 食後3時間のpHモニタリングからみた胃食道逆流症

    稲森 正彦, 秋本 恵子, 秋山 智之, 高橋 宏和, 後藤 歩, 阿部 泰伸, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    神奈川医学会雑誌   34 ( 2 )   245 - 245   2007年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • Early effects of peppermint oil on gastric emptying: a crossover study using a continuous real-time C-13 breath test (BreathID system)

    Masahiko Inamori, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 7 )   539 - 542   2007年7月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    Background. The aim of this study was to determine whether there was a correlation between peppermint oil and gastric emptying by using a novel noninvasive technique for measuring gastric emptying with a continuous real-time C-13 breath test (BreathID system, Oridion, Israel). Methods. Ten healthy male volunteers participated in this randomized, two-way crossover study. The subjects were randomly assigned to receive a test meal (200 kcal per 200 ml) containing 0.64 ml of peppermint oil or the test meal alone, after fasting overnight. A C-13-acetic acid breath test was continuously performed with the BreathID system, which monitors gastric emptying, for 4 h after the administration of the test meal. Using Oridion Research Software (beta version), the time for emptying of 50% of the labeled meals (T 1/2), the analog to the scintigraphy lag time for 10% emptying of the labeled meal (T lag), the gastric emptying coefficient (GEC), and the regression-estimated constants (beta and kappa) were calculated. The parameters between two occasions were compared using the Wilcoxon signed-rank test. Results. After peppermint oil intake, the T lag and beta constant were significantly decreased. No significant differences in T 1/2, GEC, or kappa were observed between the two occasions. Conclusions. The decrease in the T lag and beta constant suggests acceleration of gastric emptying during the early phase. This study showed that peppermint oil enhances gastric emptying, suggesting the potential use of peppermint oil in clinical settings for patients with functional gastrointestinal disorders.

    DOI: 10.1007/s00535-007-2067-3

    Web of Science

    researchmap

  • Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment?

    Masahiko Inamori, Keiko Akimoto, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 6 )   510 - 511   2007年6月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    DOI: 10.1007/s00535-007-2024-1

    Web of Science

    researchmap

  • 小腸ダブルバルーン内視鏡で診断しえた小腸原発GISTの一例

    高村 直子, 高橋 宏和, 馬渡 弘典, 飯田 洋, 遠藤 宏樹, 野崎 雄一, 冨本 彩子, 秋山 智之, 米満 恭子, 藤田 浩司, 米田 正人, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   71 ( 1 )   103 - 103   2007年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

    Masato Yoneda, Hironori Mawatari, Koji Fujita, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 5 )   375 - 381   2007年5月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    Background. The changes in nonalcoholic fatty liver disease range over a wide spectrum, extending, from simple steatosis to nonalcoholic steatohepatitis (NASH). We investigated the clinical usefulness of the type IV collagen 7s domain and hyaluronic acid for predicting the severity of fibrosis before progression to the cirrhotic stage in NASH patients. Methods. The type IV collagen 7s domain and hyaluronic acid were measured in 72 patients with histologically verified NASH. Results. In a univariate analysis, marked elevation of hyaluronic acid and the type IV collagen 7s domain was observed in the NASH patients with advanced fibrosis compared with those with mild fibrosis (P = 0.0028, P = 0.0006, respectively). For detection of NASH with advanced fibrosis, the area under the receiver-operating characteristic curves for type IV collagen 7s domain and hyaluronic acid were 0.767 and 0.754, respectively. However, multiple regression analysis revealed that the type IV collagen 7s domain, but not hyaluronic acid, was significantly elevated in patients with advanced fibrosis even after adjustment for age, sex, platelet count, prothrombin time, aspartate aminotransferase/alanine aminotransferase ratio, body mass index, and presence of underlying type 2 diabetes mellitus, all of which have previously been reported as useful predictors of advanced fibrosis in patients with NASH (P = 0.0127, P = 0.2804, respectively). Conclusions. This is the first report to demonstrate a consistent and profound elevation of the type IV collagen 7s domain in NASH patients with advanced fibrosis (before progression to the stage of cirrhosis) compared with those with mild fibrosis.

    DOI: 10.1007/s00535-007-2014-3

    Web of Science

    PubMed

    researchmap

  • 自己免疫性膵炎の再燃時に併発した膵尾部癌の1例

    飯田 洋, 窪田 賢輔, 小川 真実, 稲森 正彦, 斉藤 聡, 中島 淳

    膵臓   22 ( 3 )   357 - 357   2007年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本膵臓学会  

    researchmap

  • B型慢性肝炎、C型慢性肝炎、原因不明の肝炎患者におけるNV-Fの関与について

    斉藤 聡, 秋山 智之, 池田 多聞, 馬渡 弘典, 飯田 洋, 秋本 恵子, 米満 恭子, 冨本 彩子, 藤田 浩司, 藤澤 聡郎, 米田 正人, 高橋 宏和, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 上野 規男, 中島 淳

    肝臓   48 ( Suppl.1 )   A262 - A262   2007年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 上部消化器症状と内視鏡診断 胃食道逆流症の診断における内視鏡検査の意義

    稲森 正彦, 阿部 泰伸, 中島 淳

    Gastroenterological Endoscopy   49 ( Suppl.1 )   690 - 690   2007年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • A new questionnaire FSSG, frequency scale for the symptoms of GERD, better correlates with endoscopic severity than quest questionnaire, and is capable to evaluate dyspeptic symptoms in GERD patients. Japan FSSG committee multi center trial

    Motoyasu Kusano, Kanako Yamaguchi, Toshihito Saitoh, Masahiko Inamori, Takashi Ando, Tomoiko Shimatani, Kyoichi Adachi, Yasuyuki Shimoyama, Fukunori Kinjo, Shiko Kuribayasi, Shoji Mitsufuji, Kazuhide Higuchi, Shigeki Koyama, Junichi Akiyama, Atsushi Takagi, Hiroto Miwa, Kazuma Fujimoto

    GASTROENTEROLOGY   132 ( 4 )   A285 - A285   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 通常内視鏡によるBarrett粘膜の逆行的経過観察

    秋山 智之, 稲森 正彦, 中島 淳

    Gastroenterological Endoscopy   49 ( Suppl.1 )   895 - 895   2007年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 選択的胆管挿管困難例に対するprecut施行例の検討

    窪田 賢輔, 飯田 洋, 藤澤 聡郎, 小川 真実, 稲森 正彦, 阿部 泰伸, 桐越 博之, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   49 ( Suppl.1 )   878 - 878   2007年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Anatomical factors predictive of difficult biliary cannulation during ERCP

    Kensuke Kubota, Hirosi Iida, Toshio Fujisawa, Inamori Masahiko, Satoru Saito, Atushi Nakajima

    GASTROINTESTINAL ENDOSCOPY   65 ( 5 )   AB221 - AB221   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis

    Kensuke Kubota, Hiroshi Iida, Toshio Fujisawa, Masahiko Inamori, Satoru Saito, Atuhsi Nakajima

    GASTROINTESTINAL ENDOSCOPY   65 ( 5 )   AB114 - AB114   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • 当科におけるESD穿孔合併症例の検討

    阿部 泰伸, 遠藤 宏樹, 秋本 恵子, 米満 恭子, 高橋 宏和, 稲森 正彦, 上野 規男, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増総会 )   A210 - A210   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NASH診断、線維化進行判定における高感度CRP測定の有効性についての検討

    米田 正人, 中島 淳, 前山 史朗, 馬渡 弘典, 秋本 恵子, 飯田 洋, 冨本 彩子, 野崎 雄一, 遠藤 宏樹, 米満 恭子, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 高橋 宏和, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男

    日本消化器病学会雑誌   104 ( 臨増総会 )   A114 - A114   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NO代謝物のmetabolic syndrome,NAFLD病態への関与

    藤田 浩司, 米田 正人, 馬渡 弘典, 飯田 洋, 秋本 恵子, 野崎 雄一, 遠藤 宏樹, 冨本 彩子, 秋山 智之, 藤澤 聡郎, 高橋 宏和, 後藤 歩, 稲森 正彦, 阿部 泰伸, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増総会 )   A112 - A112   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Gastrointestinal: Diphyllobothriasis

    K. Goto, M. Hayashi, M. Inamori, T. Akiyama, T. Ikeda, K. Fujita, I. Ikeda, T. Fujisawa, H. Takahashi, M. Yoneda, K. Hara, H. Yasuzaki, Y. Abe, H. Kirikoshi, K. Kubota, S. Saito, I. Kawana, N. Ueno, T. Sakashita, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   22 ( 3 )   445 - 445   2007年3月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2007.04879.x

    Web of Science

    researchmap

  • 内臓脂肪は大腸前癌病変と相関する

    高橋 宏和, 米満 恭子, 藤澤 聡郎, 冨本 彩子, 馬渡 弘典, 秋本 恵子, 飯田 洋, 秋山 智之, 藤田 浩司, 米田 正人, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 高山 哲治, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増総会 )   A247 - A247   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院における酢酸オクトレオチドの使用経験

    秋本 恵子, 稲森 正彦, 飯田 洋, 馬渡 弘典, 冨本 彩子, 米満 恭子, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 高橋 宏和, 米田 正人, 後藤 歩, 阿部 泰伸, 日下部 明彦, 桐越 博之, 中戸川 満智子, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増総会 )   A169 - A169   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 酸分泌抑制薬経口投与における胃内pHの立ち上がりに関する検討(プロトンポンプ阻害薬とH2受容体拮抗薬併用の試み)

    稲森 正彦, 秋山 智之, 秋本 恵子, 飯田 洋, 馬渡 弘典, 冨本 彩子, 米満 恭子, 藤田 浩司, 藤澤 聡郎, 米田 正人, 高橋 宏和, 後藤 歩, 阿部 泰伸, 中戸川 満智子, 桐越 博之, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増総会 )   A163 - A163   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 無脂肪TPN投与により併発した肝機能異常、脂肪肝に対し脂肪乳剤が有効であった1例

    藤田 浩司, 米田 正人, 馬渡 弘典, 飯田 洋, 冨本 彩子, 遠藤 宏樹, 野崎 雄一, 秋山 智之, 米満 恭子, 藤澤 聡郎, 高橋 宏和, 後藤 歩, 阿部 泰伸, 稲森 正彦, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   104 ( 臨増総会 )   A225 - A225   2007年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Bleeding colonic diverticulum

    N. Ueno, H. Kawamura, Y. Abe, H. Takahashi, M. Inamori

    ENDOSCOPY   39   E53 - E53   2007年2月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-2006-945071

    Web of Science

    researchmap

  • Sclerosant extravasation following endoscopic injection sclerotherapy for bleeding gastric varices

    K. Akimoto, M. Inamori, T. Akiyama, H. Endo, K. Fujita, M. Yoneda, H. Taka-hashi, A. Goto, Y. Abe, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, N. Ueno, A. Nakajima

    ENDOSCOPY   39   E242 - E242   2007年2月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-2007-966832

    Web of Science

    researchmap

  • Giant subcutaneous abscess after percutaneous endoscopic gastrostomy

    H. Sakai, M. Inamori, T. Sato, K. Akimoto, T. Akiyama, K. Fujita, M. Yoneda, H. Takahashi, A. Goto, A. Kusakabe, Y. Abe, H. Kirikoshi, K. Kubota, N. Ueno, Y. Rino, A. Nakajima

    ENDOSCOPY   39   E264 - E264   2007年2月

     詳細を見る

    記述言語:英語   出版者・発行元:GEORG THIEME VERLAG KG  

    DOI: 10.1055/s-2007-966598

    Web of Science

    researchmap

  • Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue

    Masato Yoneda, Tomoyuki Iwasaki, Koji Fujita, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Shiro Maeyama, Koichiro Wada, Satoru Saito, Yasuo Terauchi, Atsushi Nakajima

    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH   31 ( 1 Suppl )   15S - 21S   2007年1月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    Background: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. The spectrum of NAFLD is broad, extending from simple steatosis through nonalcoholic steatohepatitis (NASH). Insulin resistance has been found to increase the risk of NASH, and obesity, and decreased levels of adiponectin are important factors in determining the severity of insulin resistance. Recent evidence has indicated that hypoadiponectinemia is involved in hepatic steatosis and NASH.
    Methods: To investigate whether hypoadiponectinemia causes hepatic steatosis in type 2 diabetes mellitus (DM) patients independently of visceral adipose tissue, we measured the plasma adiponectin concentration, hepatic fat content based on the liver-to-spleen ratio (L/S ratio) according to computed tomography (CT) attenuation values, and the amount of visceral adipose tissue and subcutaneous adipose tissue by CT in 248 type 2 DM patients. We also investigated the relationship between the serum level of adiponectin and hepatic fibrosis.
    Results: Significant correlations were observed between the L/S ratios and aspartate aminotransferase, alanine aminotransferase, visceral adipose tissue, subcutaneous adipose tissue, and serum adiponectin values (r=0.300, p=0.0007), and there was a highly significant inverse correlation between the visceral adipose tissue values and the serum adiponectin levels (r=-0.327, p &lt; 0.0002). The subcutaneous adipose tissue values, however, were not correlated with the serum adiponectin levels. Multiple regression analysis was used to quantify the impact of measured variables on the L/S ratio. After adjustment for age, gender, and visceral adipose tissue, the serum adiponectin levels were still significantly correlated with the L/S ratios (p=0.0064). And there was a stepwise decrease in the serum adiponectin in parallel to the severity of hepatic fibrosis.
    Conclusions: Hypoadiponectinemia is concluded to be involved in the etiology of hepatic steatosis independently of visceral adipose tissue content, and is considered to be an important factor in the progression of fibrosis; further studies will be necessary to elucidate the exact physiological role of adiponectin and its contribution to the progression of NASH.

    DOI: 10.1111/j.1530-0277.2006.00281.x

    Web of Science

    researchmap

  • Clinical significance of the duodenal papilla in patients with separate orifices for the bile and pancreatic ducts

    Kensuke Kubota, Toshio Fujisawa, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Atushi Nakajima

    JOURNAL OF GASTROENTEROLOGY   42 ( 1 )   70 - 78   2007年1月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    Background There have been few reports of separate orifices (SPO) for the bile and pancreatic ducts. The aim of this study was to elucidate the clinical significance of SPO. Methods Clinical data of patients with SPO (n = 21) were compared with those of 324 patients without SPO. The duodenal papillae in the patients with SPO were classified endoscopically into three types. Furthermore, we compared three subgroups (n = 221) among 345 patients (group A, 10 patients with bile duct stones with SPO; group B, 66 patients with bile duct stones without SPO; and group C, 145 patients without bile duct dysfunction) to evaluate the bile stasis of SPO. Various factors were retrospectively analyzed to identify any relationship in patients with SPO. Results Univariate analysis revealed that the diameter of the common bile duct, cholangiographic angulation, and the presence of common bile duct stones (CBDS) were significantly associated with the presence of SPO. Multivariate analysis of the different risk factors for SPO in all patients revealed that the presence of CBDS (relative risk, 3.000; 95% confidence interval, 1.083-8.313; P = 0.0346) and cholangiographic angulation (relative risk, 1.041; 95% confidence interval, 1.010-1.072; P = 0.0085) were independent risk factors. Moreover, univariate analysis among the three subgroups revealed that age, the presence of periampullary diverticula, the diameter of the common bile duct, and the length of the short narrow distal segment were significantly associated with the presence of SPO. Conclusions CBDS and cholangiographic angulation are independent risk factors for SPO. This result suggests that SPO may be associated with an elevated risk of CBDS owing to bile stasis.

    DOI: 10.1007/s00535-006-1973-0

    Web of Science

    PubMed

    researchmap

  • 無脂肪TPN投与により併発した脂肪肝、肝機能異常に対し脂肪乳剤を併用する事で病態改善を示した1例

    藤田 浩司, 米田 正人, 飯田 洋, 馬渡 弘典, 秋本 恵子, 冨本 彩子, 米満 恭子, 藤澤 聡郎, 高橋 宏和, 後藤 歩, 阿部 泰伸, 稲森 正彦, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    静脈経腸栄養   22 ( 増刊 )   396 - 396   2007年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ジェフコーポレーション  

    researchmap

  • ダブルバルーン内視鏡で診断しえた小腸原発GISTの1例

    稲森 正彦

    Progress of Digestive Endoscopy   71 ( 2 )   2007年

     詳細を見る

  • Protein-losing gastroenteropathy in a patient with pityriasis rubra pilaris

    Takamitsu Sato, Hitomi Sakai, Hiroshi Iida, Masahiko Inamori, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Norio Ueno, Yoshihiro Takeshita, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   98 - 98   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000102964

    Web of Science

    researchmap

  • Usefulness of transnasal ultrathin endoscopy for the placement of a postpyloric decompression tube

    Hiroki Endo, Masahiko Inamori, Takayuki Murakami, Kenichi Yoshida, Takuma Higurashi, Hiroshi Iida, Hirokazu Takahashi, Tomoyuki Akiyama, Keiko Akimoto, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima

    DIGESTION   75 ( 4 )   181 - 181   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000107937

    Web of Science

    researchmap

  • Protein-losing gastroenteropathy and gastric polyps: Successful treatment by Helicobacter pylori eradication

    Takamitsu Sato, Gaku Chiguchi, Masahiko Inamori, Hitomi Sakai, Nobutaka Fujisawa, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Norio Ueno, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   99 - 99   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000102965

    Web of Science

    researchmap

  • Balloon-occluded retrograde transvenous obliteration for gastric varices with plural draining veins: Effectiveness of coil embolization for collaterals

    Masato Yoneda, Masahiko Inamori, Tomoyuki Iwasaki, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Yasunobu Abe, Kensuke Kubota, Norio Ueno, Masato Shiiba, Aya Abe, Toshiyuki Nagashima, Tomio Inoue, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   100 - 100   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000102966

    Web of Science

    researchmap

  • Colocutaneous fistula after percutaneous endoscopic gastrostomy 査読

    Hitomi Sakai, Masahiko Inamori, Takamitsu Sato, Ayako Tomimoto, Tomoyuki Akiyama, Keiko Akimoto, Hiroki Endo, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   103 - 103   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000104729

    Web of Science

    PubMed

    researchmap

  • Rectal fecaloma: Successful treatment using endoscopic removal 査読

    Eiji Sakai, Yasuhiro Inokuchi, Masahiko Inamori, Takashi Uchiyama, Hiroshi Iida, Hirokazu Takahashi, Tomoyuki Akiyama, Keiko Akimoto, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

    DIGESTION   75 ( 4 )   198 - 198   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000108627

    Web of Science

    PubMed

    researchmap

  • Utility of endoscopic argon plasma coagulation in the treatment of radiation proctitis

    Eiji Sakai, Hirokazu Takahashi, Masahiko Inamori, Hiroki Endo, Tomoyuki Akiyama, Keiko Akimoto, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Norio Ueno, Atsushi Nakajima

    DIGESTION   75 ( 4 )   180 - 180   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000106976

    Web of Science

    researchmap

  • Knee pain and swelling secondary to ulcerative colitis

    Shogo Yanagisawa, Masahiko Inamori, Hiroki Endo, Hiroshi Iida, Keiko Akimoto, Yasunari Sakamoto, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Norio Ueno, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   144 - 144   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000106753

    Web of Science

    researchmap

  • Argon plasma coagulation for a bleeding gastrointestinal stromal tumor

    Harunobu Kawamura, Masahiko Inamori, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Norio Ueno, Yoshiaki Inayama, Hiroshi Harada, Yasushi Rino, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   164 - 164   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000106777

    Web of Science

    researchmap

  • Recovery of a misinserted gastrostomy tube during replacement: Effectiveness of gastropexy using a 'Funada style' kit

    Hitomi Sakai, Masahiko Inamori, Hiroshi Iida, Keiko Akimoto, Hiroki Endo, Yuichi Nozaki, Tomoyuki Akiyama, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Norio Ueno, Akihiko Kusakabe, Atsushi Nakajima

    DIGESTION   75 ( 4 )   179 - 179   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000106975

    Web of Science

    researchmap

  • Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices

    Yasunobu Abe, Masahiko Inamori, Keiko Akimoto, Hiroki Endo, Hiroshi Iida, Hironori Mawatari, Yuichi Nozaki, Tomoyuki Akiyama, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Noritoshi Kobayashi, Kensuke Kubota, Norio Ueno, Atsushi Nakajima

    DIGESTION   75 ( 2-3 )   145 - 145   2007年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000106754

    Web of Science

    researchmap

  • 食前酒による上部消化管知覚機能の変化に関する検討

    稲森 正彦

    アルコールと医学生物学   27   2007年

     詳細を見る

  • 【胃食道逆流症 概念の変遷と病態・診断と最新の治療】 胃食道逆流症の診断 PPIテスト

    稲森 正彦

    カレントテラピー   25 ( 5 )   2007年

     詳細を見る

  • Clinical significance of swollen duodenal papilla in autoimmune pancreatitis

    Kensuke Kubota, Hiroshi Iida, Toshio Fujisawa, Masami Ogawa, Masahiko Inamori, Satoru Saito, Yukio Kakuta, Hisashi Oshiro, Atsushi Nakajima

    Pancreas   35 ( 4 )   e51 - e60   2007年

     詳細を見る

    記述言語:英語  

    Objectives: To evaluate the clinical significance of a swollen main duodenal papilla and the associated immunohistopathologic findings in patients with autoimmune pancreatitis (AIP). Methods: Seventeen consecutive patients with AIP registered between April 2001 and October 2005 who underwent both endoscopic retrograde cholangiopancreatography and endoscopic biopsy were enrolled in this study. The endoscopic features, stromal inflammatory cell infiltrate (SICI), and results of immunohistochemical examination of the duodenal papilla using IgG4, CD3, and CD79a antibodies were retrospectively reviewed. These findings in the AIP patients were compared with those in 12 patients with chronic alcoholic tumor-forming pancreatitis (CAP). The numbers of cells in the SICI and of IgG4-positive plasma cells per high-power field were counted in all the histopathologic specimens. Results: A swollen main duodenal papilla was observed in 11 (11 [64.7%]/17) patients with AIP and 4 (4 [33.3%]/12) patients with CAP (P &lt
    0.05). Resolution of the swollen main duodenal papilla was observed in all of these 11 patients with AIP (11 [100%]/11) in response to treatment with corticosteroids. On the other hand, the 6 patients without elevated serum IgG4 or a swollen duodenal papilla, but with a swollen pancreas, improved even without corticosteroid treatment. The number of cells in the SICI in the AIP patients was significantly higher than that in the CAP patients. Although in 13 of 17 AIP patients, infiltration by IgG4-positive plasma cells was detected in the duodenal papilla, no such significant infiltration of the duodenal papilla by IgG4-positive plasma cells was observed in the patients with CAP (P &lt
    0.05). More predominant T-cell infiltration of the duodenal papilla was recognized in the AIP patients than in the CAP patients (P &lt
    0.05). Conclusions: These results suggest that a swollen main duodenal papilla with IgG4-positive plasma cell and T-cell-dominant infiltration and an abundant stromal cell infiltrate are characteristic findings in AIP. We suggest that these findings may be valuable adjuncts to the diagnosis of AIP as well as for selecting suitable candidates for corticosteroid therapy. © 2007 Lippincott Williams and Wilkins, Inc.

    DOI: 10.1097/mpa.0b013e31812575b4

    Scopus

    PubMed

    researchmap

  • 胃全摘後空腸静脈瘤破裂の1例.

    稲森 正彦

    Progress of Digestive Endoscopy   70 ( 2 )   2007年

     詳細を見る

  • 【内視鏡でみた胃炎・十二指腸炎と腹部症状の関係】 胃炎、十二指腸炎と自覚症状の対比.

    稲森 正彦

    消化器科   44 ( 6 )   2007年

     詳細を見る

  • Lupus Enteritis Detected by Capsule Endoscopy

    Hiroki Endo, Yasuyuki Kondo, Kei Kawagoe, Tomohiko R. Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Masato Yoneda, Masahiko Inamori, Atsushi Nakajima, Nobuyuki Matsuhashi

    INTERNAL MEDICINE   46 ( 18 )   1621 - 1622   2007年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.46.0137

    Web of Science

    researchmap

  • Metastatic malignant melanoma in the upper alimentary tract

    Norio Ueno, Masato Yoneda, Masahiko Inamori, Nozomi Imai

    GASTROINTESTINAL ENDOSCOPY   64 ( 6 )   1002 - 1002   2006年12月

     詳細を見る

    記述言語:英語   出版者・発行元:MOSBY-ELSEVIER  

    DOI: 10.1016/j.gie.2006.05.027

    Web of Science

    researchmap

  • スクリーニングとしての経鼻内視鏡検査の有用性と問題点 大学病院における経鼻内視鏡の使用経験 有効例の解析

    稲森 正彦, 秋山 智之, 秋本 恵子, 馬渡 弘典, 飯田 洋, 藤澤 聡郎, 藤田 浩司, 東川 なつき, 米田 正人, 高橋 宏和, 安崎 弘晃, 後藤 歩, 小川 真実, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 齋藤 聡, 川名 一郎, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   70 ( 1 )   63 - 63   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 破裂胃静脈瘤に対する硬化療法にて腹腔内にシアノアクリレートが流出した一例

    秋本 恵子, 稲森 正彦, 馬渡 弘典, 飯田 洋, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 東川 なつき, 米田 正人, 高橋 宏和, 安崎 弘晃, 後藤 歩, 小川 真実, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 川名 一朗, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   70 ( 1 )   68 - 68   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 本態性血小板血症に合併した胃静脈瘤出血に対し、シアノアクリレートを用いて止血した一例

    東川 なつき, 稲森 正彦, 秋本 恵子, 馬渡 弘典, 飯田 洋, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 米田 正人, 高橋 宏和, 安崎 弘晃, 後藤 歩, 小川 真実, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 川名 一朗, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   70 ( 1 )   68 - 68   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 膵胆管合流異常に合併した粘液産生性胆嚢癌により急性膵炎を発症した一例

    小出 真由, 窪田 賢輔, 藤澤 聡郎, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 中島 淳, 松尾 憲一, 嶋田 紘, 稲山 嘉昭

    Progress of Digestive Endoscopy   70 ( 1 )   75 - 75   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 胃全摘後空腸静脈瘤破裂の一例

    杉山 美紀子, 高橋 宏和, 稲森 正彦, 秋本 恵子, 馬渡 弘典, 飯田 洋, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 東川 なつき, 米田 正人, 安崎 弘晃, 小川 真実, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 川名 一朗, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   70 ( 1 )   69 - 69   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 無脂肪TPN投与により併発した肝機能異常、脂肪肝に対し脂肪乳剤が有効であった1例

    藤田 浩司, 米田 正人, 馬渡 弘典, 阿部 泰伸, 稲森 正彦, 桐越 博之, 窪田 賢輔, 斉藤 聡, 岩崎 知之, 寺内 康夫, 中島 淳

    日本病態栄養学会誌   9 ( 4 )   511 - 511   2006年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病態栄養学会  

    researchmap

  • Evaluation of postprandial 3 h pH monitoring for gastroesophageal reflux disease: Is there a possibility of streamlining the 24 h test?

    Masahiko Inamori, Tomoyaki Akiyama, Keiko Akimoto, Hirokazu Takahashi, Yasunobu Abe, Atsushi Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   21 ( 11 )   1761 - 1762   2006年11月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2006.04215.x

    Web of Science

    researchmap

  • 肝生検にて生前に診断されたintravascular lymphomaの1例

    佐藤 大樹, 高橋 宏和, 池田 多聞, 池田 郁子, 藤田 浩司, 秋山 智之, 藤沢 聡郎, 米田 正人, 原 浩二, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A939 - A939   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 質問紙法の簡便性に関する比較検討

    稲森 正彦, 秋本 恵子, 藤田 浩司, 藤澤 聡郎, 秋山 智之, 池田 多聞, 池田 郁子, 高橋 宏和, 米田 正人, 安崎 弘晃, 原 浩二, 日下部 明彦, 阿部 泰伸, 桐越 博之, 川口 義明, 窪田 賢輔, 斉藤 聡, 川名 一朗, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A757 - A757   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 内視鏡でみた胃炎・十二指腸炎と腹部症状の関連 胃炎、十二指腸炎と自覚症状の対比:症状は十二指腸に起因する?

    稲森 正彦, 阿部 泰伸, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A439 - A439   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 日本のnon-erosive reflux disease患者に対するlafutidineの効果に関する検討(pHモニタリングを用いて)

    稲森 正彦, 平塚 伸, 中島 淳, 藤田 雅巳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A759 - A759   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 非アルコール性脂肪性肝炎(NASH)病態進展における一酸化窒素の役割

    藤田 浩司, 米田 正人, 野崎 雄一, 遠藤 宏樹, 冨本 彩子, 米満 恭子, 秋山 智之, 小林 規俊, 池田 郁子, 藤沢 聡郎, 秋本 恵子, 馬渡 弘典, 高橋 宏和, 稲森 正彦, 阿部 泰伸, 島村 健, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    肝臓   47 ( Suppl.2 )   A428 - A428   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 非アルコール性脂肪性肝炎(NASH)の病態進展におけるiNOS由来Nitric Oxideの役割

    藤田浩司, 米田正人, 野崎雄一, 稲森正彦, 桐越博之, 斉藤聡, 中島淳, 岩崎知之, 寺内康夫, 前山史朗, 和田孝一郎

    アルコールと医学生物学 多様なアルコール研究の進歩   26   47 - 53   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)響文社  

    非アルコール性脂肪性肝炎(NASH)病態進展の系における一酸化窒素(NO)の役割を検証する為、動物モデルを用いた検討解析を加えた。6週齢のFicsher344系雄性ラットを用いて、非アルコール性脂肪性肝炎モデル(CDAA群)と対照群を作成した。CDAA投与動物モデルでは、内臓脂肪でのiNOS発現増加とNO代謝物量の増加、門脈血中のNO代謝物量の増加、肝臓でのNO代謝物量の増加とiNOS発現の不変を認めた。また、腸間膜初代培養内臓脂肪細胞を用いた解析から、脂肪組織におけるiNOS発現亢進にインスリン、レプチン、アンギオテンシンIIなどが関与していた。ヒトNASH病態とCDAA投与ラットの所見は非常に近似している点が多かった事から、仮説はヒトNASH病態においても適応される可能性が示された。

    researchmap

  • 経肝動脈的CO2造影超音波(CO2-US)を用いた、小肝細胞癌(small HCC)に対する診断・内科的治療の有用性の検討

    桐越 博之, 米田 正人, 小林 規俊, 嶌村 健, 窪田 賢輔, 阿部 泰伸, 河村 晴信, 稲森 正彦, 池田 郁子, 原 浩二, 秋山 智之, 藤沢 信隆, 高橋 宏和, 藤沢 聡郎, 池田 多聞, 藤田 浩司, 上野 規男, 坂口 隆, 斉藤 聡, 中島 淳

    肝臓   47 ( Suppl.2 )   A448 - A448   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 放射線腸炎の出血に対してArgon plasma coagulation(APC)が有効であった2例

    酒井 英嗣, 渡辺 誠太郎, 高橋 宏和, 池田 多聞, 池田 郁子, 藤田 浩司, 秋山 智之, 藤沢 聡郎, 米田 正人, 原 浩二, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   48 ( Suppl.2 )   2183 - 2183   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • PPARγリガンド及び5-ASAを用いたマウスモデルにおけるcolitic cancerの化学発癌予防の有用性の検討

    池田 郁子, 米満 恭子, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 原 浩二, 桐越 博之, 窪田 賢輔, 斉藤 悟, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A855 - A855   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 吐血を繰り返し、胃排出能の評価が臨床的に有用であった一例

    秋本 恵子, 稲森 正彦, 藤田 浩司, 藤澤 聡郎, 秋山 智之, 池田 多聞, 池田 郁子, 高橋 宏和, 米田 正人, 安崎 弘晃, 原 浩二, 日下部 明彦, 阿部 泰伸, 遠藤 雄一, 桐越 博之, 川口 義明, 窪田 賢輔, 斉藤 聡, 川名 一朗, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A790 - A790   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 約8年間経過観察中の静脈硬化症を伴った虚血性腸病変の1例

    阿部 泰伸, 池田 多聞, 池田 郁子, 藤田 浩司, 秋山 智之, 藤澤 聡郎, 米田 正人, 高橋 宏和, 原 浩二, 稲森 正彦, 安崎 晃弘, 桐越 博之, 窪田 賢輔, 坂口 隆, 斉藤 聡, 川名 一朗, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A876 - A876   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸検査前処置のリスクマネージメント 腸閉塞、穿孔などの合併症は予測可能か?

    高橋 宏和, 稲森 正彦, 野崎 雄一, 遠藤 宏樹, 冨本 彩子, 米満 恭子, 秋本 恵子, 馬渡 弘典, 藤田 浩司, 秋山 智之, 藤沢 聡郎, 米田 正人, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A875 - A875   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 嚢胞形成をきたした膵過誤腫の一例

    藤澤 聡郎, 窪田 賢輔, 秋山 智之, 池田 郁子, 藤田 浩司, 米田 正人, 高橋 宏和, 原 浩二, 稲森 正彦, 阿部 泰伸, 桐越 博之, 斎藤 聡, 上野 規男, 中島 淳, 上田 倫夫, 島田 紘, 稲山 嘉明

    日本消化器病学会雑誌   103 ( 臨増大会 )   A1010 - A1010   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • PPARγ阻害と膵臓癌細胞の転移・浸潤の関係

    池田 郁子, 米満 恭子, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 高橋 宏和, 米田 正人, 稲森 正彦, 阿部 泰伸, 原 浩二, 桐越 博之, 窪田 賢輔, 斉藤 悟, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A994 - A994   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 膵癌術後の予防的全肝照射により著明な肝細胞脂肪変性を来した1例

    内山 崇, 酒井 英嗣, 渡辺 誠太郎, 米田 正人, 高橋 宏和, 阿部 泰伸, 稲森 正彦, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 大城 久, 山中 正二, 稲山 嘉明, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A937 - A937   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • NAFLD,NASH患者の疫学より検討したNASH診断、治療判定における高感度CRP、血清フェリチン値、血清アディポネクチン値の有効性

    米田 正人, 藤田 浩司, 馬渡 弘典, 秋本 恵子, 富本 彩子, 遠藤 宏樹, 野崎 雄一, 藤澤 聡郎, 米満 恭子, 秋山 智之, 高橋 宏和, 原 浩二, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳, 前山 史朗

    日本消化器病学会雑誌   103 ( 臨増大会 )   A933 - A933   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 造影エコーが診断に有用であった出血性肝嚢胞の一例

    秋山 智之, 斉藤 聡, 高橋 宏和, 米田 正人, 藤田 浩司, 藤澤 聡郎, 池田 多聞, 原 浩二, 阿部 泰伸, 稲森 正彦, 桐越 博之, 窪田 賢輔, 上田 倫夫, 田中 邦哉, 渡合 伸治, 上野 規男, 嶋田 紘, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増大会 )   A943 - A943   2006年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 肝外性NOのNASH病態進展有力因子の検討

    藤田浩司, 米田正人, 秋山智之, 池田多聞, 池田郁子, 藤澤聡郎, 藤澤信隆, 高橋宏和, 稲森正彦, 阿部泰伸, 桐越博之, 窪田賢輔, 斉藤聡, 中島淳

    Medical Practice   23 ( 8 )   416 - 417   2006年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)先端医学社  

    非アルコール性脂肪性肝疾患(NAFLD)の病態進展メカニズムについて解析を進め,肝臓内ではなく肝臓外で発現が亢進したiNOS由来のNOが,NAFLD病態進展に関与している可能性を認めた.そこで,モデル動物を用いて検討した.コリン欠乏食投与動物モデルを非アルコール性脂肪性肝炎(NASH)モデルとして使用した.肥満に伴う内臓脂肪量増加により,インスリンやレプチン,アンジオテンシンIIの発現が亢進し,それが脂肪細胞に作用してiNOSの発現を亢進させ,過剰産生したNOが門脈を経由して肝臓内に流入し,ニトロチロシン形成やミトコンドリア機能障害を引き起こしてNAFLD病態を進展させていることが示唆された.NAFLDは肝疾患にもかかわらず肝外性NOの影響が強く受けることが示唆され,その病態形成は糖尿病のような全身性代謝疾患に類似している可能性が示唆された

    researchmap

  • 閉塞性黄疸を繰り返した粘液産生性胆管腫瘍の1例

    藤澤 聡郎, 窪田 賢輔, 冨本 彩子, 千葉 秀幸, 馬渡 弘典, 秋本 恵子, 米満 恭子, 秋山 智之, 藤田 浩司, 米田 正人, 高橋 宏和, 後藤 歩, 稲森 正彦, 阿部 泰伸, 桐越 博之, 斉藤 聡, 上野 規男, 中島 淳

    胆道   20 ( 3 )   425 - 425   2006年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本胆道学会  

    researchmap

  • 胃食道pHモニタリングからみた胃食道逆流症 食後3時間で何がわかるか?

    秋山 智之, 稲森 正彦, 中島 淳

    胃病態機能研究会誌   38   10 - 10   2006年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:胃病態機能研究会  

    researchmap

  • Gastrointestinal: Rectal polyp associated with schistosomiasis

    Y. Abe, M. Inamori, K. Fujita, T. Fujisawa, N. Fujisawa, M. Yoneda, H. Takahashi, T. Ikeda, K. Hara, T. Akiyama, H. Kawamura, A. Kato, H. Kirikoshi, N. Kobayashi, K. Kubota, S. Saito, T. Sasaki, Y. Inayama, N. Ueno, A. Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   21 ( 7 )   1216 - 1216   2006年7月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2006.04557.x

    Web of Science

    researchmap

  • 13C連続呼気テストによる胃排出能の評価:診断、治療に有用であった症例

    稲森 正彦, 高橋 宏和, 米田 正人, 安崎 弘晃, 河村 晴信, 阿部 泰伸, 日下部 明彦, 加藤 暁, 桐越 博之, 川口 義明, 窪田 賢輔, 斉藤 聡, 川名 一朗, 上野 規男, 中島 淳

    神奈川医学会雑誌   33 ( 2 )   219 - 219   2006年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 膵仮性嚢胞症例の検討

    窪田 賢輔, 藤澤 聡郎, 稲森 正彦, 阿部 泰伸, 桐越 博之, 斉藤 聡, 中島 淳, 李 進, 遠藤 格, 島田 紘

    膵臓   21 ( 3 )   231 - 231   2006年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本膵臓学会  

    researchmap

  • Blastocystis hominis infection in patient with regular dialysis

    Miho Hayashi, Masahiko Inamori, Kouki Goto, Tomoyuki Akiyama, Kouji Fujita, Ikuko Ikeda, Toshio Fujisawa, Hirokazu Takahashi, Masato Yoneda, Kouji Hara, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima, Yumiko Hamada, Hiroyuki Fukutomi, Hideyuki Satsuta

    JOURNAL OF GASTROENTEROLOGY   41 ( 6 )   605 - 606   2006年6月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:SPRINGER TOKYO  

    DOI: 10.1007/s00535-006-1817-y

    Web of Science

    PubMed

    researchmap

  • 表層拡大型胃癌合併の自己免疫性膵炎の一例

    千葉 秀幸, 窪田 賢輔, 谷田 恵美子, 藤澤 聡郎, 阿部 泰伸, 稲森 正彦, 桐越 博之, 斉藤 聡, 中島 淳, 野村 直人, 秋山 浩利, 嶋田 紘

    Progress of Digestive Endoscopy   69 ( 1 )   93 - 93   2006年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • PEGの適応と長期管理をめぐって ボタン交換後の胃内留置確認に関する検討 安全な長期管理を目指して

    稲森 正彦, 日下部 明彦, 池田 郁子, 藤田 浩司, 藤澤 聡郎, 米田 正人, 高橋 宏和, 安崎 弘晃, 阿部 泰伸, 桐越 博之, 川口 義明, 窪田 賢輔, 斎藤 聡, 川名 一朗, 上野 規男, 中島 淳

    Progress of Digestive Endoscopy   69 ( 1 )   49 - 49   2006年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis

    M Inamori, T Shimamura, H Nagase, Y Abe, T Umezawa, A Nakajima, T Saito, N Ueno, K Tanaka, H Sekihara, JI Togawa, H Kaifu, H Tsuboi, H Kayama, S Tominaga

    HEPATO-GASTROENTEROLOGY   53 ( 69 )   361 - 365   2006年5月

     詳細を見る

    記述言語:英語   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Nitric oxide (NO) production is elevated in the intestine and may contribute to intestinal injury during inflammation. However, how the expression of inducible NO synthase (iNOS) mRNA and endothelial NO synthase (eNOS) mRNA in the esophageal mucosa contribute to mucosal damage caused by reflux esophagitis remains unknown. Since vascular endothelial growth factor (VEGF) exerts its action on microcirculation, contributing to angiogenesis and inflammation, we examined the role of VEGF together with NOS and eNOS on development of reflux esophagitis.
    Methodology: The mRNA expression levels of NOS, eNOS and VEGF were measured in biopsy specimens from 25 patients with reflux esophagitis, using TaqMan PCR and reverse transcription PCR.
    Results: The expression of NOS mRNA in the esophageal mucosa increased parallel to the severity of the esophagitis. There were no significant differences between both eNOS and VEGF mRNA expression levels and the severity of the esophagitis. The existence of gastric mucosal atrophy, hiatus hernia, therapy and Helicobacter pylori infection did not affect the levels of mRNA expression.
    Conclusions: The accumulation of NO, produced by NOS, was considered to be related to the exacerbation of reflux esophagitis. Therapeutic intervention that reduces NO production may thus be of use in preventing development of esophageal mucosal injury in patients with reflux esophagitis.

    Web of Science

    researchmap

  • Pleural effusions following endoscopic injection sclerotherapy for cirrhotic patients with esophageal varices

    H Kayama, M Inamori, JI Togawa, T Shimamura, Y Tokita, T Umezawa, T Sakaguchi, M Naitoh, H Nagase, A Nakajima, T Saito, S Tominaga, N Ueno, K Tanaka, H Sekihara

    HEPATO-GASTROENTEROLOGY   53 ( 69 )   376 - 380   2006年5月

     詳細を見る

    記述言語:英語   出版者・発行元:H G E UPDATE MEDICAL PUBLISHING S A  

    Background/Aims: Endoscopic injection sclerotherapy is in widespread use for patients with esophageal varices. It is well known that pleural effusions are among complications following endoscopic sclerotherapy. However, there are few studies regarding the proportion of patients developing pleural effusions after sclerotherapy.
    Methodology: Between August 1991 and September 1998, 575 endoscopic injection sclerotherapies were carried out in 128 patients. Chest radiographs were obtained prior to and 24 hours after all procedures. We also obtained other clinical data from all patients.
    Results: In total, 17.7% of post-sclerotherapy patients were diagnosed as having small amounts of pleural effusions. Logistic regression revealed pleural effusions after sclerotherapy to be associated with ascites, chest pain for 24 hours, total volume of sclerosant and submucosal injection of more than 4mL of sclerosant. In parallel with injection of an increasing amount of submucosal sclerosant, the proportion of patients with pleural effusion increased.
    Conclusions: Pleural, effusions were related to ascites, chest pain for 24 hours, total sclerosant.

    Web of Science

    researchmap

  • EUS-FNAが診断に有用であった原発不明癌の一例

    窪田 賢輔, 谷田 恵美子, 藤澤 聡郎, 稲森 正彦, 阿部 泰伸, 桐越 博之, 齋藤 聡, 中島 淳, 市川 靖史, 大城 久

    Gastroenterological Endoscopy   48 ( Suppl.1 )   880 - 880   2006年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Clinical Impact of the Swollen Duodenal Papilla in Autoimmune Pancreatitis

    Kensuke Kubota, Tosio Fujisawa, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Satoru Saito, Atushi Nakajima, Hisashi Ohshiro

    GASTROINTESTINAL ENDOSCOPY   63 ( 5 )   AB309 - AB309   2006年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MOSBY-ELSEVIER  

    Web of Science

    researchmap

  • precutを施行した選択的胆管挿管困難例の検討

    窪田 賢輔, 藤澤 聡郎, 稲森 正彦, 阿部 泰信, 桐越 博之, 斎藤 聡, 中島 淳

    Gastroenterological Endoscopy   48 ( Suppl.1 )   794 - 794   2006年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 内視鏡的消化管瘻造設の管理と工夫の問題点 胃ろう交換時における胃内留置の確認 ボタンからのアプローチの有用性について

    稲森 正彦, 日下部 明彦, 中島 淳

    Gastroenterological Endoscopy   48 ( Suppl.1 )   640 - 640   2006年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 当院における十二指腸乳頭部腺腫に対する内視鏡的乳頭切除術の検討

    谷田 恵美子, 窪田 賢輔, 池田 郁子, 秋山 智之, 藤田 浩司, 藤澤 聡郎, 高橋 宏和, 米田 正人, 原 浩二, 加藤 暁, 河村 晴信, 稲森 正彦, 安部 泰伸, 桐越 博之, 斎藤 聡, 上野 規男, 中島 淳, 遠藤 格, 嶋田 紘

    日本消化器病学会雑誌   103 ( 臨増総会 )   A199 - A199   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 上部消化管出血における内視鏡的止血術後の再出血例の臨床的検討

    河村 晴信, 阿部 泰伸, 稲森 正彦, 藤澤 聡郎, 藤田 浩司, 池田 多聞, 池田 郁子, 秋山 智之, 高橋 宏和, 藤澤 信隆, 米田 正人, 加藤 暁, 桐越 博之, 窪田 賢輔, 上野 規男, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増総会 )   A321 - A321   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 門脈腫瘍塞栓(Vp2)合併進行肝細胞癌に対し,ペグインターフェロンα-2b(ペグイントロン)併用5-FU動注化学療法が有効であった1例

    日暮 琢磨, 桐越 博之, 藤沢 信隆, 米田 正人, 小林 規俊, 嶌村 健, 窪田 賢輔, 阿部 泰伸, 河村 晴信, 稲森 正彦, 原 浩二, 秋山 智之, 高橋 宏和, 藤沢 聡郎, 池田 多聞, 藤田 浩司, 上野 規男, 坂口 隆, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増総会 )   A273 - A273   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当科における進行肝細胞癌の治療成績 肝動脈化学塞栓療法(TAE・TACE)/経皮的エタノール注入(PEI)併用療法を中心として

    桐越 博之, 米田 正人, 小林 規俊, 嶌村 健, 窪田 賢輔, 阿部 泰伸, 河村 晴信, 稲森 正彦, 池田 郁子, 原 浩二, 秋山 智之, 藤沢 信隆, 高橋 宏和, 藤沢 聡郎, 池田 多聞, 藤田 浩司, 上野 規男, 坂口 隆, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増総会 )   A305 - A305   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Peppermint oil投与による胃排出能の変化について Breath ID systemを用いた連続呼気採取による評価

    稲森 正彦, 藤澤 信隆, 秋山 智之, 池田 郁子, 藤澤 敏郎, 藤田 浩司, 米田 正人, 高橋 宏和, 原 浩二, 安崎 弘晃, 河村 晴信, 阿部 泰伸, 日下部 明彦, 桐越 博之, 川口 義明, 窪田 賢輔, 斉藤 聡, 川名 一朗, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増総会 )   A288 - A288   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 肝外性NOは非アルコール性脂肪性肝炎(NASH)病態進展の有力因子である

    藤田 浩司, 米田 正人, 秋山 智之, 池田 多聞, 池田 郁子, 藤澤 聡郎, 藤澤 信隆, 高橋 宏和, 原 浩二, 河村 晴信, 加藤 暁, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   103 ( 臨増総会 )   A147 - A147   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸前癌病変と生活習慣病

    高橋 宏和, 高山 哲治, 中島 淳, 池田 郁子, 藤沢 聡郎, 藤田 浩司, 秋山 智之, 米田 正人, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男

    日本消化器病学会雑誌   103 ( 臨増総会 )   A212 - A212   2006年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Gastrointestinal: Gastrointestinal metastases from malignant melanoma

    M Inamori, N Ueno, K Fujita, T Fujisawa, N Fujisawa, M Yoneda, H Takahashi, T Ikeda, H Kawamura, Y Abe, A Kato, H Kirikoshi, N Kobayashi, T Shimamura, K Kubota, S Saito, T Sakaguchi, S Yamanaka, Y Inayama, A Nakajima

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   21 ( 1 )   327 - 327   2006年1月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    DOI: 10.1111/j.1440-1746.2006.04239.x

    Web of Science

    researchmap

  • IDUSでも術前進展度診断が困難であった下部胆管癌の1例.

    稲森 正彦

    Progress of Digestive Endoscopy   68 ( 2 )   166 - 167   2006年

     詳細を見る

    記述言語:日本語   出版者・発行元:Japan Gastroenterological Endoscopy Society Kanto Chapter  

    症例は74歳の男性。CTで肝内胆管と総胆管の拡張を認めた。ERCPで深部胆管挿管はAbc領域で胆管が高度に屈曲し不能であった。PTBDを行いrendezvous法で挿管した。下部胆管は10mmに渡り糸状,不整形に狭窄していた。IDUSで腫瘍はほぼSSに局在していたが,膵実質浸潤を伴う下部胆管癌と診断した。腫瘍は径1.4×0.9cmの結節浸潤型の高分化腺癌で,膵との境界の線維化が強くPanc Ⅰ aであった。

    DOI: 10.11641/pde.68.2_166

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2007006189

  • Metastatic malignant melanoma in the upper alimentary tract.

    INAMORI Masahiko

    Gastrointest Endosc.   64 ( 6 )   2006年

  • On-demand therapyに適した酸分泌抑制薬の研究(胃内pH及びCYP2C19多型に着目して).

    稲森 正彦

    横浜医学   57 ( 5 )   539 - 542   2006年

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2008261309

  • 【食道・胃・十二指腸疾患】 食道・胃・十二指腸疾患へのアプローチ 胃・食道逆流症(GERD) 最新のエビデンスに基づく診断・治療指針

    稲森 正彦

    Medical Practice   23 ( 8 )   2006年

     詳細を見る

  • 【食道・胃接合部病変】 Barrett食道 Barrett食道に対する薬物療法の効果.

    稲森 正彦

    消化器の臨床   9 ( 5 )   2006年

     詳細を見る

  • 肝硬変に合併した結核性髄膜炎の1例.

    稲森 正彦

    内科   97 ( 4 )   2006年

     詳細を見る

  • 切除不能膵癌におけるGemcitabine単独化学療法の有効例の検討.

    稲森 正彦

    癌と化学療法   33 ( 2 )   2006年

     詳細を見る

  • Precutを施行した選択的胆管挿入困難例の検討.

    稲森 正彦

    胆道   20 ( 1 )   2006年

  • Undifferentiated spindle-cell carcinoma of the gallbladder: an immunohistochemical study

    Kensuke Kubota, Yukio Kakuta, Shunji Kawamura, Yasunobu Abe, Masahiko Inamori, Harunobu Kawamura, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Atushi Nakajima

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY   13 ( 5 )   468 - 471   2006年

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER TOKYO  

    A case of undifferentiated spindle-cell carcinoma of the gallbladder is described. A 72-year-old man presented with right hypochondralgia and fever. Imaging studies revealed a well-demarcated solid tumor (with a necrotic center) in the gallbladder that invaded the liver and transverse colon. On gross examination of the surgical specimen, the cut surface of the polypoid tumor showed nodular invasive growth. Microscopically, the tumor was composed of atypical spindle-shaped tumor cells that proliferated in a whirling or interlacing pattern. The tumor also showed foci with a malignant epithelial component that simulated a carcinosarcoma. Immunohistochemically, the biphasic differentiation of the tumor was highlighted by the different immunoreactivity to antibodies against cytokeratins, epithelial membrane antigen (EMA), and vimentin shown by the malignant epithelial components and the spindle-cell components. However the latter showed faint positivity for cytokeratin antibody. These results suggested that the spindle-cell carcinoma of the gallbladder originated from cholecystic mucosa and showed sarcomatous reaction or dedifferentiation, as indicated by the presence of vimentin-positive cells. The proliferation index, as detected by ki-67, in the spindle-cell component was higher than that in the epithelial component, which may account for the more aggressive biological behavior of the spindle-cell component.

    DOI: 10.1007/s00534-006-1100-x

    Web of Science

    PubMed

    researchmap

  • 食前酒による胃排出能の変化について Breath ID systemを用いた連続呼気採取による評価.

    稲森 正彦

    アルコールと医学生物学   26   2006年

     詳細を見る

  • Two cases of pyloduodenal stenosis: The efficiency of gastric emptying evaluation using C-13 continuous breath test (BreathID system)

    Hiroyuki Yamanaka, Masahiko Inamori, Nobutaka Fujisawa, Keiko Akimoto, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima

    DIGESTION   74 ( 3-4 )   238 - 238   2006年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)   出版者・発行元:KARGER  

    DOI: 10.1159/000100968

    Web of Science

    researchmap

  • 肝外性NOのNASH病態進展有力因子の検討.

    稲森 正彦

    G.I.Research   14 ( 4 )   2006年

     詳細を見る

  • 吐血を契機に診断し得た進行胃癌の1例.

    稲森 正彦

    Medical Practice   23 ( 8 )   2006年

     詳細を見る

  • 硬化性胆管炎の1例.

    稲森 正彦

    消化器画像   8 ( 5 )   2006年

     詳細を見る

  • IDUSが診断に有用であった下部胆管癌の一例

    藤澤 隆弘, 窪田 賢輔, 鈴木 香峰理, 藤澤 聡郎, 阿部 泰伸, 河村 晴信, 稲森 正彦, 桐越 博之, 斉藤 聡, 上野 規男, 中島 淳, 武田 和永, 遠藤 格, 嶋田 紘

    Progress of Digestive Endoscopy   68 ( 1 )   75 - 75   2005年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 単純性脂肪肝患者とNASH患者の肝組織における遺伝子発現プロファイリング解析よりNASHに進展するのに関与する遺伝子を同定する試み

    米田 正人, 藤田 浩司, 岩崎 知之, 藤澤 聡郎, 池田 多聞, 藤澤 信隆, 高橋 宏和, 河村 晴信, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳, 中江 大, 前山 史朗

    日本消化吸収学会総会プログラム・講演抄録集   36回   150 - 150   2005年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本消化吸収学会  

    researchmap

  • 【実地医家のための画像診断実践ガイド CT,MRI,PETをいかに日常診療に利用するか】 実地医家がCT,MRI,PETを日常診療にとり入れるときに必要な基本情報 機器と撮影法の種類 目的による選択法 PET検査

    稲森 正彦, 高橋 延和, 中島 淳

    Medical Practice   22 ( 臨増 )   41 - 44   2005年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)文光堂  

    researchmap

  • 頸部リンパ節転移巣にて脱分化を示した大腸癌の1例

    藤澤 信隆, 池田 多聞, 高橋 宏和, 藤澤 聡郎, 米田 正人, 河村 晴信, 稲森 正彦, 阿部 泰伸, 島村 健, 桐越 博之, 小林 規俊, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A793 - A793   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • PPARγ阻害剤によるβカテニンの発現増加を介した大腸発癌の促進

    藤澤 聡郎, 藤澤 信隆, 高橋 宏和, 米田 正人, 藤田 浩司, 池田 多聞, 阿部 泰伸, 加藤 暁, 河村 晴信, 稲森 正彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 坂口 隆, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A790 - A790   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 膵臓癌細胞に対するPPARγの作用解析

    高橋 宏和, 池田 多聞, 藤田 浩司, 藤沢 聡郎, 藤沢 信隆, 米田 正人, 河村 晴信, 稲森 正彦, 阿部 泰伸, 桐越 博之, 小林 規俊, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 高山 哲治, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A849 - A849   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • FDG-PETによる浸潤型膵管癌の予後予測は可能か?

    小林 規俊, 藤田 浩司, 藤沢 聡郎, 高橋 宏和, 藤沢 信隆, 米田 正人, 阿部 泰伸, 稲森 正彦, 河村 晴信, 桐越 博之, 池田 多聞, 窪田 賢輔, 坂口 隆, 斎藤 聡, 中島 淳, 上野 規男

    日本消化器病学会雑誌   102 ( 臨増大会 )   A848 - A848   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 汎血球減少を契機に発見された脾血管腫の1例

    加藤 暁, 高橋 宏和, 米田 正人, 藤田 浩司, 藤澤 聡郎, 藤澤 信隆, 池田 多聞, 稲森 正彦, 河村 晴信, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斎藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A867 - A867   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • コリン欠乏ラットを用いたアンギオテンシン2受容体拮抗薬によるNAFLD,NASH進展抑制メカニズムの解析

    藤田 浩司, 米田 正人, 池田 多聞, 藤澤 聡郎, 藤澤 信隆, 高橋 宏和, 河村 晴信, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 坂口 隆, 上野 規男, 中島 淳, 前山 史郎, 中江 大

    日本消化器病学会雑誌   102 ( 臨増大会 )   A815 - A815   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • C型慢性肝炎患者での内臓脂肪と肝線維化の関係

    池田 多聞, 藤田 浩司, 藤澤 聡郎, 高橋 宏和, 藤澤 信隆, 米田 正人, 河村 晴信, 稲森 正彦, 加藤 暁, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A802 - A802   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胆嚢内出血を造影超音波検査にて診断し得た1例

    河村 晴信, 上野 規男, 阿部 泰伸, 蓮尾 公篤, 藤澤 聡郎, 藤田 浩司, 高橋 宏和, 藤澤 信隆, 米田 正人, 池田 多聞, 稲森 正彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A844 - A844   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 非アルコール性脂肪性肝炎の治療におけるpioglitazone投与の適応に関する検討

    藤田 浩司, 米田 正人, 藤澤 聡郎, 藤澤 信隆, 高橋 宏和, 池田 多聞, 河村 晴信, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳, 前山 史郎, 中江 大

    日本消化器病学会雑誌   102 ( 臨増大会 )   A816 - A816   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 下血が発見の契機になった抗リン脂質抗体陽性若年女性の1例

    秋本 恵子, 稲森 正彦, 池田 多聞, 藤澤 聡郎, 藤田 浩司, 高橋 宏和, 藤澤 信隆, 米田 正人, 河村 晴信, 阿部 泰伸, 中村 ちの, 中戸川 満智子, 加藤 暁, 桐越 博之, 島村 健, 小林 規俊, 窪田 賢輔, 斎藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A783 - A783   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 単純性脂肪肝患者とNASH患者の肝組織における遺伝子発現プロファイリング解析よりNASHに進展するのに関与する遺伝子を同定する試み

    米田 正人, 藤田 浩司, 岩崎 知之, 藤澤 聡郎, 池田 多聞, 藤澤 信隆, 高橋 宏和, 河村 晴信, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳, 中江 大, 前山 史朗

    肝臓   46 ( Suppl.2 )   A400 - A400   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Breath ID systemを用いた連続呼気採取による胃排出能の評価 体位による変化

    稲森 正彦, 池田 多聞, 藤澤 聡郎, 藤田 浩司, 高橋 宏和, 藤澤 信隆, 米田 正人, 河村 晴信, 阿部 泰伸, 中村 ちの, 中戸川 満智子, 加藤 暁, 桐越 博之, 島村 健, 小林 規俊, 窪田 賢輔, 斎藤 聡, 坂口 隆, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A719 - A719   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Helicobacter pylori陽性患者の除菌療法に関する検討

    藤澤 信隆, 米田 正人, 高橋 宏和, 藤澤 聡郎, 藤田 浩司, 池田 多聞, 河村 晴信, 稲森 正彦, 阿部 泰伸, 島村 健, 桐越 博之, 小林 規俊, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A717 - A717   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 毛孔性紅色粃糠疹の治療中に発症した蛋白漏出性胃腸症の1例

    飯田 洋, 稲森 正彦, 池田 多聞, 藤澤 聡郎, 高橋 宏和, 藤澤 信隆, 米田 正人, 藤田 浩司, 阿部 泰伸, 河村 晴信, 中戸川 満智子, 加藤 暁, 桐越 博之, 島村 健, 小林 規俊, 窪田 賢輔, 中村 ちの, 斎藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A778 - A778   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • PPARγ阻害剤による胃癌の増殖,浸潤の抑制

    藤澤 聡郎, 高橋 宏和, 藤澤 信隆, 米田 正人, 藤田 浩司, 池田 多聞, 阿部 泰伸, 加藤 暁, 河村 晴信, 稲森 正彦, 桐越 博之, 小林 規俊, 窪田 賢輔, 坂口 隆, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増大会 )   A729 - A729   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 単純性脂肪肝患者とNASH患者の肝組織における遺伝子発現プロファイリング解析よりNASHに進展するのに関与する遺伝子を同定する試み

    米田 正人, 藤田 浩司, 岩崎 知之, 藤澤 聡郎, 池田 多聞, 藤澤 信隆, 高橋 宏和, 河村 晴信, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳, 中江 大, 前山 史朗

    Gastroenterological Endoscopy   47 ( Suppl.2 )   1943 - 1943   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 膵臓癌に対する治療戦略としてのPPARγ

    高橋 宏和, 池田 多聞, 藤田 浩司, 藤沢 聡郎, 藤沢 信隆, 米田 正人, 河村 晴信, 稲森 正彦, 阿部 泰伸, 桐越 博之, 窪田 賢輔, 斉藤 聡, 中島 淳

    日本癌学会総会記事   64回   115 - 115   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本癌学会  

    researchmap

  • 単純性脂肪肝患者とNASH患者の肝組織における遺伝子発現プロファイリング解析よりNASHに進展するのに関与する遺伝子を同定する試み

    米田 正人, 藤田 浩司, 岩崎 知之, 藤澤 聡郎, 池田 多聞, 藤澤 信隆, 高橋 宏和, 河村 晴信, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳, 中江 大, 前山 史朗

    日本消化器病学会雑誌   102 ( 臨増大会 )   A687 - A687   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 単純性脂肪肝患者とNASH患者の肝組織における遺伝子発現プロファイリング解析よりNASHに進展するのに関与する遺伝子を同定する試み

    米田 正人, 藤田 浩司, 岩崎 知之, 藤澤 聡郎, 池田 多聞, 藤澤 信隆, 高橋 宏和, 河村 晴信, 稲森 正彦, 阿部 泰伸, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 上野 規男, 中島 淳, 中江 大, 前山 史朗

    日本消化器集団検診学会雑誌   43 ( 5 )   237 - 237   2005年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器がん検診学会  

    researchmap

  • 食道静脈瘤に対する地固め療法後に粘膜下血腫を発症した1例

    河村 晴信, 稲森 正彦, 藤澤 聡郎, 藤田 浩司, 米田 正人, 高橋 宏和, 藤澤 信隆, 池田 多聞, 阿部 泰伸, 桐越 博之, 小林 規俊, 島村 健, 窪田 賢輔, 斉藤 聡, 中島 淳, 上野 規男

    Progress of Digestive Endoscopy   67 ( 1 )   61 - 61   2005年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 術前に内視鏡的経鼻膵管ドレナージチューブを留置し安全に膵腫瘍核出術を施行し得た1例.

    小林規俊, 藤沢信隆, 高橋宏和, 米田正人, 藤田浩司, 藤沢聡郎, 阿部泰伸, 稲森正彦, 河村晴信, 桐越博之, 島村健, 窪田賢輔, 斉藤聡, 中島淳, 嶋田紘, 上野規男

    Progress of Digestive Endoscopy(消化器内視鏡の進歩)   66 ( 2 )   100 - 101   2005年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    59歳女.15年前から低血糖症状を自覚していたが放置していたところ,2年前から意識消失発作が出現し,交通事故につながることもあった.そのため,精査を行い腹部超音波,造影CT,MRI,EUSにて膵頭部に15mm大の多血性腫瘍を認めた.術前に内視鏡的経鼻膵管ドレナージを行い,これを指標に開腹手術を行うことで膵腫瘍の核出手術が容易に可能であった.免疫組織学的検討からinsulinomaと診断された

    DOI: 10.11641/pde.66.2_100

    researchmap

  • 【興味ある症例】先天性門脈欠損症に肝腫瘍を合併した1例.

    小林規俊, 藤沢信隆, 高橋宏和, 藤田浩司, 藤沢聡郎, 阿部泰伸, 稲森正彦, 河村晴信, 桐越博之, 島村健, 窪田賢輔, 坂口隆, 斉藤聡, 中島淳, 上野規男, 山中正二, 稲山嘉明

    Liver Cancer   11 ( 1 )   99 - 110   2005年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)アークメディア  

    27歳女.心房中隔欠損症,先天性白内障で手術歴があり,実妹が卵巣癌で死亡したのを機会に受診し,肝腫瘍を指摘された.血液生化学検査では特に異常がなかった.腹部超音波で肝門部に門脈が認められず,肝動脈が著明に発達していた.肝に萎縮や腫大はなく,S2,S7に境界明瞭な3cm大の高エコー結節を認めた.CTで腫瘤はlow densityで,造影効果はなかった.MRIではS2腫瘤がT1,T2強調像で高信号,S7腫瘤はそれぞれ高信号,等信号であった.腹部血管造影では門脈相で門脈が描出されず,脾静脈と上腸間膜静脈が描出された.生検を施行し,腫瘍部は不規則な索状の増生を示す肝細胞と類洞からなり,軽度の脂肪沈着を伴っていた.肝細胞はやや好酸性で軽度の核の大小不同と核の軽度濃染があり,索状配列の乱れを認めた.肝細胞癌と診断したが,悪性疾患と断定できない点もあり,無治療で経過観察とした.その後9ヵ月経過し,病変に変化はない

    researchmap

  • 胃瘻チューブからの内視鏡観察の試み(胃瘻交換時におけるリスクの軽減)

    稲森 正彦, 藤田 浩司, 藤澤 聡郎, 藤澤 信隆, 米田 正人, 高橋 宏和, 池田 多聞, 河村 晴信, 阿部 泰伸, 小林 規俊, 島村 健, 桐越 博之, 中村 ちの, 中戸川 満智子, 森田 幸恵, 梅澤 正, 窪田 賢輔, 坂口 隆, 斎藤 聡, 上野 規男, 中島 淳

    Gastroenterological Endoscopy   47 ( Suppl.1 )   768 - 768   2005年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 肝細胞癌の局所療法後に胸腔内播種を来たし,放射線療法が有効であった症例

    桐越 博之, 池田 多聞, 小林 規俊, 嶌村 健, 窪田 賢輔, 阿部 泰伸, 河村 晴信, 稲森 正彦, 米田 正人, 藤沢 信隆, 高橋 宏和, 藤沢 聡郎, 藤田 浩司, 上野 規男, 坂口 隆, 斉藤 聡, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増総会 )   A365 - A365   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 大腸癌におけるPPARγ遺伝子の分子標的治療への応用

    高橋 宏和, 藤田 浩司, 藤沢 聡郎, 藤沢 信隆, 米田 正人, 池田 多聞, 稲森 正彦, 河村 晴信, 阿部 泰伸, 嶌村 健, 桐越 博之, 小林 規俊, 窪田 賢輔, 坂口 隆, 斉藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増総会 )   A240 - A240   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 内臓脂肪量およびadiponectin低下の相加効果は肝臓内の脂肪蓄積を促進しNAFLDの進展に関与する

    米田 正人, 岩崎 知之, 高橋 宏和, 藤澤 信隆, 藤澤 聡朗, 藤田 浩司, 池田 多聞, 河村 晴信, 稲森 正彦, 阿部 泰伸, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 坂口 隆, 上野 規男, 中江 大, 前山 史朗, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増総会 )   A218 - A218   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃食道逆流症の診断におけるpHモニタリングの位置づけ(食後3時間のモニタリングの検討を含めて)(第2報)

    稲森 正彦, 藤田 浩司, 藤澤 聡郎, 藤澤 信隆, 米田 正人, 高橋 宏和, 池田 多聞, 河村 晴信, 阿部 泰伸, 小林 規俊, 島村 健, 桐越 博之, 中戸川 満智子, 窪田 賢輔, 坂口 隆, 齋藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増総会 )   A282 - A282   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 2型糖尿病患者の体内貯蔵鉄,内臓・皮下脂肪と非アルコール性脂肪性肝障害の解析

    岩崎 知之, 米田 正人, 伊藤 聡, 藤田 浩司, 松津 詩子, 稲森 正彦, 藤沢 信孝, 中江 大, 中島 淳

    日本消化器病学会雑誌   102 ( 臨増総会 )   A278 - A278   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 繰り返す腹痛,黄疸,肝機能障害などの消化器症状を来し診断に苦慮した遺伝性球状赤血球症の1例

    片山 公美, 小林 規俊, 阿部 泰伸, 河村 晴信, 稲森 正彦, 窪田 賢輔, 斉藤 聡, 中島 淳, 金森 平和

    日本内科学会関東地方会   525回   21 - 21   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 消化管ホルモンと消化吸収に関する新しい展開 糖の吸収・代謝と摂食調節におけるGalanin,Enterostatinの役割.

    永瀬肇, 稲森正彦, 中島淳

    消化と吸収   27 ( 1 )   35 - 38   2005年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本消化吸収学会  

    ラットに対してGalanin(以下G)と Enterostatin(以下E)を胃カニューレから投与し,脂肪食摂取量,血糖値,血清インスリン濃度,肝臓の活性型ピルビン酸脱水素酵素(PDHa)活性,迷走神経求心性電気活動に及ぼす影響を検討した.Gは高脂肪食の摂食量を有意に増加させ,低脂肪食の摂食量には影響を及ぼさなかった.Eは高脂肪食の摂食量を有意に低下させ,低脂肪食の摂食量には影響を及ぼさなかった.G投与により血糖値は頸静脈血で上昇したが,門脈血では変化がなかった.E投与では頸静脈,門脈とも血糖値に変化はなかった.血清インスリン濃度はGとEによって有意に低下した.肝臓のPDHaはG投与によって低下傾向を示し,Eによって有意に上昇した.迷走神経求心性電気活動はG投与約5分後から15分間低下し,E投与では5分後から40分以上上昇し続けた

    researchmap

  • PET検査

    稲森正彦, 高橋延和, 中島淳

    実地医家のための画像診断実践ガイド   22   41 - 44   2005年

     詳細を見る

  • GERDの薬物治療(H2ブロッカー、消化器運動機能改善薬の使用法)

    稲森正彦, 阿部泰伸, 中島淳

    内科臨床誌メディチーナ   42 ( 1 )   62 - 64   2005年

     詳細を見る

  • 悪心、嘔吐 講義録

    稲森正彦, 中島淳

    消化器学   137 - 139   2005年

     詳細を見る

  • クローン病

    稲森正彦, 中島淳

    Medical Practice   22 ( 2 )   2005年

     詳細を見る

  • 内視鏡的膵管ドレナージチューブを留置し安全に膵頭部腫瘍核出術を施行し得た1例

    小林 規俊, 藤沢 信隆, 高橋 宏和, 米田 正人, 藤田 浩司, 藤沢 聡郎, 阿部 泰伸, 稲森 正彦, 河村 晴信, 桐越 博之, 島村 健, 窪田 賢輔, 斉藤 聡, 中島 淳, 上田 倫夫, 三浦 靖彦, 窪田 徹, 嶋田 紘, 上野 規男

    Progress of Digestive Endoscopy   66 ( 1 )   91 - 91   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • シアノアクリレートによる止血後,バルーン下逆行性経静脈的塞栓術(B-RTO)を施行した胃静脈瘤の1例

    稲森正彦, 米田正人, 藤澤信隆, 高橋宏和, 池田多聞, 島村健, 小林規俊, 河村晴信, 阿部泰伸, 桐越博之, 窪田賢輔, 斎藤聡, 坂口隆, 高邑知生, 上野規男, 中島淳

    Progress of Digestive Endoscopy (消化器内視鏡の進歩)   65 ( 2 )   64 - 65   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    DOI: 10.11641/pde.65.2_64

    researchmap

  • 【消化管病変への新たなる知見】 消化器内視鏡検査におけるリスクマネジメント

    稲森 正彦, 中島 淳

    クリニシアン   51 ( 12 )   1248 - 1254   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:エーザイ(株)  

    researchmap

  • 2型糖尿病患者に合併するnon-alcoholic fatty liver diseaseの解析

    米田 正人, 岩崎 知之, 高橋 宏和, 藤澤 信隆, 藤沢 聡郎, 藤田 浩司, 小倉 孝氏, 河村 晴信, 稲森 正彦, 阿部 泰伸, 島村 健, 小林 規俊, 桐越 博之, 窪田 賢輔, 斉藤 聡, 坂口 隆, 上野 規男, 中島 淳

    肝臓   45 ( Suppl.2 )   A518 - A518   2004年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 胃食道逆流症の診断におけるpHモニタリング:食後3時間での評価は可能か?

    稲森 正彦, 藤田 浩司, 小倉 孝氏, 藤澤 聡朗, 藤澤 信隆, 米田 正人, 高橋 宏和, 河村 晴信, 阿部 泰伸, 小林 規俊, 島村 健, 桐越 博之, 中村 ちの, 中戸川 満智子, 森田 幸恵, 窪田 賢輔, 坂口 隆, 斎藤 聡, 上野 規男, 中島 淳

    日本消化器病学会雑誌   101 ( 臨増大会 )   A675 - A675   2004年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 癌治療の進歩(肝・胆・膵) 当科における切除不能膵臓癌の治療成績 Gemcitabineの有効例の検討

    小林 規俊, 藤田 浩司, 藤沢 聡郎, 高橋 宏和, 藤沢 信隆, 米田 正人, 阿部 泰伸, 稲森 正彦, 河村 晴信, 桐越 博之, 島村 健, 窪田 賢輔, 坂口 隆, 斎藤 聡, 中島 淳, 上野 規男

    日本癌治療学会誌   39 ( 2 )   453 - 453   2004年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本癌治療学会  

    researchmap

  • 膵悪性リンパ腫の1例

    前田 晃延, 小林 規俊, 稲森 正彦, 阿部 泰伸, 河村 晴信, 桐越 博之, 島村 健, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男

    日本消化器病学会雑誌   101 ( 臨増大会 )   A862 - A862   2004年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • アレルギー性紫斑病の大腸病変の一例

    細野 邦広, 島村 健, 高橋 宏和, 稲森 正彦, 小林 規俊, 阿部 泰伸, 河村 晴信, 桐越 博之, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男

    日本消化器病学会雑誌   101 ( 臨増大会 )   A771 - A771   2004年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃体下部前壁より出血をきたしたDieulafoy潰瘍の1例

    河村 晴信, 稲森 正彦, 高橋 宏和, 藤澤 信隆, 米田 正人, 藤田 浩司, 藤澤 敏郎, 中戸川 満智子, 森田 幸恵, 中村 ちの, 桐越 博之, 小林 規俊, 島村 健, 窪田 賢輔, 坂口 隆, 斉藤 聡, 中島 淳

    Gastroenterological Endoscopy   46 ( Suppl.2 )   1913 - 1913   2004年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 経皮的胆嚢内瘻術が有効であった無石胆嚢炎の一例

    窪田 賢輔, 藤田 浩司, 藤澤 聡郎, 高橋 宏和, 藤澤 信隆, 米田 正人, 河村 晴信, 稲森 正彦, 阿部 泰伸, 桐越 博之, 島村 健, 小林 規俊, 齋藤 聡, 坂口 隆, 上野 規男, 中島 淳

    胆道   18 ( 3 )   458 - 458   2004年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本胆道学会  

    researchmap

  • 酸分泌抑制薬の即効性に関する検討(on demand therapyとの関連)

    稲森 正彦, 河村 晴信, 阿部 泰伸, 島村 健, 桐越 博之, 小林 規俊, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    神奈川医学会雑誌   31 ( 2 )   220 - 220   2004年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • シアノアクリレートによる止血後,バルーン下逆行性経静脈的塞栓術(B-RTO)を施行した胃静脈瘤の1例

    稲森 正彦, 島村 健, 小林 規俊, 河村 晴信, 阿部 泰伸, 桐越 博之, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男

    Progress of Digestive Endoscopy   65 ( 1 )   81 - 81   2004年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    DOI: 10.11641/pde.65.2_64

    researchmap

  • FDG-PETにて回復過程を観察し得た腫瘤形成性膵炎の1例

    小林 規俊, 藤沢 信隆, 高橋 宏和, 米田 正人, 藤田 浩司, 藤沢 聡郎, 小倉 孝氏, 阿部 泰伸, 稲森 正彦, 河村 晴信, 桐越 博之, 島村 健, 窪田 賢輔, 坂口 隆, 斎藤 聡, 中島 淳, 上野 規男, 森田 勝巳

    横浜医学   55 ( 3 )   91 - 96   2004年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    52歳男性.患者は飲酒後の心窩部痛,嘔吐で近医に急性膵炎と診断され,入院加療で症状は改善したが,CTで膵頭部に腫瘤を指摘され転院となった.造影CTでは膵頭部に4cm大の腫瘤を認め,病変は早期で不均一,後期には病変の辺縁,内部に不均一なlow density areaを認めた.MRIではT1で低信号,T2で高信号,dynamic studyで不均一な造影効果を認め,FDG-PET検査で膵頭部にSUVがmax6.67と極めて高い集積を認めたが,内視鏡的逆行性膵管造影(ERP)ではファーター乳頭および膵管に異常は認めなかった.経過より膵頭部癌を疑い,再度FDG-PETを行ったところ,SUV max3.851と集積低下を認め,造影CTでは膵頭部病変は3cm大と縮小傾向を認めた.無治療での消退傾向から腫瘤形成性膵炎と診断して外来経過観察とし,以後現在まで再燃は認めていない

    researchmap

  • 酸分泌抑制薬静注投与における胃内pHの立ち上がりに関する検討(プロトンポンプ阻害薬とH2受容体拮抗薬併用の試み)

    稲森 正彦, 阿部 泰伸, 戸川 淳一, 岩崎 知之, 米田 正人, 藤澤 信隆, 高橋 宏和, 河村 晴信, 桐越 博之, 島村 健, 吉井 貴子, 森田 幸恵, 中戸川 満智子, 小林 規俊, 中村 ちの, 坂口 隆, 高邑 知生, 上野 規男, 中島 淳, 関原 久彦

    日本消化器病学会雑誌   101 ( 臨増総会 )   A193 - A193   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 消化管のneuroscience ガラニンを中心とした消化管機能の神経内分泌性調節機構

    永瀬 肇, 稲森 正彦, 中島 淳

    日本消化器病学会雑誌   101 ( 臨増総会 )   A149 - A149   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 高齢者胃潰瘍の臨床的検討 報告2

    河村 晴信, 稲森 正彦, 米田 正人, 藤澤 信隆, 高橋 宏和, 戸川 淳一, 阿部 泰伸, 森田 幸恵, 中戸川 満智子, 吉井 貴子, 桐越 博之, 島村 健, 小林 規俊, 中村 ちの, 梅澤 正, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   101 ( 臨増総会 )   A322 - A322   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Humoral hypercalcemia of malignancy(HHM)をきたした膵腺扁平上皮癌の1例

    小林 規俊, 村田 依子, 稲森 正彦, 河村 晴信, 阿部 泰伸, 桐越 博之, 島村 健, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   101 ( 臨増総会 )   A337 - A337   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 浸潤性膵管がんにおけるGalectin-3の発現

    島村 健, 坂口 隆, 中島 淳, 藤澤 信隆, 高橋 宏和, 米田 正人, 小林 規俊, 桐越 博之, 阿部 泰伸, 河村 晴信, 稲森 正彦, 吉井 貴子, 高村 知生, 上野 規男, 嶋田 紘, 田中 克明, 今田 敏夫, 坂元 亨宇, 広橋 説雄, 関原 久彦

    日本消化器病学会雑誌   101 ( 臨増総会 )   A331 - A331   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 黄色肉芽腫性胆嚢炎の1例 造影超音波所見を中心に.

    藤田浩司, 小林規俊, 阿部泰伸, 稲森正彦, 河村晴信, 桐越博之, 島村健, 坂口隆, 高邑知生, 中島淳, 関原久彦, 上野規男, 遠藤格, 関戸仁, 嶋田紘

    Rad Fan   2 ( 2 )   34 - 37   2004年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカルアイ  

    黄色肉芽腫性胆嚢炎(XGC)の症例(77歳男)の,造影超音波検査を中心とした画像所見と病理所見とを比較した.造影超音波上,造影早期から内腔と思われていた領域が染まり始め,造影後期までenhanceの遷延を認めた.胆嚢壁,および壁周囲には染影されない領域がみられたが,XGCは染影された.胆嚢の炎症を疑い,腹腔鏡下胆嚢摘出術を行った.嚢底-体部に黄白色の結節状の病変を伴った著明な壁の肥厚を認めた.迅速標本は,組織学的にリンパ球,組織球,泡沫細胞,炎症細胞,繊維組織の増生からなる肉芽組織であり,悪性像は認められなかった.永久標本では,迅速標本同様の肉芽組織を認める他,粘膜固有層内にリンパ濾胞形成や炎症細胞浸潤を認めた.悪性所見は認められなかった.染影されない領域は,XGCや小膿瘍よりも脂肪組織である可能性が考えられた

    researchmap

  • Levovist造影エコーにて良好に鑑別された門脈血栓の1例

    高橋 宏和, 桐越 博之, 上野 規男, 米田 正人, 藤沢 信隆, 稲森 正彦, 阿部 泰伸, 河村 晴信, 吉井 貴子, 小林 規俊, 嶌村 健, 坂口 隆, 高邑 知生, 中島 淳, 関原 久彦

    超音波医学   31 ( 1 )   J50 - J50   2004年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本超音波医学会  

    researchmap

  • 胸やけ専門外来における臨床的検討

    稲森 正彦, 河村 晴信, 阿部 泰伸, 島村 健, 桐越 博之, 小林 規俊, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    神奈川医学会雑誌   31 ( 1 )   39 - 39   2004年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 消化器内視鏡検査におけるリスクマネジメント

    稲森正彦, 中島淳

    CLINICIAN   535   1248 - 1253   2004年

     詳細を見る

  • 結核性髄膜炎を合併した肝硬変の1例

    岡田 興造, 小林 規俊, 稲森 正彦, 島村 健, 吉井 貴子, 高邑 知生, 坂口 隆, 上野 規男, 中島 淳, 関原 久彦

    日本内科学会関東地方会   514回   26 - 26   2003年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 膵嚢胞性疾患を合併したカロリー病の1例

    増谷 朋英, 島村 健, 小林 規俊, 稲森 正彦, 河村 晴信, 阿部 泰伸, 桐越 博之, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    Progress of Digestive Endoscopy   64 ( 1 )   101 - 101   2003年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 胃食道逆流症の治療におけるH2受容体拮抗薬の位置づけ(on-demand therapyに適した薬剤の検討)

    稲森 正彦, 中島 淳, 上野 規男

    日本消化器病学会雑誌   100 ( 臨増大会 )   A599 - A599   2003年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 浸潤性膵管がんにおけるDysadherinの発現について

    島村 健, 坂口 隆, 中島 淳, 藤澤 信隆, 高橋 宏和, 米田 正人, 小林 規俊, 桐越 博之, 阿部 泰伸, 河村 晴信, 稲森 正彦, 吉井 貴子, 高邑 知生, 田中 克明, 今田 敏夫, 嶋田 紘, 猪野 義典, 坂元 亨宇, 広橋 説雄, 関原 久彦

    日本消化器病学会雑誌   100 ( 臨増大会 )   A779 - A779   2003年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 高齢者胃潰瘍の臨床的検討

    河村 晴信, 稲森 正彦, 米田 正人, 藤澤 信隆, 高橋 宏和, 戸川 淳一, 阿部 泰伸, 水野 幸恵, 中戸川 満智子, 吉井 貴子, 桐越 博之, 島村 健, 小林 規俊, 中村 ちの, 梅澤 正, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   100 ( 臨増大会 )   A656 - A656   2003年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 原発性硬化性胆管炎の臨床像と診断

    中村 篤志, 河村 春信, 阿部 泰伸, 稲森 正彦, 中村 ちの, 坂口 隆, 中島 淳, 上野 規男, 関原 久彦, 佐藤 慎一郎, 鈴木 一幸, 増田 友之, 全 陽, 中沼 安二

    Gastroenterological Endoscopy   45 ( Suppl.2 )   1770 - 1770   2003年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • Hepatobiliary and pancreatic: Right-upper-quadrant pain

    M Inamori, M Naitoh, K Numata, T Saitoh, K Tanaka, H Sekihara

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   18 ( 4 )   458 - 458   2003年4月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING ASIA  

    Web of Science

    researchmap

  • プロトンポンプ阻害薬抵抗性の難治性逆流性食道炎に対し,H2受容体拮抗薬の就寝前追加投与が有効であった1例

    稲森 正彦, 米田 正人, 藤澤 信隆, 高橋 宏和, 小澤 穣, 戸川 淳一, 阿部 泰伸, 河村 晴信, 小林 規俊, 桐越 博之, 梅澤 正, 中村 篤志, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    Gastroenterological Endoscopy   45 ( Suppl.1 )   683 - 683   2003年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 薬剤単回投与における胃内pHの立ち上がりに関する検討(頓服やon demandに適した薬剤を探して)

    稲森 正彦, 米田 正人, 藤澤 信隆, 高橋 宏和, 小澤 穣, 岩崎 知之, 地口 学, 戸川 淳一, 河村 晴信, 阿部 泰伸, 松本 秀平, 桐越 博之, 小林 規俊, 坂口 隆, 高邑 知生, 中島 淳, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   100 ( 臨増総会 )   A211 - A211   2003年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃食道逆流症専門外来(胸やけ外来)における臨床的検討

    稲森 正彦, 戸川 淳一, 河村 晴信, 阿部 泰伸, 桐越 博之, 小林 規俊, 坂口 隆, 中島 淳, 上野 規男, 関原 久彦

    日本内科学会雑誌   92 ( Suppl. )   214 - 214   2003年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    researchmap

  • 多発性胃過形成性ポリープの経過観察中に発見された高分化型腺癌の一例

    藤澤 信隆, 戸川 淳一, 地口 学, 稲森 正彦, 河村 晴信, 阿部 泰伸, 坂口 隆, 中島 淳, 上野 則男, 関原 久彦

    日本内科学会関東地方会   505回   32 - 32   2002年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 診断に苦慮した十二指腸Brunner腺腫の1例

    河村 晋平, 稲森 正彦, 阿部 泰伸, 地口 学, 戸川 淳一, 梅澤 正, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦, 河野 尚美, 稲葉 將陽, 利野 靖, 高梨 吉則

    消化器の臨床   5 ( 6 )   719 - 722   2002年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)ヴァンメディカル  

    75歳女.内視鏡検査にて十二指腸球部の腫瘍を指摘された.超音波内視鏡像からBrunner腺腫が疑われたが,腹部MRではT1強調像で筋とほぼ等信号,T2強調像でやや高信号を呈して鑑別診断に苦慮した.エタノール潰瘍を作成し生検を行うも診断には至らなかった為,開腹下の十二指腸腫瘍切除術を施行した.腫瘍は山田IV型の形態を示し,腫瘍の頭部は約3cm大のBrunner腺腫であった

    researchmap

  • 病変の初期像と約8ヵ月間後の像が経過観察しえたIntraductal-papillary mucinous tumorの1例

    河村 晴信, 小澤 穣, 地口 学, 大澤 映美, 戸川 淳一, 原 浩二, 稲森 正彦, 松本 秀平, 阿部 泰伸, 中村 篤志, 梅澤 正, 坂口 隆, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦

    Progress of Digestive Endoscopy   61 ( 2 )   138,11 - 139,11   2002年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    63歳男.上腹部痛を主訴とした.腹部CTで主膵管は膵体部から尾部にかけて7mmと拡張を示したが膵管内腫瘍は同定できなかった.再検査では主膵管径は更に10mmと拡張傾向を示し,膵尾部の膵管内に約1cm大の腫瘍像を認めた.ERPの初回検査時,主膵管は6mmと拡張して膵尾部で途絶を示したが,膵管内に明らかな腫瘍像を認めなかった.途絶部の膵管生検にてintraductal papillary adenomaの所見を得た.約半年の経過で主膵管径が拡張傾向を示し,更に粘液貯留により急性膵炎を繰り返し発症していることから,膵体尾部,脾臓合併切除,1群,2群リンパ節郭清を行った.主病変は膵尾部膵管内の7mm大の隆起性病変で,膵管内乳頭腺癌由来の微小浸潤癌であった.膵内神経浸潤を認めたが,膵内リンパ節,静脈浸潤は認めなかった.膵切除断端の主膵管上皮は正常で,断端より1cm尾側より腺腫が出現して2cmの部位より徐々に異型度が増し,3〜4.5cmの範囲が微小浸潤癌の範囲であった.合併切除した脾臓及び郭清した1群,2群リンパ節に転移はみられなかった

    DOI: 10.11641/pde.61.2_138

    researchmap

  • 消化管腫瘍に対するAPC治療の有効性と問題点

    永瀬 肇, 梅澤 正, 海部 大樹, 遠藤 雄一, 塩沢 牧子, 地口 学, 川名 憲一, 稲森 正彦, 戸川 淳一, 阿部 泰伸, 中島 淳, 上野 規男, 関原 久彦

    Gastroenterological Endoscopy   44 ( Suppl.2 )   1535 - 1535   2002年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 重篤な肝機能障害を繰り返した神経性食思不振症の1例

    小林 規俊, 稲森 正彦, 阿部 泰伸, 河村 晴信, 桐越 博之, 坂口 隆, 沼田 和司, 中島 淳, 上野 規男, 関原 久彦

    日本内科学会関東地方会   499回   25 - 25   2002年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 胸部腫瘤を合併した胃MALTリンパ腫の1例

    地口 学, 稲森 正彦, 小澤 穣, 原 浩二, 戸川 淳一, 松本 秀平, 阿部 泰伸, 磯崎 哲男, 梅澤 正, 坂口 隆, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   99 ( 臨増総会 )   A319 - A319   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 頭頸部癌に合併する食道早期癌の治療 EMRは必要か

    永瀬 肇, 上野 規男, 梅澤 正, 坂口 隆, 阿部 泰伸, 稲森 正彦, 戸川 淳一, 中島 淳, 関原 久彦

    Gastroenterological Endoscopy   44 ( Suppl.1 )   477 - 477   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 黒色表皮腫と口腔及び食道に多発性乳頭状隆起を伴った胃癌の1例

    阿部 泰伸, 稲森 正彦, 戸川 淳一, 地口 学, 梅澤 正, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦

    Gastroenterological Endoscopy   44 ( Suppl.1 )   514 - 514   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 薬剤単回投与による胃内pHの立ち上がりに関する検討(on demandや頓用に適した薬剤を探して)

    稲森 正彦, 戸川 淳一, 小澤 穣, 岩崎 知之, 原 浩二, 地口 学, 松本 秀平, 阿部 泰伸, 梅澤 正, 坂口 隆, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   99 ( 臨増総会 )   A251 - A251   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • H.pylori除菌失敗例における2次治療としてのrabeprasole,amoxicillin,faropenem併用療法の有効性

    戸川 淳一, 稲森 正彦, 小澤 穣, 原 浩二, 地口 学, 松本 秀平, 阿部 泰伸, 梅澤 正, 坂口 隆, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   99 ( 臨増総会 )   A207 - A207   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • ラット急性酸逆流食道炎モデルにおけるラクトフェリン投与効果の検討

    稲森 正彦, 戸川 淳一, 永瀬 肇, 松本 秀平, 梅澤 正, 中島 淳, 上野 規男, 斎藤 紀文, 田中 克明, 関原 久彦

    日本内科学会雑誌   91 ( 臨増 )   237 - 237   2002年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    researchmap

  • 消化管治療におけるAPCの位置づけ 消化管早期癌に対するEMRにおけるアルゴンプラズマ凝固法(APC)併用の有用性と意義

    永瀬 肇, 上野 規男, 梅澤 正, 稲森 正彦, 戸川 淳一, 坂口 隆, 阿部 泰伸, 中島 淳, 関原 久彦

    Progress of Digestive Endoscopy   60 ( 1 )   45 - 45   2001年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 術前組織診断に至らずK-ras及びp53検索が異常を示したts1膵癌の1例

    阿部 泰伸, 戸川 純一, 地口 学, 稲森 正彦, 梅沢 正, 坂口 隆, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦

    Progress of Digestive Endoscopy   60 ( 1 )   95 - 95   2001年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • D-ガラクトサミン/リポポリサッカライド誘発急性肝不全に対するラクトフェリンによる肝炎抑制効果の検討

    松本 秀平, 田中 克明, 斎藤 聡, 原 浩二, 戸川 淳, 稲森 正彦, 中島 淳, 長瀬 肇, 上野 則男, 関原 久彦

    肝臓   42 ( Suppl.2 )   A392 - A392   2001年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Metronidazoleの経口投与が有効であった,進行性全身性硬化症(PSS)に伴う偽性腸閉塞症の2例

    梅澤 正, 稲森 正彦, 戸川 淳一, 阿部 泰伸, 坂口 隆, 永瀬 肇, 沼田 和司, 中島 淳, 上野 規男, 関原 久彦

    日本消化器病学会雑誌   98 ( 臨増大会 )   A516 - A516   2001年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • ラットDSS(Dextran Sulfate Sodium)誘起性大腸炎におけるlactoferrin投与効果の基礎的検討

    戸川 淳一, 永瀬 肇, 稲森 正彦, 原 浩二, 地口 学, 松本 秀平, 梅澤 正, 坂口 隆, 中島 淳, 上野 規男

    日本消化器病学会雑誌   98 ( 臨増大会 )   A542 - A542   2001年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胃に限局した有茎性ポリポーシスの1例

    磯崎 哲男, 地口 学, 稲森 正彦, 原 浩二, 戸川 淳一, 松本 秀平, 梅澤 正, 坂口 隆, 内藤 実, 中島 淳

    Progress of Digestive Endoscopy   59 ( 1 )   69 - 69   2001年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会-関東支部  

    researchmap

  • 不定愁訴にて通院中,偶然発見された腎癌の2例

    稲森 正彦, 松本 秀平, 戸川 淳一, 阿部 泰伸, 梅澤 正, 坂口 隆, 中島 淳, 永瀬 肇, 上野 規男, 関原 久彦

    日本内科学会関東地方会   491回   19 - 19   2001年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • Oral administration of bovine lactoferrin reduces trinitrobenzene sulphonic acid-induced colitis in rats by modulation of the immune system and correction of cytokine imbalance

    JI Togawa, K Tanaka, M Inamori, T Umezawa, A Nakajima, M Naito, H Nagase, S Sato, N Ueno, T Saito, H Sekihara

    GASTROENTEROLOGY   120 ( 5 )   A687 - A687   2001年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO  

    Web of Science

    researchmap

  • 興味深い上部消化管内視鏡像を呈した特発性好酸球増多症の1例

    戸川 淳一, 国崎 玲子, 稲森 正彦, 磯崎 哲男, 梅澤 正, 内藤 実, 中島 淳, 上田 規男, 斎藤 紀文, 富永 静男

    Gastroenterological Endoscopy   43 ( Suppl.1 )   740 - 740   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本消化器内視鏡学会  

    researchmap

  • 【消化器 消化管緊急止血法/最新の止血はこうする】 クリップ法

    稲森 正彦, 中島 淳, 松橋 信之

    Mebio   18 ( 3 )   12 - 16   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メジカルビュー社  

    researchmap

  • C型肝硬変・肝細胞癌の治療経過中に口腔内腫瘍を合併した1例

    地口 学, 磯崎 哲男, 戸川 淳一, 稲森 正彦, 松本 秀平, 梅澤 正, 坂口 隆, 中島 淳, 上野 規男, 関原 久彦

    日本内科学会関東地方会   489回   28 - 28   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 胸部腫瘤を合併した胃MALTリンパ腫の1例

    磯崎 哲男, 稲森 正彦, 斎藤 紀文, 富永 静男, 戸川 淳一, 国崎 玲子, 粉川 敦史, 梅澤 正, 内藤 実, 中島 淳

    神奈川医学会雑誌   28 ( 1 )   96 - 97   2001年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • ラットTNBS大腸炎におけるlactoferrin投与効果の基礎的検討

    戸川 淳一, 永瀬 肇, 大澤 映美, 稲森 正彦, 国崎 玲子, 梅澤 正, 中島 淳, 内藤 実, 佐藤 忍, 斎藤 紀文

    日本消化器病学会雑誌   97 ( 臨増大会 )   A613 - A613   2000年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Examination of factor which takes part in pleural effusion stagnation according to sclerosing of esophageal varix.

    M Inamori, T Umezawa, Y Tokita, M Naitoh, TS Saitoh, S Tominaga, K Tanaka, H Sekihara

    GASTROENTEROLOGY   118 ( 4 )   A1249 - A1249   2000年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 23)糖尿病歴を有しミトコンドリア遺伝子の解析で3243変異を認めた心不全の一例

    稲森 正彦, 石上 友章, 高橋 延和, 芦野 和博, 住田 晋一, 落合 久夫, 石井 當男

    Japanese circulation journal   61   796 - 796   1998年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:社団法人日本循環器学会  

    CiNii Books

    researchmap

▼全件表示

講演・口頭発表等

  • シンポジウム 内視鏡でみた胃炎・十二指腸炎と腹部症状の関連 胃炎、十二指腸炎と自覚症状の対比:症状は十二指腸に起因する?

    第14回日本消化器関連学会週間  2006年 

     詳細を見る

  • シンポジウム 胃食道逆流症の診断における各種検査の臨床的有用性に関する検討.

    第60回日本食道学会学術集会  2006年 

     詳細を見る

  • Inhibitory effect of a unique gastric acid-secretion inhibitor lafutidine on acid reflux in Japanese NERD patients.

    The 14th United European Gastroenterology Week.  2006年 

     詳細を見る

    会議種別:ポスター発表  

    researchmap

  • Postprandial 3-hour pH monitoring for heartburn patients: comparison with proton pomp inhibitor test.

    The 12th International Conference on Ulcer Research  2006年 

     詳細を見る

  • 主題演題 胃食道pHモニタリングからみた胃食道逆流症:食後3時間で何がわかるか?

    第38回日本胃病態機能研究会  2006年 

     詳細を見る

  • シンポジウム PEGの適応と長期管理をめぐって ボタン交換後の胃内留置確認に関する検討 安全な長期管理を目指して

    第82回日本消化器内視鏡学会関東地方会  2006年 

     詳細を見る

  • Gastric surgery is not a risk factor for the development or progression of Barrett's epithelium

    11th World Congress of the International Society for the Diseases of the ESOPHAGUS  2008年 

     詳細を見る

  • パネルディスカッション 低用量アスピリンによる上部消化管病変の臨床的検討

    JDDW2008  2008年 

     詳細を見る

  • ALCOHOL CONSUMPTION IS ASSOCIATED WITH AN INCREASED RISK OF EROSIVE ESOPHAGITIS AND BARRETT’S EPITHELIUM IN JAPANESE MEN

    The Second USA-Japan Joint Workshop on Alcohol-Related Problems  2008年 

     詳細を見る

  • Comparative Study of the Convenience of the QUEST and FSSG Questionnaires

    11th World Congress of the International Society for the Diseases of the ESOPHAGUS  2008年 

     詳細を見る

  • パネルディスカッション 胃瘻カテーテル交換時偶発症の現状 胃瘻カテーテル交換時のろう孔損傷の2例:胃壁固定を用いたリカバリーの有用性

    第1回胃瘻カテーテルの安全な交換方法検討研究会  2008年 

     詳細を見る

  • ワークショップ 内視鏡的消化管瘻造設の管理と工夫の問題点 胃ろう交換時における胃内留置の確認 ボタンからのアプローチの有用性について

    第71回日本消化器内視鏡学会総会  2006年 

     詳細を見る

  • シンポジウム 上部消化器症状と内視鏡診断 胃食道逆流症の診断における内視鏡検査の意義.

    第73回日本消化器内視鏡学会総会.  2007年 

     詳細を見る

  • シンポジウム 「FGID(機能性消化管障害)の原因を探るー“胃酸分泌”か“運動障害”か?」 消化器症状のなりたちに関する考察:胃排出能の観点から.

    第15回北関東GIセミナー  2007年 

     詳細を見る

  • Aperitif effects on drinking capacity: a crossover study with water drinking test.

    The 21th International Symposium on Neurogastroenterology and Motility.  2007年 

     詳細を見る

    会議種別:ポスター発表  

    researchmap

  • Effects of body positions on gastric emptying: a crossover study using a continuous real time 13C breath test (BreathID system)

    The 21th International Symposium on Neurogastroenterology and Motility.  2007年 

     詳細を見る

    会議種別:ポスター発表  

    researchmap

  • ワークショップ Barrett粘膜の内視鏡的診断と経過観察における The Prague C&M Criteria の有用性

    第86回日本消化器内視鏡学会 関東地方会  2008年 

     詳細を見る

  • パネルディスカッション 胃食道逆流症診療における on demand therapy : on demandの研究はなぜ少ないのか?

    第62回日本食道学会学術集会  2008年 

     詳細を見る

  • 主題演題 出血を認めた低用量アスピリン起因性小腸潰瘍のカプセル内視鏡診断

    第1回日本カプセル内視鏡研究会学術集会  2008年 

     詳細を見る

▼全件表示

受賞

  • 平成17年度横浜市立大学医学研究奨励賞

    2006年  

     詳細を見る

    受賞国:日本国

    researchmap

共同研究・競争的資金等の研究課題

  • 一般市民の教育参画システム構築から探索する市民に寄り添う医学教育の質的研究

    研究課題/領域番号:19K10567  2019年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    藤倉 輝道, 樫村 正美, 稲森 正彦, 池田 直樹, 亀井 尚也, 早坂 明哲, 大久保 由美子, 井上 千鹿子

      詳細を見る

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    本研究では大学が自律的に社会のニーズを把握し、医学教育に反映させるための「一般市民の声を収集し活用するシステム」構築を目指している。わが国のAMEDにおけるPatient Public Involvement (PPI)の取り組み、英国におけるPPIなど、先行研究を参考にしながら研究者間で「一般市民」の定義付けに関する議論を重ね、本研究趣旨に添うと考えられる一般市民候補者6名を研究者らの個人的人脈を通じて選抜した。一般会社員、主婦、公務員、NPO職員、模擬患者などから構成されている。現在、本人ならびに家族が闘病中であるなど特記すべき患者経験はないことを前提とした。このメンバーをコアメンバーとして、その知人の中からさらに「一般市民」に相当する方々を募りインタビューなどを通じて医学教育における社会のニーズを広く探索する予定であった。しかし、COVID-19感染拡大が重なり、普段、医療と関わりを持たず、その必要も無い一般市民に集まっていただき、かつこの状況下で、COVID-19禍という特殊な要素の影響を観念上排除した上で研究に参加して頂くことは困難であった。そこで、ニーズ探索については、Web上にある一般市民の医療や教育に関する質問、意見を取り扱うコンテンツを利用し、その内容をテキストとして用いた質的研究を先行させることに方向を修正した。その結果をもとに、上記コアメンバーの知人等を通じてWebアンケートを行い、ニーズのブラッシュアップを行うこととし準備を進めているのが現状である。今後その結果も踏まえ、再度コアメンバーを対象にインタビューを行い質的研究へと展開する予定である。

    researchmap

  • 高脂肪食およびアディポネクチンが大腸がん発がんに与える作用の分子メカニズムの解明

    研究課題/領域番号:20390212  2008年 - 2010年

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    中島 淳, 阿部 泰伸, 稲森 正彦, 高橋 宏和

      詳細を見る

    配分額:18720000円 ( 直接経費:14400000円 、 間接経費:4320000円 )

    高脂肪食負荷によるマウス大腸発がん亢進におけるアディポネクチンの発がん抑制作用はAMPKを介したことであることを解明し、AMPK活性化薬であるメトフォルミンを実際の大腸がん化学予防にヒトで投与して発がん予防効果を実証した。

    researchmap

  • PPARγリガンドを用いた大腸化学発癌予防の研究

    研究課題/領域番号:18390222  2006年 - 2007年

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    中島 淳, 稲森 正彦, 阿部 泰伸

      詳細を見る

    配分額:17110000円 ( 直接経費:14800000円 、 間接経費:2310000円 )

    我々はリガンド依存性核内受容体Peroxisome Proliferator Activated Recepter-γ(PPARγ)リガンド投与が大腸がんの発生のみならず大腸がん前がん病変であるAberrant Crypt Foci(ACF)の発生を抑制し、PPARγリガンドが大腸がんの化学発癌予防に有効であることを世界に先駆けて報告してきた。今回の研究では
    大腸がん前がん病変であるACFを指標とした大腸化学発癌予防薬としてPPARγリガンドのピオグリタゾンが有望な候補になるかの検討をヒトにおいて拡大大腸内視鏡を用いて実証した。約20人の患者に対してピオグリタゾンの3ケ月から半年の投与でほとんどの患者において有意なACFの数の減少を認めた。この結果はPPARγリガンドであるピオグリタゾンの投与が大腸がんの化学予防に有効であることを示しており、全く新しい予防法を示した。
    今後はわが国においてなかなか実施困難である臨床治験にてその予防効果を証明していく予定である。一報でピオグリタゾン以外の化学予防に有効な薬剤の検討もヒトにおいて行っている。今愛の基盤研究で得た知見を実際の大腸がん予防に向けてさらに研究を進めていく予定である。

    researchmap